{"f17d10cd0c4d494da58713c1f3330a38": {"prediction": {"id": "f17d10cd0c4d494da58713c1f3330a38", "prediction_text": "Neutrophil elastase gene"}, "reference": {"id": "f17d10cd0c4d494da58713c1f3330a38", "answers": {"answer_start": [0], "text": ["The neutrophil elastase gene (ELANE)"]}}}, "c0fa7a7b086e4d269805b9a54a072c20": {"prediction": {"id": "c0fa7a7b086e4d269805b9a54a072c20", "prediction_text": "abnormal involuntary facial movements induced by chronic therapy with classical antipsychotic medications"}, "reference": {"id": "c0fa7a7b086e4d269805b9a54a072c20", "answers": {"answer_start": [0], "text": ["Tardive dyskinesia (TD) is a movement disorder characterized by abnormal involuntary facial movements induced by chronic therapy with classical antipsychotic medications."]}}}, "c8d76407c9064e7bbc27d76e6f9c64f3": {"prediction": {"id": "c8d76407c9064e7bbc27d76e6f9c64f3", "prediction_text": "antioxidant"}, "reference": {"id": "c8d76407c9064e7bbc27d76e6f9c64f3", "answers": {"answer_start": [274], "text": ["antioxidant"]}}}, "d6c0791c10084182be1f61034e34d900": {"prediction": {"id": "d6c0791c10084182be1f61034e34d900", "prediction_text": "Down syndrome"}, "reference": {"id": "d6c0791c10084182be1f61034e34d900", "answers": {"answer_start": [195], "text": ["antioxidant"]}}}, "231413ac71fc437c9d56a78db6c8ab30": {"prediction": {"id": "231413ac71fc437c9d56a78db6c8ab30", "prediction_text": "antioxidant"}, "reference": {"id": "231413ac71fc437c9d56a78db6c8ab30", "answers": {"answer_start": [52], "text": ["antioxidant"]}}}, "3f1f0655c12149febdc8babd31fa5baf": {"prediction": {"id": "3f1f0655c12149febdc8babd31fa5baf", "prediction_text": "antioxidant"}, "reference": {"id": "3f1f0655c12149febdc8babd31fa5baf", "answers": {"answer_start": [1311], "text": ["antioxidant"]}}}, "591d5b7677724ea1a845e529e25838b7": {"prediction": {"id": "591d5b7677724ea1a845e529e25838b7", "prediction_text": "antioxidant"}, "reference": {"id": "591d5b7677724ea1a845e529e25838b7", "answers": {"answer_start": [657], "text": ["antioxidant"]}}}, "f63747969ece4b639baa74665474eacc": {"prediction": {"id": "f63747969ece4b639baa74665474eacc", "prediction_text": "cyclin-dependent kinase"}, "reference": {"id": "f63747969ece4b639baa74665474eacc", "answers": {"answer_start": [856], "text": ["antioxidant"]}}}, "77aee350c51d41e5986f8e243e7bce2c": {"prediction": {"id": "77aee350c51d41e5986f8e243e7bce2c", "prediction_text": "abundant mammalian"}, "reference": {"id": "77aee350c51d41e5986f8e243e7bce2c", "answers": {"answer_start": [1094], "text": ["antioxidant"]}}}, "53b0994e7a1a49a0a4125f65665c95fa": {"prediction": {"id": "53b0994e7a1a49a0a4125f65665c95fa", "prediction_text": "pro-apoptotic"}, "reference": {"id": "53b0994e7a1a49a0a4125f65665c95fa", "answers": {"answer_start": [888], "text": ["antioxidant"]}}}, "c28631d78f8e4ee0b09c9eef2f6e60eb": {"prediction": {"id": "c28631d78f8e4ee0b09c9eef2f6e60eb", "prediction_text": "antioxidant"}, "reference": {"id": "c28631d78f8e4ee0b09c9eef2f6e60eb", "answers": {"answer_start": [233], "text": ["antioxidant"]}}}, "7e891c681a754679a80acdea89bfe0cc": {"prediction": {"id": "7e891c681a754679a80acdea89bfe0cc", "prediction_text": "thiol-dependent peroxidase"}, "reference": {"id": "7e891c681a754679a80acdea89bfe0cc", "answers": {"answer_start": [1133], "text": ["antioxidant"]}}}, "a0f95a01b56542928f76bf38d11f507f": {"prediction": {"id": "a0f95a01b56542928f76bf38d11f507f", "prediction_text": "lymphocyte"}, "reference": {"id": "a0f95a01b56542928f76bf38d11f507f", "answers": {"answer_start": [1127], "text": ["antioxidant"]}}}, "418ea37596764f6f8f4beb71900b95ac": {"prediction": {"id": "418ea37596764f6f8f4beb71900b95ac", "prediction_text": "reducing hydrogen peroxide and lipid peroxides"}, "reference": {"id": "418ea37596764f6f8f4beb71900b95ac", "answers": {"answer_start": [371], "text": ["antioxidant"]}}}, "2ba10811161747478e28ab1e9135950e": {"prediction": {"id": "2ba10811161747478e28ab1e9135950e", "prediction_text": "D2 receptor"}, "reference": {"id": "2ba10811161747478e28ab1e9135950e", "answers": {"answer_start": [485], "text": ["L-Dopa"]}}}, "42972ea5f9a842a6a47943fbdcf4dc46": {"prediction": {"id": "42972ea5f9a842a6a47943fbdcf4dc46", "prediction_text": "DOPA decarboxylase inhibitor"}, "reference": {"id": "42972ea5f9a842a6a47943fbdcf4dc46", "answers": {"answer_start": [26], "text": ["L-Dopa"]}}}, "6e73fd07f6824464ab73c24d4611ed5e": {"prediction": {"id": "6e73fd07f6824464ab73c24d4611ed5e", "prediction_text": "3,4-dihydroxyphenyl-l-alanine (l-DOPA) in Parkinson's disease. The biological mechanisms behind this side effect are not fully comprehended although involvement of dopaminergic, serotonergic, and glutamatergic systems has been suggested. The present study utilizes in vivo amperometry to investigate the impact from unilateral 6-hydroxydopamine lesions and l-DOPA (4 mg/kg, including benserazide 15 mg/kg) -induced dyskinetic behavior on striatal basal extracellular glutamate concentration and potassium-evoked glutamate release in urethane-anesthetized rats. Recordings were performed before and after local L-DOPA application in the striatum. In addition, effects from the 5-HT(1A) receptor agonist"}, "reference": {"id": "6e73fd07f6824464ab73c24d4611ed5e", "answers": {"answer_start": [1542], "text": ["L-Dopa"]}}}, "855c16039a4a4c439827591d3d798d36": {"prediction": {"id": "855c16039a4a4c439827591d3d798d36", "prediction_text": "buspirone"}, "reference": {"id": "855c16039a4a4c439827591d3d798d36", "answers": {"answer_start": [1086], "text": ["L-Dopa"]}}}, "5d0a3be61e384a12baf37456dd3c62ab": {"prediction": {"id": "5d0a3be61e384a12baf37456dd3c62ab", "prediction_text": "L-Dopa methyl ester"}, "reference": {"id": "5d0a3be61e384a12baf37456dd3c62ab", "answers": {"answer_start": [1279], "text": ["L-Dopa"]}}}, "e09d077599c040a4a9c7ba2630738299": {"prediction": {"id": "e09d077599c040a4a9c7ba2630738299", "prediction_text": "L-DOPA methyl ester"}, "reference": {"id": "e09d077599c040a4a9c7ba2630738299", "answers": {"answer_start": [642], "text": ["L-Dopa"]}}}, "0103e7557a0e4943826d1c2e21b8811e": {"prediction": {"id": "0103e7557a0e4943826d1c2e21b8811e", "prediction_text": "L-dopa + benserazide"}, "reference": {"id": "0103e7557a0e4943826d1c2e21b8811e", "answers": {"answer_start": [725], "text": ["L-Dopa"]}}}, "f48549c4d6244c5b9186574c45a636bf": {"prediction": {"id": "f48549c4d6244c5b9186574c45a636bf", "prediction_text": "peripheral DDC inhibitors"}, "reference": {"id": "f48549c4d6244c5b9186574c45a636bf", "answers": {"answer_start": [298], "text": ["L-Dopa"]}}}, "1b48cb09d55d4fe982cabb5e265e1890": {"prediction": {"id": "1b48cb09d55d4fe982cabb5e265e1890", "prediction_text": "DOPA decarboxylase inhibitor"}, "reference": {"id": "1b48cb09d55d4fe982cabb5e265e1890", "answers": {"answer_start": [518], "text": ["L-Dopa"]}}}, "cd4fe53b64e84b359759d951ad5e7210": {"prediction": {"id": "cd4fe53b64e84b359759d951ad5e7210", "prediction_text": "tolcapone"}, "reference": {"id": "cd4fe53b64e84b359759d951ad5e7210", "answers": {"answer_start": [189], "text": ["L-Dopa"]}}}, "05d1e6143e194a5b8115187ef01ab050": {"prediction": {"id": "05d1e6143e194a5b8115187ef01ab050", "prediction_text": "brainstem migraine"}, "reference": {"id": "05d1e6143e194a5b8115187ef01ab050", "answers": {"answer_start": [131], "text": ["Notch3 gene"]}}}, "3f92d6efb163404dbbe4b849ffdd8c62": {"prediction": {"id": "3f92d6efb163404dbbe4b849ffdd8c62", "prediction_text": "glutamate"}, "reference": {"id": "3f92d6efb163404dbbe4b849ffdd8c62", "answers": {"answer_start": [167], "text": ["Notch3 gene"]}}}, "13578c8aad2645c08f53868361ed9e49": {"prediction": {"id": "13578c8aad2645c08f53868361ed9e49", "prediction_text": "NOTCH3"}, "reference": {"id": "13578c8aad2645c08f53868361ed9e49", "answers": {"answer_start": [83], "text": ["Notch3 gene"]}}}, "adafd3bff98d4ab2981497869031936c": {"prediction": {"id": "adafd3bff98d4ab2981497869031936c", "prediction_text": "Notch3"}, "reference": {"id": "adafd3bff98d4ab2981497869031936c", "answers": {"answer_start": [160], "text": ["Notch3 gene"]}}}, "988cd016ea334aa3a384a92bead742ae": {"prediction": {"id": "988cd016ea334aa3a384a92bead742ae", "prediction_text": "Notch3"}, "reference": {"id": "988cd016ea334aa3a384a92bead742ae", "answers": {"answer_start": [453], "text": ["Notch3 gene"]}}}, "546d7933065e4ad5aa2eadd9cb05b15c": {"prediction": {"id": "546d7933065e4ad5aa2eadd9cb05b15c", "prediction_text": "NOTCH3"}, "reference": {"id": "546d7933065e4ad5aa2eadd9cb05b15c", "answers": {"answer_start": [182], "text": ["Notch3 gene"]}}}, "a0f78096568a44aeab70ea872649fe68": {"prediction": {"id": "a0f78096568a44aeab70ea872649fe68", "prediction_text": "early stroke syndrome"}, "reference": {"id": "a0f78096568a44aeab70ea872649fe68", "answers": {"answer_start": [680], "text": ["Notch3 gene"]}}}, "6d34ca80de874bd194bd71b2d48504d9": {"prediction": {"id": "6d34ca80de874bd194bd71b2d48504d9", "prediction_text": "Notch receptor family. Notch proteins are involved in a very conserved signaling system (Notch signaling) with a broad spectrum of functions, from cell proliferation and differentiation to apoptosis. Mutations in Notch3 gene are linked to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy"}, "reference": {"id": "6d34ca80de874bd194bd71b2d48504d9", "answers": {"answer_start": [276], "text": ["Notch3 gene"]}}}, "88d73869d00b42859c372e8cb6eae2e2": {"prediction": {"id": "88d73869d00b42859c372e8cb6eae2e2", "prediction_text": "NOTCH3"}, "reference": {"id": "88d73869d00b42859c372e8cb6eae2e2", "answers": {"answer_start": [184], "text": ["Notch3 gene"]}}}, "1f6ee5fbbd0d4f93b305b04f8e4faf1a": {"prediction": {"id": "1f6ee5fbbd0d4f93b305b04f8e4faf1a", "prediction_text": "NOTCH3"}, "reference": {"id": "1f6ee5fbbd0d4f93b305b04f8e4faf1a", "answers": {"answer_start": [275], "text": ["Notch3 gene"]}}}, "6f36c74b8f814233a77df13bdd0352d4": {"prediction": {"id": "6f36c74b8f814233a77df13bdd0352d4", "prediction_text": "RA"}, "reference": {"id": "6f36c74b8f814233a77df13bdd0352d4", "answers": {"answer_start": [482], "text": ["IFN signature"]}}}, "ad353f8ceb1b4325a1ebdb2b5dd4d18b": {"prediction": {"id": "ad353f8ceb1b4325a1ebdb2b5dd4d18b", "prediction_text": "RA"}, "reference": {"id": "ad353f8ceb1b4325a1ebdb2b5dd4d18b", "answers": {"answer_start": [601], "text": ["IFN signature"]}}}, "06482e2e93e74bb080c3a86755586c71": {"prediction": {"id": "06482e2e93e74bb080c3a86755586c71", "prediction_text": "rituximab"}, "reference": {"id": "06482e2e93e74bb080c3a86755586c71", "answers": {"answer_start": [1615], "text": ["IFN signature"]}}}, "2846e48bcaa4478aa2d4eb1793484ce3": {"prediction": {"id": "2846e48bcaa4478aa2d4eb1793484ce3", "prediction_text": "RA"}, "reference": {"id": "2846e48bcaa4478aa2d4eb1793484ce3", "answers": {"answer_start": [1227], "text": ["IFN signature"]}}}, "8a3df0a7ba7547f5af12d5ec3366cdf7": {"prediction": {"id": "8a3df0a7ba7547f5af12d5ec3366cdf7", "prediction_text": "interferon"}, "reference": {"id": "8a3df0a7ba7547f5af12d5ec3366cdf7", "answers": {"answer_start": [1169], "text": ["Interferon signature"]}}}, "7cc5fd35eae247f4b74f2161274894cd": {"prediction": {"id": "7cc5fd35eae247f4b74f2161274894cd", "prediction_text": "interferon"}, "reference": {"id": "7cc5fd35eae247f4b74f2161274894cd", "answers": {"answer_start": [457], "text": ["Interferon signature"]}}}, "0c73593735ee4a7c8d8105abc51e4d4f": {"prediction": {"id": "0c73593735ee4a7c8d8105abc51e4d4f", "prediction_text": "RA"}, "reference": {"id": "0c73593735ee4a7c8d8105abc51e4d4f", "answers": {"answer_start": [1644], "text": ["IFN signature"]}}}, "82254de5fc164b0b9cfc7acd06affa88": {"prediction": {"id": "82254de5fc164b0b9cfc7acd06affa88", "prediction_text": "interferon"}, "reference": {"id": "82254de5fc164b0b9cfc7acd06affa88", "answers": {"answer_start": [936], "text": ["Interferon signature"]}}}, "eea093e1c3e84a96b3c915ec0cd137c3": {"prediction": {"id": "eea093e1c3e84a96b3c915ec0cd137c3", "prediction_text": "epidermal growth factor receptor"}, "reference": {"id": "eea093e1c3e84a96b3c915ec0cd137c3", "answers": {"answer_start": [52], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "4890f3b9607940f481f76450fd582d15": {"prediction": {"id": "4890f3b9607940f481f76450fd582d15", "prediction_text": "EGFR tyrosine kinase"}, "reference": {"id": "4890f3b9607940f481f76450fd582d15", "answers": {"answer_start": [203], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "9e3fbc1cd6da4ee0b17415f9cd161ed0": {"prediction": {"id": "9e3fbc1cd6da4ee0b17415f9cd161ed0", "prediction_text": "epidermal growth factor receptor"}, "reference": {"id": "9e3fbc1cd6da4ee0b17415f9cd161ed0", "answers": {"answer_start": [17], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "dc95280ac13844eb86a7d811d6ca2e8a": {"prediction": {"id": "dc95280ac13844eb86a7d811d6ca2e8a", "prediction_text": "EGFR"}, "reference": {"id": "dc95280ac13844eb86a7d811d6ca2e8a", "answers": {"answer_start": [56], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "eb8fd95900f947499cd8e270943c019b": {"prediction": {"id": "eb8fd95900f947499cd8e270943c019b", "prediction_text": "Epidermal growth factor receptor"}, "reference": {"id": "eb8fd95900f947499cd8e270943c019b", "answers": {"answer_start": [0], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "51f47e97ceb94305a4225421abea3ac3": {"prediction": {"id": "51f47e97ceb94305a4225421abea3ac3", "prediction_text": "epidermal growth factor receptor"}, "reference": {"id": "51f47e97ceb94305a4225421abea3ac3", "answers": {"answer_start": [44], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "d7f2196d85c945a6a45abd2fb85750ef": {"prediction": {"id": "d7f2196d85c945a6a45abd2fb85750ef", "prediction_text": "epidermal growth factor receptor"}, "reference": {"id": "d7f2196d85c945a6a45abd2fb85750ef", "answers": {"answer_start": [55], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "a9aee2d9cf5f44bcbd57b46d55098120": {"prediction": {"id": "a9aee2d9cf5f44bcbd57b46d55098120", "prediction_text": "epidermal growth factor receptor"}, "reference": {"id": "a9aee2d9cf5f44bcbd57b46d55098120", "answers": {"answer_start": [25], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "faa893e4337244a5b57ad68d6759a097": {"prediction": {"id": "faa893e4337244a5b57ad68d6759a097", "prediction_text": "tyrosine kinase"}, "reference": {"id": "faa893e4337244a5b57ad68d6759a097", "answers": {"answer_start": [70], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "70b3ac324d4842d3b7f95661d8aa698a": {"prediction": {"id": "70b3ac324d4842d3b7f95661d8aa698a", "prediction_text": "epidermal growth factor receptor (EGFR) gene are reportedly associated with sensitivity of lung cancers to gefitinib (Iressa), kinase inhibitor. In-frame deletions occur in exon 19, whereas point mutations occur frequently in codon 858 (exon 21). We found from sequencing the EGFR TK domain that 7 of 10 gefitinib-sensitive tumors had similar types of alterations; no mutations were found in eight gefitinib-refractory tumors (P = 0.004). Five of seven tumors sensitive to erlotinib (Tarceva), a related kinase inhibitor for which the clinically relevant target is undocumented, had analogous somatic mutations, as opposed to none of 10 erlotinib-refractory tumors (P = 0.003). Because most mutation-positive tumors were adenocarcinomas from patients who smoked <100 cigarettes in a lifetime (\"never smokers\"), we screened EGFR exons 2-28 in 15 adenocarcinomas resected from untreated never smokers. Seven tumors had TK domain mutations, in contrast to 4 of 81 non-small cell lung cancers resected from untreated former or current smokers (P = 0.0001). Immunoblotting of lysates from cells transiently transfected with various EGFR constructs demonstrated that, compared to wild-type protein, an exon 19 deletion mutant induced diminished levels of phosphotyrosine, whereas the phosphorylation at tyrosine 1092 of an exon 21 point mutant was inhibited at 10-fold lower concentrations of drug. Collectively, these data show that adenocarcinomas from never smokers comprise a distinct subset of lung cancers, frequently containing mutations within the TK domain of EGFR"}, "reference": {"id": "70b3ac324d4842d3b7f95661d8aa698a", "answers": {"answer_start": [60], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "c0cc8152a1a64537b3694f1767d9284f": {"prediction": {"id": "c0cc8152a1a64537b3694f1767d9284f", "prediction_text": "epidermal growth factor receptor"}, "reference": {"id": "c0cc8152a1a64537b3694f1767d9284f", "answers": {"answer_start": [121], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "3810fc1310af48c7b7ad2cedb5531cae": {"prediction": {"id": "3810fc1310af48c7b7ad2cedb5531cae", "prediction_text": "Parkinson's disease"}, "reference": {"id": "3810fc1310af48c7b7ad2cedb5531cae", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "744e91dfa4384f98bf0ee4daa3c26fc7": {"prediction": {"id": "744e91dfa4384f98bf0ee4daa3c26fc7", "prediction_text": "Parkinson's disease"}, "reference": {"id": "744e91dfa4384f98bf0ee4daa3c26fc7", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "aa167abe88824f29a240ba3bc1ff508d": {"prediction": {"id": "aa167abe88824f29a240ba3bc1ff508d", "prediction_text": "Parkinson's"}, "reference": {"id": "aa167abe88824f29a240ba3bc1ff508d", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "4df5c3f09abc43b3b4f81fae64dfcf3d": {"prediction": {"id": "4df5c3f09abc43b3b4f81fae64dfcf3d", "prediction_text": "Parkinson's disease"}, "reference": {"id": "4df5c3f09abc43b3b4f81fae64dfcf3d", "answers": {"answer_start": [128], "text": ["Parkinson's disease (PD)"]}}}, "aaad2fa7050a4500bfbd573e803a3698": {"prediction": {"id": "aaad2fa7050a4500bfbd573e803a3698", "prediction_text": "Parkinson's"}, "reference": {"id": "aaad2fa7050a4500bfbd573e803a3698", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "3d9cbba9f3a74ac38c6f5126214e6894": {"prediction": {"id": "3d9cbba9f3a74ac38c6f5126214e6894", "prediction_text": "Parkinson's"}, "reference": {"id": "3d9cbba9f3a74ac38c6f5126214e6894", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "40658fb9e8944c59abb1b0d3efd43146": {"prediction": {"id": "40658fb9e8944c59abb1b0d3efd43146", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "40658fb9e8944c59abb1b0d3efd43146", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "4b05b0e0828f4d98bb253b9557cf936d": {"prediction": {"id": "4b05b0e0828f4d98bb253b9557cf936d", "prediction_text": "Parkinson's Disease"}, "reference": {"id": "4b05b0e0828f4d98bb253b9557cf936d", "answers": {"answer_start": [170], "text": ["Parkinson's disease (PD)"]}}}, "c2d1cc9aebc94ee59ad4e3eb79f08c4c": {"prediction": {"id": "c2d1cc9aebc94ee59ad4e3eb79f08c4c", "prediction_text": "AF-LB and Parkinson's disease"}, "reference": {"id": "c2d1cc9aebc94ee59ad4e3eb79f08c4c", "answers": {"answer_start": [153], "text": ["Parkinson's disease (PD)"]}}}, "3123305f175b46be85760a2be897de5a": {"prediction": {"id": "3123305f175b46be85760a2be897de5a", "prediction_text": "Intron F"}, "reference": {"id": "3123305f175b46be85760a2be897de5a", "answers": {"answer_start": [391], "text": ["UUCCUUAAC"]}}}, "3a794fa704ac44859041ef4df60f04ec": {"prediction": {"id": "3a794fa704ac44859041ef4df60f04ec", "prediction_text": "antiparallel spectrin dimers"}, "reference": {"id": "3a794fa704ac44859041ef4df60f04ec", "answers": {"answer_start": [865], "text": ["antiparallel"]}}}, "a1d8567fb97247cca268cb07d30c80fd": {"prediction": {"id": "a1d8567fb97247cca268cb07d30c80fd", "prediction_text": "triple alpha-helical coiled coil"}, "reference": {"id": "a1d8567fb97247cca268cb07d30c80fd", "answers": {"answer_start": [126], "text": ["antiparallel"]}}}, "ec1771ffe0ef46bc8c2e2acccfa02f15": {"prediction": {"id": "ec1771ffe0ef46bc8c2e2acccfa02f15", "prediction_text": "spectrin heterodimer"}, "reference": {"id": "ec1771ffe0ef46bc8c2e2acccfa02f15", "answers": {"answer_start": [42], "text": ["antiparallel"]}}}, "2b8426f650134c06ad9ff447a096a8ad": {"prediction": {"id": "2b8426f650134c06ad9ff447a096a8ad", "prediction_text": "linkers of five amino acid residues"}, "reference": {"id": "2b8426f650134c06ad9ff447a096a8ad", "answers": {"answer_start": [746], "text": ["antiparallel"]}}}, "89f8b4b690d14645896852aea0dd10c2": {"prediction": {"id": "89f8b4b690d14645896852aea0dd10c2", "prediction_text": "Cys"}, "reference": {"id": "89f8b4b690d14645896852aea0dd10c2", "answers": {"answer_start": [1239], "text": ["antiparallel"]}}}, "f4f7459378274708913d17cfbd98972b": {"prediction": {"id": "f4f7459378274708913d17cfbd98972b", "prediction_text": "antiparallel side-to-side association of spectrin alpha and beta monomers is a two-step process which occurs in seconds even at 0 degrees C and at low concentrations. Assembly involves initial contact of complementary nucleation sites on each subunit, which are located near the actin binding end of the long, flexible heterodimer rod. The minimum nucleation sites are comprised of approximately four contiguous 106-residue homologous segments or repeats. Three repeats in the nucleation site contain an 8-residue insertion and have the highest homology to the four spectrin-like repeats in alpha-actinin. The adjacent actin binding domain on the beta subunit and the adjacent EF hand motifs on the alpha subunit are not required for heterodimer assembly. The nucleation sites probably have a specific lock and key structure which defines the unique side-to-side pairing of the many homologous segments in both subunits. Assembly of spectrin heterodimers is probably most analogous to a zipper. After initial nucleation site binding, the remainder of the subunits quickly associate along their full lengths to reconstitute a normal dimer by supercoiling around each other to form a rope-like, flexible rod"}, "reference": {"id": "f4f7459378274708913d17cfbd98972b", "answers": {"answer_start": [4], "text": ["antiparallel"]}}}, "4b189643d129474d846ea5cb748d47f5": {"prediction": {"id": "4b189643d129474d846ea5cb748d47f5", "prediction_text": "antiparallel"}, "reference": {"id": "4b189643d129474d846ea5cb748d47f5", "answers": {"answer_start": [546], "text": ["antiparallel"]}}}, "020e75ef777e418aa74970fe1891bde3": {"prediction": {"id": "020e75ef777e418aa74970fe1891bde3", "prediction_text": "antiparallel dimers"}, "reference": {"id": "020e75ef777e418aa74970fe1891bde3", "answers": {"answer_start": [1285], "text": ["antiparallel"]}}}, "f7d1c9d7702842f2a671b1964ec02d8d": {"prediction": {"id": "f7d1c9d7702842f2a671b1964ec02d8d", "prediction_text": "erythrocyte spectrin"}, "reference": {"id": "f7d1c9d7702842f2a671b1964ec02d8d", "answers": {"answer_start": [33], "text": ["antiparallel"]}}}, "b1961b38fc284b52a481fcd9ba414641": {"prediction": {"id": "b1961b38fc284b52a481fcd9ba414641", "prediction_text": "antiparallel heterodimer"}, "reference": {"id": "b1961b38fc284b52a481fcd9ba414641", "answers": {"answer_start": [717], "text": ["antiparallel"]}}}, "10cb42b4f3a54f9eab101d8ba49f924d": {"prediction": {"id": "10cb42b4f3a54f9eab101d8ba49f924d", "prediction_text": "Affymetrix *.CEL files"}, "reference": {"id": "10cb42b4f3a54f9eab101d8ba49f924d", "answers": {"answer_start": [520], "text": ["CAFE"]}}}, "468701ccaa8444c290f5fc2b0c31719b": {"prediction": {"id": "468701ccaa8444c290f5fc2b0c31719b", "prediction_text": "Clinical inflammatory signs"}, "reference": {"id": "468701ccaa8444c290f5fc2b0c31719b", "answers": {"answer_start": [262], "text": ["diabetic foot osteomyelitis"]}}}, "24d4075170764398933a6f8f4d5501fe": {"prediction": {"id": "24d4075170764398933a6f8f4d5501fe", "prediction_text": "diabetic foot osteomyelitis"}, "reference": {"id": "24d4075170764398933a6f8f4d5501fe", "answers": {"answer_start": [312], "text": ["diabetic foot osteomyelitis"]}}}, "02fc86e853464663a60545cd44a0251c": {"prediction": {"id": "02fc86e853464663a60545cd44a0251c", "prediction_text": "osteomyelitis"}, "reference": {"id": "02fc86e853464663a60545cd44a0251c", "answers": {"answer_start": [140], "text": ["diabetic foot osteomyelitis"]}}}, "0ece69c02d0944919bc8a649633ea19b": {"prediction": {"id": "0ece69c02d0944919bc8a649633ea19b", "prediction_text": "Osteomyelitis"}, "reference": {"id": "0ece69c02d0944919bc8a649633ea19b", "answers": {"answer_start": [1460], "text": ["diabetic foot osteomyelitis"]}}}, "9b28febb11b241f2914ad94133a985ce": {"prediction": {"id": "9b28febb11b241f2914ad94133a985ce", "prediction_text": "diabetic foot osteomyelitis"}, "reference": {"id": "9b28febb11b241f2914ad94133a985ce", "answers": {"answer_start": [1597], "text": ["diabetic foot osteomyelitis"]}}}, "159d6a5154e3428aaa524b5c25596706": {"prediction": {"id": "159d6a5154e3428aaa524b5c25596706", "prediction_text": "X"}, "reference": {"id": "159d6a5154e3428aaa524b5c25596706", "answers": {"answer_start": [501], "text": ["X-linked intellectual disability"]}}}, "2fe4672c297843e2bc3e65d6c19ad599": {"prediction": {"id": "2fe4672c297843e2bc3e65d6c19ad599", "prediction_text": "violaceous erythema and scaling of the nose, aural helices, fingers, and toes, with keratoderma and severe nail dystrophy"}, "reference": {"id": "2fe4672c297843e2bc3e65d6c19ad599", "answers": {"answer_start": [581], "text": ["Bazex syndrome"]}}}, "18834ea4b6e14c0581a00ff3475dfa1a": {"prediction": {"id": "18834ea4b6e14c0581a00ff3475dfa1a", "prediction_text": "Bazex' syndrome"}, "reference": {"id": "18834ea4b6e14c0581a00ff3475dfa1a", "answers": {"answer_start": [31], "text": ["Bazex syndrome"]}}}, "23666c64ec0546f2a7604fac514485b6": {"prediction": {"id": "23666c64ec0546f2a7604fac514485b6", "prediction_text": "Bazex syndrome"}, "reference": {"id": "23666c64ec0546f2a7604fac514485b6", "answers": {"answer_start": [751], "text": ["Bazex syndrome"]}}}, "644ce11d50ea4f0aaf4bf95e11b33105": {"prediction": {"id": "644ce11d50ea4f0aaf4bf95e11b33105", "prediction_text": "Bazex syndrome"}, "reference": {"id": "644ce11d50ea4f0aaf4bf95e11b33105", "answers": {"answer_start": [0], "text": ["Bazex syndrome"]}}}, "57bdf8dbf2054bf2b2b6e280e6d45281": {"prediction": {"id": "57bdf8dbf2054bf2b2b6e280e6d45281", "prediction_text": "cervical metastatic adenopathy"}, "reference": {"id": "57bdf8dbf2054bf2b2b6e280e6d45281", "answers": {"answer_start": [257], "text": ["Bazex syndrome"]}}}, "bffd7746abb04ceb879b7857c9347a00": {"prediction": {"id": "bffd7746abb04ceb879b7857c9347a00", "prediction_text": "Bazex syndrome"}, "reference": {"id": "bffd7746abb04ceb879b7857c9347a00", "answers": {"answer_start": [497], "text": ["Bazex syndrome"]}}}, "c250c14e24784f2985b3ef98dd5698fd": {"prediction": {"id": "c250c14e24784f2985b3ef98dd5698fd", "prediction_text": "Bazex syndrome"}, "reference": {"id": "c250c14e24784f2985b3ef98dd5698fd", "answers": {"answer_start": [0], "text": ["Bazex syndrome"]}}}, "6532fd41b8ce4cab9846d06a686c152d": {"prediction": {"id": "6532fd41b8ce4cab9846d06a686c152d", "prediction_text": "VIM"}, "reference": {"id": "6532fd41b8ce4cab9846d06a686c152d", "answers": {"answer_start": [236], "text": ["globus pallidus internus"]}}}, "927a446c9e1044e3939962d307502ce9": {"prediction": {"id": "927a446c9e1044e3939962d307502ce9", "prediction_text": "globus pallidus internus"}, "reference": {"id": "927a446c9e1044e3939962d307502ce9", "answers": {"answer_start": [49], "text": ["globus pallidus internus"]}}}, "ab06f7cce8b247a58aceefb86251d0d0": {"prediction": {"id": "ab06f7cce8b247a58aceefb86251d0d0", "prediction_text": "Voa/Vop"}, "reference": {"id": "ab06f7cce8b247a58aceefb86251d0d0", "answers": {"answer_start": [839], "text": ["globus pallidus internus"]}}}, "182eb1ba896f4a3fb1932b12c2fe54d4": {"prediction": {"id": "182eb1ba896f4a3fb1932b12c2fe54d4", "prediction_text": "Deep brain stimulation"}, "reference": {"id": "182eb1ba896f4a3fb1932b12c2fe54d4", "answers": {"answer_start": [503], "text": ["globus pallidus internus"]}}}, "7074b7c5217c4c80b1acabed08c971d5": {"prediction": {"id": "7074b7c5217c4c80b1acabed08c971d5", "prediction_text": "Bilateral pallidal"}, "reference": {"id": "7074b7c5217c4c80b1acabed08c971d5", "answers": {"answer_start": [209], "text": ["globus pallidus internus"]}}}, "3356fadff5e9402c85f87ac49c108eea": {"prediction": {"id": "3356fadff5e9402c85f87ac49c108eea", "prediction_text": "Compression of the median nerve at the wrist"}, "reference": {"id": "3356fadff5e9402c85f87ac49c108eea", "answers": {"answer_start": [195], "text": ["median"]}}}, "71d7830b542d4f5c8f8a4429e224041b": {"prediction": {"id": "71d7830b542d4f5c8f8a4429e224041b", "prediction_text": "entrapment of the median nerve in the wrist"}, "reference": {"id": "71d7830b542d4f5c8f8a4429e224041b", "answers": {"answer_start": [1283], "text": ["median"]}}}, "d31e943bbdd147f6a3f1179bae07ce90": {"prediction": {"id": "d31e943bbdd147f6a3f1179bae07ce90", "prediction_text": "pathophysiology"}, "reference": {"id": "d31e943bbdd147f6a3f1179bae07ce90", "answers": {"answer_start": [14], "text": ["median"]}}}, "56084fadc5f34150b94d16956478e722": {"prediction": {"id": "56084fadc5f34150b94d16956478e722", "prediction_text": "median nerve"}, "reference": {"id": "56084fadc5f34150b94d16956478e722", "answers": {"answer_start": [138], "text": ["median"]}}}, "05176b39d5114764bc7a901483c3388d": {"prediction": {"id": "05176b39d5114764bc7a901483c3388d", "prediction_text": "nerve neuropathy"}, "reference": {"id": "05176b39d5114764bc7a901483c3388d", "answers": {"answer_start": [366], "text": ["median"]}}}, "c75b74c0af6c4e849431d7c5677a16e4": {"prediction": {"id": "c75b74c0af6c4e849431d7c5677a16e4", "prediction_text": "Ultrasound"}, "reference": {"id": "c75b74c0af6c4e849431d7c5677a16e4", "answers": {"answer_start": [175], "text": ["median"]}}}, "d74a0cbe170a4ac59a5aaa49d92d3fe8": {"prediction": {"id": "d74a0cbe170a4ac59a5aaa49d92d3fe8", "prediction_text": "inlet-to-outlet ratio"}, "reference": {"id": "d74a0cbe170a4ac59a5aaa49d92d3fe8", "answers": {"answer_start": [272], "text": ["median"]}}}, "7f8bd8ac1f3c4b85b0df174d6b0c1a31": {"prediction": {"id": "7f8bd8ac1f3c4b85b0df174d6b0c1a31", "prediction_text": "wrist"}, "reference": {"id": "7f8bd8ac1f3c4b85b0df174d6b0c1a31", "answers": {"answer_start": [70], "text": ["median"]}}}, "185185f453784827b489a8d87e8a4883": {"prediction": {"id": "185185f453784827b489a8d87e8a4883", "prediction_text": "median nerve epineurectomy"}, "reference": {"id": "185185f453784827b489a8d87e8a4883", "answers": {"answer_start": [1130], "text": ["median"]}}}, "61f1487fe6304e5bbdddcde41d07b928": {"prediction": {"id": "61f1487fe6304e5bbdddcde41d07b928", "prediction_text": "vasomotor response"}, "reference": {"id": "61f1487fe6304e5bbdddcde41d07b928", "answers": {"answer_start": [82], "text": ["median"]}}}, "32cad0f2a2d94153934507a9a94c81d7": {"prediction": {"id": "32cad0f2a2d94153934507a9a94c81d7", "prediction_text": "nerve/tunnel index"}, "reference": {"id": "32cad0f2a2d94153934507a9a94c81d7", "answers": {"answer_start": [1072], "text": ["median"]}}}, "7ca6566fa78445c196aa49b22729992a": {"prediction": {"id": "7ca6566fa78445c196aa49b22729992a", "prediction_text": "woolly hair"}, "reference": {"id": "7ca6566fa78445c196aa49b22729992a", "answers": {"answer_start": [933], "text": ["The Plakoglobin gene"]}}}, "d9ba425c59f9430398c5a6cab77f9b2e": {"prediction": {"id": "d9ba425c59f9430398c5a6cab77f9b2e", "prediction_text": "plakoglobin"}, "reference": {"id": "d9ba425c59f9430398c5a6cab77f9b2e", "answers": {"answer_start": [1565], "text": ["The Plakoglobin gene"]}}}, "1d43e04dfd594a599c9c4f3fbe19cdb0": {"prediction": {"id": "1d43e04dfd594a599c9c4f3fbe19cdb0", "prediction_text": "repressed growth"}, "reference": {"id": "1d43e04dfd594a599c9c4f3fbe19cdb0", "answers": {"answer_start": [470], "text": ["Mitotic arrest"]}}}, "43e5fcc248b145b5803b38082154a4cd": {"prediction": {"id": "43e5fcc248b145b5803b38082154a4cd", "prediction_text": "epileptic disease"}, "reference": {"id": "43e5fcc248b145b5803b38082154a4cd", "answers": {"answer_start": [652], "text": ["focal cortical dysplasia"]}}}, "d2b3f08b05614b0f965958bcecf50c8b": {"prediction": {"id": "d2b3f08b05614b0f965958bcecf50c8b", "prediction_text": "drug-resistant epilepsy"}, "reference": {"id": "d2b3f08b05614b0f965958bcecf50c8b", "answers": {"answer_start": [96], "text": ["focal cortical dysplasia"]}}}, "080eb77fa1a4495696f00fe308859efc": {"prediction": {"id": "080eb77fa1a4495696f00fe308859efc", "prediction_text": "FCD type II"}, "reference": {"id": "080eb77fa1a4495696f00fe308859efc", "answers": {"answer_start": [94], "text": ["focal cortical dysplasia"]}}}, "b66f3b194bee434fa718497878fee9ad": {"prediction": {"id": "b66f3b194bee434fa718497878fee9ad", "prediction_text": "Type I, Type II, and Type III"}, "reference": {"id": "b66f3b194bee434fa718497878fee9ad", "answers": {"answer_start": [800], "text": ["focal cortical dysplasia"]}}}, "fdf5f4c8d70f4b5c8310cfd3918146ea": {"prediction": {"id": "fdf5f4c8d70f4b5c8310cfd3918146ea", "prediction_text": "mild cortical dysplasia"}, "reference": {"id": "fdf5f4c8d70f4b5c8310cfd3918146ea", "answers": {"answer_start": [49], "text": ["focal cortical dysplasia"]}}}, "ee97dd9e60eb41a18547f2f97ff6402d": {"prediction": {"id": "ee97dd9e60eb41a18547f2f97ff6402d", "prediction_text": "Meningioangiomatosis is a rare, benign, developmental, or hamartomatous lesion which may involve the leptomeninges and underlying brain parenchyma. Histologically, meningioangiomatosis is marked by a proliferation of blood vessels in the parenchyma, rimmed by collars of spindled meningothelial cells. There are anecdotal reports of an association of meningioangiomatosis with focal cortical dysplasia. We retrospectively analyzed the clinical, histopathologic, and treatment outcomes of 16 patients with a diagnosis of meningioangiomatosis, specifically investigating these cases for evidence of adjacent focal cortical dysplasia. Patients ranged in age from 1 to 34 years (median 18), 12 of whom had medically-intractable epilepsy"}, "reference": {"id": "ee97dd9e60eb41a18547f2f97ff6402d", "answers": {"answer_start": [1569], "text": ["focal cortical dysplasia"]}}}, "922de7f1b51240ac8a1142a6664bb82d": {"prediction": {"id": "922de7f1b51240ac8a1142a6664bb82d", "prediction_text": "focal cortical dysplasias"}, "reference": {"id": "922de7f1b51240ac8a1142a6664bb82d", "answers": {"answer_start": [1295], "text": ["focal cortical dysplasia"]}}}, "b2fdd003ebad4f3e9cbbb604d389991b": {"prediction": {"id": "b2fdd003ebad4f3e9cbbb604d389991b", "prediction_text": "focal cortical dysplasia (FCD) type II"}, "reference": {"id": "b2fdd003ebad4f3e9cbbb604d389991b", "answers": {"answer_start": [601], "text": ["focal cortical dysplasia"]}}}, "f0b1a9e3c46144e0a4db9b5cbb594c6f": {"prediction": {"id": "f0b1a9e3c46144e0a4db9b5cbb594c6f", "prediction_text": "mild malformations of cortical development (mMCDs) were disclosed in three patients, focal cortical dysplasia"}, "reference": {"id": "f0b1a9e3c46144e0a4db9b5cbb594c6f", "answers": {"answer_start": [1238], "text": ["focal cortical dysplasia"]}}}, "2c49c8a9c4f14439b75f1bfb41b62867": {"prediction": {"id": "2c49c8a9c4f14439b75f1bfb41b62867", "prediction_text": "focal cortical dysplasia"}, "reference": {"id": "2c49c8a9c4f14439b75f1bfb41b62867", "answers": {"answer_start": [326], "text": ["focal cortical dysplasia"]}}}, "9f8297023b144727b313e00ddceaa965": {"prediction": {"id": "9f8297023b144727b313e00ddceaa965", "prediction_text": "histologic"}, "reference": {"id": "9f8297023b144727b313e00ddceaa965", "answers": {"answer_start": [72], "text": ["focal cortical dysplasia"]}}}, "f8fd73bdb6cc4e5898710b36c7b6a060": {"prediction": {"id": "f8fd73bdb6cc4e5898710b36c7b6a060", "prediction_text": "cortical dysplasia"}, "reference": {"id": "f8fd73bdb6cc4e5898710b36c7b6a060", "answers": {"answer_start": [621], "text": ["focal cortical dysplasia"]}}}, "f0005f202fb14557a5384d39fddf8a83": {"prediction": {"id": "f0005f202fb14557a5384d39fddf8a83", "prediction_text": "dynamin"}, "reference": {"id": "f0005f202fb14557a5384d39fddf8a83", "answers": {"answer_start": [53], "text": ["mitochondrial intermembrane space"]}}}, "978eea25595d49aeb399196e5d2c9d94": {"prediction": {"id": "978eea25595d49aeb399196e5d2c9d94", "prediction_text": "Mgm1/OPA1"}, "reference": {"id": "978eea25595d49aeb399196e5d2c9d94", "answers": {"answer_start": [486], "text": ["mitochondrial intermembrane space"]}}}, "bf4351192b974e568a56992ad930a9e1": {"prediction": {"id": "bf4351192b974e568a56992ad930a9e1", "prediction_text": "Sulphation"}, "reference": {"id": "bf4351192b974e568a56992ad930a9e1", "answers": {"answer_start": [116], "text": ["catechol-O-methyltransferase"]}}}, "01b1cb8e476f4ee19cde5b82d01ef80f": {"prediction": {"id": "01b1cb8e476f4ee19cde5b82d01ef80f", "prediction_text": "COMT"}, "reference": {"id": "01b1cb8e476f4ee19cde5b82d01ef80f", "answers": {"answer_start": [96], "text": ["catechol-O-methyltransferase"]}}}, "53f8a1c065014194b41a1cd1760527fd": {"prediction": {"id": "53f8a1c065014194b41a1cd1760527fd", "prediction_text": "catechol-O-methyltransferase"}, "reference": {"id": "53f8a1c065014194b41a1cd1760527fd", "answers": {"answer_start": [38], "text": ["catechol-O-methyltransferase"]}}}, "1b1cdd96c23f477b9097aed04ce13b56": {"prediction": {"id": "1b1cdd96c23f477b9097aed04ce13b56", "prediction_text": "catechol-O-methyltransferase"}, "reference": {"id": "1b1cdd96c23f477b9097aed04ce13b56", "answers": {"answer_start": [21], "text": ["catechol-O-methyltransferase"]}}}, "1ab117cf974b404ebed8891b7b7aa967": {"prediction": {"id": "1ab117cf974b404ebed8891b7b7aa967", "prediction_text": "catechol-O-methyltransferase"}, "reference": {"id": "1ab117cf974b404ebed8891b7b7aa967", "answers": {"answer_start": [27], "text": ["catechol-O-methyltransferase"]}}}, "21dd9cea31c343fb81e23a634c53c067": {"prediction": {"id": "21dd9cea31c343fb81e23a634c53c067", "prediction_text": "base-excision repair"}, "reference": {"id": "21dd9cea31c343fb81e23a634c53c067", "answers": {"answer_start": [109], "text": ["base excision repair (BER) pathway"]}}}, "7f706ea2c3444fc68f6a83a6f870bbd7": {"prediction": {"id": "7f706ea2c3444fc68f6a83a6f870bbd7", "prediction_text": "autosomal dominant"}, "reference": {"id": "7f706ea2c3444fc68f6a83a6f870bbd7", "answers": {"answer_start": [1468], "text": ["autosomal dominant"]}}}, "190a49909c8b4eca84479372a8952d48": {"prediction": {"id": "190a49909c8b4eca84479372a8952d48", "prediction_text": "autosomal dominant"}, "reference": {"id": "190a49909c8b4eca84479372a8952d48", "answers": {"answer_start": [790], "text": ["autosomal dominant"]}}}, "f3f4680e3ec34e70ae0f7d62717d7048": {"prediction": {"id": "f3f4680e3ec34e70ae0f7d62717d7048", "prediction_text": "autosomal dominant or recessive"}, "reference": {"id": "f3f4680e3ec34e70ae0f7d62717d7048", "answers": {"answer_start": [706], "text": ["autosomal dominant"]}}}, "cfbb6d4d9cd54cf5aebf82a0469118bd": {"prediction": {"id": "cfbb6d4d9cd54cf5aebf82a0469118bd", "prediction_text": "NSD1"}, "reference": {"id": "cfbb6d4d9cd54cf5aebf82a0469118bd", "answers": {"answer_start": [630], "text": ["NSD1 gene"]}}}, "c1755260c9eb46589cdc1094b78ccd98": {"prediction": {"id": "c1755260c9eb46589cdc1094b78ccd98", "prediction_text": "NSD1"}, "reference": {"id": "c1755260c9eb46589cdc1094b78ccd98", "answers": {"answer_start": [31], "text": ["NSD1 gene"]}}}, "8ba7420ee77f400ba5ecd36a9e6564b9": {"prediction": {"id": "8ba7420ee77f400ba5ecd36a9e6564b9", "prediction_text": "NSD1"}, "reference": {"id": "8ba7420ee77f400ba5ecd36a9e6564b9", "answers": {"answer_start": [903], "text": ["NSD1 gene"]}}}, "a957394bdc594669b87b718ae34ad343": {"prediction": {"id": "a957394bdc594669b87b718ae34ad343", "prediction_text": "NSD1"}, "reference": {"id": "a957394bdc594669b87b718ae34ad343", "answers": {"answer_start": [234], "text": ["NSD1 gene"]}}}, "71d9e21a5d8f40daab73be67a19692a5": {"prediction": {"id": "71d9e21a5d8f40daab73be67a19692a5", "prediction_text": "NSD1"}, "reference": {"id": "71d9e21a5d8f40daab73be67a19692a5", "answers": {"answer_start": [225], "text": ["NSD1 gene"]}}}, "7f4b8165b31d4f83b20bbc8b7dde8857": {"prediction": {"id": "7f4b8165b31d4f83b20bbc8b7dde8857", "prediction_text": "SoS"}, "reference": {"id": "7f4b8165b31d4f83b20bbc8b7dde8857", "answers": {"answer_start": [209], "text": ["NSD1 gene"]}}}, "aaadeab696164eeba409e1858feb09d4": {"prediction": {"id": "aaadeab696164eeba409e1858feb09d4", "prediction_text": "NSD1) gene have been described as the major cause of Japanese patients with the Sotos syndrome, whereas point mutations have been identified in the majority of European Sotos syndrome patients. In order to investigate a possible phenotype-genotype correlation and to further define the predictive value of NSD1 mutations, we performed mutational analysis of the NSD1 gene in 20 patients and one familial case with Sotos syndrome, five patients with Weaver syndrome, six patients with unclassified overgrowth/mental retardation, and six patients with macrocephaly/mental retardation. We were able to identify mutations within the NSD1"}, "reference": {"id": "aaadeab696164eeba409e1858feb09d4", "answers": {"answer_start": [438], "text": ["NSD1 gene"]}}}, "e2f4797b09c4432fabae56b3b5ef2028": {"prediction": {"id": "e2f4797b09c4432fabae56b3b5ef2028", "prediction_text": "NSD1"}, "reference": {"id": "e2f4797b09c4432fabae56b3b5ef2028", "answers": {"answer_start": [192], "text": ["NSD1 gene"]}}}, "06ef7d917fce4a7ba79fceb9eed09277": {"prediction": {"id": "06ef7d917fce4a7ba79fceb9eed09277", "prediction_text": "NSD1"}, "reference": {"id": "06ef7d917fce4a7ba79fceb9eed09277", "answers": {"answer_start": [83], "text": ["NSD1 gene"]}}}, "983693fa6eb94e32bb07616e2fdf0f1d": {"prediction": {"id": "983693fa6eb94e32bb07616e2fdf0f1d", "prediction_text": "T-cell immunodeficiency and growth dysfunctions"}, "reference": {"id": "983693fa6eb94e32bb07616e2fdf0f1d", "answers": {"answer_start": [0, 121], "text": ["SMARCAL1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A-Like 1)", "HARP"]}}}, "5d1f2fdfefe24695a19e3c433db3cd39": {"prediction": {"id": "5d1f2fdfefe24695a19e3c433db3cd39", "prediction_text": "SMARCAL1 (swi/snf-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), a gene encoding a putative chromatin remodeling protein"}, "reference": {"id": "5d1f2fdfefe24695a19e3c433db3cd39", "answers": {"answer_start": [125], "text": ["SMARCAL1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A-Like 1)"]}}}, "f1d8402bbade455786f4ee8f78c6ec2c": {"prediction": {"id": "f1d8402bbade455786f4ee8f78c6ec2c", "prediction_text": "DNA annealing helicase SMARCAL1"}, "reference": {"id": "f1d8402bbade455786f4ee8f78c6ec2c", "answers": {"answer_start": [50], "text": ["SMARCAL1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A-Like 1)"]}}}, "61fbabf0f6f44f059a39dc89f49a7a85": {"prediction": {"id": "61fbabf0f6f44f059a39dc89f49a7a85", "prediction_text": "Lamp2a"}, "reference": {"id": "61fbabf0f6f44f059a39dc89f49a7a85", "answers": {"answer_start": [0], "text": ["LAMP2A"]}}}, "5a05627dfcd04f4eae4449a14edd14b9": {"prediction": {"id": "5a05627dfcd04f4eae4449a14edd14b9", "prediction_text": "lysosome-associated membrane protein type 2a"}, "reference": {"id": "5a05627dfcd04f4eae4449a14edd14b9", "answers": {"answer_start": [282], "text": ["LAMP2A"]}}}, "6454b33c707942f8b76bab0b0a7cf758": {"prediction": {"id": "6454b33c707942f8b76bab0b0a7cf758", "prediction_text": "lamp2a)"}, "reference": {"id": "6454b33c707942f8b76bab0b0a7cf758", "answers": {"answer_start": [628], "text": ["LAMP2A"]}}}, "8bdde363f9d5401da380b76518b90cb7": {"prediction": {"id": "8bdde363f9d5401da380b76518b90cb7", "prediction_text": "CMA"}, "reference": {"id": "8bdde363f9d5401da380b76518b90cb7", "answers": {"answer_start": [528], "text": ["LAMP2A"]}}}, "11deab48b26041058c6969e459c30f46": {"prediction": {"id": "11deab48b26041058c6969e459c30f46", "prediction_text": "CMA"}, "reference": {"id": "11deab48b26041058c6969e459c30f46", "answers": {"answer_start": [1096], "text": ["LAMP2A"]}}}, "cdd2f01c0e8b41bd826bfd816371c78c": {"prediction": {"id": "cdd2f01c0e8b41bd826bfd816371c78c", "prediction_text": "lysosome-associated membrane protein (lamp) type 2a"}, "reference": {"id": "cdd2f01c0e8b41bd826bfd816371c78c", "answers": {"answer_start": [630], "text": ["LAMP2A"]}}}, "e3d78bac2fca4bc9830c93d4c2f0ef2d": {"prediction": {"id": "e3d78bac2fca4bc9830c93d4c2f0ef2d", "prediction_text": "CMA"}, "reference": {"id": "e3d78bac2fca4bc9830c93d4c2f0ef2d", "answers": {"answer_start": [876], "text": ["LAMP2A"]}}}, "daf5ee9f6db4470d8d665fa165f818ef": {"prediction": {"id": "daf5ee9f6db4470d8d665fa165f818ef", "prediction_text": "CMA"}, "reference": {"id": "daf5ee9f6db4470d8d665fa165f818ef", "answers": {"answer_start": [1227], "text": ["LAMP2A"]}}}, "74485f466b1346d4a0df0207286592a0": {"prediction": {"id": "74485f466b1346d4a0df0207286592a0", "prediction_text": "CMA"}, "reference": {"id": "74485f466b1346d4a0df0207286592a0", "answers": {"answer_start": [777], "text": ["LAMP2A"]}}}, "0c25c555afa3406a8ded5d7b7554a93a": {"prediction": {"id": "0c25c555afa3406a8ded5d7b7554a93a", "prediction_text": "JNK"}, "reference": {"id": "0c25c555afa3406a8ded5d7b7554a93a", "answers": {"answer_start": [178], "text": ["JNK"]}}}, "5f81a376d4c040fdbd19311c7e261905": {"prediction": {"id": "5f81a376d4c040fdbd19311c7e261905", "prediction_text": "polyglutamine"}, "reference": {"id": "5f81a376d4c040fdbd19311c7e261905", "answers": {"answer_start": [314], "text": ["JNK"]}}}, "06a952dad6654f4bb67cf904e4c98901": {"prediction": {"id": "06a952dad6654f4bb67cf904e4c98901", "prediction_text": "M3/6 phosphatase. However, while anisomycin treatment of cells leads to M3/6 protein degradation, arsenite"}, "reference": {"id": "06a952dad6654f4bb67cf904e4c98901", "answers": {"answer_start": [474], "text": ["JNK"]}}}, "1fbc361182084c28877bbf25eeaecd21": {"prediction": {"id": "1fbc361182084c28877bbf25eeaecd21", "prediction_text": "Rosiglitazone, a synthetic peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3) agonist, prevents cell death after cerebral ischemia in animal models, but the underlying mechanism has not been clarified. In this study, we examined how rosiglitazone protects neurons against ischemia. Mice treated with rosiglitazone were subjected to 60 minutes of focal ischemia followed by reperfusion. Rosiglitazone reduced infarct volume after ischemia and reperfusion. We show that this neuroprotective effect was reversed with a PPAR\u03b3 antagonist. Western blot analysis showed a significant increase in expression of phosphorylated stress-activated protein kinases (c-Jun N-terminal kinase (JNK) and p38) in ischemic brain tissue. Rosiglitazone blocked this increase. Furthermore, we observed that rosiglitazone increased expression of the dual-specificity phosphatase 8 (DUSP8) protein and messenger RNA in ischemic brain tissue. Dual-specificity phosphatase 8 is a mitogen-activated protein kinase phosphatase"}, "reference": {"id": "1fbc361182084c28877bbf25eeaecd21", "answers": {"answer_start": [1025], "text": ["JNK"]}}}, "fd0d3dfafce14d728082319b14169496": {"prediction": {"id": "fd0d3dfafce14d728082319b14169496", "prediction_text": "JNK"}, "reference": {"id": "fd0d3dfafce14d728082319b14169496", "answers": {"answer_start": [260], "text": ["JNK"]}}}, "b035afb53cf54e499c122ec46dc5e7ee": {"prediction": {"id": "b035afb53cf54e499c122ec46dc5e7ee", "prediction_text": "Pyrrolidine dithiocarbamate"}, "reference": {"id": "b035afb53cf54e499c122ec46dc5e7ee", "answers": {"answer_start": [233], "text": ["JNK"]}}}, "12a398a452cd4bca83a891a62a6b33eb": {"prediction": {"id": "12a398a452cd4bca83a891a62a6b33eb", "prediction_text": "Phosphatases"}, "reference": {"id": "12a398a452cd4bca83a891a62a6b33eb", "answers": {"answer_start": [1726], "text": ["JNK"]}}}, "4e8c1cc3ddae4503af9d479549da1de0": {"prediction": {"id": "4e8c1cc3ddae4503af9d479549da1de0", "prediction_text": "blepharoconjunctivitis in which Pthirus pubis infest the eyelashes"}, "reference": {"id": "4e8c1cc3ddae4503af9d479549da1de0", "answers": {"answer_start": [80], "text": ["Pthirus pubis"]}}}, "2ae6f01642234c4e9e5834fa85ac9bb7": {"prediction": {"id": "2ae6f01642234c4e9e5834fa85ac9bb7", "prediction_text": "infestation of the eyelashes"}, "reference": {"id": "2ae6f01642234c4e9e5834fa85ac9bb7", "answers": {"answer_start": [79], "text": ["Pthirus pubis"]}}}, "569fa098a7aa4802913641b510b2df2c": {"prediction": {"id": "569fa098a7aa4802913641b510b2df2c", "prediction_text": "misdiagnosis in rare cases of infestation of the eyelashes"}, "reference": {"id": "569fa098a7aa4802913641b510b2df2c", "answers": {"answer_start": [71], "text": ["Pthirus pubis"]}}}, "8e128adadc9042018acd8c039d2369fa": {"prediction": {"id": "8e128adadc9042018acd8c039d2369fa", "prediction_text": "Primary sinonasal intestinal-type adenocarcinomas"}, "reference": {"id": "8e128adadc9042018acd8c039d2369fa", "answers": {"answer_start": [744], "text": ["neuroendocrine cells"]}}}, "688280a1903a4800934bc925463f8de3": {"prediction": {"id": "688280a1903a4800934bc925463f8de3", "prediction_text": "Northeast Siberia"}, "reference": {"id": "688280a1903a4800934bc925463f8de3", "answers": {"answer_start": [70], "text": ["Northeast Siberia"]}}}, "d33ca20a8acc4d6b962425e0b792da8a": {"prediction": {"id": "d33ca20a8acc4d6b962425e0b792da8a", "prediction_text": "Gro"}, "reference": {"id": "d33ca20a8acc4d6b962425e0b792da8a", "answers": {"answer_start": [0], "text": ["Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor"]}}}, "4256c06313b54f4c90358c8a39081bbe": {"prediction": {"id": "4256c06313b54f4c90358c8a39081bbe", "prediction_text": "SET domains"}, "reference": {"id": "4256c06313b54f4c90358c8a39081bbe", "answers": {"answer_start": [0], "text": ["SET domain"]}}}, "54ca34b14a3b4b078fdc00712520a95a": {"prediction": {"id": "54ca34b14a3b4b078fdc00712520a95a", "prediction_text": "zinc-finger motif"}, "reference": {"id": "54ca34b14a3b4b078fdc00712520a95a", "answers": {"answer_start": [153], "text": ["SET domain"]}}}, "61237615e9434edeb1f772629838cf2f": {"prediction": {"id": "61237615e9434edeb1f772629838cf2f", "prediction_text": "alpha-helical N-terminal domain"}, "reference": {"id": "61237615e9434edeb1f772629838cf2f", "answers": {"answer_start": [187], "text": ["SET domain"]}}}, "b8c49b1416c344cdbec96af9bdc7a3f2": {"prediction": {"id": "b8c49b1416c344cdbec96af9bdc7a3f2", "prediction_text": "SET-domain"}, "reference": {"id": "b8c49b1416c344cdbec96af9bdc7a3f2", "answers": {"answer_start": [298], "text": ["SET domain"]}}}, "19a53d8d6360488fa345d62b75dd339b": {"prediction": {"id": "19a53d8d6360488fa345d62b75dd339b", "prediction_text": "2"}, "reference": {"id": "19a53d8d6360488fa345d62b75dd339b", "answers": {"answer_start": [742], "text": ["SET domain"]}}}, "e39cc60d52e7470e8da4ea4e36c98db0": {"prediction": {"id": "e39cc60d52e7470e8da4ea4e36c98db0", "prediction_text": "mono-methylase"}, "reference": {"id": "e39cc60d52e7470e8da4ea4e36c98db0", "answers": {"answer_start": [928], "text": ["SET domain"]}}}, "ce566b9aa79249219f0f1bcfa6daf017": {"prediction": {"id": "ce566b9aa79249219f0f1bcfa6daf017", "prediction_text": "SET domain methyltransferases deposit methyl marks"}, "reference": {"id": "ce566b9aa79249219f0f1bcfa6daf017", "answers": {"answer_start": [0], "text": ["SET domain"]}}}, "d5a09f7102bd45319f3e97b06395a8fb": {"prediction": {"id": "d5a09f7102bd45319f3e97b06395a8fb", "prediction_text": "C termini"}, "reference": {"id": "d5a09f7102bd45319f3e97b06395a8fb", "answers": {"answer_start": [4], "text": ["SET domain"]}}}, "c9c915cbba75456eaf6cc24f5f538fb7": {"prediction": {"id": "c9c915cbba75456eaf6cc24f5f538fb7", "prediction_text": "SET domain"}, "reference": {"id": "c9c915cbba75456eaf6cc24f5f538fb7", "answers": {"answer_start": [435], "text": ["SET domain"]}}}, "4b43474feacd4325ae461570be28b52a": {"prediction": {"id": "4b43474feacd4325ae461570be28b52a", "prediction_text": "SET domain"}, "reference": {"id": "4b43474feacd4325ae461570be28b52a", "answers": {"answer_start": [4], "text": ["SET domain"]}}}, "1b90b5618dd2420d9b0f1387ab8117e7": {"prediction": {"id": "1b90b5618dd2420d9b0f1387ab8117e7", "prediction_text": "Set1 complex"}, "reference": {"id": "1b90b5618dd2420d9b0f1387ab8117e7", "answers": {"answer_start": [516], "text": ["SET domain"]}}}, "e4cfea4c3f9d4145b83fb0fb56e36ffe": {"prediction": {"id": "e4cfea4c3f9d4145b83fb0fb56e36ffe", "prediction_text": "narrow substrate"}, "reference": {"id": "e4cfea4c3f9d4145b83fb0fb56e36ffe", "answers": {"answer_start": [443], "text": ["SET domain"]}}}, "b691d061e90448f3a700e2291f2f8a81": {"prediction": {"id": "b691d061e90448f3a700e2291f2f8a81", "prediction_text": "SET domain"}, "reference": {"id": "b691d061e90448f3a700e2291f2f8a81", "answers": {"answer_start": [150], "text": ["SET domain"]}}}, "2dd73b115f784194b7d5b248cf55c6f0": {"prediction": {"id": "2dd73b115f784194b7d5b248cf55c6f0", "prediction_text": "SET domain"}, "reference": {"id": "2dd73b115f784194b7d5b248cf55c6f0", "answers": {"answer_start": [100], "text": ["SET domain"]}}}, "f0ecba4c048442f4942e90d269755531": {"prediction": {"id": "f0ecba4c048442f4942e90d269755531", "prediction_text": "C-terminal SET domain"}, "reference": {"id": "f0ecba4c048442f4942e90d269755531", "answers": {"answer_start": [462], "text": ["SET domain"]}}}, "ae741f63d0944007806610b40a92764a": {"prediction": {"id": "ae741f63d0944007806610b40a92764a", "prediction_text": "dimethylates nucleosomal histone H3 lysine 36"}, "reference": {"id": "ae741f63d0944007806610b40a92764a", "answers": {"answer_start": [44], "text": ["SET domain"]}}}, "f41bddf6acbc4904a8eb9948f484e4b9": {"prediction": {"id": "f41bddf6acbc4904a8eb9948f484e4b9", "prediction_text": "SET domain"}, "reference": {"id": "f41bddf6acbc4904a8eb9948f484e4b9", "answers": {"answer_start": [644], "text": ["SET domain"]}}}, "d7401eaa005d4d1e94e624c9d9d0115e": {"prediction": {"id": "d7401eaa005d4d1e94e624c9d9d0115e", "prediction_text": "Set1B complex"}, "reference": {"id": "d7401eaa005d4d1e94e624c9d9d0115e", "answers": {"answer_start": [300], "text": ["SET domain"]}}}, "262bc005e18d4a93800199a1dfe529d1": {"prediction": {"id": "262bc005e18d4a93800199a1dfe529d1", "prediction_text": "SET domain"}, "reference": {"id": "262bc005e18d4a93800199a1dfe529d1", "answers": {"answer_start": [36], "text": ["SET domain"]}}}, "5a18423fccc6414781ee6a4343430a90": {"prediction": {"id": "5a18423fccc6414781ee6a4343430a90", "prediction_text": "methylation"}, "reference": {"id": "5a18423fccc6414781ee6a4343430a90", "answers": {"answer_start": [1857], "text": ["SET domain"]}}}, "4326bf55529d462885c58c7df5a8c442": {"prediction": {"id": "4326bf55529d462885c58c7df5a8c442", "prediction_text": "PcG) repressors"}, "reference": {"id": "4326bf55529d462885c58c7df5a8c442", "answers": {"answer_start": [310], "text": ["SET domain"]}}}, "eb2b111410e547e7b8ae8784a6e3e3b3": {"prediction": {"id": "eb2b111410e547e7b8ae8784a6e3e3b3", "prediction_text": "SET domain"}, "reference": {"id": "eb2b111410e547e7b8ae8784a6e3e3b3", "answers": {"answer_start": [304], "text": ["SET domain"]}}}, "2f037136cdf3491496355fa79bbdf26c": {"prediction": {"id": "2f037136cdf3491496355fa79bbdf26c", "prediction_text": "SET domain"}, "reference": {"id": "2f037136cdf3491496355fa79bbdf26c", "answers": {"answer_start": [269], "text": ["SET domain"]}}}, "cbbc4bb90c8d45e68cba7d09925abb0d": {"prediction": {"id": "cbbc4bb90c8d45e68cba7d09925abb0d", "prediction_text": "SPRY"}, "reference": {"id": "cbbc4bb90c8d45e68cba7d09925abb0d", "answers": {"answer_start": [826], "text": ["SET domain"]}}}, "1802106ac5b1401db0001d6e733bbfa7": {"prediction": {"id": "1802106ac5b1401db0001d6e733bbfa7", "prediction_text": "SET domain protein lysine methyltransferase"}, "reference": {"id": "1802106ac5b1401db0001d6e733bbfa7", "answers": {"answer_start": [117], "text": ["SET domain"]}}}, "efc5f81b34174fcabc1f9f3f2bd6a400": {"prediction": {"id": "efc5f81b34174fcabc1f9f3f2bd6a400", "prediction_text": "carboxyl-terminal SET domain"}, "reference": {"id": "efc5f81b34174fcabc1f9f3f2bd6a400", "answers": {"answer_start": [517], "text": ["SET domain"]}}}, "45e96984cdd34a9f8fbc67cce68e48a6": {"prediction": {"id": "45e96984cdd34a9f8fbc67cce68e48a6", "prediction_text": "CDS"}, "reference": {"id": "45e96984cdd34a9f8fbc67cce68e48a6", "answers": {"answer_start": [462], "text": ["pulmonary embolism"]}}}, "7887a8efb2614b8cb772523a119f45f3": {"prediction": {"id": "7887a8efb2614b8cb772523a119f45f3", "prediction_text": "priori clinical assessment of a high probability of PE"}, "reference": {"id": "7887a8efb2614b8cb772523a119f45f3", "answers": {"answer_start": [37], "text": ["pulmonary embolism"]}}}, "7baa9ca320984427b2cf2d6e1d26809b": {"prediction": {"id": "7baa9ca320984427b2cf2d6e1d26809b", "prediction_text": "pretest probability"}, "reference": {"id": "7baa9ca320984427b2cf2d6e1d26809b", "answers": {"answer_start": [150], "text": ["pulmonary embolism"]}}}, "9db9082a8f1d4d8e8b739aed3c40ec8d": {"prediction": {"id": "9db9082a8f1d4d8e8b739aed3c40ec8d", "prediction_text": "clinical probability of pulmonary embolism (PE) with Wells scoring system is the first step towards diagnosis of PE. Definitive diagnosis of PE is confirmed by computed tomography pulmonary angiography (CTPA). This was a prospective study on 80 patients referred to the Institute for Pulmonary Diseases of Vojvodina with suspected PE between April 2010 and August 2012. Clinical probability of PE was determined according to the Wells and modified Wells scoring system. CTPA was performed in 60 patients. The degree of pulmonary vascular obstruction was quantified by the Qanadli index. Low clinical probability of PE was present in one patient (1.6%), moderate in 43 (71.6%) and high in 16 (26.6%) patients. PE was confirmed in 50 (83.3%) patients. There were 21 patients (42%) whose Quanadli index was <25%, 18 (36%) between 25%-50%, while Quanadli index was \u226550 in 11 patients (22%). When compared to CTPA findings, modified Wells scoring system showed 90% sensitivity [95% confidence interval (CI) 78.2%-96.6%], and 20% specificity (95% CI 3.11%-55.6%), positive predictive value (PPV) 84.9% (95% CI 72.4%-93.2%) and negative predictive value (NPV) 28.6% (95% CI 4.5%-70.7%). There was weak positive correlation between Wells score and Quanadli index (r\u2009=\u20090.14; P\u2009=\u20090.29), without statistical significance. Wells score was significantly higher in haemodynamically unstable than in haemodynamically stable patients (6.8 vs 5.6, P\u2009=\u20090.014). There was no statistically significant difference between the values of Quanadli index in these two groups (31.33% vs 26.64%, P\u2009=\u20090.062). Modified Wells criteria have high sensitivity but low specificity in PE diagnostics"}, "reference": {"id": "9db9082a8f1d4d8e8b739aed3c40ec8d", "answers": {"answer_start": [36], "text": ["pulmonary embolism"]}}}, "962eb3bfab974250b800333f19ef83c0": {"prediction": {"id": "962eb3bfab974250b800333f19ef83c0", "prediction_text": "pretest probability"}, "reference": {"id": "962eb3bfab974250b800333f19ef83c0", "answers": {"answer_start": [628], "text": ["pulmonary embolism"]}}}, "e887a3c3aae5498aa980aab32df3fb7b": {"prediction": {"id": "e887a3c3aae5498aa980aab32df3fb7b", "prediction_text": "CDS intervention"}, "reference": {"id": "e887a3c3aae5498aa980aab32df3fb7b", "answers": {"answer_start": [149], "text": ["pulmonary embolism"]}}}, "23d7dcdd116a4c71a8301523f271a1ff": {"prediction": {"id": "23d7dcdd116a4c71a8301523f271a1ff", "prediction_text": "Limb-Enhancer Genie"}, "reference": {"id": "23d7dcdd116a4c71a8301523f271a1ff", "answers": {"answer_start": [435], "text": ["Limb-Enhancer Genie (LEG)"]}}}, "c66a0ad3476e4c8db797a6fe5a609752": {"prediction": {"id": "c66a0ad3476e4c8db797a6fe5a609752", "prediction_text": "nuclear factor \u03baB ligand"}, "reference": {"id": "c66a0ad3476e4c8db797a6fe5a609752", "answers": {"answer_start": [67], "text": ["receptor activator of nuclear factor-\u03baB ligand"]}}}, "044a1a6a1bae457fbc37d149708ea535": {"prediction": {"id": "044a1a6a1bae457fbc37d149708ea535", "prediction_text": "Dmab) is a fully human monoclonal antibody against the receptor activator of nuclear factor-\u03baB ligand (RANKL), which, through the prevention of the RANKL/RANK interaction, inhibits osteoclast-mediated bone resorption and significantly reduces the risk of vertebral, nonvertebral, and hip fractures. It is administered subcutaneously every 6 months for the treatment of postmenopausal osteoporosis"}, "reference": {"id": "044a1a6a1bae457fbc37d149708ea535", "answers": {"answer_start": [532, 625], "text": ["receptor activator of nuclear factor-\u03baB ligand", "RANKL"]}}}, "77da28a0ebbe42a180aad1dd0132d50c": {"prediction": {"id": "77da28a0ebbe42a180aad1dd0132d50c", "prediction_text": "RANKL, in this disease. In 2013, the US Food and Drug Administration approved denosumab for use in patients with recurrent/unresectable/metastatic giant-cell tumor of bone"}, "reference": {"id": "77da28a0ebbe42a180aad1dd0132d50c", "answers": {"answer_start": [432, 480], "text": ["receptor activator of nuclear factor-\u03baB ligand", "RANKL"]}}}, "a11a4e73640a47b891ac1b534d2e3593": {"prediction": {"id": "a11a4e73640a47b891ac1b534d2e3593", "prediction_text": "replication defects"}, "reference": {"id": "a11a4e73640a47b891ac1b534d2e3593", "answers": {"answer_start": [0], "text": ["Lack of the yeast Rrm3p DNA helicase causes replication defects at multiple sites within ribosomal DNA (rDNA), including at the replication fork barrier (RFB)."]}}}, "9f091021bc244e2d8e306afc6a0a7e7c": {"prediction": {"id": "9f091021bc244e2d8e306afc6a0a7e7c", "prediction_text": "skipping of dystrophin exon 51 in patients with relevant deletions"}, "reference": {"id": "9f091021bc244e2d8e306afc6a0a7e7c", "answers": {"answer_start": [203], "text": ["skipping of dystrophin exon 51"]}}}, "4002e32c825c4ad281c5da435a09c5eb": {"prediction": {"id": "4002e32c825c4ad281c5da435a09c5eb", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "4002e32c825c4ad281c5da435a09c5eb", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "fd130c81c28944ef94e958f6b66e2a7c": {"prediction": {"id": "fd130c81c28944ef94e958f6b66e2a7c", "prediction_text": "restless legs syndrome"}, "reference": {"id": "fd130c81c28944ef94e958f6b66e2a7c", "answers": {"answer_start": [166], "text": ["Restless legs syndrome"]}}}, "ef56c9219a354049ad1000690e2df6ae": {"prediction": {"id": "ef56c9219a354049ad1000690e2df6ae", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "ef56c9219a354049ad1000690e2df6ae", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "a11e87b6414e4faaacc2deaa4a92044b": {"prediction": {"id": "a11e87b6414e4faaacc2deaa4a92044b", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "a11e87b6414e4faaacc2deaa4a92044b", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "bbe30993942542bf875217f611f9a361": {"prediction": {"id": "bbe30993942542bf875217f611f9a361", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "bbe30993942542bf875217f611f9a361", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "1840b7428d3f4c1aa7021559069d74f3": {"prediction": {"id": "1840b7428d3f4c1aa7021559069d74f3", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "1840b7428d3f4c1aa7021559069d74f3", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "392bd356a6a145228128e9534fdc48ff": {"prediction": {"id": "392bd356a6a145228128e9534fdc48ff", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "392bd356a6a145228128e9534fdc48ff", "answers": {"answer_start": [279], "text": ["Restless legs syndrome"]}}}, "d40afca003fe4210a25a01bc44c590e9": {"prediction": {"id": "d40afca003fe4210a25a01bc44c590e9", "prediction_text": "restless legs syndrome"}, "reference": {"id": "d40afca003fe4210a25a01bc44c590e9", "answers": {"answer_start": [60], "text": ["Restless legs syndrome"]}}}, "6135cc79be97439691246c27b791a850": {"prediction": {"id": "6135cc79be97439691246c27b791a850", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "6135cc79be97439691246c27b791a850", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "58a21eaba3c0400fa7660da5c6838055": {"prediction": {"id": "58a21eaba3c0400fa7660da5c6838055", "prediction_text": "restless legs syndrome"}, "reference": {"id": "58a21eaba3c0400fa7660da5c6838055", "answers": {"answer_start": [5], "text": ["Restless legs syndrome"]}}}, "dba1061498a546249096c1c8a7b065bf": {"prediction": {"id": "dba1061498a546249096c1c8a7b065bf", "prediction_text": "restless legs syndrome"}, "reference": {"id": "dba1061498a546249096c1c8a7b065bf", "answers": {"answer_start": [142], "text": ["Restless legs syndrome"]}}}, "f4fae284214e4ec9ad0c5fd1bda3dac9": {"prediction": {"id": "f4fae284214e4ec9ad0c5fd1bda3dac9", "prediction_text": "restless legs syndrome"}, "reference": {"id": "f4fae284214e4ec9ad0c5fd1bda3dac9", "answers": {"answer_start": [21], "text": ["Restless legs syndrome"]}}}, "b042ab3621fb49ce99b2d04f1978ffd2": {"prediction": {"id": "b042ab3621fb49ce99b2d04f1978ffd2", "prediction_text": "restless legs syndrome/Willis-Ekbom disease (RLS/WED"}, "reference": {"id": "b042ab3621fb49ce99b2d04f1978ffd2", "answers": {"answer_start": [201], "text": ["Restless legs syndrome"]}}}, "22acc80a9b394b8c924b199446de96b3": {"prediction": {"id": "22acc80a9b394b8c924b199446de96b3", "prediction_text": "restless legs syndrome"}, "reference": {"id": "22acc80a9b394b8c924b199446de96b3", "answers": {"answer_start": [780], "text": ["Restless legs syndrome"]}}}, "dd03fcb306ba45b2a15606589ab22ad7": {"prediction": {"id": "dd03fcb306ba45b2a15606589ab22ad7", "prediction_text": "Willis Ekbom disease"}, "reference": {"id": "dd03fcb306ba45b2a15606589ab22ad7", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "7951f8c0e43845ab8577a335f331d2d2": {"prediction": {"id": "7951f8c0e43845ab8577a335f331d2d2", "prediction_text": "restless legs syndrome"}, "reference": {"id": "7951f8c0e43845ab8577a335f331d2d2", "answers": {"answer_start": [168], "text": ["Restless legs syndrome"]}}}, "aeb15d9593cc475799ec160a5566a4ed": {"prediction": {"id": "aeb15d9593cc475799ec160a5566a4ed", "prediction_text": "restless legs syndrome"}, "reference": {"id": "aeb15d9593cc475799ec160a5566a4ed", "answers": {"answer_start": [128], "text": ["Restless legs syndrome"]}}}, "bb9566f1c5de45a6b156c863b35b86d0": {"prediction": {"id": "bb9566f1c5de45a6b156c863b35b86d0", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "bb9566f1c5de45a6b156c863b35b86d0", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "0c01637c896a4e05895d3cc556a207ac": {"prediction": {"id": "0c01637c896a4e05895d3cc556a207ac", "prediction_text": "restless legs syndrome"}, "reference": {"id": "0c01637c896a4e05895d3cc556a207ac", "answers": {"answer_start": [21], "text": ["Restless legs syndrome"]}}}, "31c3bbd887f3483daec26529fba6db29": {"prediction": {"id": "31c3bbd887f3483daec26529fba6db29", "prediction_text": "restless legs syndrome"}, "reference": {"id": "31c3bbd887f3483daec26529fba6db29", "answers": {"answer_start": [50], "text": ["Restless legs syndrome"]}}}, "0f54ea0af25a44af9e02a07341ea0f88": {"prediction": {"id": "0f54ea0af25a44af9e02a07341ea0f88", "prediction_text": "restless legs syndrome"}, "reference": {"id": "0f54ea0af25a44af9e02a07341ea0f88", "answers": {"answer_start": [143], "text": ["Restless legs syndrome"]}}}, "88ee22aa7e5543abbbc49bd54f585cf0": {"prediction": {"id": "88ee22aa7e5543abbbc49bd54f585cf0", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "88ee22aa7e5543abbbc49bd54f585cf0", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "e14e6593e8ec4b80b661336fddf89147": {"prediction": {"id": "e14e6593e8ec4b80b661336fddf89147", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "e14e6593e8ec4b80b661336fddf89147", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "cbc1e9b3359f43c480c19e957246f0a8": {"prediction": {"id": "cbc1e9b3359f43c480c19e957246f0a8", "prediction_text": "Restless Legs Syndrome"}, "reference": {"id": "cbc1e9b3359f43c480c19e957246f0a8", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "4527a1dfecc9437a9d8957585053cf9b": {"prediction": {"id": "4527a1dfecc9437a9d8957585053cf9b", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "4527a1dfecc9437a9d8957585053cf9b", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "743a3849f211400dbc2349ca76164448": {"prediction": {"id": "743a3849f211400dbc2349ca76164448", "prediction_text": "restless legs syndrome"}, "reference": {"id": "743a3849f211400dbc2349ca76164448", "answers": {"answer_start": [213], "text": ["Restless legs syndrome"]}}}, "c64b0419939e40cba350352e7b14c430": {"prediction": {"id": "c64b0419939e40cba350352e7b14c430", "prediction_text": "restless legs syndrome"}, "reference": {"id": "c64b0419939e40cba350352e7b14c430", "answers": {"answer_start": [19], "text": ["Restless legs syndrome"]}}}, "bb74d66ba08c4b1da3aaf64fa6f87908": {"prediction": {"id": "bb74d66ba08c4b1da3aaf64fa6f87908", "prediction_text": "Restless legs syndrome"}, "reference": {"id": "bb74d66ba08c4b1da3aaf64fa6f87908", "answers": {"answer_start": [133], "text": ["Restless legs syndrome"]}}}, "dfdbaadb9d9a4669810640da5cd48e0b": {"prediction": {"id": "dfdbaadb9d9a4669810640da5cd48e0b", "prediction_text": "restless legs syndrome"}, "reference": {"id": "dfdbaadb9d9a4669810640da5cd48e0b", "answers": {"answer_start": [82], "text": ["Restless legs syndrome"]}}}, "19cba7326e4242b88997e682d733a3c0": {"prediction": {"id": "19cba7326e4242b88997e682d733a3c0", "prediction_text": "restless legs syndrome"}, "reference": {"id": "19cba7326e4242b88997e682d733a3c0", "answers": {"answer_start": [811], "text": ["Restless legs syndrome"]}}}, "d96851f1ae2141a3949deffc07965527": {"prediction": {"id": "d96851f1ae2141a3949deffc07965527", "prediction_text": "Restless Legs Syndrome"}, "reference": {"id": "d96851f1ae2141a3949deffc07965527", "answers": {"answer_start": [738], "text": ["Restless legs syndrome"]}}}, "e5f80d9803954782ae1ce8cdaf4b5ece": {"prediction": {"id": "e5f80d9803954782ae1ce8cdaf4b5ece", "prediction_text": "chromDraw"}, "reference": {"id": "e5f80d9803954782ae1ce8cdaf4b5ece", "answers": {"answer_start": [916], "text": ["chromDraw"]}}}, "b35d02066a514b72b437c94ca7aa4c8e": {"prediction": {"id": "b35d02066a514b72b437c94ca7aa4c8e", "prediction_text": "lysosomal"}, "reference": {"id": "b35d02066a514b72b437c94ca7aa4c8e", "answers": {"answer_start": [280], "text": ["Beta glucocerebrosidase"]}}}, "e54c6fb8ba9343f09fc7a0c75ed20a61": {"prediction": {"id": "e54c6fb8ba9343f09fc7a0c75ed20a61", "prediction_text": "glucocerebrosidase"}, "reference": {"id": "e54c6fb8ba9343f09fc7a0c75ed20a61", "answers": {"answer_start": [121], "text": ["Beta glucocerebrosidase"]}}}, "a6aebb99221d406ca8e615cd7364844e": {"prediction": {"id": "a6aebb99221d406ca8e615cd7364844e", "prediction_text": "glucocerebrosidase"}, "reference": {"id": "a6aebb99221d406ca8e615cd7364844e", "answers": {"answer_start": [109], "text": ["Beta glucocerebrosidase"]}}}, "7984c131d1f149f3b8096f436db53d4b": {"prediction": {"id": "7984c131d1f149f3b8096f436db53d4b", "prediction_text": "dabigatran"}, "reference": {"id": "7984c131d1f149f3b8096f436db53d4b", "answers": {"answer_start": [856], "text": ["dabigatran"]}}}, "80da621b93284461bcd75452f9bd63e5": {"prediction": {"id": "80da621b93284461bcd75452f9bd63e5", "prediction_text": "dabigatran"}, "reference": {"id": "80da621b93284461bcd75452f9bd63e5", "answers": {"answer_start": [924], "text": ["dabigatran"]}}}, "bc4c3c11db22458497c9e4400d6df153": {"prediction": {"id": "bc4c3c11db22458497c9e4400d6df153", "prediction_text": "dabigatran"}, "reference": {"id": "bc4c3c11db22458497c9e4400d6df153", "answers": {"answer_start": [405], "text": ["dabigatran"]}}}, "c76e64136c454d7ab54aa1eb53d6ad4d": {"prediction": {"id": "c76e64136c454d7ab54aa1eb53d6ad4d", "prediction_text": "dabigatran etexilate"}, "reference": {"id": "c76e64136c454d7ab54aa1eb53d6ad4d", "answers": {"answer_start": [214], "text": ["dabigatran"]}}}, "83213f7391014cb4a2e0c694527bd7ec": {"prediction": {"id": "83213f7391014cb4a2e0c694527bd7ec", "prediction_text": "dabigatran"}, "reference": {"id": "83213f7391014cb4a2e0c694527bd7ec", "answers": {"answer_start": [1252], "text": ["dabigatran"]}}}, "213d74d99989407190b16c6c7a274031": {"prediction": {"id": "213d74d99989407190b16c6c7a274031", "prediction_text": "blood products"}, "reference": {"id": "213d74d99989407190b16c6c7a274031", "answers": {"answer_start": [385], "text": ["dabigatran"]}}}, "b473ef899ecc4f7aba0367961c2cb787": {"prediction": {"id": "b473ef899ecc4f7aba0367961c2cb787", "prediction_text": "Dabigatran etexilate"}, "reference": {"id": "b473ef899ecc4f7aba0367961c2cb787", "answers": {"answer_start": [432], "text": ["dabigatran"]}}}, "57beafc1d79747f1bcd0e3d942afc64b": {"prediction": {"id": "57beafc1d79747f1bcd0e3d942afc64b", "prediction_text": "Idarucizumab"}, "reference": {"id": "57beafc1d79747f1bcd0e3d942afc64b", "answers": {"answer_start": [102], "text": ["dabigatran"]}}}, "06fdf653d7e04d1bacfcbceb377d37df": {"prediction": {"id": "06fdf653d7e04d1bacfcbceb377d37df", "prediction_text": "VKAs"}, "reference": {"id": "06fdf653d7e04d1bacfcbceb377d37df", "answers": {"answer_start": [1138], "text": ["dabigatran"]}}}, "962c201c55d54238a6956864848a6faf": {"prediction": {"id": "962c201c55d54238a6956864848a6faf", "prediction_text": "Dabigatran, an oral direct thrombin inhibitor, is increasingly used in place of warfarin. The lack of an antidote is a concern in patients who overdose on dabigatran, even though the drug can be eliminated with hemodialysis"}, "reference": {"id": "962c201c55d54238a6956864848a6faf", "answers": {"answer_start": [95], "text": ["dabigatran"]}}}, "edfe6362d8c441fbb953efafcaa68a04": {"prediction": {"id": "edfe6362d8c441fbb953efafcaa68a04", "prediction_text": "anticoagulation"}, "reference": {"id": "edfe6362d8c441fbb953efafcaa68a04", "answers": {"answer_start": [463], "text": ["dabigatran"]}}}, "aa7ea441bbbb454daecdbe0569904861": {"prediction": {"id": "aa7ea441bbbb454daecdbe0569904861", "prediction_text": "dabigatran"}, "reference": {"id": "aa7ea441bbbb454daecdbe0569904861", "answers": {"answer_start": [0], "text": ["dabigatran"]}}}, "a9f4afeda4e04f6f88c735ace448cff1": {"prediction": {"id": "a9f4afeda4e04f6f88c735ace448cff1", "prediction_text": "dabigatran, with the promise of less frequent monitoring and decreased bleeding tendencies as compared to Coumadin. The main disadvantage of dabigatran has been the lack of a reversal agent in case of severe bleeding or emergent surgical intervention. This was until the recent The Food and Drug Administration"}, "reference": {"id": "a9f4afeda4e04f6f88c735ace448cff1", "answers": {"answer_start": [938], "text": ["dabigatran"]}}}, "ec6005d668f54dbe88eefd9fa277e360": {"prediction": {"id": "ec6005d668f54dbe88eefd9fa277e360", "prediction_text": "andexanet alfa"}, "reference": {"id": "ec6005d668f54dbe88eefd9fa277e360", "answers": {"answer_start": [1399], "text": ["dabigatran"]}}}, "54d41e2794a946d7a92ab3d3cbefeba1": {"prediction": {"id": "54d41e2794a946d7a92ab3d3cbefeba1", "prediction_text": "activated partial thromboplastin time"}, "reference": {"id": "54d41e2794a946d7a92ab3d3cbefeba1", "answers": {"answer_start": [1474], "text": ["dabigatran"]}}}, "3190581f750148c5b46c62779169f450": {"prediction": {"id": "3190581f750148c5b46c62779169f450", "prediction_text": "oral anticoagulants"}, "reference": {"id": "3190581f750148c5b46c62779169f450", "answers": {"answer_start": [1870], "text": ["dabigatran"]}}}, "010343d1af964dc996c6a2f98353aaab": {"prediction": {"id": "010343d1af964dc996c6a2f98353aaab", "prediction_text": "thrombin generation to baseline levels. Following trauma, therapy with tranexamic acid"}, "reference": {"id": "010343d1af964dc996c6a2f98353aaab", "answers": {"answer_start": [301], "text": ["dabigatran"]}}}, "228790c3154b479386d01f939dd7cb22": {"prediction": {"id": "228790c3154b479386d01f939dd7cb22", "prediction_text": "Dabigatran etexilate"}, "reference": {"id": "228790c3154b479386d01f939dd7cb22", "answers": {"answer_start": [746], "text": ["dabigatran"]}}}, "eedf8a1de894435785d7838685621aad": {"prediction": {"id": "eedf8a1de894435785d7838685621aad", "prediction_text": "placebo"}, "reference": {"id": "eedf8a1de894435785d7838685621aad", "answers": {"answer_start": [1024], "text": ["dabigatran"]}}}, "fa40f72a435741c39abd2f2247d98302": {"prediction": {"id": "fa40f72a435741c39abd2f2247d98302", "prediction_text": "dabigatran"}, "reference": {"id": "fa40f72a435741c39abd2f2247d98302", "answers": {"answer_start": [405], "text": ["dabigatran"]}}}, "6ac327e674f048b6893b13c491c8a418": {"prediction": {"id": "6ac327e674f048b6893b13c491c8a418", "prediction_text": "dabigatran-induced anticoagulation"}, "reference": {"id": "6ac327e674f048b6893b13c491c8a418", "answers": {"answer_start": [1357], "text": ["dabigatran"]}}}, "82c3a6df9531489e8cef1f35b49e329b": {"prediction": {"id": "82c3a6df9531489e8cef1f35b49e329b", "prediction_text": "dabigatran"}, "reference": {"id": "82c3a6df9531489e8cef1f35b49e329b", "answers": {"answer_start": [906], "text": ["dabigatran"]}}}, "23385c4dc226412083a87c0e829f3457": {"prediction": {"id": "23385c4dc226412083a87c0e829f3457", "prediction_text": "Eichhoff's test"}, "reference": {"id": "23385c4dc226412083a87c0e829f3457", "answers": {"answer_start": [1461], "text": ["de Quervain's disease"]}}}, "f7795b6ad6374fbf8483f3d346a8694b": {"prediction": {"id": "f7795b6ad6374fbf8483f3d346a8694b", "prediction_text": "de Quervain's disease"}, "reference": {"id": "f7795b6ad6374fbf8483f3d346a8694b", "answers": {"answer_start": [1061], "text": ["de Quervain's disease"]}}}, "99db9757ac554ad4b3fffdd4c7cbd341": {"prediction": {"id": "99db9757ac554ad4b3fffdd4c7cbd341", "prediction_text": "de Quervain's"}, "reference": {"id": "99db9757ac554ad4b3fffdd4c7cbd341", "answers": {"answer_start": [54], "text": ["de Quervain's disease"]}}}, "e3c231fd3b5245849a3cd3b5a3b1a7e1": {"prediction": {"id": "e3c231fd3b5245849a3cd3b5a3b1a7e1", "prediction_text": "negative"}, "reference": {"id": "e3c231fd3b5245849a3cd3b5a3b1a7e1", "answers": {"answer_start": [18], "text": ["de Quervain's disease"]}}}, "1094f26d5a524788b4a9f46488cc3ab4": {"prediction": {"id": "1094f26d5a524788b4a9f46488cc3ab4", "prediction_text": "de Quervain's disease"}, "reference": {"id": "1094f26d5a524788b4a9f46488cc3ab4", "answers": {"answer_start": [0], "text": ["de Quervain's disease"]}}}, "388ac698f82946e2ba3b8f04ab750ae9": {"prediction": {"id": "388ac698f82946e2ba3b8f04ab750ae9", "prediction_text": "plays an essential role in maintaining calcium homeostasis"}, "reference": {"id": "388ac698f82946e2ba3b8f04ab750ae9", "answers": {"answer_start": [4], "text": ["The calcium-sensing receptor (CaSR) is a G-protein-coupled receptor that plays an essential role in maintaining calcium homeostasis."]}}}, "ece2e10ce923497483077b98f5369b78": {"prediction": {"id": "ece2e10ce923497483077b98f5369b78", "prediction_text": "gas"}, "reference": {"id": "ece2e10ce923497483077b98f5369b78", "answers": {"answer_start": [1553], "text": ["pneumoperitoneum"]}}}, "e01a02a67329456d9dd32c37d2d68d48": {"prediction": {"id": "e01a02a67329456d9dd32c37d2d68d48", "prediction_text": "PPFA sign, we compared the PPFA sign with the falciform ligament sign and the ligamentum teres sign, both of which are well-known CT signs of pneumoperitoneum"}, "reference": {"id": "e01a02a67329456d9dd32c37d2d68d48", "answers": {"answer_start": [923], "text": ["pneumoperitoneum"]}}}, "ddfa9d61f2d04e148b5bf7ab7a0e966e": {"prediction": {"id": "ddfa9d61f2d04e148b5bf7ab7a0e966e", "prediction_text": "high fever, dry cough and general malaise"}, "reference": {"id": "ddfa9d61f2d04e148b5bf7ab7a0e966e", "answers": {"answer_start": [128], "text": ["Schistosoma spp"]}}}, "594013feb172476a850739c96a638893": {"prediction": {"id": "594013feb172476a850739c96a638893", "prediction_text": "gene regulatory blocks"}, "reference": {"id": "594013feb172476a850739c96a638893", "answers": {"answer_start": [362], "text": ["gene regulatory blocks (GRBs)"]}}}, "4781801694c54fa284f5c2d98275845e": {"prediction": {"id": "4781801694c54fa284f5c2d98275845e", "prediction_text": "7SL RNA-derived retroposing monomeric element"}, "reference": {"id": "4781801694c54fa284f5c2d98275845e", "answers": {"answer_start": [799], "text": ["7SL RNA"]}}}, "a05a801097794829912a7e530e506f78": {"prediction": {"id": "a05a801097794829912a7e530e506f78", "prediction_text": "7SL RNA gene"}, "reference": {"id": "a05a801097794829912a7e530e506f78", "answers": {"answer_start": [312], "text": ["7SL RNA"]}}}, "e41864b263584044bdc9a2bb57927010": {"prediction": {"id": "e41864b263584044bdc9a2bb57927010", "prediction_text": "Third"}, "reference": {"id": "e41864b263584044bdc9a2bb57927010", "answers": {"answer_start": [234], "text": ["OikoBase"]}}}, "001a8b32e17f4d20a2596fd819ac4bf0": {"prediction": {"id": "001a8b32e17f4d20a2596fd819ac4bf0", "prediction_text": "centriole"}, "reference": {"id": "001a8b32e17f4d20a2596fd819ac4bf0", "answers": {"answer_start": [618], "text": ["centrosome"]}}}, "99436e7a90a349869d619b2074a4e866": {"prediction": {"id": "99436e7a90a349869d619b2074a4e866", "prediction_text": "NEURL4"}, "reference": {"id": "99436e7a90a349869d619b2074a4e866", "answers": {"answer_start": [1151], "text": ["centrosome"]}}}, "50c5fb2ce739454c94bb7aa49d306b3f": {"prediction": {"id": "50c5fb2ce739454c94bb7aa49d306b3f", "prediction_text": "underneath a CP110 cap"}, "reference": {"id": "50c5fb2ce739454c94bb7aa49d306b3f", "answers": {"answer_start": [80], "text": ["centrosome"]}}}, "4b2a52b43e3d4ea7b4ee9542893bd48f": {"prediction": {"id": "4b2a52b43e3d4ea7b4ee9542893bd48f", "prediction_text": "the centrosome"}, "reference": {"id": "4b2a52b43e3d4ea7b4ee9542893bd48f", "answers": {"answer_start": [770], "text": ["centrosome"]}}}, "4c3243a2fd634215b404973652ad20ed": {"prediction": {"id": "4c3243a2fd634215b404973652ad20ed", "prediction_text": "G1/S cells"}, "reference": {"id": "4c3243a2fd634215b404973652ad20ed", "answers": {"answer_start": [26], "text": ["centrosome"]}}}, "54602b3cd45c40ae9f1b65055697ac14": {"prediction": {"id": "54602b3cd45c40ae9f1b65055697ac14", "prediction_text": "mammalian"}, "reference": {"id": "54602b3cd45c40ae9f1b65055697ac14", "answers": {"answer_start": [756], "text": ["centrosome"]}}}, "814ecb5726a7484887e113cbf7478d98": {"prediction": {"id": "814ecb5726a7484887e113cbf7478d98", "prediction_text": "C-terminus"}, "reference": {"id": "814ecb5726a7484887e113cbf7478d98", "answers": {"answer_start": [97], "text": ["centrosome"]}}}, "0b4360d2d4654108af75fd286554702e": {"prediction": {"id": "0b4360d2d4654108af75fd286554702e", "prediction_text": "cell cycle regulation. CEP family protein is the active component of centrosome and plays a vital role in centriole biogenesis and cell cycle progression control. A total of 31 proteins have been categorized into CEP family protein category and many more are under candidate evaluation"}, "reference": {"id": "0b4360d2d4654108af75fd286554702e", "answers": {"answer_start": [0], "text": ["centrosome"]}}}, "089b7c3669a646f0baa0df566e63d7e2": {"prediction": {"id": "089b7c3669a646f0baa0df566e63d7e2", "prediction_text": "colorectal cancer cells"}, "reference": {"id": "089b7c3669a646f0baa0df566e63d7e2", "answers": {"answer_start": [978], "text": ["centrosome"]}}}, "f7077ace9bbc415bb3cb80f9d2adb1fa": {"prediction": {"id": "f7077ace9bbc415bb3cb80f9d2adb1fa", "prediction_text": "the intestine"}, "reference": {"id": "f7077ace9bbc415bb3cb80f9d2adb1fa", "answers": {"answer_start": [1486], "text": ["centrosome"]}}}, "39fc2e2fce2e40358822b01d0b80de28": {"prediction": {"id": "39fc2e2fce2e40358822b01d0b80de28", "prediction_text": "CBB components"}, "reference": {"id": "39fc2e2fce2e40358822b01d0b80de28", "answers": {"answer_start": [112], "text": ["centrosome"]}}}, "8f8afd12fcee4b37a7e222d117cb2ae9": {"prediction": {"id": "8f8afd12fcee4b37a7e222d117cb2ae9", "prediction_text": "clam centrosomes. It is predicted to be a highly coiled-coil protein with an extensive alpha-helix, suggesting that Cep135 is a structural component of the centrosome. To evaluate how the protein is arranged in the centrosomal structure, we overexpressed Cep135 polypeptides in CHO cells"}, "reference": {"id": "8f8afd12fcee4b37a7e222d117cb2ae9", "answers": {"answer_start": [1086], "text": ["centrosome"]}}}, "53469c595be24c82bfa659ee3460eda5": {"prediction": {"id": "53469c595be24c82bfa659ee3460eda5", "prediction_text": "phenoxy]-5-ethoxyaniline"}, "reference": {"id": "53469c595be24c82bfa659ee3460eda5", "answers": {"answer_start": [34, 253], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "273ee5c13c444b3ba28d87fa247c3211": {"prediction": {"id": "273ee5c13c444b3ba28d87fa247c3211", "prediction_text": "NCX"}, "reference": {"id": "273ee5c13c444b3ba28d87fa247c3211", "answers": {"answer_start": [53, 419], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "78000c222bd4438594dda2311d7be4be": {"prediction": {"id": "78000c222bd4438594dda2311d7be4be", "prediction_text": "p38 MAP kinase"}, "reference": {"id": "78000c222bd4438594dda2311d7be4be", "answers": {"answer_start": [4, 1572], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "6d191c47f354453ea8ff40354b48d7a1": {"prediction": {"id": "6d191c47f354453ea8ff40354b48d7a1", "prediction_text": "NCX"}, "reference": {"id": "6d191c47f354453ea8ff40354b48d7a1", "answers": {"answer_start": [127, 1491], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "e95d75a38d6542b8a9a97f665c19432b": {"prediction": {"id": "e95d75a38d6542b8a9a97f665c19432b", "prediction_text": "NCX"}, "reference": {"id": "e95d75a38d6542b8a9a97f665c19432b", "answers": {"answer_start": [356], "text": ["NCX"]}}}, "79c15bb577494d46907f0b02008991ad": {"prediction": {"id": "79c15bb577494d46907f0b02008991ad", "prediction_text": "Na(+)/Ca(2+"}, "reference": {"id": "79c15bb577494d46907f0b02008991ad", "answers": {"answer_start": [35], "text": ["Na(+)/Ca(2+) exchanger"]}}}, "5ea94920dba141239f2f3c7b532b4f25": {"prediction": {"id": "5ea94920dba141239f2f3c7b532b4f25", "prediction_text": "NCX"}, "reference": {"id": "5ea94920dba141239f2f3c7b532b4f25", "answers": {"answer_start": [336], "text": ["NCX"]}}}, "4e88f9ba8eeb4cb3bbc5dbbb714b9b07": {"prediction": {"id": "4e88f9ba8eeb4cb3bbc5dbbb714b9b07", "prediction_text": "NCX) inhibitor, on the NCX current and other membrane currents were examined in isolated guinea-pig ventricular myocytes and compared with those of 2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl]isothiourea (KB-R7943"}, "reference": {"id": "4e88f9ba8eeb4cb3bbc5dbbb714b9b07", "answers": {"answer_start": [390], "text": ["NCX"]}}}, "eed93a685e8746e2af175f306ec83305": {"prediction": {"id": "eed93a685e8746e2af175f306ec83305", "prediction_text": "Na(+)/Ca(2+"}, "reference": {"id": "eed93a685e8746e2af175f306ec83305", "answers": {"answer_start": [250], "text": ["Na(+)/Ca(2+) exchanger"]}}}, "4103e373c392457380a6278681b5a161": {"prediction": {"id": "4103e373c392457380a6278681b5a161", "prediction_text": "NCX 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline"}, "reference": {"id": "4103e373c392457380a6278681b5a161", "answers": {"answer_start": [20, 489], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "a333097886424b008aabbe138bdaf775": {"prediction": {"id": "a333097886424b008aabbe138bdaf775", "prediction_text": "Na+-Ca2+"}, "reference": {"id": "a333097886424b008aabbe138bdaf775", "answers": {"answer_start": [1422], "text": ["NCX"]}}}, "45b32516c94241798afc0f7fe81092ce": {"prediction": {"id": "45b32516c94241798afc0f7fe81092ce", "prediction_text": "PPADS"}, "reference": {"id": "45b32516c94241798afc0f7fe81092ce", "answers": {"answer_start": [176], "text": ["NCX"]}}}, "b91d7856aeab47159f67b588693693b2": {"prediction": {"id": "b91d7856aeab47159f67b588693693b2", "prediction_text": "nitric oxide"}, "reference": {"id": "b91d7856aeab47159f67b588693693b2", "answers": {"answer_start": [32, 420], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "3b62b1ca0cfb482aac03525fae305338": {"prediction": {"id": "3b62b1ca0cfb482aac03525fae305338", "prediction_text": "NCX"}, "reference": {"id": "3b62b1ca0cfb482aac03525fae305338", "answers": {"answer_start": [198], "text": ["NCX"]}}}, "c26daf40030540c4ba35e380b55a92fb": {"prediction": {"id": "c26daf40030540c4ba35e380b55a92fb", "prediction_text": "guanylate cyclase"}, "reference": {"id": "c26daf40030540c4ba35e380b55a92fb", "answers": {"answer_start": [471, 574], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "9ec73ed014934e908377a79c4f9f9c0c": {"prediction": {"id": "9ec73ed014934e908377a79c4f9f9c0c", "prediction_text": "Na+-Ca2+"}, "reference": {"id": "9ec73ed014934e908377a79c4f9f9c0c", "answers": {"answer_start": [1293], "text": ["NCX"]}}}, "5a41be72a39a4b279200eb72612bb377": {"prediction": {"id": "5a41be72a39a4b279200eb72612bb377", "prediction_text": "\u03b2-binomial"}, "reference": {"id": "5a41be72a39a4b279200eb72612bb377", "answers": {"answer_start": [864], "text": ["LARVA"]}}}, "2c44761c1f344a81bbfcedb6e63c3407": {"prediction": {"id": "2c44761c1f344a81bbfcedb6e63c3407", "prediction_text": "PU.1"}, "reference": {"id": "2c44761c1f344a81bbfcedb6e63c3407", "answers": {"answer_start": [689], "text": ["PU.1"]}}}, "b7bb36cc536a48d9a020253671f92d13": {"prediction": {"id": "b7bb36cc536a48d9a020253671f92d13", "prediction_text": "MBP"}, "reference": {"id": "b7bb36cc536a48d9a020253671f92d13", "answers": {"answer_start": [1325], "text": ["PU.1"]}}}, "3486f489108e442eb66ac6da500cdfe8": {"prediction": {"id": "3486f489108e442eb66ac6da500cdfe8", "prediction_text": "nuclear factor \u03baB ligand"}, "reference": {"id": "3486f489108e442eb66ac6da500cdfe8", "answers": {"answer_start": [981], "text": ["RANKL"]}}}, "8c8aa4c6e68944639092f9bb43d0b167": {"prediction": {"id": "8c8aa4c6e68944639092f9bb43d0b167", "prediction_text": "NF-\u03baB ligand"}, "reference": {"id": "8c8aa4c6e68944639092f9bb43d0b167", "answers": {"answer_start": [954], "text": ["RANKL"]}}}, "08fa6a00c61c464bae92f9190cb1982e": {"prediction": {"id": "08fa6a00c61c464bae92f9190cb1982e", "prediction_text": "monoclonal"}, "reference": {"id": "08fa6a00c61c464bae92f9190cb1982e", "answers": {"answer_start": [449], "text": ["RANKL"]}}}, "a99401a8939b4088834ac55a42abfcd0": {"prediction": {"id": "a99401a8939b4088834ac55a42abfcd0", "prediction_text": "NF-kappaB"}, "reference": {"id": "a99401a8939b4088834ac55a42abfcd0", "answers": {"answer_start": [847], "text": ["RANKL"]}}}, "6e6657715b4643d4a06bde23ff3e9bff": {"prediction": {"id": "6e6657715b4643d4a06bde23ff3e9bff", "prediction_text": "nuclear factor-kappaB ligand"}, "reference": {"id": "6e6657715b4643d4a06bde23ff3e9bff", "answers": {"answer_start": [670], "text": ["RANKL"]}}}, "5cf15ac10bb84bf79185c055d0ebeb28": {"prediction": {"id": "5cf15ac10bb84bf79185c055d0ebeb28", "prediction_text": "RANKL"}, "reference": {"id": "5cf15ac10bb84bf79185c055d0ebeb28", "answers": {"answer_start": [513], "text": ["RANKL"]}}}, "8b9d2b88ee4b499cb8edee3467bee557": {"prediction": {"id": "8b9d2b88ee4b499cb8edee3467bee557", "prediction_text": "prostate cancer"}, "reference": {"id": "8b9d2b88ee4b499cb8edee3467bee557", "answers": {"answer_start": [1736], "text": ["RANKL"]}}}, "ac3adce9d31a4cba97f45bab108c5a8c": {"prediction": {"id": "ac3adce9d31a4cba97f45bab108c5a8c", "prediction_text": "monoclonal"}, "reference": {"id": "ac3adce9d31a4cba97f45bab108c5a8c", "answers": {"answer_start": [1065], "text": ["RANKL"]}}}, "e111abc1c61640698dbd89736703c92a": {"prediction": {"id": "e111abc1c61640698dbd89736703c92a", "prediction_text": "\u03b2-blocker"}, "reference": {"id": "e111abc1c61640698dbd89736703c92a", "answers": {"answer_start": [1391], "text": ["RANKL"]}}}, "9f9f88ebe51c49ecae984a8c06d93aa5": {"prediction": {"id": "9f9f88ebe51c49ecae984a8c06d93aa5", "prediction_text": "decoy"}, "reference": {"id": "9f9f88ebe51c49ecae984a8c06d93aa5", "answers": {"answer_start": [634], "text": ["RANKL"]}}}, "61230219ae4d4bca9fa8eff587a0e2b4": {"prediction": {"id": "61230219ae4d4bca9fa8eff587a0e2b4", "prediction_text": "nuclear factor-\u03ba\u0392 ligand/receptor"}, "reference": {"id": "61230219ae4d4bca9fa8eff587a0e2b4", "answers": {"answer_start": [1287], "text": ["RANKL"]}}}, "a627e461e7ab457bacf54ddc52a4b6d6": {"prediction": {"id": "a627e461e7ab457bacf54ddc52a4b6d6", "prediction_text": "chronic lymphocytic leukemia"}, "reference": {"id": "a627e461e7ab457bacf54ddc52a4b6d6", "answers": {"answer_start": [397], "text": ["RANKL"]}}}, "42d6a7dd30a74e748ff793e607214d31": {"prediction": {"id": "42d6a7dd30a74e748ff793e607214d31", "prediction_text": "RANKL"}, "reference": {"id": "42d6a7dd30a74e748ff793e607214d31", "answers": {"answer_start": [1192], "text": ["RANKL"]}}}, "301ceec3d9424d9caf9bf5b1ea46743f": {"prediction": {"id": "301ceec3d9424d9caf9bf5b1ea46743f", "prediction_text": "RANK"}, "reference": {"id": "301ceec3d9424d9caf9bf5b1ea46743f", "answers": {"answer_start": [766], "text": ["RANKL"]}}}, "209805cb38f14d2d831c6599ccd6c6ce": {"prediction": {"id": "209805cb38f14d2d831c6599ccd6c6ce", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "209805cb38f14d2d831c6599ccd6c6ce", "answers": {"answer_start": [809], "text": ["\u03b1-synuclein"]}}}, "e31f1f1e6ebc4fdfaae7747e4be4cdcb": {"prediction": {"id": "e31f1f1e6ebc4fdfaae7747e4be4cdcb", "prediction_text": "presynaptic protein alpha-synuclein"}, "reference": {"id": "e31f1f1e6ebc4fdfaae7747e4be4cdcb", "answers": {"answer_start": [344], "text": ["alpha-synuclein"]}}}, "b536657d388a4f2a9b0d861eb49e7978": {"prediction": {"id": "b536657d388a4f2a9b0d861eb49e7978", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "b536657d388a4f2a9b0d861eb49e7978", "answers": {"answer_start": [167], "text": ["\u03b1-synuclein"]}}}, "0d58e815be4442619660c5bdb97854ac": {"prediction": {"id": "0d58e815be4442619660c5bdb97854ac", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "0d58e815be4442619660c5bdb97854ac", "answers": {"answer_start": [0], "text": ["alpha-synuclein"]}}}, "b6160e4fa49441e29b475b187e6c2e84": {"prediction": {"id": "b6160e4fa49441e29b475b187e6c2e84", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "b6160e4fa49441e29b475b187e6c2e84", "answers": {"answer_start": [149], "text": ["\u03b1-synuclein"]}}}, "e420245e4dcf46ed81d24d57cdc39bd8": {"prediction": {"id": "e420245e4dcf46ed81d24d57cdc39bd8", "prediction_text": "alpha-synuclein"}, "reference": {"id": "e420245e4dcf46ed81d24d57cdc39bd8", "answers": {"answer_start": [343], "text": ["alpha-synuclein"]}}}, "a805552329344f34b147f91a7b68a941": {"prediction": {"id": "a805552329344f34b147f91a7b68a941", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "a805552329344f34b147f91a7b68a941", "answers": {"answer_start": [15, 967], "text": ["\u03b1-synuclein", "\u03b1Syn"]}}}, "26a3f9aae8034dd990aa0240b8454634": {"prediction": {"id": "26a3f9aae8034dd990aa0240b8454634", "prediction_text": "alpha-synuclein filaments"}, "reference": {"id": "26a3f9aae8034dd990aa0240b8454634", "answers": {"answer_start": [1055], "text": ["alpha-synuclein"]}}}, "d17db2d2f8b649b38a429e7e3bf1bff4": {"prediction": {"id": "d17db2d2f8b649b38a429e7e3bf1bff4", "prediction_text": "alpha-synuclein"}, "reference": {"id": "d17db2d2f8b649b38a429e7e3bf1bff4", "answers": {"answer_start": [776], "text": ["alpha-synuclein"]}}}, "21c022bba11a4edcb04b3234e6b3121e": {"prediction": {"id": "21c022bba11a4edcb04b3234e6b3121e", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "21c022bba11a4edcb04b3234e6b3121e", "answers": {"answer_start": [252], "text": ["\u03b1-synuclein"]}}}, "ab1898ed7c34475c9b49664bba4b4900": {"prediction": {"id": "ab1898ed7c34475c9b49664bba4b4900", "prediction_text": "Fibrillar \u03b1-synuclein"}, "reference": {"id": "ab1898ed7c34475c9b49664bba4b4900", "answers": {"answer_start": [10], "text": ["\u03b1-synuclein"]}}}, "195d27b966f34a58a4a9ff853b6408d4": {"prediction": {"id": "195d27b966f34a58a4a9ff853b6408d4", "prediction_text": "Fibrillar \u03b1-synuclein"}, "reference": {"id": "195d27b966f34a58a4a9ff853b6408d4", "answers": {"answer_start": [10], "text": ["\u03b1-synuclein"]}}}, "cf77dc6452f846788b44e4e78e16fdca": {"prediction": {"id": "cf77dc6452f846788b44e4e78e16fdca", "prediction_text": "\u03b2-amyloid protein levels in cortical regions with and without Lewy bodies. In all Lewy body disease cases, we identified decreased ATP13A2 protein levels that correlated with increases in both \u03b1-synuclein and \u03b2-amyloid. Partial colocalization was observed between ATP13A2 and \u03b1-synuclein"}, "reference": {"id": "cf77dc6452f846788b44e4e78e16fdca", "answers": {"answer_start": [853], "text": ["\u03b1-synuclein"]}}}, "701e9f74ef7b4b1aa448ec37fceb18ae": {"prediction": {"id": "701e9f74ef7b4b1aa448ec37fceb18ae", "prediction_text": "alpha-synuclein"}, "reference": {"id": "701e9f74ef7b4b1aa448ec37fceb18ae", "answers": {"answer_start": [1031], "text": ["alpha-synuclein"]}}}, "b99726f7bdb8416c89bff48f4fb75b1f": {"prediction": {"id": "b99726f7bdb8416c89bff48f4fb75b1f", "prediction_text": "alpha-synuclein"}, "reference": {"id": "b99726f7bdb8416c89bff48f4fb75b1f", "answers": {"answer_start": [767], "text": ["alpha-synuclein"]}}}, "2b31a755fbab499cbd20561423296179": {"prediction": {"id": "2b31a755fbab499cbd20561423296179", "prediction_text": "alpha-synuclein"}, "reference": {"id": "2b31a755fbab499cbd20561423296179", "answers": {"answer_start": [697], "text": ["alpha-synuclein"]}}}, "468d7736bfb34d20b5ea61bf25a2fffd": {"prediction": {"id": "468d7736bfb34d20b5ea61bf25a2fffd", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "468d7736bfb34d20b5ea61bf25a2fffd", "answers": {"answer_start": [0], "text": ["alpha-synuclein"]}}}, "bd7c19f731c24eefb7ae72121e51aed8": {"prediction": {"id": "bd7c19f731c24eefb7ae72121e51aed8", "prediction_text": "alpha-synuclein"}, "reference": {"id": "bd7c19f731c24eefb7ae72121e51aed8", "answers": {"answer_start": [508], "text": ["alpha-synuclein"]}}}, "0811599be9df4048b6abae67d300616d": {"prediction": {"id": "0811599be9df4048b6abae67d300616d", "prediction_text": "TDP-43"}, "reference": {"id": "0811599be9df4048b6abae67d300616d", "answers": {"answer_start": [1014], "text": ["alpha-synuclein"]}}}, "e53186ed511c4f83af4948c30491408b": {"prediction": {"id": "e53186ed511c4f83af4948c30491408b", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "e53186ed511c4f83af4948c30491408b", "answers": {"answer_start": [1031], "text": ["alpha-synuclein"]}}}, "c758931cdbae463496012c4c901cda38": {"prediction": {"id": "c758931cdbae463496012c4c901cda38", "prediction_text": "fibrillar"}, "reference": {"id": "c758931cdbae463496012c4c901cda38", "answers": {"answer_start": [6], "text": ["\u03b1-synuclein"]}}}, "689620d9de644b4987cb359d20796f68": {"prediction": {"id": "689620d9de644b4987cb359d20796f68", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "689620d9de644b4987cb359d20796f68", "answers": {"answer_start": [698], "text": ["alpha-synuclein"]}}}, "e6abe4b48ef54202adffcbfd2f760209": {"prediction": {"id": "e6abe4b48ef54202adffcbfd2f760209", "prediction_text": "Lipids"}, "reference": {"id": "e6abe4b48ef54202adffcbfd2f760209", "answers": {"answer_start": [370], "text": ["alpha-synuclein"]}}}, "1672d1e4b8fd421cbc7098f74ace76c9": {"prediction": {"id": "1672d1e4b8fd421cbc7098f74ace76c9", "prediction_text": "caspase-cleaved TDP-43"}, "reference": {"id": "1672d1e4b8fd421cbc7098f74ace76c9", "answers": {"answer_start": [986], "text": ["alpha-synuclein"]}}}, "aceab6340db74ecaa6589d960db1fa77": {"prediction": {"id": "aceab6340db74ecaa6589d960db1fa77", "prediction_text": "alpha-synuclein"}, "reference": {"id": "aceab6340db74ecaa6589d960db1fa77", "answers": {"answer_start": [1111], "text": ["alpha-synuclein"]}}}, "20fbfb23fdbf4f24af6bdae784ac5e08": {"prediction": {"id": "20fbfb23fdbf4f24af6bdae784ac5e08", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "20fbfb23fdbf4f24af6bdae784ac5e08", "answers": {"answer_start": [0], "text": ["alpha-synuclein"]}}}, "c92b08c54851444da782765409079832": {"prediction": {"id": "c92b08c54851444da782765409079832", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "c92b08c54851444da782765409079832", "answers": {"answer_start": [282], "text": ["alpha-synuclein"]}}}, "5b66cc44d4e944b6ad47273509397d02": {"prediction": {"id": "5b66cc44d4e944b6ad47273509397d02", "prediction_text": "\u03b1-Synuclein (\u03b1-syn) is a soluble protein present in the pre-synaptic terminal of neurons. Evidence suggests that \u03b1-syn"}, "reference": {"id": "5b66cc44d4e944b6ad47273509397d02", "answers": {"answer_start": [225], "text": ["\u03b1-synuclein"]}}}, "b2494e439b8640d5a2962a9cde036930": {"prediction": {"id": "b2494e439b8640d5a2962a9cde036930", "prediction_text": "alpha-synuclein"}, "reference": {"id": "b2494e439b8640d5a2962a9cde036930", "answers": {"answer_start": [910], "text": ["alpha-synuclein"]}}}, "20e4faf3a9de448ba7cce572275301f3": {"prediction": {"id": "20e4faf3a9de448ba7cce572275301f3", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "20e4faf3a9de448ba7cce572275301f3", "answers": {"answer_start": [450], "text": ["\u03b1-synuclein"]}}}, "d80618cda8db46b9b28661e3621e5718": {"prediction": {"id": "d80618cda8db46b9b28661e3621e5718", "prediction_text": "alpha-synuclein"}, "reference": {"id": "d80618cda8db46b9b28661e3621e5718", "answers": {"answer_start": [413], "text": ["alpha-synuclein"]}}}, "f4d7189379f34ed693bfaf98793580a5": {"prediction": {"id": "f4d7189379f34ed693bfaf98793580a5", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "f4d7189379f34ed693bfaf98793580a5", "answers": {"answer_start": [1593], "text": ["\u03b1-synuclein"]}}}, "0aaf3f5894e14f7aaa7a4b0f7986f120": {"prediction": {"id": "0aaf3f5894e14f7aaa7a4b0f7986f120", "prediction_text": "alpha-Syn"}, "reference": {"id": "0aaf3f5894e14f7aaa7a4b0f7986f120", "answers": {"answer_start": [199], "text": ["alpha-synuclein"]}}}, "1b82c57ab6e4417ba56a0b14f19ade30": {"prediction": {"id": "1b82c57ab6e4417ba56a0b14f19ade30", "prediction_text": "LB"}, "reference": {"id": "1b82c57ab6e4417ba56a0b14f19ade30", "answers": {"answer_start": [450], "text": ["alpha-synuclein"]}}}, "85f7453af9004e9585d48d3ff2dc431f": {"prediction": {"id": "85f7453af9004e9585d48d3ff2dc431f", "prediction_text": "alpha-synuclein"}, "reference": {"id": "85f7453af9004e9585d48d3ff2dc431f", "answers": {"answer_start": [12], "text": ["alpha-synuclein"]}}}, "efc157b28b6d4937876c1875ff14d36a": {"prediction": {"id": "efc157b28b6d4937876c1875ff14d36a", "prediction_text": "alpha-synuclein"}, "reference": {"id": "efc157b28b6d4937876c1875ff14d36a", "answers": {"answer_start": [12], "text": ["alpha-synuclein"]}}}, "cb781a280d7a4af7b5cd9b4f42149deb": {"prediction": {"id": "cb781a280d7a4af7b5cd9b4f42149deb", "prediction_text": "alpha-synuclein"}, "reference": {"id": "cb781a280d7a4af7b5cd9b4f42149deb", "answers": {"answer_start": [17], "text": ["alpha-synuclein"]}}}, "113ce2933d934ea38af0be0dd75784e8": {"prediction": {"id": "113ce2933d934ea38af0be0dd75784e8", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "113ce2933d934ea38af0be0dd75784e8", "answers": {"answer_start": [0], "text": ["alpha-synuclein"]}}}, "3e96d94e1a5849918a4a90bed00bc982": {"prediction": {"id": "3e96d94e1a5849918a4a90bed00bc982", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "3e96d94e1a5849918a4a90bed00bc982", "answers": {"answer_start": [481], "text": ["\u03b1-synuclein"]}}}, "bbcbba74dbcd4e5d8e63948d7ab2db84": {"prediction": {"id": "bbcbba74dbcd4e5d8e63948d7ab2db84", "prediction_text": "amyloid fibrils"}, "reference": {"id": "bbcbba74dbcd4e5d8e63948d7ab2db84", "answers": {"answer_start": [0, 1046], "text": ["\u03b1-synuclein", "\u03b1Syn"]}}}, "1c5b5f6f4aa24a12a173eade3b311fd0": {"prediction": {"id": "1c5b5f6f4aa24a12a173eade3b311fd0", "prediction_text": "beta-spectrin"}, "reference": {"id": "1c5b5f6f4aa24a12a173eade3b311fd0", "answers": {"answer_start": [1683], "text": ["\u03b1-synuclein"]}}}, "28bf28f66c6a4259821c4c33246678c4": {"prediction": {"id": "28bf28f66c6a4259821c4c33246678c4", "prediction_text": "alpha-synuclein"}, "reference": {"id": "28bf28f66c6a4259821c4c33246678c4", "answers": {"answer_start": [1661], "text": ["alpha-synuclein"]}}}, "6b1dc9142a7c4cc38c87ab4b1ccdc450": {"prediction": {"id": "6b1dc9142a7c4cc38c87ab4b1ccdc450", "prediction_text": "alpha-synuclein"}, "reference": {"id": "6b1dc9142a7c4cc38c87ab4b1ccdc450", "answers": {"answer_start": [1431], "text": ["alpha-synuclein"]}}}, "c28cb603cab641498123a4ddbb475b76": {"prediction": {"id": "c28cb603cab641498123a4ddbb475b76", "prediction_text": "misfolded alpha-synuclein"}, "reference": {"id": "c28cb603cab641498123a4ddbb475b76", "answers": {"answer_start": [305], "text": ["alpha-synuclein"]}}}, "7a98d905dc6c4b43aa5df1ce52e74359": {"prediction": {"id": "7a98d905dc6c4b43aa5df1ce52e74359", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "7a98d905dc6c4b43aa5df1ce52e74359", "answers": {"answer_start": [1208], "text": ["\u03b1-synuclein"]}}}, "8a5c7f9e29a3483da2df1f33be98ad1a": {"prediction": {"id": "8a5c7f9e29a3483da2df1f33be98ad1a", "prediction_text": "deletions in AS"}, "reference": {"id": "8a5c7f9e29a3483da2df1f33be98ad1a", "answers": {"answer_start": [171], "text": ["Prader-Willi syndrome"]}}}, "487806b0668d459c92180ecb4abb79eb": {"prediction": {"id": "487806b0668d459c92180ecb4abb79eb", "prediction_text": "maternal inheritance"}, "reference": {"id": "487806b0668d459c92180ecb4abb79eb", "answers": {"answer_start": [5], "text": ["Prader-Willi syndrome"]}}}, "bf545711d10d419599d3c5e1ca107ac0": {"prediction": {"id": "bf545711d10d419599d3c5e1ca107ac0", "prediction_text": "Prader-Willi syndrome"}, "reference": {"id": "bf545711d10d419599d3c5e1ca107ac0", "answers": {"answer_start": [518], "text": ["Prader-Willi syndrome"]}}}, "69d395e47073432f90a99617a06cd5f8": {"prediction": {"id": "69d395e47073432f90a99617a06cd5f8", "prediction_text": "PWS"}, "reference": {"id": "69d395e47073432f90a99617a06cd5f8", "answers": {"answer_start": [158], "text": ["Prader-Willi syndrome"]}}}, "8994a0cf3eaf465b935af8d8d83bb2c9": {"prediction": {"id": "8994a0cf3eaf465b935af8d8d83bb2c9", "prediction_text": "9.27 \u00b1 3.16 years"}, "reference": {"id": "8994a0cf3eaf465b935af8d8d83bb2c9", "answers": {"answer_start": [0], "text": ["Prader-Willi syndrome"]}}}, "c63ebefa817741f5a9356a6c50a31027": {"prediction": {"id": "c63ebefa817741f5a9356a6c50a31027", "prediction_text": "loss-of-function mutations"}, "reference": {"id": "c63ebefa817741f5a9356a6c50a31027", "answers": {"answer_start": [1756], "text": ["Recessive hypolipidemia"]}}}, "dc164febd1c14ccb835287f16a6238e3": {"prediction": {"id": "dc164febd1c14ccb835287f16a6238e3", "prediction_text": "SLC9A6"}, "reference": {"id": "dc164febd1c14ccb835287f16a6238e3", "answers": {"answer_start": [287], "text": ["SLC9A6"]}}}, "115c423ca2e947318f08ea0526f0d7a9": {"prediction": {"id": "115c423ca2e947318f08ea0526f0d7a9", "prediction_text": "X"}, "reference": {"id": "115c423ca2e947318f08ea0526f0d7a9", "answers": {"answer_start": [466], "text": ["SLC9A6"]}}}, "628f2a923c4643e9bab461cf1a41d682": {"prediction": {"id": "628f2a923c4643e9bab461cf1a41d682", "prediction_text": "SLC9A6"}, "reference": {"id": "628f2a923c4643e9bab461cf1a41d682", "answers": {"answer_start": [17], "text": ["SLC9A6"]}}}, "bd26a91dfc1e46169c6c776c592f4531": {"prediction": {"id": "bd26a91dfc1e46169c6c776c592f4531", "prediction_text": "SLC9A6"}, "reference": {"id": "bd26a91dfc1e46169c6c776c592f4531", "answers": {"answer_start": [557], "text": ["SLC9A6"]}}}, "b2398ab405224336b8d7a65bed5ba338": {"prediction": {"id": "b2398ab405224336b8d7a65bed5ba338", "prediction_text": "CS"}, "reference": {"id": "b2398ab405224336b8d7a65bed5ba338", "answers": {"answer_start": [105], "text": ["SLC9A6"]}}}, "6616d9034f6a4439855dfe8abb69f69d": {"prediction": {"id": "6616d9034f6a4439855dfe8abb69f69d", "prediction_text": "SLC9A6"}, "reference": {"id": "6616d9034f6a4439855dfe8abb69f69d", "answers": {"answer_start": [303], "text": ["SLC9A6"]}}}, "400e9a8c434343ec83431accb9b19553": {"prediction": {"id": "400e9a8c434343ec83431accb9b19553", "prediction_text": "TCF4"}, "reference": {"id": "400e9a8c434343ec83431accb9b19553", "answers": {"answer_start": [413], "text": ["SLC9A6"]}}}, "8694f06a2abe46f78409a5cfc245b8a5": {"prediction": {"id": "8694f06a2abe46f78409a5cfc245b8a5", "prediction_text": "SLC9A6"}, "reference": {"id": "8694f06a2abe46f78409a5cfc245b8a5", "answers": {"answer_start": [1010], "text": ["SLC9A6"]}}}, "a6a4f3d89398432a928c6cb2579e4a5d": {"prediction": {"id": "a6a4f3d89398432a928c6cb2579e4a5d", "prediction_text": "SLC9A6"}, "reference": {"id": "a6a4f3d89398432a928c6cb2579e4a5d", "answers": {"answer_start": [576], "text": ["SLC9A6"]}}}, "a98fd1d150724b96a1b6e26510a89c30": {"prediction": {"id": "a98fd1d150724b96a1b6e26510a89c30", "prediction_text": "sodium-hydrogen exchanger 6"}, "reference": {"id": "a98fd1d150724b96a1b6e26510a89c30", "answers": {"answer_start": [2091], "text": ["SLC9A6"]}}}, "69d32a86aac54cca904c5899d226c79a": {"prediction": {"id": "69d32a86aac54cca904c5899d226c79a", "prediction_text": "UBE3A"}, "reference": {"id": "69d32a86aac54cca904c5899d226c79a", "answers": {"answer_start": [879], "text": ["SLC9A6"]}}}, "56ff05456c6e482385c5b66b395c4289": {"prediction": {"id": "56ff05456c6e482385c5b66b395c4289", "prediction_text": "SLC9A6"}, "reference": {"id": "56ff05456c6e482385c5b66b395c4289", "answers": {"answer_start": [124], "text": ["SLC9A6"]}}}, "7ea72d03a7d44486b9b6952df6ec253a": {"prediction": {"id": "7ea72d03a7d44486b9b6952df6ec253a", "prediction_text": "SLC9A6"}, "reference": {"id": "7ea72d03a7d44486b9b6952df6ec253a", "answers": {"answer_start": [1702], "text": ["SLC9A6"]}}}, "328195af96124a239333bc9d4ec74bfc": {"prediction": {"id": "328195af96124a239333bc9d4ec74bfc", "prediction_text": "OMIM 300243"}, "reference": {"id": "328195af96124a239333bc9d4ec74bfc", "answers": {"answer_start": [1346], "text": ["SLC9A6"]}}}, "bd741ab6cbd941159cf99525d20ec34d": {"prediction": {"id": "bd741ab6cbd941159cf99525d20ec34d", "prediction_text": "SLC9A6"}, "reference": {"id": "bd741ab6cbd941159cf99525d20ec34d", "answers": {"answer_start": [837], "text": ["SLC9A6"]}}}, "9f7b3948ee734c59bb42abfc1de958b6": {"prediction": {"id": "9f7b3948ee734c59bb42abfc1de958b6", "prediction_text": "Chediak-Higashi Syndrome"}, "reference": {"id": "9f7b3948ee734c59bb42abfc1de958b6", "answers": {"answer_start": [337], "text": ["Chediak-Higashi syndrome"]}}}, "f9d65459b9a8441483fb78487fcef8d0": {"prediction": {"id": "f9d65459b9a8441483fb78487fcef8d0", "prediction_text": "Chediak Higashi syndrome"}, "reference": {"id": "f9d65459b9a8441483fb78487fcef8d0", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "5adf8c6a6a0546d4bcf3123778c65c25": {"prediction": {"id": "5adf8c6a6a0546d4bcf3123778c65c25", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "5adf8c6a6a0546d4bcf3123778c65c25", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "bd007e7f9eb44b049b788a433473b0f0": {"prediction": {"id": "bd007e7f9eb44b049b788a433473b0f0", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "bd007e7f9eb44b049b788a433473b0f0", "answers": {"answer_start": [93], "text": ["Chediak-Higashi syndrome"]}}}, "9343251da8fa41a7a9ff0c0056c1e38c": {"prediction": {"id": "9343251da8fa41a7a9ff0c0056c1e38c", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "9343251da8fa41a7a9ff0c0056c1e38c", "answers": {"answer_start": [147], "text": ["Chediak-Higashi syndrome"]}}}, "27c05021a2cf49ca91aa158c16a96d8c": {"prediction": {"id": "27c05021a2cf49ca91aa158c16a96d8c", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "27c05021a2cf49ca91aa158c16a96d8c", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "564486408aaa4b22bb2313b93364776b": {"prediction": {"id": "564486408aaa4b22bb2313b93364776b", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "564486408aaa4b22bb2313b93364776b", "answers": {"answer_start": [926], "text": ["Chediak-Higashi syndrome"]}}}, "d19d2ee9b7634cc995d71ee87e72cd21": {"prediction": {"id": "d19d2ee9b7634cc995d71ee87e72cd21", "prediction_text": "Chediak- Higashi syndrome"}, "reference": {"id": "d19d2ee9b7634cc995d71ee87e72cd21", "answers": {"answer_start": [68], "text": ["Chediak-Higashi syndrome"]}}}, "5c97854936244d90990be81ac1a0f4bf": {"prediction": {"id": "5c97854936244d90990be81ac1a0f4bf", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "5c97854936244d90990be81ac1a0f4bf", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "8dfba52a7ce24859b43db0fd89fa6c84": {"prediction": {"id": "8dfba52a7ce24859b43db0fd89fa6c84", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "8dfba52a7ce24859b43db0fd89fa6c84", "answers": {"answer_start": [148], "text": ["Chediak-Higashi syndrome"]}}}, "3bccb50ab05e452f874a993bf7db9ef3": {"prediction": {"id": "3bccb50ab05e452f874a993bf7db9ef3", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "3bccb50ab05e452f874a993bf7db9ef3", "answers": {"answer_start": [676], "text": ["Chediak-Higashi syndrome"]}}}, "82007549c6354377a9c269bb61ebb6b6": {"prediction": {"id": "82007549c6354377a9c269bb61ebb6b6", "prediction_text": "Chediak-Higashi Syndrome"}, "reference": {"id": "82007549c6354377a9c269bb61ebb6b6", "answers": {"answer_start": [187], "text": ["Chediak-Higashi syndrome"]}}}, "c3e971401b0b4361b1c0e308723c3ff2": {"prediction": {"id": "c3e971401b0b4361b1c0e308723c3ff2", "prediction_text": "Kufor-Rakeb syndrome"}, "reference": {"id": "c3e971401b0b4361b1c0e308723c3ff2", "answers": {"answer_start": [1253], "text": ["Chediak-Higashi syndrome"]}}}, "c33ab3d2aac74c08ab496571b30db4f9": {"prediction": {"id": "c33ab3d2aac74c08ab496571b30db4f9", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "c33ab3d2aac74c08ab496571b30db4f9", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "5c4e847e3e09402a8cff7830ec76677a": {"prediction": {"id": "5c4e847e3e09402a8cff7830ec76677a", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "5c4e847e3e09402a8cff7830ec76677a", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "93a4c0f2946f4083baa1e10f3faa658c": {"prediction": {"id": "93a4c0f2946f4083baa1e10f3faa658c", "prediction_text": "Chediak-Higashi Syndrome"}, "reference": {"id": "93a4c0f2946f4083baa1e10f3faa658c", "answers": {"answer_start": [12], "text": ["Chediak-Higashi syndrome"]}}}, "f3d823daf0e6431f9aee5069c2cd59ff": {"prediction": {"id": "f3d823daf0e6431f9aee5069c2cd59ff", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "f3d823daf0e6431f9aee5069c2cd59ff", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "2c860f4088114c3e901295b30723776c": {"prediction": {"id": "2c860f4088114c3e901295b30723776c", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "2c860f4088114c3e901295b30723776c", "answers": {"answer_start": [48], "text": ["Chediak-Higashi syndrome"]}}}, "b5dd91913dc449939090ea8a8092adbd": {"prediction": {"id": "b5dd91913dc449939090ea8a8092adbd", "prediction_text": "lymphoproliferative syndrome"}, "reference": {"id": "b5dd91913dc449939090ea8a8092adbd", "answers": {"answer_start": [265], "text": ["Chediak-Higashi syndrome"]}}}, "dca4f3e13d254450accaac8855f2f7ec": {"prediction": {"id": "dca4f3e13d254450accaac8855f2f7ec", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "dca4f3e13d254450accaac8855f2f7ec", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "eed0583b38e74729beb033132ce5ee88": {"prediction": {"id": "eed0583b38e74729beb033132ce5ee88", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "eed0583b38e74729beb033132ce5ee88", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "2b140d66933a4d85b29c4b0beb526149": {"prediction": {"id": "2b140d66933a4d85b29c4b0beb526149", "prediction_text": "plays a role in serotonin clearance and influences mood and behavior. Protein kinase signaling mediates rapid modulation of cerebral processes, but little is known about acute regulation of OCT3 by protein kinases. Therefore, we cloned mouse OCT3 (mOCT3) and generated a human embryonic kidney cell line stably expressing the transporter to study transport characteristics, acute regulation by protein kinases, and interaction with psychotropic drugs. Uptake measurement was performed using the fluorescent cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP(+), 1\u00a0\u03bcM) as a substrate. The translational value of these findings was determined by comparing results obtained with cloned mouse and human OCT3. mOCT3-mediated transport is membrane potential dependent and pH independent. ASP(+) uptake"}, "reference": {"id": "2b140d66933a4d85b29c4b0beb526149", "answers": {"answer_start": [214], "text": ["serotonin clearance"]}}}, "d988cf19b84d4d2fb3cb21fad1b416b5": {"prediction": {"id": "d988cf19b84d4d2fb3cb21fad1b416b5", "prediction_text": "male"}, "reference": {"id": "d988cf19b84d4d2fb3cb21fad1b416b5", "answers": {"answer_start": [1337], "text": ["Women"]}}}, "73f03e3e62514bbebd6856285c378bb1": {"prediction": {"id": "73f03e3e62514bbebd6856285c378bb1", "prediction_text": "not only more common"}, "reference": {"id": "73f03e3e62514bbebd6856285c378bb1", "answers": {"answer_start": [1320], "text": ["Women"]}}}, "f986bfaad9424891b114fa0ce6253841": {"prediction": {"id": "f986bfaad9424891b114fa0ce6253841", "prediction_text": "not in men"}, "reference": {"id": "f986bfaad9424891b114fa0ce6253841", "answers": {"answer_start": [1297], "text": ["Women"]}}}, "39ab78568a944322a43fa1b96e5c1355": {"prediction": {"id": "39ab78568a944322a43fa1b96e5c1355", "prediction_text": "women"}, "reference": {"id": "39ab78568a944322a43fa1b96e5c1355", "answers": {"answer_start": [900], "text": ["Women"]}}}, "f238aa561d924950b587f264e51d877d": {"prediction": {"id": "f238aa561d924950b587f264e51d877d", "prediction_text": "women"}, "reference": {"id": "f238aa561d924950b587f264e51d877d", "answers": {"answer_start": [786], "text": ["Women"]}}}, "729a00e18c944bac898ddee3e0b0a1f1": {"prediction": {"id": "729a00e18c944bac898ddee3e0b0a1f1", "prediction_text": "women and men showed the same degree of radiological changes and functional ability and were treated similarly except for the more frequent use of hydroxychloroquine in women"}, "reference": {"id": "729a00e18c944bac898ddee3e0b0a1f1", "answers": {"answer_start": [1255], "text": ["Women"]}}}, "2e5a240286ad433bbd36ec1af48179d2": {"prediction": {"id": "2e5a240286ad433bbd36ec1af48179d2", "prediction_text": "women"}, "reference": {"id": "2e5a240286ad433bbd36ec1af48179d2", "answers": {"answer_start": [1012], "text": ["Women"]}}}, "5130df924ea84e16bf156cce2d9dbdcc": {"prediction": {"id": "5130df924ea84e16bf156cce2d9dbdcc", "prediction_text": "not in women"}, "reference": {"id": "5130df924ea84e16bf156cce2d9dbdcc", "answers": {"answer_start": [1176], "text": ["Women"]}}}, "e7eb42ce589a4454ae1b2ec80b7496b7": {"prediction": {"id": "e7eb42ce589a4454ae1b2ec80b7496b7", "prediction_text": "women"}, "reference": {"id": "e7eb42ce589a4454ae1b2ec80b7496b7", "answers": {"answer_start": [86], "text": ["Women"]}}}, "d56a17919934480fbd5ea8c9522890a8": {"prediction": {"id": "d56a17919934480fbd5ea8c9522890a8", "prediction_text": "women, whereas most of the patients with IBD or psoriasis were men"}, "reference": {"id": "d56a17919934480fbd5ea8c9522890a8", "answers": {"answer_start": [1522], "text": ["Women"]}}}, "49bf6c6ee7e141fdb10903c875127a27": {"prediction": {"id": "49bf6c6ee7e141fdb10903c875127a27", "prediction_text": "FAM105B"}, "reference": {"id": "49bf6c6ee7e141fdb10903c875127a27", "answers": {"answer_start": [710], "text": ["deubiquitination"]}}}, "457ec4261cea4a60a2a857292d8d225b": {"prediction": {"id": "457ec4261cea4a60a2a857292d8d225b", "prediction_text": "a neuromuscular, degenerative and progressive disease"}, "reference": {"id": "457ec4261cea4a60a2a857292d8d225b", "answers": {"answer_start": [92], "text": ["autosomal dominant"]}}}, "01bf1713206a4f6f8b1eed7a6926a3fa": {"prediction": {"id": "01bf1713206a4f6f8b1eed7a6926a3fa", "prediction_text": "mainly by the autosomal dominant type"}, "reference": {"id": "01bf1713206a4f6f8b1eed7a6926a3fa", "answers": {"answer_start": [75], "text": ["autosomal dominant"]}}}, "9dcf804f3e7345749613f4f5d531fa17": {"prediction": {"id": "9dcf804f3e7345749613f4f5d531fa17", "prediction_text": "an expansion of a CTG triplet repeat in the DMPK gene"}, "reference": {"id": "9dcf804f3e7345749613f4f5d531fa17", "answers": {"answer_start": [38], "text": ["autosomal dominant"]}}}, "78aeb7acd6a74b0c980c43b35aa55455": {"prediction": {"id": "78aeb7acd6a74b0c980c43b35aa55455", "prediction_text": "a clinically and genetically heterogeneous neuromuscular disorder"}, "reference": {"id": "78aeb7acd6a74b0c980c43b35aa55455", "answers": {"answer_start": [172], "text": ["autosomal dominant"]}}}, "3376f2e0ecfb4dba8a6fcf28801d7fbf": {"prediction": {"id": "3376f2e0ecfb4dba8a6fcf28801d7fbf", "prediction_text": "CCTG tetranucleotide repeat expansion located in intron 1 of the zinc finger protein 9 gene (ZNF9 gene) on chromosome 3q 21.3"}, "reference": {"id": "3376f2e0ecfb4dba8a6fcf28801d7fbf", "answers": {"answer_start": [38], "text": ["autosomal dominant"]}}}, "a5d0195ba8f44601b684bc53c93a5e71": {"prediction": {"id": "a5d0195ba8f44601b684bc53c93a5e71", "prediction_text": "INteractive Codon usage Analysis"}, "reference": {"id": "a5d0195ba8f44601b684bc53c93a5e71", "answers": {"answer_start": [595], "text": ["INCA"]}}}, "fd431d27000b4e79b3ced7106ca28837": {"prediction": {"id": "fd431d27000b4e79b3ced7106ca28837", "prediction_text": "serine 129"}, "reference": {"id": "fd431d27000b4e79b3ced7106ca28837", "answers": {"answer_start": [34], "text": ["Serine 129"]}}}, "df66596793dd4f42b84d24ecc80cb356": {"prediction": {"id": "df66596793dd4f42b84d24ecc80cb356", "prediction_text": "serine 129"}, "reference": {"id": "df66596793dd4f42b84d24ecc80cb356", "answers": {"answer_start": [37], "text": ["Serine 129"]}}}, "396463c863b94fa8838c5d1caba9f7e9": {"prediction": {"id": "396463c863b94fa8838c5d1caba9f7e9", "prediction_text": "\u03b1-syn"}, "reference": {"id": "396463c863b94fa8838c5d1caba9f7e9", "answers": {"answer_start": [367], "text": ["Serine 129"]}}}, "d7becd250f31430b96a8ef3890a126db": {"prediction": {"id": "d7becd250f31430b96a8ef3890a126db", "prediction_text": "Mycobacterium tuberculosis"}, "reference": {"id": "d7becd250f31430b96a8ef3890a126db", "answers": {"answer_start": [78], "text": ["tuberculosis"]}}}, "859bfcbdb2564accbeb7acb447100ccb": {"prediction": {"id": "859bfcbdb2564accbeb7acb447100ccb", "prediction_text": "TST (by standard Mantoux technique) and IGRA (by QuantiFERON-TB) as first- and second-level screening tests, respectively. Out of 2290 HCW enrolled, 141 (6.1%) had a positive TST; among them, 99 (70.2%) underwent the IGRA and 16 tested positive (16.1%). The frequency of HCW tested positive for TB"}, "reference": {"id": "859bfcbdb2564accbeb7acb447100ccb", "answers": {"answer_start": [64], "text": ["tuberculosis"]}}}, "680d2d0264b2457d8c3bf0f584b2a5f8": {"prediction": {"id": "680d2d0264b2457d8c3bf0f584b2a5f8", "prediction_text": "tuberculosis"}, "reference": {"id": "680d2d0264b2457d8c3bf0f584b2a5f8", "answers": {"answer_start": [615], "text": ["tuberculosis"]}}}, "5c37f11aa0584677ba6f93c440709088": {"prediction": {"id": "5c37f11aa0584677ba6f93c440709088", "prediction_text": "tuberculosis"}, "reference": {"id": "5c37f11aa0584677ba6f93c440709088", "answers": {"answer_start": [68], "text": ["tuberculosis"]}}}, "035cbb61a57240c3b2a1d09e5335fee4": {"prediction": {"id": "035cbb61a57240c3b2a1d09e5335fee4", "prediction_text": "pathogenic mycobacteria"}, "reference": {"id": "035cbb61a57240c3b2a1d09e5335fee4", "answers": {"answer_start": [196], "text": ["tuberculosis"]}}}, "706c24e9aa6645b2938414d3629cd861": {"prediction": {"id": "706c24e9aa6645b2938414d3629cd861", "prediction_text": "tuberculosis"}, "reference": {"id": "706c24e9aa6645b2938414d3629cd861", "answers": {"answer_start": [658], "text": ["tuberculosis"]}}}, "d0d2c988ff9d45528c3bc6fa34f1a0ce": {"prediction": {"id": "d0d2c988ff9d45528c3bc6fa34f1a0ce", "prediction_text": "TB disease and 278 latent tuberculosis"}, "reference": {"id": "d0d2c988ff9d45528c3bc6fa34f1a0ce", "answers": {"answer_start": [810], "text": ["tuberculosis"]}}}, "bff3afdabb92486ebb8659af121f00fe": {"prediction": {"id": "bff3afdabb92486ebb8659af121f00fe", "prediction_text": "tuberculosis"}, "reference": {"id": "bff3afdabb92486ebb8659af121f00fe", "answers": {"answer_start": [86], "text": ["tuberculosis"]}}}, "58d588f3016948bea9874e4be87b5841": {"prediction": {"id": "58d588f3016948bea9874e4be87b5841", "prediction_text": "tuberculosis"}, "reference": {"id": "58d588f3016948bea9874e4be87b5841", "answers": {"answer_start": [865], "text": ["tuberculosis"]}}}, "63c1597e34244536b84b5151d9f30866": {"prediction": {"id": "63c1597e34244536b84b5151d9f30866", "prediction_text": "tuberculosis"}, "reference": {"id": "63c1597e34244536b84b5151d9f30866", "answers": {"answer_start": [0], "text": ["tuberculosis"]}}}, "9081a81a6c984b9190a1004fb8d6dd86": {"prediction": {"id": "9081a81a6c984b9190a1004fb8d6dd86", "prediction_text": "eight"}, "reference": {"id": "9081a81a6c984b9190a1004fb8d6dd86", "answers": {"answer_start": [423], "text": ["eight"]}}}, "7c81b48eefdd43c59362f6f523ce4104": {"prediction": {"id": "7c81b48eefdd43c59362f6f523ce4104", "prediction_text": "tyrosine"}, "reference": {"id": "7c81b48eefdd43c59362f6f523ce4104", "answers": {"answer_start": [58], "text": ["Protein-Tyrosine Kinase"]}}}, "d9eabd351d9343cb957f2901d55ab303": {"prediction": {"id": "d9eabd351d9343cb957f2901d55ab303", "prediction_text": "mismatch repair were also defective in the transcription-coupled repair (TCR) of UV"}, "reference": {"id": "d9eabd351d9343cb957f2901d55ab303", "answers": {"answer_start": [513], "text": ["the transcribed strand"]}}}, "30810cd5ff054e94aa9eb2fb8eedf4f4": {"prediction": {"id": "30810cd5ff054e94aa9eb2fb8eedf4f4", "prediction_text": "global genome repair"}, "reference": {"id": "30810cd5ff054e94aa9eb2fb8eedf4f4", "answers": {"answer_start": [524], "text": ["the transcribed strand"]}}}, "0382632bf521441180defcf4babfeaa1": {"prediction": {"id": "0382632bf521441180defcf4babfeaa1", "prediction_text": "hMSH2"}, "reference": {"id": "0382632bf521441180defcf4babfeaa1", "answers": {"answer_start": [669], "text": ["the transcribed strand"]}}}, "f60f400ad3c1490dab6977b6eba05115": {"prediction": {"id": "f60f400ad3c1490dab6977b6eba05115", "prediction_text": "RNA polymerase II"}, "reference": {"id": "f60f400ad3c1490dab6977b6eba05115", "answers": {"answer_start": [99], "text": ["the transcribed strand"]}}}, "b816a381bff149fbb5eaacd50a506f9d": {"prediction": {"id": "b816a381bff149fbb5eaacd50a506f9d", "prediction_text": "nucleotide excision repair"}, "reference": {"id": "b816a381bff149fbb5eaacd50a506f9d", "answers": {"answer_start": [843], "text": ["the transcribed strand"]}}}, "8c5a728cdffb44e59c9805a51e94eba4": {"prediction": {"id": "8c5a728cdffb44e59c9805a51e94eba4", "prediction_text": "NER"}, "reference": {"id": "8c5a728cdffb44e59c9805a51e94eba4", "answers": {"answer_start": [906], "text": ["the transcribed strand"]}}}, "206243c08f364bb1a6630e4166a9dcf6": {"prediction": {"id": "206243c08f364bb1a6630e4166a9dcf6", "prediction_text": "Cockayne syndrome"}, "reference": {"id": "206243c08f364bb1a6630e4166a9dcf6", "answers": {"answer_start": [116], "text": ["the transcribed strand"]}}}, "f814f69282da4483af2939dd08c25a7e": {"prediction": {"id": "f814f69282da4483af2939dd08c25a7e", "prediction_text": "specialized nucleotide"}, "reference": {"id": "f814f69282da4483af2939dd08c25a7e", "answers": {"answer_start": [538], "text": ["the transcribed strand"]}}}, "1e4d460484a84829901e3697c390b08c": {"prediction": {"id": "1e4d460484a84829901e3697c390b08c", "prediction_text": "adenine phosphoribosyltransferase"}, "reference": {"id": "1e4d460484a84829901e3697c390b08c", "answers": {"answer_start": [992], "text": ["the transcribed strand"]}}}, "706ee3dfd9ee42cdb3676934cb03e6d8": {"prediction": {"id": "706ee3dfd9ee42cdb3676934cb03e6d8", "prediction_text": "CHO-UV61"}, "reference": {"id": "706ee3dfd9ee42cdb3676934cb03e6d8", "answers": {"answer_start": [605], "text": ["the transcribed strand"]}}}, "b1e4714eb5b84ac8a53dcfb3c25dba18": {"prediction": {"id": "b1e4714eb5b84ac8a53dcfb3c25dba18", "prediction_text": "Escherichia coli"}, "reference": {"id": "b1e4714eb5b84ac8a53dcfb3c25dba18", "answers": {"answer_start": [128], "text": ["the transcribed strand"]}}}, "b8ebd6e7ee594121ae45ab47854428f7": {"prediction": {"id": "b8ebd6e7ee594121ae45ab47854428f7", "prediction_text": "nontranscribed"}, "reference": {"id": "b8ebd6e7ee594121ae45ab47854428f7", "answers": {"answer_start": [443], "text": ["the transcribed strand"]}}}, "419b0f0b312944b092790f622f94d421": {"prediction": {"id": "419b0f0b312944b092790f622f94d421", "prediction_text": "CS fibroblasts"}, "reference": {"id": "419b0f0b312944b092790f622f94d421", "answers": {"answer_start": [1531], "text": ["the transcribed strand"]}}}, "be95846552c243148df1dc1a2e73251e": {"prediction": {"id": "be95846552c243148df1dc1a2e73251e", "prediction_text": "Cockayne syndrome B"}, "reference": {"id": "be95846552c243148df1dc1a2e73251e", "answers": {"answer_start": [883], "text": ["the transcribed strand"]}}}, "10795d0b37bf4cc19d40bf1173612f8b": {"prediction": {"id": "10795d0b37bf4cc19d40bf1173612f8b", "prediction_text": "Nucleotide excision repair (NER) is a remarkably versatile DNA repair system, essential for maintenance of genomic stability. Hereditary alterations in NER enzymes can result in increased cancer propensity, but also in developmental, neurodegenerative, and progeroid syndromes. NER can be operationally divided in three subtypes, which share many common steps: global genomic repair (GGR) operates on the whole genome level, transcription domain-associated repair (DAR"}, "reference": {"id": "10795d0b37bf4cc19d40bf1173612f8b", "answers": {"answer_start": [606], "text": ["the transcribed strand"]}}}, "c8acc2bbbb2548d9bcc498307a998a91": {"prediction": {"id": "c8acc2bbbb2548d9bcc498307a998a91", "prediction_text": "GGR"}, "reference": {"id": "c8acc2bbbb2548d9bcc498307a998a91", "answers": {"answer_start": [402], "text": ["the transcribed strand"]}}}, "4b36419894cd4449a8eac2d91c93e3b4": {"prediction": {"id": "4b36419894cd4449a8eac2d91c93e3b4", "prediction_text": "W303-1B"}, "reference": {"id": "4b36419894cd4449a8eac2d91c93e3b4", "answers": {"answer_start": [186], "text": ["the transcribed strand"]}}}, "fce61f8805da42dda1c46daa578a9a26": {"prediction": {"id": "fce61f8805da42dda1c46daa578a9a26", "prediction_text": "S-II"}, "reference": {"id": "fce61f8805da42dda1c46daa578a9a26", "answers": {"answer_start": [1350], "text": ["the transcribed strand"]}}}, "0c6ada047146428c87488b7b858bf769": {"prediction": {"id": "0c6ada047146428c87488b7b858bf769", "prediction_text": "nucleotide excision repair"}, "reference": {"id": "0c6ada047146428c87488b7b858bf769", "answers": {"answer_start": [728], "text": ["the transcribed strand"]}}}, "93a7356660784d918f6885af46a66232": {"prediction": {"id": "93a7356660784d918f6885af46a66232", "prediction_text": "dG-C8-AF"}, "reference": {"id": "93a7356660784d918f6885af46a66232", "answers": {"answer_start": [1361], "text": ["the transcribed strand"]}}}, "8f059d3f9c2f4c7688f92867934fe709": {"prediction": {"id": "8f059d3f9c2f4c7688f92867934fe709", "prediction_text": "active transcription"}, "reference": {"id": "8f059d3f9c2f4c7688f92867934fe709", "answers": {"answer_start": [582], "text": ["the transcribed strand"]}}}, "d056beb049504754bdfa585acc5ee72a": {"prediction": {"id": "d056beb049504754bdfa585acc5ee72a", "prediction_text": "excision repair pathway"}, "reference": {"id": "d056beb049504754bdfa585acc5ee72a", "answers": {"answer_start": [1360], "text": ["the transcribed strand"]}}}, "9a236a1e944b48cbaa3d1024ce8bec69": {"prediction": {"id": "9a236a1e944b48cbaa3d1024ce8bec69", "prediction_text": "thymine glycols"}, "reference": {"id": "9a236a1e944b48cbaa3d1024ce8bec69", "answers": {"answer_start": [288], "text": ["the transcribed strand"]}}}, "af24dfd9ed2a420881a903194dd2f223": {"prediction": {"id": "af24dfd9ed2a420881a903194dd2f223", "prediction_text": "T4 endonuclease V"}, "reference": {"id": "af24dfd9ed2a420881a903194dd2f223", "answers": {"answer_start": [125], "text": ["the transcribed strand"]}}}, "22414cfc7a4c48a7a7444f56868440e5": {"prediction": {"id": "22414cfc7a4c48a7a7444f56868440e5", "prediction_text": "gg) NER"}, "reference": {"id": "22414cfc7a4c48a7a7444f56868440e5", "answers": {"answer_start": [223], "text": ["the transcribed strand"]}}}, "cc849630842a483ba9bab2798de909f7": {"prediction": {"id": "cc849630842a483ba9bab2798de909f7", "prediction_text": "hereditary connective tissue disorders"}, "reference": {"id": "cc849630842a483ba9bab2798de909f7", "answers": {"answer_start": [65], "text": ["connective tissue"]}}}, "50f88aea7e914bf19bcee2abc8dd6153": {"prediction": {"id": "50f88aea7e914bf19bcee2abc8dd6153", "prediction_text": "tissue fragility"}, "reference": {"id": "50f88aea7e914bf19bcee2abc8dd6153", "answers": {"answer_start": [73], "text": ["connective tissue"]}}}, "fbeed0c10f3c4e2eb1a06a4af2fe9165": {"prediction": {"id": "fbeed0c10f3c4e2eb1a06a4af2fe9165", "prediction_text": "eyes and intestine"}, "reference": {"id": "fbeed0c10f3c4e2eb1a06a4af2fe9165", "answers": {"answer_start": [78], "text": ["connective tissue"]}}}, "cbca65be94c048199f7bceecc6bd877f": {"prediction": {"id": "cbca65be94c048199f7bceecc6bd877f", "prediction_text": "collagen deficiency"}, "reference": {"id": "cbca65be94c048199f7bceecc6bd877f", "answers": {"answer_start": [52], "text": ["connective tissue"]}}}, "4596ba6382994fda84604670736ef0c9": {"prediction": {"id": "4596ba6382994fda84604670736ef0c9", "prediction_text": "uterine fragility"}, "reference": {"id": "4596ba6382994fda84604670736ef0c9", "answers": {"answer_start": [128], "text": ["connective tissue"]}}}, "84eb9ca22dbb4315a67a17941818fc42": {"prediction": {"id": "84eb9ca22dbb4315a67a17941818fc42", "prediction_text": "tissue fragility"}, "reference": {"id": "84eb9ca22dbb4315a67a17941818fc42", "answers": {"answer_start": [49], "text": ["connective tissue"]}}}, "1588228a5daa4ce8af3904c7ace5330f": {"prediction": {"id": "1588228a5daa4ce8af3904c7ace5330f", "prediction_text": "connective"}, "reference": {"id": "1588228a5daa4ce8af3904c7ace5330f", "answers": {"answer_start": [104], "text": ["connective tissue"]}}}, "7807777db6ed4d2e9e2152e3f12ec639": {"prediction": {"id": "7807777db6ed4d2e9e2152e3f12ec639", "prediction_text": "collagen fibrils"}, "reference": {"id": "7807777db6ed4d2e9e2152e3f12ec639", "answers": {"answer_start": [1522], "text": ["connective tissue"]}}}, "72a811aad82240218f5ee88565ead0c6": {"prediction": {"id": "72a811aad82240218f5ee88565ead0c6", "prediction_text": "connective"}, "reference": {"id": "72a811aad82240218f5ee88565ead0c6", "answers": {"answer_start": [47], "text": ["connective tissue"]}}}, "89eb6bb3a4e14275be421ab08be6e81f": {"prediction": {"id": "89eb6bb3a4e14275be421ab08be6e81f", "prediction_text": "connective"}, "reference": {"id": "89eb6bb3a4e14275be421ab08be6e81f", "answers": {"answer_start": [56], "text": ["connective tissue"]}}}, "4f5eb4b8115c4a1db9ca26f55cb7ba83": {"prediction": {"id": "4f5eb4b8115c4a1db9ca26f55cb7ba83", "prediction_text": "connective"}, "reference": {"id": "4f5eb4b8115c4a1db9ca26f55cb7ba83", "answers": {"answer_start": [90], "text": ["connective tissue"]}}}, "e9c38ccba4fa448bb751b058b704528f": {"prediction": {"id": "e9c38ccba4fa448bb751b058b704528f", "prediction_text": "Collagen"}, "reference": {"id": "e9c38ccba4fa448bb751b058b704528f", "answers": {"answer_start": [67], "text": ["connective tissue"]}}}, "0abb1186f3254bc6971eca9579b0f46f": {"prediction": {"id": "0abb1186f3254bc6971eca9579b0f46f", "prediction_text": "tissue fragility, hyperelasticity of the skin and joint hypermobility"}, "reference": {"id": "0abb1186f3254bc6971eca9579b0f46f", "answers": {"answer_start": [73], "text": ["connective tissue"]}}}, "adf2c564c6274536bf7c8c58d968597a": {"prediction": {"id": "adf2c564c6274536bf7c8c58d968597a", "prediction_text": "type IV"}, "reference": {"id": "adf2c564c6274536bf7c8c58d968597a", "answers": {"answer_start": [59], "text": ["connective tissue"]}}}, "6894aa27bd34436db2d597d861df95c1": {"prediction": {"id": "6894aa27bd34436db2d597d861df95c1", "prediction_text": "tissue fragility"}, "reference": {"id": "6894aa27bd34436db2d597d861df95c1", "answers": {"answer_start": [70], "text": ["connective tissue"]}}}, "945fb63eac704d998ee212ea482ababf": {"prediction": {"id": "945fb63eac704d998ee212ea482ababf", "prediction_text": "bone fragility"}, "reference": {"id": "945fb63eac704d998ee212ea482ababf", "answers": {"answer_start": [61], "text": ["connective tissue"]}}}, "1e66114e588347219fdf951ed7d3a7eb": {"prediction": {"id": "1e66114e588347219fdf951ed7d3a7eb", "prediction_text": "tissue fragility"}, "reference": {"id": "1e66114e588347219fdf951ed7d3a7eb", "answers": {"answer_start": [99], "text": ["connective tissue"]}}}, "17b4187c32b446889b72c84304cb0b6a": {"prediction": {"id": "17b4187c32b446889b72c84304cb0b6a", "prediction_text": "connective tissue"}, "reference": {"id": "17b4187c32b446889b72c84304cb0b6a", "answers": {"answer_start": [127], "text": ["connective tissue"]}}}, "e543bf93b2f94c7db5093c2ac007d210": {"prediction": {"id": "e543bf93b2f94c7db5093c2ac007d210", "prediction_text": "tissue fragility"}, "reference": {"id": "e543bf93b2f94c7db5093c2ac007d210", "answers": {"answer_start": [68], "text": ["connective tissue"]}}}, "cd9004a8f5154996a756d5421056b681": {"prediction": {"id": "cd9004a8f5154996a756d5421056b681", "prediction_text": "haploinsufficiency of type V collagen"}, "reference": {"id": "cd9004a8f5154996a756d5421056b681", "answers": {"answer_start": [46], "text": ["connective tissue"]}}}, "a3d4f3265b2e49e0859266aa2dd3ffb8": {"prediction": {"id": "a3d4f3265b2e49e0859266aa2dd3ffb8", "prediction_text": "soft connective tissues"}, "reference": {"id": "a3d4f3265b2e49e0859266aa2dd3ffb8", "answers": {"answer_start": [43], "text": ["connective tissue"]}}}, "89e54e7edbbf4c159a9664ca441be5f4": {"prediction": {"id": "89e54e7edbbf4c159a9664ca441be5f4", "prediction_text": "ligamentous laxity and skin and tissue fragility"}, "reference": {"id": "89e54e7edbbf4c159a9664ca441be5f4", "answers": {"answer_start": [56], "text": ["connective tissue"]}}}, "d1ae3d42364540838c727df90d66af0e": {"prediction": {"id": "d1ae3d42364540838c727df90d66af0e", "prediction_text": "heritable connective tissue disorders"}, "reference": {"id": "d1ae3d42364540838c727df90d66af0e", "answers": {"answer_start": [69], "text": ["connective tissue"]}}}, "721de424b2b0425d9c9cf1a47fa40d92": {"prediction": {"id": "721de424b2b0425d9c9cf1a47fa40d92", "prediction_text": "defects in fibrillar-collagen"}, "reference": {"id": "721de424b2b0425d9c9cf1a47fa40d92", "answers": {"answer_start": [42], "text": ["connective tissue"]}}}, "acdaadfa2b3a4a6ea7e034a56a7a1d06": {"prediction": {"id": "acdaadfa2b3a4a6ea7e034a56a7a1d06", "prediction_text": "soft connective tissues"}, "reference": {"id": "acdaadfa2b3a4a6ea7e034a56a7a1d06", "answers": {"answer_start": [1707], "text": ["connective tissue"]}}}, "e769f891ab5444ae9a8ac7d9a12252ab": {"prediction": {"id": "e769f891ab5444ae9a8ac7d9a12252ab", "prediction_text": "recently evolved"}, "reference": {"id": "e769f891ab5444ae9a8ac7d9a12252ab", "answers": {"answer_start": [742], "text": ["enhancers"]}}}, "be7934c853584de3aa62183616a3b3b4": {"prediction": {"id": "be7934c853584de3aa62183616a3b3b4", "prediction_text": "evolve"}, "reference": {"id": "be7934c853584de3aa62183616a3b3b4", "answers": {"answer_start": [150], "text": ["enhancers"]}}}, "e29c4d04b1c04418aefc1acce090a948": {"prediction": {"id": "e29c4d04b1c04418aefc1acce090a948", "prediction_text": "Recent comparative studies have begun to investigate the evolution of the sequence architecture within enhancers"}, "reference": {"id": "e29c4d04b1c04418aefc1acce090a948", "answers": {"answer_start": [152], "text": ["enhancers"]}}}, "8361dda6842a429d8894b58111bb774e": {"prediction": {"id": "8361dda6842a429d8894b58111bb774e", "prediction_text": "form emerged from pre-existing ones"}, "reference": {"id": "8361dda6842a429d8894b58111bb774e", "answers": {"answer_start": [445], "text": ["enhancers"]}}}, "f9b7eb9a97c74bd9ba0ba524b497a57c": {"prediction": {"id": "f9b7eb9a97c74bd9ba0ba524b497a57c", "prediction_text": "autosomal dominant"}, "reference": {"id": "f9b7eb9a97c74bd9ba0ba524b497a57c", "answers": {"answer_start": [94], "text": ["autosomal dominant"]}}}, "a24ae6ebaf4f4597acd54688403289e4": {"prediction": {"id": "a24ae6ebaf4f4597acd54688403289e4", "prediction_text": "autosomal dominant"}, "reference": {"id": "a24ae6ebaf4f4597acd54688403289e4", "answers": {"answer_start": [657], "text": ["autosomal dominant or autosomal recessive"]}}}, "3355e146f89546a2a1dcbbc9d7120770": {"prediction": {"id": "3355e146f89546a2a1dcbbc9d7120770", "prediction_text": "totalis suffering from left upper quadrant pain"}, "reference": {"id": "3355e146f89546a2a1dcbbc9d7120770", "answers": {"answer_start": [348], "text": ["Situs inversus totalis is a rare congenital anomaly with a complete mirror image of the thoracic and abdominal organs."]}}}, "83d115ddbf0e4d55a0f53caaae14894b": {"prediction": {"id": "83d115ddbf0e4d55a0f53caaae14894b", "prediction_text": "RNA-7"}, "reference": {"id": "83d115ddbf0e4d55a0f53caaae14894b", "answers": {"answer_start": [939], "text": ["miR-7"]}}}, "6f4a84f5bdff4b079f27e8330b46081c": {"prediction": {"id": "6f4a84f5bdff4b079f27e8330b46081c", "prediction_text": "Activating point mutations"}, "reference": {"id": "6f4a84f5bdff4b079f27e8330b46081c", "answers": {"answer_start": [11], "text": ["Point mutations"]}}}, "d3cea80337ef46faaf2d3061f3922f3a": {"prediction": {"id": "d3cea80337ef46faaf2d3061f3922f3a", "prediction_text": "pancreatic carcinogenesis"}, "reference": {"id": "d3cea80337ef46faaf2d3061f3922f3a", "answers": {"answer_start": [1111], "text": ["Point mutations"]}}}, "0f91f441148e42868ea3ddf73f5c7997": {"prediction": {"id": "0f91f441148e42868ea3ddf73f5c7997", "prediction_text": "allele-specific oligonucleotide hybridization"}, "reference": {"id": "0f91f441148e42868ea3ddf73f5c7997", "answers": {"answer_start": [1107], "text": ["Point mutations"]}}}, "457103396ecf4bf983e868da073592b1": {"prediction": {"id": "457103396ecf4bf983e868da073592b1", "prediction_text": "PCR ribotype 027"}, "reference": {"id": "457103396ecf4bf983e868da073592b1", "answers": {"answer_start": [494], "text": ["Ribotype 027"]}}}, "fcdca61bac074774a7cb39e5878e1f41": {"prediction": {"id": "fcdca61bac074774a7cb39e5878e1f41", "prediction_text": "ribotype 027"}, "reference": {"id": "fcdca61bac074774a7cb39e5878e1f41", "answers": {"answer_start": [235], "text": ["Ribotype 027"]}}}, "2c7b3415f01940dcaacff648da6affc7": {"prediction": {"id": "2c7b3415f01940dcaacff648da6affc7", "prediction_text": "C.\u00a0difficile ribotype 027"}, "reference": {"id": "2c7b3415f01940dcaacff648da6affc7", "answers": {"answer_start": [157], "text": ["Ribotype 027"]}}}, "72ef39e2289d4cc083ee94cecd892242": {"prediction": {"id": "72ef39e2289d4cc083ee94cecd892242", "prediction_text": "ribotype 027"}, "reference": {"id": "72ef39e2289d4cc083ee94cecd892242", "answers": {"answer_start": [877], "text": ["Ribotype 027"]}}}, "a89765aa76aa482cafd5c04a8713cd26": {"prediction": {"id": "a89765aa76aa482cafd5c04a8713cd26", "prediction_text": "Epidemiology"}, "reference": {"id": "a89765aa76aa482cafd5c04a8713cd26", "answers": {"answer_start": [930], "text": ["Ribotype 027"]}}}, "a05798cae68f42fb872538f1d70ea1ff": {"prediction": {"id": "a05798cae68f42fb872538f1d70ea1ff", "prediction_text": "CDI) might help doctors guide treatment. We aimed to validate 3 published prediction models: Hensgens (2014), Na (2015), and Welfare (2011). METHODS The validation cohort comprised 148 patients diagnosed with CDI between May 2013 and March 2014. During this period, 70 endemic cases of CDI occurred as well as 78 cases of CDI related to an outbreak of C. difficile ribotype 027"}, "reference": {"id": "a05798cae68f42fb872538f1d70ea1ff", "answers": {"answer_start": [455], "text": ["Ribotype 027"]}}}, "a12e16a2ce0d40a4889c02b6bfb92985": {"prediction": {"id": "a12e16a2ce0d40a4889c02b6bfb92985", "prediction_text": "ribotype 027"}, "reference": {"id": "a12e16a2ce0d40a4889c02b6bfb92985", "answers": {"answer_start": [37], "text": ["Ribotype 027"]}}}, "2707aa5c067546e09560c1588ff2c9f3": {"prediction": {"id": "2707aa5c067546e09560c1588ff2c9f3", "prediction_text": "ribotype 027"}, "reference": {"id": "2707aa5c067546e09560c1588ff2c9f3", "answers": {"answer_start": [63], "text": ["Ribotype 027"]}}}, "b56df3c727a04670986d0eaf8a047614": {"prediction": {"id": "b56df3c727a04670986d0eaf8a047614", "prediction_text": "utilizes radioactively labelled nucleotides"}, "reference": {"id": "b56df3c727a04670986d0eaf8a047614", "answers": {"answer_start": [189], "text": ["Telomerase enzyme activity can be detected in whole cell lysates by a polymerase chain reaction (PCR)-based method referred to as the telomeric repeat amplification protocol (TRAP)."]}}}, "8d063e003964440c94e5e8ae9c7c5e53": {"prediction": {"id": "8d063e003964440c94e5e8ae9c7c5e53", "prediction_text": "ADAR"}, "reference": {"id": "8d063e003964440c94e5e8ae9c7c5e53", "answers": {"answer_start": [896], "text": ["ADAR"]}}}, "46b901ec8b2f44ba8d03deba1e20c7e0": {"prediction": {"id": "46b901ec8b2f44ba8d03deba1e20c7e0", "prediction_text": "ADARs"}, "reference": {"id": "46b901ec8b2f44ba8d03deba1e20c7e0", "answers": {"answer_start": [665], "text": ["ADAR"]}}}, "e9e344389681408eab7f3223843377d8": {"prediction": {"id": "e9e344389681408eab7f3223843377d8", "prediction_text": "cis-RNA"}, "reference": {"id": "e9e344389681408eab7f3223843377d8", "answers": {"answer_start": [130, 136], "text": ["ADAR", "adenosine deaminase, RNA-specific"]}}}, "0d89e66fd41b48918c0b4782cb233de4": {"prediction": {"id": "0d89e66fd41b48918c0b4782cb233de4", "prediction_text": "adenosine deaminase"}, "reference": {"id": "0d89e66fd41b48918c0b4782cb233de4", "answers": {"answer_start": [606, 38], "text": ["ADAR", "adenosine deaminase, RNA-specific"]}}}, "1a841da8e9144c4f98840f550e5ba7a9": {"prediction": {"id": "1a841da8e9144c4f98840f550e5ba7a9", "prediction_text": "ion channel subunits"}, "reference": {"id": "1a841da8e9144c4f98840f550e5ba7a9", "answers": {"answer_start": [1685], "text": ["ADAR"]}}}, "2337b4570f6e4743bc80656fe1c1fb57": {"prediction": {"id": "2337b4570f6e4743bc80656fe1c1fb57", "prediction_text": "P transposable elements in Drosophila melanogaster. Three kinds of RNA editing were detected at 20 sites around the terminal inverted repeats (TIR); 15 A-to-G, four U-to-C, and one C-to-U conversions. A-to-G conversions are suggested to be attributed to A-to-I RNA editing on KP element RNAs, because inosine (I) in RNA is recognized as G by reverse transcriptase. TIRs"}, "reference": {"id": "2337b4570f6e4743bc80656fe1c1fb57", "answers": {"answer_start": [721], "text": ["ADAR"]}}}, "0030a904e36e43fa9f85c3aef41661d4": {"prediction": {"id": "0030a904e36e43fa9f85c3aef41661d4", "prediction_text": "ADAR"}, "reference": {"id": "0030a904e36e43fa9f85c3aef41661d4", "answers": {"answer_start": [994], "text": ["ADAR"]}}}, "10bdfdf8be4d48b093b86d5df8d791d6": {"prediction": {"id": "10bdfdf8be4d48b093b86d5df8d791d6", "prediction_text": "ADAR"}, "reference": {"id": "10bdfdf8be4d48b093b86d5df8d791d6", "answers": {"answer_start": [625], "text": ["ADAR"]}}}, "b73bb1bb3cd448c89a067e5bd8a59f98": {"prediction": {"id": "b73bb1bb3cd448c89a067e5bd8a59f98", "prediction_text": "Recoding"}, "reference": {"id": "b73bb1bb3cd448c89a067e5bd8a59f98", "answers": {"answer_start": [645], "text": ["ADAR"]}}}, "4c7d7e6c7daa4657978e9157e08efac2": {"prediction": {"id": "4c7d7e6c7daa4657978e9157e08efac2", "prediction_text": "Polaris"}, "reference": {"id": "4c7d7e6c7daa4657978e9157e08efac2", "answers": {"answer_start": [0], "text": ["Polycystic kidney disease (PKD)"]}}}, "ef6ae9a392644a5f9bfac7a9d4a4b437": {"prediction": {"id": "ef6ae9a392644a5f9bfac7a9d4a4b437", "prediction_text": "PKD"}, "reference": {"id": "ef6ae9a392644a5f9bfac7a9d4a4b437", "answers": {"answer_start": [1176], "text": ["Polycystic kidney disease (PKD)"]}}}, "2c1b4a6f0fad4a45a39a06ff6c77159f": {"prediction": {"id": "2c1b4a6f0fad4a45a39a06ff6c77159f", "prediction_text": "vulvar infection, best diagnosed by its fluorescence under the Wood lamp. This report shows that despite a negative Wood lamp examination, the diagnosis can be made histologically. A 42-year-old woman was referred to our clinic with a persistent candidal infection. Evaluation included a Wood lamp examination, wet mount, and potassium hydroxide test of the affected skin, all of which were negative. A biopsy of the area demonstrated rods and filamentous organisms in the keratotic layer consistent with a Corynebacterium minutissimum infection. The patient was diagnosed as having erythrasma, and she responded to oral erythromycin. Persistent vulvar diseases"}, "reference": {"id": "2c1b4a6f0fad4a45a39a06ff6c77159f", "answers": {"answer_start": [533], "text": ["Corynebacterium minutissimum"]}}}, "623cc68d864d4f0e8cd675bd04e7ce32": {"prediction": {"id": "623cc68d864d4f0e8cd675bd04e7ce32", "prediction_text": "Corynebacterium minutissimum"}, "reference": {"id": "623cc68d864d4f0e8cd675bd04e7ce32", "answers": {"answer_start": [136], "text": ["Corynebacterium minutissimum"]}}}, "5df8023bfafc4c6fbe5d785fbae127c8": {"prediction": {"id": "5df8023bfafc4c6fbe5d785fbae127c8", "prediction_text": "Corynebacterium minutissimum"}, "reference": {"id": "5df8023bfafc4c6fbe5d785fbae127c8", "answers": {"answer_start": [53], "text": ["Corynebacterium minutissimum"]}}}, "cd9717119bd34ae9a761bb8876dd088a": {"prediction": {"id": "cd9717119bd34ae9a761bb8876dd088a", "prediction_text": "mucocutaneous inhabitant"}, "reference": {"id": "cd9717119bd34ae9a761bb8876dd088a", "answers": {"answer_start": [157], "text": ["Corynebacterium minutissimum"]}}}, "7a329bf8a31f494cb68e51d81ec5c17d": {"prediction": {"id": "7a329bf8a31f494cb68e51d81ec5c17d", "prediction_text": "Corynebacterium minutissimum"}, "reference": {"id": "7a329bf8a31f494cb68e51d81ec5c17d", "answers": {"answer_start": [50], "text": ["Corynebacterium minutissimum"]}}}, "9ad13ffe68174b738880c197fae20eb6": {"prediction": {"id": "9ad13ffe68174b738880c197fae20eb6", "prediction_text": "Corynebacterium minutissimum"}, "reference": {"id": "9ad13ffe68174b738880c197fae20eb6", "answers": {"answer_start": [0], "text": ["Corynebacterium minutissimum"]}}}, "a61b2969145e49cebad9254de6251e36": {"prediction": {"id": "a61b2969145e49cebad9254de6251e36", "prediction_text": "Corynebacterium minutissimum"}, "reference": {"id": "a61b2969145e49cebad9254de6251e36", "answers": {"answer_start": [48], "text": ["Corynebacterium minutissimum"]}}}, "d88feb2a9f9b448d88ff574b25e21d20": {"prediction": {"id": "d88feb2a9f9b448d88ff574b25e21d20", "prediction_text": "Corynebacterium minutissimum"}, "reference": {"id": "d88feb2a9f9b448d88ff574b25e21d20", "answers": {"answer_start": [58], "text": ["Corynebacterium minutissimum"]}}}, "55b605bfee8c419b9ada78c950ac1607": {"prediction": {"id": "55b605bfee8c419b9ada78c950ac1607", "prediction_text": "Riociguat"}, "reference": {"id": "55b605bfee8c419b9ada78c950ac1607", "answers": {"answer_start": [0], "text": ["riociguat"]}}}, "6190c3506ff84d6d8fa105734dcf9e6b": {"prediction": {"id": "6190c3506ff84d6d8fa105734dcf9e6b", "prediction_text": "riociguat"}, "reference": {"id": "6190c3506ff84d6d8fa105734dcf9e6b", "answers": {"answer_start": [31], "text": ["riociguat"]}}}, "e570d3d0300a485987a080b6340fd5c9": {"prediction": {"id": "e570d3d0300a485987a080b6340fd5c9", "prediction_text": "Riociguat"}, "reference": {"id": "e570d3d0300a485987a080b6340fd5c9", "answers": {"answer_start": [0], "text": ["riociguat"]}}}, "9dd07241859e4019b4698c5ba9209621": {"prediction": {"id": "9dd07241859e4019b4698c5ba9209621", "prediction_text": "Riociguat"}, "reference": {"id": "9dd07241859e4019b4698c5ba9209621", "answers": {"answer_start": [0], "text": ["riociguat"]}}}, "38d496811f1444ba89f8e67f90005c60": {"prediction": {"id": "38d496811f1444ba89f8e67f90005c60", "prediction_text": "riociguat"}, "reference": {"id": "38d496811f1444ba89f8e67f90005c60", "answers": {"answer_start": [743], "text": ["riociguat"]}}}, "b1d0bff5a83245d4a273b48d1deca6ae": {"prediction": {"id": "b1d0bff5a83245d4a273b48d1deca6ae", "prediction_text": "alpha-galactosidase mRNA"}, "reference": {"id": "b1d0bff5a83245d4a273b48d1deca6ae", "answers": {"answer_start": [654], "text": ["alpha-galactosidase A"]}}}, "16a469a6648245d2b8e1d46127654a74": {"prediction": {"id": "16a469a6648245d2b8e1d46127654a74", "prediction_text": "genetic loss-of-function defect"}, "reference": {"id": "16a469a6648245d2b8e1d46127654a74", "answers": {"answer_start": [755], "text": ["alpha-galactosidase A"]}}}, "5f81e1e0e56f4e709eedf0d2db5774ce": {"prediction": {"id": "5f81e1e0e56f4e709eedf0d2db5774ce", "prediction_text": "globotriaosylceramide"}, "reference": {"id": "5f81e1e0e56f4e709eedf0d2db5774ce", "answers": {"answer_start": [132], "text": ["alpha-galactosidase A"]}}}, "33d19be876234b4ca82efa68d2021912": {"prediction": {"id": "33d19be876234b4ca82efa68d2021912", "prediction_text": "excessive globotriaosylceramide"}, "reference": {"id": "33d19be876234b4ca82efa68d2021912", "answers": {"answer_start": [182], "text": ["alpha-galactosidase A"]}}}, "c9eb6fabb50242148b569db156685b99": {"prediction": {"id": "c9eb6fabb50242148b569db156685b99", "prediction_text": "McKusick 301500"}, "reference": {"id": "c9eb6fabb50242148b569db156685b99", "answers": {"answer_start": [6], "text": ["alpha-galactosidase A"]}}}, "65b3cfe52939409c90bf26988fff96f4": {"prediction": {"id": "65b3cfe52939409c90bf26988fff96f4", "prediction_text": "N-arginine dibasic convertase"}, "reference": {"id": "65b3cfe52939409c90bf26988fff96f4", "answers": {"answer_start": [315], "text": ["Nardilysin (N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding of the precursor forms of various growth factors and cytokines by enhancing the protease activities of a disintegrin and metalloproteinase (ADAM) proteins."]}}}, "47dcec6d4d6c42049d506277f2c3dc11": {"prediction": {"id": "47dcec6d4d6c42049d506277f2c3dc11", "prediction_text": "murine Fgfr3"}, "reference": {"id": "47dcec6d4d6c42049d506277f2c3dc11", "answers": {"answer_start": [75], "text": ["Fibroblast Growth Factor Receptor 3 (FGFR3)"]}}}, "0fc0089cea3c49839b7d546c458158cd": {"prediction": {"id": "0fc0089cea3c49839b7d546c458158cd", "prediction_text": "FGFR3"}, "reference": {"id": "0fc0089cea3c49839b7d546c458158cd", "answers": {"answer_start": [202], "text": ["Fibroblast Growth Factor Receptor 3 (FGFR3)"]}}}, "f9e4ce44dddc45b683fe59808cca6f89": {"prediction": {"id": "f9e4ce44dddc45b683fe59808cca6f89", "prediction_text": "MIM 602849"}, "reference": {"id": "f9e4ce44dddc45b683fe59808cca6f89", "answers": {"answer_start": [35], "text": ["Fibroblast Growth Factor Receptor 3 (FGFR3)"]}}}, "1827ac1963ae44258c7af1ee22d8f34e": {"prediction": {"id": "1827ac1963ae44258c7af1ee22d8f34e", "prediction_text": "FGFR3"}, "reference": {"id": "1827ac1963ae44258c7af1ee22d8f34e", "answers": {"answer_start": [479], "text": ["Fibroblast Growth Factor Receptor 3 (FGFR3)"]}}}, "318e1e46975548daaedd5148c5a5e602": {"prediction": {"id": "318e1e46975548daaedd5148c5a5e602", "prediction_text": "calcineurin"}, "reference": {"id": "318e1e46975548daaedd5148c5a5e602", "answers": {"answer_start": [282], "text": ["Calcineurin"]}}}, "fe85204a3d4c48fe930f8cb678f8c4de": {"prediction": {"id": "fe85204a3d4c48fe930f8cb678f8c4de", "prediction_text": "Calcineurin"}, "reference": {"id": "fe85204a3d4c48fe930f8cb678f8c4de", "answers": {"answer_start": [0], "text": ["Calcineurin"]}}}, "91ce4b561a5c4a27a725ab211e9989c2": {"prediction": {"id": "91ce4b561a5c4a27a725ab211e9989c2", "prediction_text": "calcineurin"}, "reference": {"id": "91ce4b561a5c4a27a725ab211e9989c2", "answers": {"answer_start": [1168], "text": ["Calcineurin"]}}}, "f92f0ea9c62e423bbcaeabe179b0cc9b": {"prediction": {"id": "f92f0ea9c62e423bbcaeabe179b0cc9b", "prediction_text": "calmodulin"}, "reference": {"id": "f92f0ea9c62e423bbcaeabe179b0cc9b", "answers": {"answer_start": [580, 557], "text": ["Calcineurin", "CaN"]}}}, "0bc7edfd0a4f4ed789ffabc608077358": {"prediction": {"id": "0bc7edfd0a4f4ed789ffabc608077358", "prediction_text": "calcineurin"}, "reference": {"id": "0bc7edfd0a4f4ed789ffabc608077358", "answers": {"answer_start": [1427], "text": ["Calcineurin"]}}}, "a5c44d8382d84edc9b0a7c414b0b59de": {"prediction": {"id": "a5c44d8382d84edc9b0a7c414b0b59de", "prediction_text": "Calcineurin"}, "reference": {"id": "a5c44d8382d84edc9b0a7c414b0b59de", "answers": {"answer_start": [0], "text": ["Calcineurin"]}}}, "3f03ed17a82c45faa1c1b31e564b072f": {"prediction": {"id": "3f03ed17a82c45faa1c1b31e564b072f", "prediction_text": "calcineurin"}, "reference": {"id": "3f03ed17a82c45faa1c1b31e564b072f", "answers": {"answer_start": [1106], "text": ["Calcineurin"]}}}, "b7dd2682cff64cc48d984d30bebc8e51": {"prediction": {"id": "b7dd2682cff64cc48d984d30bebc8e51", "prediction_text": "calcineurin"}, "reference": {"id": "b7dd2682cff64cc48d984d30bebc8e51", "answers": {"answer_start": [490, 586], "text": ["Calcineurin", "CaN"]}}}, "6d3d0e8e57464e13ae859e364c513479": {"prediction": {"id": "6d3d0e8e57464e13ae859e364c513479", "prediction_text": "Cn"}, "reference": {"id": "6d3d0e8e57464e13ae859e364c513479", "answers": {"answer_start": [1079], "text": ["Calcineurin"]}}}, "2cd056da5e1c48d7837281caf04c9411": {"prediction": {"id": "2cd056da5e1c48d7837281caf04c9411", "prediction_text": "serine/threonine phosphatase calcineurin"}, "reference": {"id": "2cd056da5e1c48d7837281caf04c9411", "answers": {"answer_start": [1015], "text": ["Calcineurin"]}}}, "b47412c1761746c8be6fb6df90b10067": {"prediction": {"id": "b47412c1761746c8be6fb6df90b10067", "prediction_text": "Ca(2+)/calmodulin"}, "reference": {"id": "b47412c1761746c8be6fb6df90b10067", "answers": {"answer_start": [285, 571, 270], "text": ["Calcineurin", "CaN", "phosphatase 2b"]}}}, "327887747dec4cdfa9eb1af752f3db7a": {"prediction": {"id": "327887747dec4cdfa9eb1af752f3db7a", "prediction_text": "filter-aided sample preparation"}, "reference": {"id": "327887747dec4cdfa9eb1af752f3db7a", "answers": {"answer_start": [23], "text": ["proteomic sample preparation"]}}}, "ee01e6014ad44fb4995d0419ca9c004c": {"prediction": {"id": "ee01e6014ad44fb4995d0419ca9c004c", "prediction_text": "in the inner mitochondrial membrane"}, "reference": {"id": "ee01e6014ad44fb4995d0419ca9c004c", "answers": {"answer_start": [92], "text": ["In the inner mitochondrial membrane"]}}}, "a81c6c655b8b4e058faece5dc0a08b00": {"prediction": {"id": "a81c6c655b8b4e058faece5dc0a08b00", "prediction_text": "LC-MS/MS analysis"}, "reference": {"id": "a81c6c655b8b4e058faece5dc0a08b00", "answers": {"answer_start": [629], "text": ["Immunoaffinity purification"]}}}, "1072706c282a4712b52114cf71df3538": {"prediction": {"id": "1072706c282a4712b52114cf71df3538", "prediction_text": "Genomiser"}, "reference": {"id": "1072706c282a4712b52114cf71df3538", "answers": {"answer_start": [232], "text": ["Genomiser"]}}}, "1e12806d0fa2411b93368221d8c5acf6": {"prediction": {"id": "1e12806d0fa2411b93368221d8c5acf6", "prediction_text": "LYST gene"}, "reference": {"id": "1e12806d0fa2411b93368221d8c5acf6", "answers": {"answer_start": [1285], "text": ["LYST gene"]}}}, "60215fc4b29649b9894067772415c14e": {"prediction": {"id": "60215fc4b29649b9894067772415c14e", "prediction_text": "mink"}, "reference": {"id": "60215fc4b29649b9894067772415c14e", "answers": {"answer_start": [481], "text": ["LYST gene"]}}}, "d01b3a07a04c44db8fd845d5389d21a4": {"prediction": {"id": "d01b3a07a04c44db8fd845d5389d21a4", "prediction_text": "LYST"}, "reference": {"id": "d01b3a07a04c44db8fd845d5389d21a4", "answers": {"answer_start": [804], "text": ["LYST gene"]}}}, "f2ba44a339f448d19694af8c4c1c30c9": {"prediction": {"id": "f2ba44a339f448d19694af8c4c1c30c9", "prediction_text": "CHS"}, "reference": {"id": "f2ba44a339f448d19694af8c4c1c30c9", "answers": {"answer_start": [699], "text": ["LYST gene"]}}}, "da568cd7f31b439b98b7070623aadb23": {"prediction": {"id": "da568cd7f31b439b98b7070623aadb23", "prediction_text": "Chediak-Higashi syndrome (CHS) is a rare multiorgan disease entity with autosomal recessive inheritance characterized by oculocutaneous albinism"}, "reference": {"id": "da568cd7f31b439b98b7070623aadb23", "answers": {"answer_start": [585], "text": ["LYST gene"]}}}, "779d2615d35d404fb49cc341199d7274": {"prediction": {"id": "779d2615d35d404fb49cc341199d7274", "prediction_text": "Mutations in LYST"}, "reference": {"id": "779d2615d35d404fb49cc341199d7274", "answers": {"answer_start": [13], "text": ["LYST gene"]}}}, "0db83a8c44f4411bbbf17811911ff13d": {"prediction": {"id": "0db83a8c44f4411bbbf17811911ff13d", "prediction_text": "Lyst"}, "reference": {"id": "0db83a8c44f4411bbbf17811911ff13d", "answers": {"answer_start": [131], "text": ["LYST gene"]}}}, "1ec0a229f64647d393c56505cd2e17eb": {"prediction": {"id": "1ec0a229f64647d393c56505cd2e17eb", "prediction_text": "immunodeficiency, neurological dysfunction, and oculocutaneous albinism"}, "reference": {"id": "1ec0a229f64647d393c56505cd2e17eb", "answers": {"answer_start": [525], "text": ["LYST gene"]}}}, "b5e11ceba4934a018e478149504b464c": {"prediction": {"id": "b5e11ceba4934a018e478149504b464c", "prediction_text": "Intravenous immunoglobulin"}, "reference": {"id": "b5e11ceba4934a018e478149504b464c", "answers": {"answer_start": [0], "text": ["Intravenous"]}}}, "e2be3a35d9c84221bb5f77c846aa6672": {"prediction": {"id": "e2be3a35d9c84221bb5f77c846aa6672", "prediction_text": "phospholipase A2"}, "reference": {"id": "e2be3a35d9c84221bb5f77c846aa6672", "answers": {"answer_start": [37], "text": ["secretory phospholipase A2"]}}}, "446e2718ec96438f955f9453fa6110b6": {"prediction": {"id": "446e2718ec96438f955f9453fa6110b6", "prediction_text": "sPLA2"}, "reference": {"id": "446e2718ec96438f955f9453fa6110b6", "answers": {"answer_start": [101], "text": ["secretory phospholipase A2"]}}}, "5a51740b80574cecb1eac7274becfca5": {"prediction": {"id": "5a51740b80574cecb1eac7274becfca5", "prediction_text": "methyl"}, "reference": {"id": "5a51740b80574cecb1eac7274becfca5", "answers": {"answer_start": [30], "text": ["secretory phospholipase A2"]}}}, "ffdd7d223bf84426aaa465150a8acb1c": {"prediction": {"id": "ffdd7d223bf84426aaa465150a8acb1c", "prediction_text": "Varespladib acid"}, "reference": {"id": "ffdd7d223bf84426aaa465150a8acb1c", "answers": {"answer_start": [37], "text": ["secretory phospholipase A2"]}}}, "6ebdaa3301b94420be3e0c1ac77b71a6": {"prediction": {"id": "6ebdaa3301b94420be3e0c1ac77b71a6", "prediction_text": "sPLA2"}, "reference": {"id": "6ebdaa3301b94420be3e0c1ac77b71a6", "answers": {"answer_start": [0], "text": ["secretory phospholipase A2"]}}}, "fc8d1740c4da4f79b4b32d58b5a72217": {"prediction": {"id": "fc8d1740c4da4f79b4b32d58b5a72217", "prediction_text": "sPLA2"}, "reference": {"id": "fc8d1740c4da4f79b4b32d58b5a72217", "answers": {"answer_start": [0], "text": ["secretory phospholipase A2"]}}}, "2a377a9e4fd54220aecb278061939baa": {"prediction": {"id": "2a377a9e4fd54220aecb278061939baa", "prediction_text": "Acute"}, "reference": {"id": "2a377a9e4fd54220aecb278061939baa", "answers": {"answer_start": [254], "text": ["secretory phospholipase A2"]}}}, "e131d2e6465d4970a0fd882e95c80f47": {"prediction": {"id": "e131d2e6465d4970a0fd882e95c80f47", "prediction_text": "BTK"}, "reference": {"id": "e131d2e6465d4970a0fd882e95c80f47", "answers": {"answer_start": [1510], "text": ["Ibrutinib"]}}}, "3b28f307797f44e795db54a7ca0b10d3": {"prediction": {"id": "3b28f307797f44e795db54a7ca0b10d3", "prediction_text": "BTK"}, "reference": {"id": "3b28f307797f44e795db54a7ca0b10d3", "answers": {"answer_start": [52], "text": ["Ibrutinib"]}}}, "582366a8463246c1ab907482893aceec": {"prediction": {"id": "582366a8463246c1ab907482893aceec", "prediction_text": "Ibrutinib"}, "reference": {"id": "582366a8463246c1ab907482893aceec", "answers": {"answer_start": [629], "text": ["Ibrutinib"]}}}, "3c81032a207b45aa9cbedac4b9a9f059": {"prediction": {"id": "3c81032a207b45aa9cbedac4b9a9f059", "prediction_text": "ibrutinib"}, "reference": {"id": "3c81032a207b45aa9cbedac4b9a9f059", "answers": {"answer_start": [997], "text": ["Ibrutinib"]}}}, "b64b90d0b6184d71b793d0eb006efb13": {"prediction": {"id": "b64b90d0b6184d71b793d0eb006efb13", "prediction_text": "Btk"}, "reference": {"id": "b64b90d0b6184d71b793d0eb006efb13", "answers": {"answer_start": [1103], "text": ["Ibrutinib"]}}}, "7e66f8db5f114ce588a9edd0a7f10114": {"prediction": {"id": "7e66f8db5f114ce588a9edd0a7f10114", "prediction_text": "Ibrutinib"}, "reference": {"id": "7e66f8db5f114ce588a9edd0a7f10114", "answers": {"answer_start": [292], "text": ["Ibrutinib"]}}}, "3065d269e6a04e518eba3791edec4478": {"prediction": {"id": "3065d269e6a04e518eba3791edec4478", "prediction_text": "BTK"}, "reference": {"id": "3065d269e6a04e518eba3791edec4478", "answers": {"answer_start": [1141], "text": ["Ibrutinib"]}}}, "08332d1fd77d462bb6c9656815391460": {"prediction": {"id": "08332d1fd77d462bb6c9656815391460", "prediction_text": "ibrutinib"}, "reference": {"id": "08332d1fd77d462bb6c9656815391460", "answers": {"answer_start": [1168], "text": ["Ibrutinib"]}}}, "9ac6891d94f542f78f7c2139309f376b": {"prediction": {"id": "9ac6891d94f542f78f7c2139309f376b", "prediction_text": "Btk"}, "reference": {"id": "9ac6891d94f542f78f7c2139309f376b", "answers": {"answer_start": [354], "text": ["Ibrutinib"]}}}, "67e9d22598904d2dbb58df54cc0875cc": {"prediction": {"id": "67e9d22598904d2dbb58df54cc0875cc", "prediction_text": "BTK"}, "reference": {"id": "67e9d22598904d2dbb58df54cc0875cc", "answers": {"answer_start": [931], "text": ["Ibrutinib"]}}}, "e8d688f1433340938926fa9192b42151": {"prediction": {"id": "e8d688f1433340938926fa9192b42151", "prediction_text": "ibrutinib"}, "reference": {"id": "e8d688f1433340938926fa9192b42151", "answers": {"answer_start": [1135], "text": ["Ibrutinib"]}}}, "9ffa18c3640649e4bd48c2a9c654c83e": {"prediction": {"id": "9ffa18c3640649e4bd48c2a9c654c83e", "prediction_text": "Ibrutinib, AVL-263"}, "reference": {"id": "9ffa18c3640649e4bd48c2a9c654c83e", "answers": {"answer_start": [917], "text": ["Ibrutinib"]}}}, "6662f6e54f6e44e1be60d7b8daba91c4": {"prediction": {"id": "6662f6e54f6e44e1be60d7b8daba91c4", "prediction_text": "frontotemporal dementia"}, "reference": {"id": "6662f6e54f6e44e1be60d7b8daba91c4", "answers": {"answer_start": [376], "text": ["ALS"]}}}, "31643bea317b4291a9d283ecaf8523f4": {"prediction": {"id": "31643bea317b4291a9d283ecaf8523f4", "prediction_text": "Amyotrophic lateral sclerosis"}, "reference": {"id": "31643bea317b4291a9d283ecaf8523f4", "answers": {"answer_start": [1041, 0], "text": ["ALS", "amyotrophic lateral sclerosis"]}}}, "c35434f6538244cbab1de983a86a5d45": {"prediction": {"id": "c35434f6538244cbab1de983a86a5d45", "prediction_text": "amyotrophic lateral sclerosis"}, "reference": {"id": "c35434f6538244cbab1de983a86a5d45", "answers": {"answer_start": [246, 91], "text": ["ALS", "amyotrophic lateral sclerosis"]}}}, "d4b4f2d2df964b188e70d5f57ad93e49": {"prediction": {"id": "d4b4f2d2df964b188e70d5f57ad93e49", "prediction_text": "Amyotrophic Lateral Sclerosis"}, "reference": {"id": "d4b4f2d2df964b188e70d5f57ad93e49", "answers": {"answer_start": [1748, 0], "text": ["ALS", "amyotrophic lateral sclerosis"]}}}, "79c173d090c74842a80f175ac1c40cac": {"prediction": {"id": "79c173d090c74842a80f175ac1c40cac", "prediction_text": "amyotrophic lateral sclerosis"}, "reference": {"id": "79c173d090c74842a80f175ac1c40cac", "answers": {"answer_start": [312, 222], "text": ["ALS", "amyotrophic lateral sclerosis"]}}}, "24cd164d79c7456783de0ab5f4d9241f": {"prediction": {"id": "24cd164d79c7456783de0ab5f4d9241f", "prediction_text": "2-4%"}, "reference": {"id": "24cd164d79c7456783de0ab5f4d9241f", "answers": {"answer_start": [14], "text": ["2-4%"]}}}, "f1109ca457464628972b95d852961389": {"prediction": {"id": "f1109ca457464628972b95d852961389", "prediction_text": "apoE4 isoform"}, "reference": {"id": "f1109ca457464628972b95d852961389", "answers": {"answer_start": [232], "text": ["ApoE4 isoform"]}}}, "339f9dda7f974591912ca7db0049fef0": {"prediction": {"id": "339f9dda7f974591912ca7db0049fef0", "prediction_text": "ApoE4"}, "reference": {"id": "339f9dda7f974591912ca7db0049fef0", "answers": {"answer_start": [1647], "text": ["ApoE4 isoform"]}}}, "50975ece69e8407ea228e55b9f009285": {"prediction": {"id": "50975ece69e8407ea228e55b9f009285", "prediction_text": "apolipoprotein E type 4 allele"}, "reference": {"id": "50975ece69e8407ea228e55b9f009285", "answers": {"answer_start": [300], "text": ["ApoE4 isoform"]}}}, "6c0e278b5f754230a84b535fa27ac5d8": {"prediction": {"id": "6c0e278b5f754230a84b535fa27ac5d8", "prediction_text": "ApoE \u03b54 allele"}, "reference": {"id": "6c0e278b5f754230a84b535fa27ac5d8", "answers": {"answer_start": [1598], "text": ["ApoE4 isoform"]}}}, "8f35001488da4aba85676adda5d89271": {"prediction": {"id": "8f35001488da4aba85676adda5d89271", "prediction_text": "apolipoprotein E (ApoE) \u03b54 allele"}, "reference": {"id": "8f35001488da4aba85676adda5d89271", "answers": {"answer_start": [1133], "text": ["ApoE4 isoform"]}}}, "721f20308478421c8ec47b0b1b1d0e96": {"prediction": {"id": "721f20308478421c8ec47b0b1b1d0e96", "prediction_text": "APOE-epsilon4"}, "reference": {"id": "721f20308478421c8ec47b0b1b1d0e96", "answers": {"answer_start": [1415], "text": ["ApoE4 isoform"]}}}, "b8576e2bb9934802a5e819a192393a49": {"prediction": {"id": "b8576e2bb9934802a5e819a192393a49", "prediction_text": "ChIP-chip"}, "reference": {"id": "b8576e2bb9934802a5e819a192393a49", "answers": {"answer_start": [488], "text": ["HilbertVis"]}}}, "5895bfee862042478d6b531e17ecdeb2": {"prediction": {"id": "5895bfee862042478d6b531e17ecdeb2", "prediction_text": "NF1"}, "reference": {"id": "5895bfee862042478d6b531e17ecdeb2", "answers": {"answer_start": [623], "text": ["NF1"]}}}, "0e2c8c1244e141f08183206ca738c019": {"prediction": {"id": "0e2c8c1244e141f08183206ca738c019", "prediction_text": "NF2"}, "reference": {"id": "0e2c8c1244e141f08183206ca738c019", "answers": {"answer_start": [40], "text": ["NF1"]}}}, "f78a5d2c834649be839d1508363ce119": {"prediction": {"id": "f78a5d2c834649be839d1508363ce119", "prediction_text": "NF2"}, "reference": {"id": "f78a5d2c834649be839d1508363ce119", "answers": {"answer_start": [411], "text": ["NF1"]}}}, "f4cb9ea0610c4ecbbb4e61afc2f7d35d": {"prediction": {"id": "f4cb9ea0610c4ecbbb4e61afc2f7d35d", "prediction_text": "NF1"}, "reference": {"id": "f4cb9ea0610c4ecbbb4e61afc2f7d35d", "answers": {"answer_start": [93], "text": ["NF1"]}}}, "3cd225d0b14c41a9bb78f9d27f0fe243": {"prediction": {"id": "3cd225d0b14c41a9bb78f9d27f0fe243", "prediction_text": "NF1"}, "reference": {"id": "3cd225d0b14c41a9bb78f9d27f0fe243", "answers": {"answer_start": [1499], "text": ["NF1"]}}}, "b283c3ede036495a9fbab8018f57e9c7": {"prediction": {"id": "b283c3ede036495a9fbab8018f57e9c7", "prediction_text": "NF1"}, "reference": {"id": "b283c3ede036495a9fbab8018f57e9c7", "answers": {"answer_start": [877], "text": ["NF1"]}}}, "a8ea7c1c6f794b1d8fe4988d9af19660": {"prediction": {"id": "a8ea7c1c6f794b1d8fe4988d9af19660", "prediction_text": "NF1"}, "reference": {"id": "a8ea7c1c6f794b1d8fe4988d9af19660", "answers": {"answer_start": [522], "text": ["NF1"]}}}, "db2a3b4e80704390a561f5ac30c49f07": {"prediction": {"id": "db2a3b4e80704390a561f5ac30c49f07", "prediction_text": "NF1"}, "reference": {"id": "db2a3b4e80704390a561f5ac30c49f07", "answers": {"answer_start": [484], "text": ["NF1"]}}}, "24ed097402ba480784763d2427be3603": {"prediction": {"id": "24ed097402ba480784763d2427be3603", "prediction_text": "NF1"}, "reference": {"id": "24ed097402ba480784763d2427be3603", "answers": {"answer_start": [1228], "text": ["NF1"]}}}, "e037e4b734b640e1826ee5ea648ee789": {"prediction": {"id": "e037e4b734b640e1826ee5ea648ee789", "prediction_text": "NF1 tumor-suppressor"}, "reference": {"id": "e037e4b734b640e1826ee5ea648ee789", "answers": {"answer_start": [95], "text": ["NF1"]}}}, "aca1077f93e044718251ac0e017e05fd": {"prediction": {"id": "aca1077f93e044718251ac0e017e05fd", "prediction_text": "NF1"}, "reference": {"id": "aca1077f93e044718251ac0e017e05fd", "answers": {"answer_start": [354], "text": ["NF1"]}}}, "b8d0b0138c6c4876bb5fa710471e7ab1": {"prediction": {"id": "b8d0b0138c6c4876bb5fa710471e7ab1", "prediction_text": "NF1"}, "reference": {"id": "b8d0b0138c6c4876bb5fa710471e7ab1", "answers": {"answer_start": [414], "text": ["NF1"]}}}, "34577f86089d46cbb025c75a8f6910a3": {"prediction": {"id": "34577f86089d46cbb025c75a8f6910a3", "prediction_text": "NF1"}, "reference": {"id": "34577f86089d46cbb025c75a8f6910a3", "answers": {"answer_start": [709], "text": ["NF1"]}}}, "850139bca1914a3d9183e0d25ece10fd": {"prediction": {"id": "850139bca1914a3d9183e0d25ece10fd", "prediction_text": "N-ras"}, "reference": {"id": "850139bca1914a3d9183e0d25ece10fd", "answers": {"answer_start": [447], "text": ["NF1"]}}}, "f93c0a304f3f477d837b5d189e7d52d6": {"prediction": {"id": "f93c0a304f3f477d837b5d189e7d52d6", "prediction_text": "NF1"}, "reference": {"id": "f93c0a304f3f477d837b5d189e7d52d6", "answers": {"answer_start": [708], "text": ["NF1"]}}}, "5c101db024064faf880aa78dd81d047c": {"prediction": {"id": "5c101db024064faf880aa78dd81d047c", "prediction_text": "BMPR2"}, "reference": {"id": "5c101db024064faf880aa78dd81d047c", "answers": {"answer_start": [1370], "text": ["NF1"]}}}, "994eab43e97942578e9ac4cecb8116de": {"prediction": {"id": "994eab43e97942578e9ac4cecb8116de", "prediction_text": "neurofibromin"}, "reference": {"id": "994eab43e97942578e9ac4cecb8116de", "answers": {"answer_start": [464], "text": ["NF1"]}}}, "e6cf06534cc145b4b2bb160cc6638868": {"prediction": {"id": "e6cf06534cc145b4b2bb160cc6638868", "prediction_text": "NF1"}, "reference": {"id": "e6cf06534cc145b4b2bb160cc6638868", "answers": {"answer_start": [115], "text": ["NF1"]}}}, "8adc2b9d73d7428196df46907183ef93": {"prediction": {"id": "8adc2b9d73d7428196df46907183ef93", "prediction_text": "NF1"}, "reference": {"id": "8adc2b9d73d7428196df46907183ef93", "answers": {"answer_start": [291], "text": ["NF1"]}}}, "8c66275dfd7e4f3a8eb8ac58a8508a83": {"prediction": {"id": "8c66275dfd7e4f3a8eb8ac58a8508a83", "prediction_text": "c.1005T>C"}, "reference": {"id": "8c66275dfd7e4f3a8eb8ac58a8508a83", "answers": {"answer_start": [524], "text": ["NF1"]}}}, "69a11ed1d518452580e952ef04978f8e": {"prediction": {"id": "69a11ed1d518452580e952ef04978f8e", "prediction_text": "NF1"}, "reference": {"id": "69a11ed1d518452580e952ef04978f8e", "answers": {"answer_start": [721], "text": ["NF1"]}}}, "809be51b27a64d3dbfe6863ff12ffea0": {"prediction": {"id": "809be51b27a64d3dbfe6863ff12ffea0", "prediction_text": "NF1"}, "reference": {"id": "809be51b27a64d3dbfe6863ff12ffea0", "answers": {"answer_start": [1703], "text": ["NF1"]}}}, "094b3308b60544158105ad7eac12bcf2": {"prediction": {"id": "094b3308b60544158105ad7eac12bcf2", "prediction_text": "familial cancer syndromes"}, "reference": {"id": "094b3308b60544158105ad7eac12bcf2", "answers": {"answer_start": [602], "text": ["NF1"]}}}, "8cda72e237b74c9faf16bf988f2943c7": {"prediction": {"id": "8cda72e237b74c9faf16bf988f2943c7", "prediction_text": "NF1"}, "reference": {"id": "8cda72e237b74c9faf16bf988f2943c7", "answers": {"answer_start": [1174], "text": ["NF1"]}}}, "7bc69ec3361b47ee95117c0f3492a74d": {"prediction": {"id": "7bc69ec3361b47ee95117c0f3492a74d", "prediction_text": "NF1"}, "reference": {"id": "7bc69ec3361b47ee95117c0f3492a74d", "answers": {"answer_start": [396], "text": ["NF1"]}}}, "1cc6329254e04cb4b4f172075261d23e": {"prediction": {"id": "1cc6329254e04cb4b4f172075261d23e", "prediction_text": "Rapamycin"}, "reference": {"id": "1cc6329254e04cb4b4f172075261d23e", "answers": {"answer_start": [440], "text": ["mammalian target of rapamycin"]}}}, "e60ca85064514263a2066a66eaea7177": {"prediction": {"id": "e60ca85064514263a2066a66eaea7177", "prediction_text": "rapamycin"}, "reference": {"id": "e60ca85064514263a2066a66eaea7177", "answers": {"answer_start": [4], "text": ["mammalian target of rapamycin"]}}}, "6133f235a10f46baa180c1be8ad22993": {"prediction": {"id": "6133f235a10f46baa180c1be8ad22993", "prediction_text": "idiopathic pulmonary arterial hypertension (PAH). The role of the distinct mammalian target of rapamycin (mTOR) complexes mTORC1 (mTOR-Raptor) and mTORC2 (mTOR-Rictor) in PAVSMC proliferation and survival in PAH and their therapeutic relevance are unknown. Immunohistochemical and immunoblot analyses revealed that mTORC1 and mTORC2 pathways are markedly upregulated in small remodeled pulmonary arteries and isolated distal PAVSMCs from subjects with idiopathic PAH that have increased ATP levels, proliferation, and survival that depend on glycolytic metabolism. Small interfering RNA- and pharmacology-based analysis showed that although both mTORC1 and mTORC2 contribute to proliferation, only mTORC2 is required for ATP generation and survival of idiopathic PAH PAVSMCs. mTORC2 downregulated the energy sensor AMP-activated protein kinase, which led to activation of mTORC1-S6 and increased proliferation, as well as a deficiency of the proapoptotic protein Bim and idiopathic PAH PAVSMC survival. NADPH oxidase 4"}, "reference": {"id": "6133f235a10f46baa180c1be8ad22993", "answers": {"answer_start": [293], "text": ["mammalian target of rapamycin"]}}}, "f8eed36efcbd4205b6803786207494b9": {"prediction": {"id": "f8eed36efcbd4205b6803786207494b9", "prediction_text": "rapamycin"}, "reference": {"id": "f8eed36efcbd4205b6803786207494b9", "answers": {"answer_start": [603], "text": ["mammalian target of rapamycin"]}}}, "3425bc4c2ecb47c88c42d2126559e528": {"prediction": {"id": "3425bc4c2ecb47c88c42d2126559e528", "prediction_text": "rapamycin (mTOR) in oncology, distinct cutaneous and oral adverse events have been identified. In fact, stomatitis and rash are documented as the most frequent and potentially dose-limiting side effects. Clinically, mTOR inhibitor-associated stomatitis"}, "reference": {"id": "3425bc4c2ecb47c88c42d2126559e528", "answers": {"answer_start": [46], "text": ["mammalian target of rapamycin"]}}}, "b6dc85cce1ae4f769553d28aa047c469": {"prediction": {"id": "b6dc85cce1ae4f769553d28aa047c469", "prediction_text": "rapamycin (mTOR) leads to CSC survival, the effect of branched chain amino acids (BCAAs), an mTOR complex 1"}, "reference": {"id": "b6dc85cce1ae4f769553d28aa047c469", "answers": {"answer_start": [142], "text": ["mammalian target of rapamycin"]}}}, "bc793872f90f4654b9a3a74029ca7e43": {"prediction": {"id": "bc793872f90f4654b9a3a74029ca7e43", "prediction_text": "Progression-free survival"}, "reference": {"id": "bc793872f90f4654b9a3a74029ca7e43", "answers": {"answer_start": [95], "text": ["mammalian target of rapamycin"]}}}, "4597492a0a2c49d3946bbcf0595ce23f": {"prediction": {"id": "4597492a0a2c49d3946bbcf0595ce23f", "prediction_text": "Vascular endothelial growth factor"}, "reference": {"id": "4597492a0a2c49d3946bbcf0595ce23f", "answers": {"answer_start": [282], "text": ["mammalian target of rapamycin"]}}}, "4962052341d54858bbc298b1336fd2c6": {"prediction": {"id": "4962052341d54858bbc298b1336fd2c6", "prediction_text": "ZEB2"}, "reference": {"id": "4962052341d54858bbc298b1336fd2c6", "answers": {"answer_start": [322], "text": ["ZEB2"]}}}, "0ab998d9af5641dcbb79ceb2960436e9": {"prediction": {"id": "0ab998d9af5641dcbb79ceb2960436e9", "prediction_text": "1B"}, "reference": {"id": "0ab998d9af5641dcbb79ceb2960436e9", "answers": {"answer_start": [486], "text": ["ZFHX1B"]}}}, "7c9825eee0b44a53afdaa873fcb64e54": {"prediction": {"id": "7c9825eee0b44a53afdaa873fcb64e54", "prediction_text": "ZEB2"}, "reference": {"id": "7c9825eee0b44a53afdaa873fcb64e54", "answers": {"answer_start": [564], "text": ["ZEB2"]}}}, "b927d44944334854a576d753c52b6b46": {"prediction": {"id": "b927d44944334854a576d753c52b6b46", "prediction_text": "ZFHX1B"}, "reference": {"id": "b927d44944334854a576d753c52b6b46", "answers": {"answer_start": [379], "text": ["ZFHX1B"]}}}, "13c1aab3943643ddac5fa7649ff4a7ee": {"prediction": {"id": "13c1aab3943643ddac5fa7649ff4a7ee", "prediction_text": "ZFHX1B"}, "reference": {"id": "13c1aab3943643ddac5fa7649ff4a7ee", "answers": {"answer_start": [31], "text": ["ZFHX1B"]}}}, "960f40c13bd948f68f14d7537bf06064": {"prediction": {"id": "960f40c13bd948f68f14d7537bf06064", "prediction_text": "facial phenotype in addition to moderate to severe cognitive disability with severe speech impairment and variable multiple congenital anomalies. The anomalies may include Hirschsprung disease, heart defects, structural eye anomalies including microphthalmia, agenesis of the corpus callosum, and urogenital anomalies. Microcephaly, seizure disorder and constipation are common. All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described. Approximately 80% of patients have a nonsense or frameshift mutation detectable by sequencing, with the rest having gross deletions necessitating a dosage sensitive assay. Here we report on the results of comprehensive molecular testing for 27 patients testing positive for MWS. Twenty-one patients had a nonsense, frameshift, or splice site mutation identified by sequencing; 14 of which localized to exon 8 and 17 of which are novel. Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions. This report, the first such analysis in North American patients, adds to the growing list of both novel pathogenic mutations associated with MWS, as well as other variants in the ZEB2"}, "reference": {"id": "960f40c13bd948f68f14d7537bf06064", "answers": {"answer_start": [532, 1307, 542], "text": ["ZFHX1B", "ZEB2", "SIP-1"]}}}, "36686e3336464a48a177c050d8437085": {"prediction": {"id": "36686e3336464a48a177c050d8437085", "prediction_text": "ZEB2"}, "reference": {"id": "36686e3336464a48a177c050d8437085", "answers": {"answer_start": [102], "text": ["ZEB2"]}}}, "0653da47946b460aa3ca811e7bb08777": {"prediction": {"id": "0653da47946b460aa3ca811e7bb08777", "prediction_text": "Zinc Finger Homeobox 1 B"}, "reference": {"id": "0653da47946b460aa3ca811e7bb08777", "answers": {"answer_start": [146], "text": ["ZFHX1B"]}}}, "d34910f7be0e4d62906e7821f7f0bf21": {"prediction": {"id": "d34910f7be0e4d62906e7821f7f0bf21", "prediction_text": "zfhz1b"}, "reference": {"id": "d34910f7be0e4d62906e7821f7f0bf21", "answers": {"answer_start": [718], "text": ["ZFHX1B"]}}}, "4b4a5679ceb344b290debd875fe47837": {"prediction": {"id": "4b4a5679ceb344b290debd875fe47837", "prediction_text": "ZEB2"}, "reference": {"id": "4b4a5679ceb344b290debd875fe47837", "answers": {"answer_start": [576], "text": ["ZEB2"]}}}, "b4fe3c51fa734fbba84cf8308fc5151d": {"prediction": {"id": "b4fe3c51fa734fbba84cf8308fc5151d", "prediction_text": "ZEB2"}, "reference": {"id": "b4fe3c51fa734fbba84cf8308fc5151d", "answers": {"answer_start": [1028], "text": ["ZEB2"]}}}, "2723cefb9d494fc0abb9361ed90aab0e": {"prediction": {"id": "2723cefb9d494fc0abb9361ed90aab0e", "prediction_text": "ZEB2"}, "reference": {"id": "2723cefb9d494fc0abb9361ed90aab0e", "answers": {"answer_start": [411], "text": ["ZEB2"]}}}, "89e6e115c1fd4d81afa05d6723e6f273": {"prediction": {"id": "89e6e115c1fd4d81afa05d6723e6f273", "prediction_text": "ZFHX1B"}, "reference": {"id": "89e6e115c1fd4d81afa05d6723e6f273", "answers": {"answer_start": [0], "text": ["ZFHX1B"]}}}, "6d25673ab1194139a7cd2771fa8f535a": {"prediction": {"id": "6d25673ab1194139a7cd2771fa8f535a", "prediction_text": "Zfhx1b"}, "reference": {"id": "6d25673ab1194139a7cd2771fa8f535a", "answers": {"answer_start": [1052], "text": ["ZFHX1B"]}}}, "a82a4707c9364ce4a119c71a49124c7c": {"prediction": {"id": "a82a4707c9364ce4a119c71a49124c7c", "prediction_text": "ZEB2"}, "reference": {"id": "a82a4707c9364ce4a119c71a49124c7c", "answers": {"answer_start": [134], "text": ["ZEB2"]}}}, "c9580401ebe54361b2627039510450db": {"prediction": {"id": "c9580401ebe54361b2627039510450db", "prediction_text": "Haploinsufficiency"}, "reference": {"id": "c9580401ebe54361b2627039510450db", "answers": {"answer_start": [153], "text": ["ZFHX1B"]}}}, "abca6b5a61b24abbbbe3a7681aa05a90": {"prediction": {"id": "abca6b5a61b24abbbbe3a7681aa05a90", "prediction_text": "ZFHX1B"}, "reference": {"id": "abca6b5a61b24abbbbe3a7681aa05a90", "answers": {"answer_start": [864], "text": ["ZFHX1B"]}}}, "d01964ce6c504836b8d88ed5c4217f0a": {"prediction": {"id": "d01964ce6c504836b8d88ed5c4217f0a", "prediction_text": "isoform"}, "reference": {"id": "d01964ce6c504836b8d88ed5c4217f0a", "answers": {"answer_start": [619], "text": ["FSHD"]}}}, "91edd5e95d374c6d91ea9632654ceeee": {"prediction": {"id": "91edd5e95d374c6d91ea9632654ceeee", "prediction_text": "facioscapulohumeral muscular dystrophy"}, "reference": {"id": "91edd5e95d374c6d91ea9632654ceeee", "answers": {"answer_start": [59], "text": ["FSHD"]}}}, "78d0257c359b4a61a63d02ec82e7a293": {"prediction": {"id": "78d0257c359b4a61a63d02ec82e7a293", "prediction_text": "Facioscapulohumeral dystrophy"}, "reference": {"id": "78d0257c359b4a61a63d02ec82e7a293", "answers": {"answer_start": [0, 920], "text": ["Facioscapulohumeral dystrophy", "FSHD"]}}}, "1243f072c372425ab9c6a7253f582735": {"prediction": {"id": "1243f072c372425ab9c6a7253f582735", "prediction_text": "FSHD"}, "reference": {"id": "1243f072c372425ab9c6a7253f582735", "answers": {"answer_start": [785], "text": ["FSHD"]}}}, "9cb3c8b77fbf4e009ba52db5f782c5f8": {"prediction": {"id": "9cb3c8b77fbf4e009ba52db5f782c5f8", "prediction_text": "facioscapulohumeral muscular dystrophy"}, "reference": {"id": "9cb3c8b77fbf4e009ba52db5f782c5f8", "answers": {"answer_start": [403], "text": ["FSHD"]}}}, "fafef25b056a463992844bda5c26f90b": {"prediction": {"id": "fafef25b056a463992844bda5c26f90b", "prediction_text": "Facioscapulohumeral muscular dystrophy"}, "reference": {"id": "fafef25b056a463992844bda5c26f90b", "answers": {"answer_start": [40], "text": ["FSHD"]}}}, "ea37888e0ff946ee9277df8c00f24937": {"prediction": {"id": "ea37888e0ff946ee9277df8c00f24937", "prediction_text": "Facioscapulohumeral dystrophy"}, "reference": {"id": "ea37888e0ff946ee9277df8c00f24937", "answers": {"answer_start": [0, 31], "text": ["Facioscapulohumeral dystrophy", "FSHD"]}}}, "e3961c79894c4914b4423235f8cab700": {"prediction": {"id": "e3961c79894c4914b4423235f8cab700", "prediction_text": "Facioscapulohumeral muscular dystrophy"}, "reference": {"id": "e3961c79894c4914b4423235f8cab700", "answers": {"answer_start": [384], "text": ["FSHD"]}}}, "9fad376f01c9490a9cdeeff02fc58366": {"prediction": {"id": "9fad376f01c9490a9cdeeff02fc58366", "prediction_text": "FSHD"}, "reference": {"id": "9fad376f01c9490a9cdeeff02fc58366", "answers": {"answer_start": [555], "text": ["FSHD"]}}}, "294ac92e8f9c4ae089b0f337979976c0": {"prediction": {"id": "294ac92e8f9c4ae089b0f337979976c0", "prediction_text": "pathogenesis"}, "reference": {"id": "294ac92e8f9c4ae089b0f337979976c0", "answers": {"answer_start": [1517], "text": ["FSHD"]}}}, "996e174befd24e6eab8c18305bd0959b": {"prediction": {"id": "996e174befd24e6eab8c18305bd0959b", "prediction_text": "facioscapulohumeral muscular dystrophy"}, "reference": {"id": "996e174befd24e6eab8c18305bd0959b", "answers": {"answer_start": [148], "text": ["FSHD"]}}}, "d7c03520dd044acea351ee8770886fe8": {"prediction": {"id": "d7c03520dd044acea351ee8770886fe8", "prediction_text": "Repeat contractions"}, "reference": {"id": "d7c03520dd044acea351ee8770886fe8", "answers": {"answer_start": [802], "text": ["FSHD"]}}}, "6bef1cbe11b843ce9c8a6d62048c8dc0": {"prediction": {"id": "6bef1cbe11b843ce9c8a6d62048c8dc0", "prediction_text": "facioscapulohumeral dystrophy"}, "reference": {"id": "6bef1cbe11b843ce9c8a6d62048c8dc0", "answers": {"answer_start": [57, 1063], "text": ["Facioscapulohumeral dystrophy", "FSHD"]}}}, "fda990790bef4725963f76623fa0af19": {"prediction": {"id": "fda990790bef4725963f76623fa0af19", "prediction_text": "facioscapulohumeral muscular dystrophy"}, "reference": {"id": "fda990790bef4725963f76623fa0af19", "answers": {"answer_start": [387], "text": ["FSHD"]}}}, "6a316fe8e98048d5b6f895bc4d300934": {"prediction": {"id": "6a316fe8e98048d5b6f895bc4d300934", "prediction_text": "Facioscapulohumeral muscular dystrophy"}, "reference": {"id": "6a316fe8e98048d5b6f895bc4d300934", "answers": {"answer_start": [1432], "text": ["FSHD"]}}}, "9956c7ba48e94b248e3afbcc3b3a8df6": {"prediction": {"id": "9956c7ba48e94b248e3afbcc3b3a8df6", "prediction_text": "Facioscapulohumeral Disease"}, "reference": {"id": "9956c7ba48e94b248e3afbcc3b3a8df6", "answers": {"answer_start": [1470], "text": ["FSHD"]}}}, "1eecb3d3ff874053970b47da3817bb3e": {"prediction": {"id": "1eecb3d3ff874053970b47da3817bb3e", "prediction_text": "Facio-scapulo-humeral dystrophy"}, "reference": {"id": "1eecb3d3ff874053970b47da3817bb3e", "answers": {"answer_start": [1222], "text": ["FSHD"]}}}, "c2a359cca279429995bb3d2507091ce8": {"prediction": {"id": "c2a359cca279429995bb3d2507091ce8", "prediction_text": "fine-tuning the RNA life cycle"}, "reference": {"id": "c2a359cca279429995bb3d2507091ce8", "answers": {"answer_start": [683], "text": ["mRNA stability"]}}}, "96dbc0a3765f487caaf60a90f5ea64f3": {"prediction": {"id": "96dbc0a3765f487caaf60a90f5ea64f3", "prediction_text": "distinct molecular properties"}, "reference": {"id": "96dbc0a3765f487caaf60a90f5ea64f3", "answers": {"answer_start": [642], "text": ["mRNA stability"]}}}, "00621c58f5754fdeb67d4139320497a4": {"prediction": {"id": "00621c58f5754fdeb67d4139320497a4", "prediction_text": "\u03b2-galactosidase and \u03b2-hexosaminidase"}, "reference": {"id": "00621c58f5754fdeb67d4139320497a4", "answers": {"answer_start": [333], "text": ["\u03b2-galactosidase"]}}}, "d4103622505a4424a23b9aba31c12931": {"prediction": {"id": "d4103622505a4424a23b9aba31c12931", "prediction_text": "Insulin"}, "reference": {"id": "d4103622505a4424a23b9aba31c12931", "answers": {"answer_start": [336], "text": ["IL-1\u03b2"]}}}, "f309ae4738284862a5fed51391e92089": {"prediction": {"id": "f309ae4738284862a5fed51391e92089", "prediction_text": "XOMA 052"}, "reference": {"id": "f309ae4738284862a5fed51391e92089", "answers": {"answer_start": [828], "text": ["IL-1\u03b2"]}}}, "c0dffeaff4e64dd297244b6f2add44b5": {"prediction": {"id": "c0dffeaff4e64dd297244b6f2add44b5", "prediction_text": "IL-1\u03b2 modulator gevokizumab in a rat carotid denudation model. Sprague-Dawley rats"}, "reference": {"id": "c0dffeaff4e64dd297244b6f2add44b5", "answers": {"answer_start": [1330], "text": ["IL-1\u03b2"]}}}, "5af060576daf4d958e0f6ce3c48f6d40": {"prediction": {"id": "5af060576daf4d958e0f6ce3c48f6d40", "prediction_text": "IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity for IL-1\u03b2"}, "reference": {"id": "5af060576daf4d958e0f6ce3c48f6d40", "answers": {"answer_start": [100], "text": ["IL-1\u03b2"]}}}, "e4c6125fd54f4eeea0bf980f89e840c6": {"prediction": {"id": "e4c6125fd54f4eeea0bf980f89e840c6", "prediction_text": "interleukin (IL)-1\u03b2 contributes to \u03b2-cell failure in type 2 diabetes. Gevokizumab is a novel, human-engineered monoclonal anti-IL-1\u03b2"}, "reference": {"id": "e4c6125fd54f4eeea0bf980f89e840c6", "answers": {"answer_start": [1400], "text": ["IL-1\u03b2"]}}}, "75f94e94bbd44dc78edb9cb1006bb5e7": {"prediction": {"id": "75f94e94bbd44dc78edb9cb1006bb5e7", "prediction_text": "anti-IL-1\u03b2"}, "reference": {"id": "75f94e94bbd44dc78edb9cb1006bb5e7", "answers": {"answer_start": [794], "text": ["IL-1\u03b2"]}}}, "da7456d8ef1e471ba2e723e46de140fe": {"prediction": {"id": "da7456d8ef1e471ba2e723e46de140fe", "prediction_text": "Fab"}, "reference": {"id": "da7456d8ef1e471ba2e723e46de140fe", "answers": {"answer_start": [920], "text": ["IL-1\u03b2"]}}}, "7c68e609cbe14c2d9dd1e7d985eff8d6": {"prediction": {"id": "7c68e609cbe14c2d9dd1e7d985eff8d6", "prediction_text": "pulmonary arterial hypertension"}, "reference": {"id": "7c68e609cbe14c2d9dd1e7d985eff8d6", "answers": {"answer_start": [201], "text": ["pulmonary arterial hypertension"]}}}, "4b341d6fb24c499e8c17b2221a331e7d": {"prediction": {"id": "4b341d6fb24c499e8c17b2221a331e7d", "prediction_text": "pulmonary arterial hypertension"}, "reference": {"id": "4b341d6fb24c499e8c17b2221a331e7d", "answers": {"answer_start": [395], "text": ["pulmonary arterial hypertension"]}}}, "b749e082bdd94d28a64e13394373eda2": {"prediction": {"id": "b749e082bdd94d28a64e13394373eda2", "prediction_text": "pulmonary arterial hypertension"}, "reference": {"id": "b749e082bdd94d28a64e13394373eda2", "answers": {"answer_start": [184], "text": ["pulmonary arterial hypertension"]}}}, "321f4a68cbe840728bdae503009e4e4d": {"prediction": {"id": "321f4a68cbe840728bdae503009e4e4d", "prediction_text": "pulmonary arterial hypertension"}, "reference": {"id": "321f4a68cbe840728bdae503009e4e4d", "answers": {"answer_start": [201], "text": ["pulmonary arterial hypertension"]}}}, "b726a00f4f794653bf2fb058c4a7ba84": {"prediction": {"id": "b726a00f4f794653bf2fb058c4a7ba84", "prediction_text": "pulmonary arterial hypertension"}, "reference": {"id": "b726a00f4f794653bf2fb058c4a7ba84", "answers": {"answer_start": [120], "text": ["pulmonary arterial hypertension"]}}}, "88093f789f4e428cbe488ec982457e8f": {"prediction": {"id": "88093f789f4e428cbe488ec982457e8f", "prediction_text": "CAGEr"}, "reference": {"id": "88093f789f4e428cbe488ec982457e8f", "answers": {"answer_start": [997], "text": ["CAGEr"]}}}, "5e67b8f6160d4e7cb40c60dafb214cde": {"prediction": {"id": "5e67b8f6160d4e7cb40c60dafb214cde", "prediction_text": "Protein-protein interactions are essential for many cellular processes. We have developed a technology called light-activated dimerization (LAD) to artificially induce protein hetero- and homodimerization in live cells using light. Using the FKF1 and GIGANTEA (GI) proteins of Arabidopsis thaliana, we have generated protein tags whose interaction is controlled by blue light. We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1"}, "reference": {"id": "5e67b8f6160d4e7cb40c60dafb214cde", "answers": {"answer_start": [477], "text": ["Rac1"]}}}, "b70af513b5a243a59097b725abe74a34": {"prediction": {"id": "b70af513b5a243a59097b725abe74a34", "prediction_text": "ataxin-3"}, "reference": {"id": "b70af513b5a243a59097b725abe74a34", "answers": {"answer_start": [1013], "text": ["Ataxin-3"]}}}, "e4d7037288c143abb1f1fe5355fe3943": {"prediction": {"id": "e4d7037288c143abb1f1fe5355fe3943", "prediction_text": "rapamycin ester"}, "reference": {"id": "e4d7037288c143abb1f1fe5355fe3943", "answers": {"answer_start": [1547], "text": ["Ataxin-3"]}}}, "fb69eb8111e14b1c808a6ceb4f19ad5c": {"prediction": {"id": "fb69eb8111e14b1c808a6ceb4f19ad5c", "prediction_text": "polyglutamine (PolyQ) region that, when mutationally expanded to over 52 glutamines"}, "reference": {"id": "fb69eb8111e14b1c808a6ceb4f19ad5c", "answers": {"answer_start": [0], "text": ["Ataxin-3"]}}}, "fca7f200d6524a37b207e52bd1eee546": {"prediction": {"id": "fca7f200d6524a37b207e52bd1eee546", "prediction_text": "ataxin-3"}, "reference": {"id": "fca7f200d6524a37b207e52bd1eee546", "answers": {"answer_start": [695], "text": ["Ataxin-3"]}}}, "b75f49d02e9a4c8fb40f119f7e16e23c": {"prediction": {"id": "b75f49d02e9a4c8fb40f119f7e16e23c", "prediction_text": "Machado-Joseph disease"}, "reference": {"id": "b75f49d02e9a4c8fb40f119f7e16e23c", "answers": {"answer_start": [272], "text": ["Ataxin-3"]}}}, "e547a550c8fd4b8a85353fc571aa7d25": {"prediction": {"id": "e547a550c8fd4b8a85353fc571aa7d25", "prediction_text": "Machado-Joseph disease"}, "reference": {"id": "e547a550c8fd4b8a85353fc571aa7d25", "answers": {"answer_start": [713], "text": ["Ataxin-3"]}}}, "6c11f4dd72a046ffa7e5909e9a3e54ea": {"prediction": {"id": "6c11f4dd72a046ffa7e5909e9a3e54ea", "prediction_text": "Machado-Joseph disease"}, "reference": {"id": "6c11f4dd72a046ffa7e5909e9a3e54ea", "answers": {"answer_start": [715], "text": ["Ataxin-3"]}}}, "3c7d7ad7726146dcbe34ea4a2d4f1f04": {"prediction": {"id": "3c7d7ad7726146dcbe34ea4a2d4f1f04", "prediction_text": "Ataxin-3"}, "reference": {"id": "3c7d7ad7726146dcbe34ea4a2d4f1f04", "answers": {"answer_start": [0], "text": ["Ataxin-3"]}}}, "1e86579359c24c33934db870c2003dcd": {"prediction": {"id": "1e86579359c24c33934db870c2003dcd", "prediction_text": "SCA3"}, "reference": {"id": "1e86579359c24c33934db870c2003dcd", "answers": {"answer_start": [150], "text": ["Ataxin-3"]}}}, "9911aa37cf8e493c970a6c7ba6fcf401": {"prediction": {"id": "9911aa37cf8e493c970a6c7ba6fcf401", "prediction_text": "Mutant ataxin-3"}, "reference": {"id": "9911aa37cf8e493c970a6c7ba6fcf401", "answers": {"answer_start": [622], "text": ["Ataxin-3"]}}}, "fcccbf25cb37411ea023a675f51b3c97": {"prediction": {"id": "fcccbf25cb37411ea023a675f51b3c97", "prediction_text": "Ataxin-3"}, "reference": {"id": "fcccbf25cb37411ea023a675f51b3c97", "answers": {"answer_start": [0], "text": ["Ataxin-3"]}}}, "82e7c5b4f0344550bf79ab8275509219": {"prediction": {"id": "82e7c5b4f0344550bf79ab8275509219", "prediction_text": "SCA3"}, "reference": {"id": "82e7c5b4f0344550bf79ab8275509219", "answers": {"answer_start": [206], "text": ["Ataxin-3"]}}}, "0ba40248b2ed44049515ba319315252c": {"prediction": {"id": "0ba40248b2ed44049515ba319315252c", "prediction_text": "formin family"}, "reference": {"id": "0ba40248b2ed44049515ba319315252c", "answers": {"answer_start": [0], "text": ["mDia proteins are members of the formin family"]}}}, "c3b67513961e4507857e819a6f47b8e8": {"prediction": {"id": "c3b67513961e4507857e819a6f47b8e8", "prediction_text": "ten selenocysteines"}, "reference": {"id": "c3b67513961e4507857e819a6f47b8e8", "answers": {"answer_start": [92], "text": ["Selenoprotein P"]}}}, "e123e9d680da495c91e69da49ccb11d2": {"prediction": {"id": "e123e9d680da495c91e69da49ccb11d2", "prediction_text": "Selenoprotein P"}, "reference": {"id": "e123e9d680da495c91e69da49ccb11d2", "answers": {"answer_start": [0], "text": ["Selenoprotein P"]}}}, "94f5456dbc9b4a89b6a1172e6a87afe5": {"prediction": {"id": "94f5456dbc9b4a89b6a1172e6a87afe5", "prediction_text": "P"}, "reference": {"id": "94f5456dbc9b4a89b6a1172e6a87afe5", "answers": {"answer_start": [6], "text": ["Selenoprotein P"]}}}, "98dacbb1f3c74ea587d786250dce62c9": {"prediction": {"id": "98dacbb1f3c74ea587d786250dce62c9", "prediction_text": "selenoproteins"}, "reference": {"id": "98dacbb1f3c74ea587d786250dce62c9", "answers": {"answer_start": [0], "text": ["Selenoprotein P"]}}}, "8e288097d3274650b2cca7952d8cf99e": {"prediction": {"id": "8e288097d3274650b2cca7952d8cf99e", "prediction_text": "Selenoprotein P"}, "reference": {"id": "8e288097d3274650b2cca7952d8cf99e", "answers": {"answer_start": [0], "text": ["Selenoprotein P"]}}}, "1d25b29284ee408e94094242b0783d5b": {"prediction": {"id": "1d25b29284ee408e94094242b0783d5b", "prediction_text": "Selenoprotein P"}, "reference": {"id": "1d25b29284ee408e94094242b0783d5b", "answers": {"answer_start": [939], "text": ["Selenoprotein P"]}}}, "5e7323e3d65340c695789da8f740ab9c": {"prediction": {"id": "5e7323e3d65340c695789da8f740ab9c", "prediction_text": "selenoprotein P"}, "reference": {"id": "5e7323e3d65340c695789da8f740ab9c", "answers": {"answer_start": [1148], "text": ["Selenoprotein P"]}}}, "5d0cdedc8c744b718c4d51ec006d9bcf": {"prediction": {"id": "5d0cdedc8c744b718c4d51ec006d9bcf", "prediction_text": "P cDNA"}, "reference": {"id": "5d0cdedc8c744b718c4d51ec006d9bcf", "answers": {"answer_start": [117], "text": ["Selenoprotein P"]}}}, "b411cb5cc57a4dafb8b4439161520e09": {"prediction": {"id": "b411cb5cc57a4dafb8b4439161520e09", "prediction_text": "Selenoproteins are a family of proteins that share the common feature of containing selenocysteine, the \"twenty-first\" amino acid. Selenocysteine incorporation occurs during translation of selenoprotein messages by redefinition of UGA codons, which normally specify termination of translation. Studies of the eukaryotic selenocysteine incorporation mechanism suggest that selenocysteine insertion is inefficient compared with termination. Nevertheless, selenoprotein P"}, "reference": {"id": "b411cb5cc57a4dafb8b4439161520e09", "answers": {"answer_start": [453], "text": ["Selenoprotein P"]}}}, "5ea8623c576248a38635dd1b04db0604": {"prediction": {"id": "5ea8623c576248a38635dd1b04db0604", "prediction_text": "TOB1"}, "reference": {"id": "5ea8623c576248a38635dd1b04db0604", "answers": {"answer_start": [41], "text": ["Epidermal growth factor receptor (EGFR)"]}}}, "11177afbf78a43a2be0f61ab72113a71": {"prediction": {"id": "11177afbf78a43a2be0f61ab72113a71", "prediction_text": "transcription factor FOXO3a"}, "reference": {"id": "11177afbf78a43a2be0f61ab72113a71", "answers": {"answer_start": [41], "text": ["Epidermal growth factor receptor (EGFR)"]}}}, "268d8ef0c01d4d8d922cf58d55c27f33": {"prediction": {"id": "268d8ef0c01d4d8d922cf58d55c27f33", "prediction_text": "aging studies. They can be employed to test the effects of experimental manipulation on aging"}, "reference": {"id": "268d8ef0c01d4d8d922cf58d55c27f33", "answers": {"answer_start": [0], "text": ["aging research"]}}}, "0e89edfc2f2f4beb8c133bfa95b84c0d": {"prediction": {"id": "0e89edfc2f2f4beb8c133bfa95b84c0d", "prediction_text": "the aging research community"}, "reference": {"id": "0e89edfc2f2f4beb8c133bfa95b84c0d", "answers": {"answer_start": [1219], "text": ["aging research"]}}}, "996259aeafcc4ab9b7204e8f5a1f4ee2": {"prediction": {"id": "996259aeafcc4ab9b7204e8f5a1f4ee2", "prediction_text": "Spleen tyrosine kinase"}, "reference": {"id": "996259aeafcc4ab9b7204e8f5a1f4ee2", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "7bd46d299fcc46708168cb22e73daee9": {"prediction": {"id": "7bd46d299fcc46708168cb22e73daee9", "prediction_text": "spleen tyrosine kinase"}, "reference": {"id": "7bd46d299fcc46708168cb22e73daee9", "answers": {"answer_start": [846], "text": ["spleen tyrosine kinase"]}}}, "2c4e777514e04401a869642a9fc9f8b5": {"prediction": {"id": "2c4e777514e04401a869642a9fc9f8b5", "prediction_text": "Syk inhibitor"}, "reference": {"id": "2c4e777514e04401a869642a9fc9f8b5", "answers": {"answer_start": [389], "text": ["spleen tyrosine kinase"]}}}, "469ca6c9aac54ffea6eefbcfd3e50834": {"prediction": {"id": "469ca6c9aac54ffea6eefbcfd3e50834", "prediction_text": "Syk"}, "reference": {"id": "469ca6c9aac54ffea6eefbcfd3e50834", "answers": {"answer_start": [257], "text": ["spleen tyrosine kinase"]}}}, "d7b7cbfb10dc480dbbdb49840934b75e": {"prediction": {"id": "d7b7cbfb10dc480dbbdb49840934b75e", "prediction_text": "tyrosine kinase"}, "reference": {"id": "d7b7cbfb10dc480dbbdb49840934b75e", "answers": {"answer_start": [146], "text": ["spleen tyrosine kinase"]}}}, "4d5b9387932a48ee81f69617b05585b5": {"prediction": {"id": "4d5b9387932a48ee81f69617b05585b5", "prediction_text": "spleen tyrosine kinase"}, "reference": {"id": "4d5b9387932a48ee81f69617b05585b5", "answers": {"answer_start": [223], "text": ["spleen tyrosine kinase"]}}}, "7df996ed4d284e13a1a4ba7d8968cb5a": {"prediction": {"id": "7df996ed4d284e13a1a4ba7d8968cb5a", "prediction_text": "tyrosine kinase"}, "reference": {"id": "7df996ed4d284e13a1a4ba7d8968cb5a", "answers": {"answer_start": [83], "text": ["spleen tyrosine kinase"]}}}, "3c9227c6ac98408fbe1903523ee7bb4c": {"prediction": {"id": "3c9227c6ac98408fbe1903523ee7bb4c", "prediction_text": "Spleen tyrosine kinase"}, "reference": {"id": "3c9227c6ac98408fbe1903523ee7bb4c", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "20db3bee9cb94208a4fa08980c73f66a": {"prediction": {"id": "20db3bee9cb94208a4fa08980c73f66a", "prediction_text": "spleen tyrosine kinase"}, "reference": {"id": "20db3bee9cb94208a4fa08980c73f66a", "answers": {"answer_start": [91], "text": ["spleen tyrosine kinase"]}}}, "c42950598e914565ac8d9e78d4209884": {"prediction": {"id": "c42950598e914565ac8d9e78d4209884", "prediction_text": "Syk inhibitor"}, "reference": {"id": "c42950598e914565ac8d9e78d4209884", "answers": {"answer_start": [71], "text": ["spleen tyrosine kinase"]}}}, "dd326e14b10f4101b883bed855abeda1": {"prediction": {"id": "dd326e14b10f4101b883bed855abeda1", "prediction_text": "Spleen tyrosine kinase"}, "reference": {"id": "dd326e14b10f4101b883bed855abeda1", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "8a22837a282c4c03b4b0475a9e8508ac": {"prediction": {"id": "8a22837a282c4c03b4b0475a9e8508ac", "prediction_text": "Syk inhibitor"}, "reference": {"id": "8a22837a282c4c03b4b0475a9e8508ac", "answers": {"answer_start": [294], "text": ["spleen tyrosine kinase"]}}}, "2aa54f6fb2724d8da8abbfa08144b12f": {"prediction": {"id": "2aa54f6fb2724d8da8abbfa08144b12f", "prediction_text": "Spleen tyrosine kinase"}, "reference": {"id": "2aa54f6fb2724d8da8abbfa08144b12f", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "62a4ac0108c549b6abe56d89f4fb5c2d": {"prediction": {"id": "62a4ac0108c549b6abe56d89f4fb5c2d", "prediction_text": "BCR) that are triggered by binding of the BCR to an external antigen. Tonic signaling through the BCR provides growth and signals to chronic lymphocytic leukemia (CLL) cells, and plays an important role in the pathogenesis and progression of the disease. Antigen engagement of BCR is followed by intracellular recruitment and activation of BCR-associated kinases including spleen tyrosine kinase (Syk), Bruton's tyrosine kinase (Btk) and phosphatidylinositol 3-kinases (PI3K). Inhibition of signaling pathways downstream of the BCR induces disruption of chemokine-mediated CLL cell migration and cell killing. BCR signal transduction inhibitors represent a promising new strategy for targeted CLL treatment. A number of therapeutic agents have recently been developed with significant activity in CLL. The compounds that are currently investigated in patients with CLL include ibrutinib -inhibitor of Btk, fostamatinib-inhibitor of Syk and idelalisib (GS-1101) -a specific isoform of the PI3K"}, "reference": {"id": "62a4ac0108c549b6abe56d89f4fb5c2d", "answers": {"answer_start": [440], "text": ["spleen tyrosine kinase"]}}}, "90295d7bd87b4e1aa7b123bbfd69abd8": {"prediction": {"id": "90295d7bd87b4e1aa7b123bbfd69abd8", "prediction_text": "tyrosine kinase"}, "reference": {"id": "90295d7bd87b4e1aa7b123bbfd69abd8", "answers": {"answer_start": [473], "text": ["spleen tyrosine kinase"]}}}, "303554cb60774d0e96c6e7a8a302d6ef": {"prediction": {"id": "303554cb60774d0e96c6e7a8a302d6ef", "prediction_text": "Syk"}, "reference": {"id": "303554cb60774d0e96c6e7a8a302d6ef", "answers": {"answer_start": [83], "text": ["spleen tyrosine kinase"]}}}, "d3978f9d27ec40178c13c17fcfc83da1": {"prediction": {"id": "d3978f9d27ec40178c13c17fcfc83da1", "prediction_text": "tyrosine kinase"}, "reference": {"id": "d3978f9d27ec40178c13c17fcfc83da1", "answers": {"answer_start": [302], "text": ["spleen tyrosine kinase"]}}}, "f42b9c5900c84607990aa417b9a93035": {"prediction": {"id": "f42b9c5900c84607990aa417b9a93035", "prediction_text": "spleen tyrosine kinase"}, "reference": {"id": "f42b9c5900c84607990aa417b9a93035", "answers": {"answer_start": [4], "text": ["spleen tyrosine kinase"]}}}, "8b8faf5113ba4f4e8a7d9d2fa50415b6": {"prediction": {"id": "8b8faf5113ba4f4e8a7d9d2fa50415b6", "prediction_text": "Spleen tyrosine kinase"}, "reference": {"id": "8b8faf5113ba4f4e8a7d9d2fa50415b6", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "4e1efee0a2e64722b81c39b0838f2205": {"prediction": {"id": "4e1efee0a2e64722b81c39b0838f2205", "prediction_text": "tyrosine kinase"}, "reference": {"id": "4e1efee0a2e64722b81c39b0838f2205", "answers": {"answer_start": [107], "text": ["spleen tyrosine kinase"]}}}, "5363d38159844c5a81958b2a0d318ba5": {"prediction": {"id": "5363d38159844c5a81958b2a0d318ba5", "prediction_text": "CHIR-258"}, "reference": {"id": "5363d38159844c5a81958b2a0d318ba5", "answers": {"answer_start": [828], "text": ["spleen tyrosine kinase"]}}}, "56ff7cd615ee4647a96b485df9486268": {"prediction": {"id": "56ff7cd615ee4647a96b485df9486268", "prediction_text": "Spleen tyrosine kinase (Syk) is responsible for membrane-mediated signaling in various cell types including B lymphocytes, macrophages, and T cells. We investigated the ability of a small drug Syk inhibitor, R788"}, "reference": {"id": "56ff7cd615ee4647a96b485df9486268", "answers": {"answer_start": [353], "text": ["spleen tyrosine kinase"]}}}, "7762a32c93ee4864840cee84949a30ad": {"prediction": {"id": "7762a32c93ee4864840cee84949a30ad", "prediction_text": "spleen tyrosine kinase"}, "reference": {"id": "7762a32c93ee4864840cee84949a30ad", "answers": {"answer_start": [667], "text": ["spleen tyrosine kinase"]}}}, "749db16d40eb4b1f859f332c48fc6bb4": {"prediction": {"id": "749db16d40eb4b1f859f332c48fc6bb4", "prediction_text": "Spleen tyrosine kinase"}, "reference": {"id": "749db16d40eb4b1f859f332c48fc6bb4", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "2610948da59f475ba6183bdf7702ee47": {"prediction": {"id": "2610948da59f475ba6183bdf7702ee47", "prediction_text": "Spleen tyrosine kinase"}, "reference": {"id": "2610948da59f475ba6183bdf7702ee47", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "123e1abec90a4047a3a33b3b64a018b0": {"prediction": {"id": "123e1abec90a4047a3a33b3b64a018b0", "prediction_text": "ubiquitin-proteasome pathway"}, "reference": {"id": "123e1abec90a4047a3a33b3b64a018b0", "answers": {"answer_start": [650], "text": ["The ubiquitin/proteasome pathway"]}}}, "1e1124c4f8d144b8b10938028196b824": {"prediction": {"id": "1e1124c4f8d144b8b10938028196b824", "prediction_text": "anticancer"}, "reference": {"id": "1e1124c4f8d144b8b10938028196b824", "answers": {"answer_start": [4], "text": ["The ubiquitin/proteasome pathway"]}}}, "6554c05c936848cfa36c81a256b1ada6": {"prediction": {"id": "6554c05c936848cfa36c81a256b1ada6", "prediction_text": "ubiquitin-proteasome pathway"}, "reference": {"id": "6554c05c936848cfa36c81a256b1ada6", "answers": {"answer_start": [4], "text": ["The ubiquitin/proteasome pathway"]}}}, "567960003d204e2484e456f837a5f143": {"prediction": {"id": "567960003d204e2484e456f837a5f143", "prediction_text": "ubiquitin-proteasome"}, "reference": {"id": "567960003d204e2484e456f837a5f143", "answers": {"answer_start": [4], "text": ["The ubiquitin/proteasome pathway"]}}}, "8ec79033b8f74f4483818893b09740e2": {"prediction": {"id": "8ec79033b8f74f4483818893b09740e2", "prediction_text": "proteasome"}, "reference": {"id": "8ec79033b8f74f4483818893b09740e2", "answers": {"answer_start": [41], "text": ["The ubiquitin/proteasome pathway"]}}}, "c74ebeb665f9464fa9c1079270da3bfe": {"prediction": {"id": "c74ebeb665f9464fa9c1079270da3bfe", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "c74ebeb665f9464fa9c1079270da3bfe", "answers": {"answer_start": [55, 1005], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "9ece56a58c59459c9038ea8dd17fb4ad": {"prediction": {"id": "9ece56a58c59459c9038ea8dd17fb4ad", "prediction_text": "Diamond Blackfan anemia"}, "reference": {"id": "9ece56a58c59459c9038ea8dd17fb4ad", "answers": {"answer_start": [0, 25], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "cd98f74186d2467c87f11d07baf460da": {"prediction": {"id": "cd98f74186d2467c87f11d07baf460da", "prediction_text": "ribosomal protein"}, "reference": {"id": "cd98f74186d2467c87f11d07baf460da", "answers": {"answer_start": [95, 393], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "f9b3249829a84236a7fb35a72cac2b58": {"prediction": {"id": "f9b3249829a84236a7fb35a72cac2b58", "prediction_text": "anemia"}, "reference": {"id": "f9b3249829a84236a7fb35a72cac2b58", "answers": {"answer_start": [0, 759], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "ec001dc1f68c415186183405f17a4256": {"prediction": {"id": "ec001dc1f68c415186183405f17a4256", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "ec001dc1f68c415186183405f17a4256", "answers": {"answer_start": [0, 229], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "b15eb1bcbd0d43cc94dc242e363bff6f": {"prediction": {"id": "b15eb1bcbd0d43cc94dc242e363bff6f", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "b15eb1bcbd0d43cc94dc242e363bff6f", "answers": {"answer_start": [0, 479], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "328efb2adf71442baee189a7396f60e6": {"prediction": {"id": "328efb2adf71442baee189a7396f60e6", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "328efb2adf71442baee189a7396f60e6", "answers": {"answer_start": [313], "text": ["Diamond-Blackfan Anemia"]}}}, "26811b630dbb438790f71b6a6259efc5": {"prediction": {"id": "26811b630dbb438790f71b6a6259efc5", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "26811b630dbb438790f71b6a6259efc5", "answers": {"answer_start": [0, 493], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "e1fa7828445b476b9581ba7c7bafa0ce": {"prediction": {"id": "e1fa7828445b476b9581ba7c7bafa0ce", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "e1fa7828445b476b9581ba7c7bafa0ce", "answers": {"answer_start": [77, 1038], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "2a35bc9a5c004c24ad90f0722ff3d7c3": {"prediction": {"id": "2a35bc9a5c004c24ad90f0722ff3d7c3", "prediction_text": "Diamond-Blackfan Anemia"}, "reference": {"id": "2a35bc9a5c004c24ad90f0722ff3d7c3", "answers": {"answer_start": [501], "text": ["Diamond-Blackfan Anemia"]}}}, "cd0f4aff55744176a9815f8e41083786": {"prediction": {"id": "cd0f4aff55744176a9815f8e41083786", "prediction_text": "hypoplastic"}, "reference": {"id": "cd0f4aff55744176a9815f8e41083786", "answers": {"answer_start": [93, 1271], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "e2a97c8108784fc38654f2ea2e58d93a": {"prediction": {"id": "e2a97c8108784fc38654f2ea2e58d93a", "prediction_text": "anemia"}, "reference": {"id": "e2a97c8108784fc38654f2ea2e58d93a", "answers": {"answer_start": [116, 726], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "187d0a5bb1dd4cb2ba46cf4d4a733939": {"prediction": {"id": "187d0a5bb1dd4cb2ba46cf4d4a733939", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "187d0a5bb1dd4cb2ba46cf4d4a733939", "answers": {"answer_start": [0, 25], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "f685b252703a4eb28f3c832316679456": {"prediction": {"id": "f685b252703a4eb28f3c832316679456", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "f685b252703a4eb28f3c832316679456", "answers": {"answer_start": [0, 295], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "265c1b8f1bd4483ea15b29c13d6c691c": {"prediction": {"id": "265c1b8f1bd4483ea15b29c13d6c691c", "prediction_text": "RPS19"}, "reference": {"id": "265c1b8f1bd4483ea15b29c13d6c691c", "answers": {"answer_start": [0, 25], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "1c2a72da66fd4bbb98ab0dee5eed2cb2": {"prediction": {"id": "1c2a72da66fd4bbb98ab0dee5eed2cb2", "prediction_text": "Diamond Blackfan Anemia"}, "reference": {"id": "1c2a72da66fd4bbb98ab0dee5eed2cb2", "answers": {"answer_start": [1670, 1292], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "da2ff304c1e449798a0244d9c6e85450": {"prediction": {"id": "da2ff304c1e449798a0244d9c6e85450", "prediction_text": "Patisiran"}, "reference": {"id": "da2ff304c1e449798a0244d9c6e85450", "answers": {"answer_start": [0], "text": ["Patisiran"]}}}, "e4859df5122040b9937cd59fa7dd4cff": {"prediction": {"id": "e4859df5122040b9937cd59fa7dd4cff", "prediction_text": "NOX1"}, "reference": {"id": "e4859df5122040b9937cd59fa7dd4cff", "answers": {"answer_start": [613], "text": ["NOX1"]}}}, "b574b20242b24f0aac1d8c2311148086": {"prediction": {"id": "b574b20242b24f0aac1d8c2311148086", "prediction_text": "Organizer 1"}, "reference": {"id": "b574b20242b24f0aac1d8c2311148086", "answers": {"answer_start": [227, 826], "text": ["NADPH oxidase 1", "NOX1"]}}}, "2797691f05cc4202953cb8057217aa49": {"prediction": {"id": "2797691f05cc4202953cb8057217aa49", "prediction_text": "Noxo1"}, "reference": {"id": "2797691f05cc4202953cb8057217aa49", "answers": {"answer_start": [1187], "text": ["NOX1"]}}}, "d0c0593eee9a4a2f8affe53a630046aa": {"prediction": {"id": "d0c0593eee9a4a2f8affe53a630046aa", "prediction_text": "Nox organizer 1"}, "reference": {"id": "d0c0593eee9a4a2f8affe53a630046aa", "answers": {"answer_start": [0, 17], "text": ["NADPH oxidase 1", "NOX1"]}}}, "abdaea4fa7c34e5da9aeccb53e00299e": {"prediction": {"id": "abdaea4fa7c34e5da9aeccb53e00299e", "prediction_text": "Phosphorylation of Thr341"}, "reference": {"id": "abdaea4fa7c34e5da9aeccb53e00299e", "answers": {"answer_start": [25], "text": ["NOX1"]}}}, "eb3e1fb1e299474abe0d2f3dbdc81b44": {"prediction": {"id": "eb3e1fb1e299474abe0d2f3dbdc81b44", "prediction_text": "NOX1"}, "reference": {"id": "eb3e1fb1e299474abe0d2f3dbdc81b44", "answers": {"answer_start": [1888], "text": ["NOX1"]}}}, "52fd50ce600a4be3a4f5cc05517d5c30": {"prediction": {"id": "52fd50ce600a4be3a4f5cc05517d5c30", "prediction_text": "Nox"}, "reference": {"id": "52fd50ce600a4be3a4f5cc05517d5c30", "answers": {"answer_start": [510], "text": ["NOX1"]}}}, "8db4e0cf0a82459cb318a3808a17eed1": {"prediction": {"id": "8db4e0cf0a82459cb318a3808a17eed1", "prediction_text": "Nox3"}, "reference": {"id": "8db4e0cf0a82459cb318a3808a17eed1", "answers": {"answer_start": [246], "text": ["NOX1"]}}}, "18c46950abef4339b3e2ff992d5c51d7": {"prediction": {"id": "18c46950abef4339b3e2ff992d5c51d7", "prediction_text": "Nox"}, "reference": {"id": "18c46950abef4339b3e2ff992d5c51d7", "answers": {"answer_start": [1353], "text": ["NOX1"]}}}, "aee429f28490440ba05a8f3b5fc90f77": {"prediction": {"id": "aee429f28490440ba05a8f3b5fc90f77", "prediction_text": "1"}, "reference": {"id": "aee429f28490440ba05a8f3b5fc90f77", "answers": {"answer_start": [44, 1543], "text": ["NADPH oxidase 1", "NOX1"]}}}, "06cce6d0b3914781b10b40c20a6034fd": {"prediction": {"id": "06cce6d0b3914781b10b40c20a6034fd", "prediction_text": "Nox1 oxidase"}, "reference": {"id": "06cce6d0b3914781b10b40c20a6034fd", "answers": {"answer_start": [830], "text": ["NOX1"]}}}, "e6b60794814649139fd742a8c4f86527": {"prediction": {"id": "e6b60794814649139fd742a8c4f86527", "prediction_text": "Nox"}, "reference": {"id": "e6b60794814649139fd742a8c4f86527", "answers": {"answer_start": [753], "text": ["NOX1"]}}}, "f0098277817047a0a74c80a23b6fe389": {"prediction": {"id": "f0098277817047a0a74c80a23b6fe389", "prediction_text": "Nox1"}, "reference": {"id": "f0098277817047a0a74c80a23b6fe389", "answers": {"answer_start": [1472], "text": ["NOX1"]}}}, "7f775af2f20f49989b275c9e534fa5ad": {"prediction": {"id": "7f775af2f20f49989b275c9e534fa5ad", "prediction_text": "Nox1 requires both the organizer protein Noxo1"}, "reference": {"id": "7f775af2f20f49989b275c9e534fa5ad", "answers": {"answer_start": [498], "text": ["NOX1"]}}}, "a64a754dc228424a9e4926a00639fa23": {"prediction": {"id": "a64a754dc228424a9e4926a00639fa23", "prediction_text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1. However, the role of the small GTPase Rac"}, "reference": {"id": "a64a754dc228424a9e4926a00639fa23", "answers": {"answer_start": [68], "text": ["NOX1"]}}}, "5bed7cf10a7f4d5ab9d75b26bd379a95": {"prediction": {"id": "5bed7cf10a7f4d5ab9d75b26bd379a95", "prediction_text": "ROS) is required for proper cell signaling, but must be tightly regulated to minimize deleterious oxidizing effects. Activation of the NADPH oxidases (Nox) triggers ROS production and, thus, regulatory mechanisms exist to properly control Nox activity. In this study, we report a novel mechanism in which Nox1 activity is regulated through the proteasomal degradation of Nox organizer 1 (NoxO1). We found that through the interaction between NoxO1 and growth receptor-bound protein 2"}, "reference": {"id": "5bed7cf10a7f4d5ab9d75b26bd379a95", "answers": {"answer_start": [971], "text": ["NOX1"]}}}, "fab5b7bb27cb4bbe8c0c10ce4ccff433": {"prediction": {"id": "fab5b7bb27cb4bbe8c0c10ce4ccff433", "prediction_text": "dihydrofolate reductase (DHFR) function, recoupled eNOS in diabetes"}, "reference": {"id": "fab5b7bb27cb4bbe8c0c10ce4ccff433", "answers": {"answer_start": [1362], "text": ["NOX1"]}}}, "f574e17b254549acbbd46389ca893643": {"prediction": {"id": "f574e17b254549acbbd46389ca893643", "prediction_text": "p47(phox"}, "reference": {"id": "f574e17b254549acbbd46389ca893643", "answers": {"answer_start": [273], "text": ["NOX1"]}}}, "7579f39eb45e4f8da3029d1e2b9582c3": {"prediction": {"id": "7579f39eb45e4f8da3029d1e2b9582c3", "prediction_text": "p22phox"}, "reference": {"id": "7579f39eb45e4f8da3029d1e2b9582c3", "answers": {"answer_start": [700], "text": ["NOX1"]}}}, "624f1e284785406980e0812b4e168178": {"prediction": {"id": "624f1e284785406980e0812b4e168178", "prediction_text": "100%"}, "reference": {"id": "624f1e284785406980e0812b4e168178", "answers": {"answer_start": [802], "text": ["100%"]}}}, "1e39167f4a4947a180237ac9754c2703": {"prediction": {"id": "1e39167f4a4947a180237ac9754c2703", "prediction_text": "iron deficiency"}, "reference": {"id": "1e39167f4a4947a180237ac9754c2703", "answers": {"answer_start": [368], "text": ["iron"]}}}, "1dc215c92c03406fbbb701a40a1b0270": {"prediction": {"id": "1dc215c92c03406fbbb701a40a1b0270", "prediction_text": "low brain iron levels. Multiple sclerosis has been associated with the abnormal accumulation of iron in the chronic, progressive phase of axonal degeneration. Iron deficiency may play a role in demyelination. This suggests that restless legs syndrome may be caused by the inflammatory, demyelinating component of multiple sclerosis rather than axonal degeneration. The author presents a case of self-limited restless legs syndrome occurring as an acute attack of multiple sclerosis, supporting the notion that inflammatory demyelination"}, "reference": {"id": "1dc215c92c03406fbbb701a40a1b0270", "answers": {"answer_start": [369], "text": ["iron"]}}}, "d573f33728a44159bab5e26d8686a14f": {"prediction": {"id": "d573f33728a44159bab5e26d8686a14f", "prediction_text": "iron deficiency, polyneuropathy"}, "reference": {"id": "d573f33728a44159bab5e26d8686a14f", "answers": {"answer_start": [332], "text": ["iron"]}}}, "725774a218b94adfadcfebdda9b75614": {"prediction": {"id": "725774a218b94adfadcfebdda9b75614", "prediction_text": "hemoglobin"}, "reference": {"id": "725774a218b94adfadcfebdda9b75614", "answers": {"answer_start": [0], "text": ["iron"]}}}, "a400c0ab5cdf4519af5968f3db54928b": {"prediction": {"id": "a400c0ab5cdf4519af5968f3db54928b", "prediction_text": "iron deficiency"}, "reference": {"id": "a400c0ab5cdf4519af5968f3db54928b", "answers": {"answer_start": [533], "text": ["iron"]}}}, "724585bbaa4548bb93ab35167964d281": {"prediction": {"id": "724585bbaa4548bb93ab35167964d281", "prediction_text": "RLS) and the pathogenesis of RLS"}, "reference": {"id": "724585bbaa4548bb93ab35167964d281", "answers": {"answer_start": [885], "text": ["iron"]}}}, "0da1a0014d1247feae3ddf50780095bc": {"prediction": {"id": "0da1a0014d1247feae3ddf50780095bc", "prediction_text": "iron deficiency"}, "reference": {"id": "0da1a0014d1247feae3ddf50780095bc", "answers": {"answer_start": [0], "text": ["iron"]}}}, "f299014175de4372bbe488e10577c0d6": {"prediction": {"id": "f299014175de4372bbe488e10577c0d6", "prediction_text": "Iron improves hemoglobin"}, "reference": {"id": "f299014175de4372bbe488e10577c0d6", "answers": {"answer_start": [283], "text": ["iron"]}}}, "05604a61ed6748348570ce16094a102d": {"prediction": {"id": "05604a61ed6748348570ce16094a102d", "prediction_text": "pathophysiology"}, "reference": {"id": "05604a61ed6748348570ce16094a102d", "answers": {"answer_start": [0], "text": ["iron"]}}}, "377b4cd6722844cbb4bbdad18f0e2a7c": {"prediction": {"id": "377b4cd6722844cbb4bbdad18f0e2a7c", "prediction_text": "iron deficiency"}, "reference": {"id": "377b4cd6722844cbb4bbdad18f0e2a7c", "answers": {"answer_start": [161], "text": ["iron"]}}}, "e8d23981ca6b40f7bd84407c128a2ef8": {"prediction": {"id": "e8d23981ca6b40f7bd84407c128a2ef8", "prediction_text": "dopamine"}, "reference": {"id": "e8d23981ca6b40f7bd84407c128a2ef8", "answers": {"answer_start": [1392], "text": ["iron"]}}}, "0795a7c32a4b41109339c1dba41210f5": {"prediction": {"id": "0795a7c32a4b41109339c1dba41210f5", "prediction_text": "iron deficiency"}, "reference": {"id": "0795a7c32a4b41109339c1dba41210f5", "answers": {"answer_start": [617], "text": ["iron"]}}}, "a2cc8fcdc153455aa5cdad81c1d3f440": {"prediction": {"id": "a2cc8fcdc153455aa5cdad81c1d3f440", "prediction_text": "sensorimotor disorder. Clinical studies have implicated the dopaminergic system in RLS, while others have suggested that it is associated with insufficient levels of brain iron"}, "reference": {"id": "a2cc8fcdc153455aa5cdad81c1d3f440", "answers": {"answer_start": [241], "text": ["iron"]}}}, "57f5e99fcfe14ce9b9d51858898a47b6": {"prediction": {"id": "57f5e99fcfe14ce9b9d51858898a47b6", "prediction_text": "iron deficiency"}, "reference": {"id": "57f5e99fcfe14ce9b9d51858898a47b6", "answers": {"answer_start": [1358], "text": ["iron"]}}}, "1bd9a3d4827f410080728b28ecb7deba": {"prediction": {"id": "1bd9a3d4827f410080728b28ecb7deba", "prediction_text": "uncomfortable sensations deep in the legs developing at rest"}, "reference": {"id": "1bd9a3d4827f410080728b28ecb7deba", "answers": {"answer_start": [769], "text": ["iron"]}}}, "7b242c42ee274039b225ddb3f57bba50": {"prediction": {"id": "7b242c42ee274039b225ddb3f57bba50", "prediction_text": "iron deficiency"}, "reference": {"id": "7b242c42ee274039b225ddb3f57bba50", "answers": {"answer_start": [335], "text": ["iron"]}}}, "f9889cf066324671ab6c5e6bcd8a0f97": {"prediction": {"id": "f9889cf066324671ab6c5e6bcd8a0f97", "prediction_text": "Iron deficiency"}, "reference": {"id": "f9889cf066324671ab6c5e6bcd8a0f97", "answers": {"answer_start": [0], "text": ["iron"]}}}, "8e32824b34f448789a39f47d6fb9fb00": {"prediction": {"id": "8e32824b34f448789a39f47d6fb9fb00", "prediction_text": "brain iron deficiency"}, "reference": {"id": "8e32824b34f448789a39f47d6fb9fb00", "answers": {"answer_start": [139], "text": ["iron"]}}}, "07327aea21fe4610b3bef5e5e6377ae1": {"prediction": {"id": "07327aea21fe4610b3bef5e5e6377ae1", "prediction_text": "RLS"}, "reference": {"id": "07327aea21fe4610b3bef5e5e6377ae1", "answers": {"answer_start": [102], "text": ["iron"]}}}, "09200d602e9242099f0ab323f93da480": {"prediction": {"id": "09200d602e9242099f0ab323f93da480", "prediction_text": "iron deficiency"}, "reference": {"id": "09200d602e9242099f0ab323f93da480", "answers": {"answer_start": [1296], "text": ["iron"]}}}, "ac861e334489455a8f0c819011f79cb5": {"prediction": {"id": "ac861e334489455a8f0c819011f79cb5", "prediction_text": "iron deficiency anemia"}, "reference": {"id": "ac861e334489455a8f0c819011f79cb5", "answers": {"answer_start": [70], "text": ["iron"]}}}, "be61b46f18d64e819c07a7247292ca0d": {"prediction": {"id": "be61b46f18d64e819c07a7247292ca0d", "prediction_text": "Willis-Ekbom's disease"}, "reference": {"id": "be61b46f18d64e819c07a7247292ca0d", "answers": {"answer_start": [1504], "text": ["iron"]}}}, "6cf4331e14734e4787751106ebe33e4d": {"prediction": {"id": "6cf4331e14734e4787751106ebe33e4d", "prediction_text": "insomnia"}, "reference": {"id": "6cf4331e14734e4787751106ebe33e4d", "answers": {"answer_start": [1006], "text": ["iron"]}}}, "44c189398c3b450e918859fbb01422b0": {"prediction": {"id": "44c189398c3b450e918859fbb01422b0", "prediction_text": "iron depletion"}, "reference": {"id": "44c189398c3b450e918859fbb01422b0", "answers": {"answer_start": [864], "text": ["iron"]}}}, "5e2d435320884bf191156ce86c167712": {"prediction": {"id": "5e2d435320884bf191156ce86c167712", "prediction_text": "iron deficiency"}, "reference": {"id": "5e2d435320884bf191156ce86c167712", "answers": {"answer_start": [974], "text": ["iron"]}}}, "12011d1188544f0b8cd668d64786738d": {"prediction": {"id": "12011d1188544f0b8cd668d64786738d", "prediction_text": "unpaired cysteine"}, "reference": {"id": "12011d1188544f0b8cd668d64786738d", "answers": {"answer_start": [340], "text": ["Cysteine"]}}}, "c0dc770151a74bbca5d9e76c451c773b": {"prediction": {"id": "c0dc770151a74bbca5d9e76c451c773b", "prediction_text": "Mutations in NOTCH3 are the cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a hereditary angiopathy causing stroke and vascular dementia. All CADASIL mutations identified so far result in the loss or gain of one cysteine residue within epidermal growth factor"}, "reference": {"id": "c0dc770151a74bbca5d9e76c451c773b", "answers": {"answer_start": [400], "text": ["Cysteine"]}}}, "d64689e1e8d94115bf85e2da297d72ac": {"prediction": {"id": "d64689e1e8d94115bf85e2da297d72ac", "prediction_text": "cysteine residues"}, "reference": {"id": "d64689e1e8d94115bf85e2da297d72ac", "answers": {"answer_start": [78], "text": ["Cysteine"]}}}, "40eb3b596c344842851753daa600fa96": {"prediction": {"id": "40eb3b596c344842851753daa600fa96", "prediction_text": "polymorphisms"}, "reference": {"id": "40eb3b596c344842851753daa600fa96", "answers": {"answer_start": [269], "text": ["Cysteine"]}}}, "2570b547c9a04a9ca3c877930f257931": {"prediction": {"id": "2570b547c9a04a9ca3c877930f257931", "prediction_text": "exons 3 and 4"}, "reference": {"id": "2570b547c9a04a9ca3c877930f257931", "answers": {"answer_start": [1277], "text": ["Cysteine"]}}}, "3462d0b4c69849bbb1f46aff784c22b1": {"prediction": {"id": "3462d0b4c69849bbb1f46aff784c22b1", "prediction_text": "1 cysteine"}, "reference": {"id": "3462d0b4c69849bbb1f46aff784c22b1", "answers": {"answer_start": [357], "text": ["Cysteine"]}}}, "dc3877a458b645cb840efb816b72c545": {"prediction": {"id": "dc3877a458b645cb840efb816b72c545", "prediction_text": "subcortical infarcts and leukoencephalopathy"}, "reference": {"id": "dc3877a458b645cb840efb816b72c545", "answers": {"answer_start": [166], "text": ["Cysteine"]}}}, "02ee2913f1e74acaa2b855550f9b5efb": {"prediction": {"id": "02ee2913f1e74acaa2b855550f9b5efb", "prediction_text": "CADASIL mutations"}, "reference": {"id": "02ee2913f1e74acaa2b855550f9b5efb", "answers": {"answer_start": [1821], "text": ["Cysteine"]}}}, "a2786439e5b04f70bc24970080ee4a36": {"prediction": {"id": "a2786439e5b04f70bc24970080ee4a36", "prediction_text": "cysteine"}, "reference": {"id": "a2786439e5b04f70bc24970080ee4a36", "answers": {"answer_start": [1818], "text": ["Cysteine"]}}}, "309d5e39a0a74956834968bb60eabaec": {"prediction": {"id": "309d5e39a0a74956834968bb60eabaec", "prediction_text": "2-3"}, "reference": {"id": "309d5e39a0a74956834968bb60eabaec", "answers": {"answer_start": [718], "text": ["Phase 3"]}}}, "92e8db2c749642bb8c37f58da8a613d4": {"prediction": {"id": "92e8db2c749642bb8c37f58da8a613d4", "prediction_text": "chromatin relaxation"}, "reference": {"id": "92e8db2c749642bb8c37f58da8a613d4", "answers": {"answer_start": [214], "text": ["autosomal dominant"]}}}, "6011bce99c704ace8bcad85942a8ece4": {"prediction": {"id": "6011bce99c704ace8bcad85942a8ece4", "prediction_text": "dominant"}, "reference": {"id": "6011bce99c704ace8bcad85942a8ece4", "answers": {"answer_start": [610], "text": ["autosomal dominant"]}}}, "2aac0449f24a44b187e0cc8a6c6b526c": {"prediction": {"id": "2aac0449f24a44b187e0cc8a6c6b526c", "prediction_text": "dominant"}, "reference": {"id": "2aac0449f24a44b187e0cc8a6c6b526c", "answers": {"answer_start": [610], "text": ["autosomal dominant"]}}}, "6aa27e5b749c473398b245f5d51ae63a": {"prediction": {"id": "6aa27e5b749c473398b245f5d51ae63a", "prediction_text": "slowly progressive myopathy"}, "reference": {"id": "6aa27e5b749c473398b245f5d51ae63a", "answers": {"answer_start": [84], "text": ["autosomal dominant"]}}}, "95d4eee3690e435faed91be136026ad4": {"prediction": {"id": "95d4eee3690e435faed91be136026ad4", "prediction_text": "an autosomal-dominant disorder"}, "reference": {"id": "95d4eee3690e435faed91be136026ad4", "answers": {"answer_start": [43], "text": ["autosomal dominant"]}}}, "078a92d156394d6791d1f3ec1f419fcf": {"prediction": {"id": "078a92d156394d6791d1f3ec1f419fcf", "prediction_text": "an autosomal-dominant muscular disorder"}, "reference": {"id": "078a92d156394d6791d1f3ec1f419fcf", "answers": {"answer_start": [43], "text": ["autosomal dominant"]}}}, "3366b51e932744bfb26fa6059de9ce32": {"prediction": {"id": "3366b51e932744bfb26fa6059de9ce32", "prediction_text": "DNA testing"}, "reference": {"id": "3366b51e932744bfb26fa6059de9ce32", "answers": {"answer_start": [594], "text": ["autosomal dominant"]}}}, "2a06202ccf9b4ce8be3cedaf0c1b6ad5": {"prediction": {"id": "2a06202ccf9b4ce8be3cedaf0c1b6ad5", "prediction_text": "autosomal"}, "reference": {"id": "2a06202ccf9b4ce8be3cedaf0c1b6ad5", "answers": {"answer_start": [200], "text": ["autosomal dominant"]}}}, "cf19fde450214d55897f57c66ab45474": {"prediction": {"id": "cf19fde450214d55897f57c66ab45474", "prediction_text": "autosomal dominant"}, "reference": {"id": "cf19fde450214d55897f57c66ab45474", "answers": {"answer_start": [80], "text": ["autosomal dominant"]}}}, "cadf7f71bf354b05b6af4b33f4b1bcc5": {"prediction": {"id": "cadf7f71bf354b05b6af4b33f4b1bcc5", "prediction_text": "autosomal dominant"}, "reference": {"id": "cadf7f71bf354b05b6af4b33f4b1bcc5", "answers": {"answer_start": [94], "text": ["autosomal dominant"]}}}, "7957131cb09f4081ae058215d38acd42": {"prediction": {"id": "7957131cb09f4081ae058215d38acd42", "prediction_text": "sarcoglycanopathy 2C type C283Q mutation was proven in one Roma family suffering from limb-girdle muscular dystrophy (LGMD). Two out of the three facioscapular-humeral dystrophy (FSHD) Roma families carried 21.8 kb and 18.5 kb alleles in FSHD A1 gene"}, "reference": {"id": "7957131cb09f4081ae058215d38acd42", "answers": {"answer_start": [1317], "text": ["autosomal dominant"]}}}, "166560ccb5e9406babaa68dedc77f82e": {"prediction": {"id": "166560ccb5e9406babaa68dedc77f82e", "prediction_text": "Borderline oxacillin-resistant Staphylococcus aureus"}, "reference": {"id": "166560ccb5e9406babaa68dedc77f82e", "answers": {"answer_start": [0], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "1949c48e64054f2eb657c7735b28e367": {"prediction": {"id": "1949c48e64054f2eb657c7735b28e367", "prediction_text": "borderline oxacillin-resistant Staphylococcus aureus"}, "reference": {"id": "1949c48e64054f2eb657c7735b28e367", "answers": {"answer_start": [90], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "690c78d0e27541d48bcf430194fe88d2": {"prediction": {"id": "690c78d0e27541d48bcf430194fe88d2", "prediction_text": "Borderline oxacillin-resistant Staphylococcus aureus"}, "reference": {"id": "690c78d0e27541d48bcf430194fe88d2", "answers": {"answer_start": [0], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "e3bd0ae572eb4c8eabe56e3effe74965": {"prediction": {"id": "e3bd0ae572eb4c8eabe56e3effe74965", "prediction_text": "Borderline oxacillin-resistant Staphylococcus aureus"}, "reference": {"id": "e3bd0ae572eb4c8eabe56e3effe74965", "answers": {"answer_start": [0], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "9dff4d0298e648baa38ff0fb661abe36": {"prediction": {"id": "9dff4d0298e648baa38ff0fb661abe36", "prediction_text": "MICs \u22642 mg/L"}, "reference": {"id": "9dff4d0298e648baa38ff0fb661abe36", "answers": {"answer_start": [90], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "3c81ed3651e84773be75128c923f8cf3": {"prediction": {"id": "3c81ed3651e84773be75128c923f8cf3", "prediction_text": "borderline oxacillin-resistant Staphylococcus aureus"}, "reference": {"id": "3c81ed3651e84773be75128c923f8cf3", "answers": {"answer_start": [326], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "8fe30d9029be449887a1dc799f81e732": {"prediction": {"id": "8fe30d9029be449887a1dc799f81e732", "prediction_text": "mecA negative MRSA"}, "reference": {"id": "8fe30d9029be449887a1dc799f81e732", "answers": {"answer_start": [687], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "4be859a32a914b1180482a71fa3f3309": {"prediction": {"id": "4be859a32a914b1180482a71fa3f3309", "prediction_text": "plasma protein profiles"}, "reference": {"id": "4be859a32a914b1180482a71fa3f3309", "answers": {"answer_start": [87], "text": ["personally normalized plasma protein profiles"]}}}, "4dedb00ba1b14f06828912fb59de7cda": {"prediction": {"id": "4dedb00ba1b14f06828912fb59de7cda", "prediction_text": "vestibular schwannoma"}, "reference": {"id": "4dedb00ba1b14f06828912fb59de7cda", "answers": {"answer_start": [313], "text": ["vestibular schwannoma"]}}}, "849ab0c456b9430cbf3b97bd306f863b": {"prediction": {"id": "849ab0c456b9430cbf3b97bd306f863b", "prediction_text": "vestibular schwannoma"}, "reference": {"id": "849ab0c456b9430cbf3b97bd306f863b", "answers": {"answer_start": [96], "text": ["vestibular schwannoma"]}}}, "65b2ece708494c2bb21dea5a7f60e8af": {"prediction": {"id": "65b2ece708494c2bb21dea5a7f60e8af", "prediction_text": "VS"}, "reference": {"id": "65b2ece708494c2bb21dea5a7f60e8af", "answers": {"answer_start": [57], "text": ["vestibular schwannoma"]}}}, "4cd560ba0cb44bb187aed5ddb734fdae": {"prediction": {"id": "4cd560ba0cb44bb187aed5ddb734fdae", "prediction_text": "House-Brackmann"}, "reference": {"id": "4cd560ba0cb44bb187aed5ddb734fdae", "answers": {"answer_start": [199], "text": ["vestibular schwannoma"]}}}, "9925c4a0fa2d472287864ec5d05fe340": {"prediction": {"id": "9925c4a0fa2d472287864ec5d05fe340", "prediction_text": "vestibular schwannoma"}, "reference": {"id": "9925c4a0fa2d472287864ec5d05fe340", "answers": {"answer_start": [51], "text": ["vestibular schwannoma"]}}}, "c2d8b0b93e7a4cafb76da1a9b4790525": {"prediction": {"id": "c2d8b0b93e7a4cafb76da1a9b4790525", "prediction_text": "8 grade II"}, "reference": {"id": "c2d8b0b93e7a4cafb76da1a9b4790525", "answers": {"answer_start": [1640], "text": ["vestibular schwannoma"]}}}, "b1986022446e452a9bfa43ecd05f9da2": {"prediction": {"id": "b1986022446e452a9bfa43ecd05f9da2", "prediction_text": "meningitis"}, "reference": {"id": "b1986022446e452a9bfa43ecd05f9da2", "answers": {"answer_start": [402], "text": ["vestibular schwannoma"]}}}, "fb5431df27754194b8abe789fb87f79d": {"prediction": {"id": "fb5431df27754194b8abe789fb87f79d", "prediction_text": "atrial fibrillation and flutter"}, "reference": {"id": "fb5431df27754194b8abe789fb87f79d", "answers": {"answer_start": [367], "text": ["atrial fibrillation and flutter"]}}}, "c6a270d51fdd4154a675520fc4c10062": {"prediction": {"id": "c6a270d51fdd4154a675520fc4c10062", "prediction_text": "deltaF508"}, "reference": {"id": "c6a270d51fdd4154a675520fc4c10062", "answers": {"answer_start": [860], "text": ["deltaF508"]}}}, "b5a9bf40f43c4ef588185300f84b53cb": {"prediction": {"id": "b5a9bf40f43c4ef588185300f84b53cb", "prediction_text": "Cystic fibrosis"}, "reference": {"id": "b5a9bf40f43c4ef588185300f84b53cb", "answers": {"answer_start": [1282], "text": ["deltaF508"]}}}, "cb733e283162413ba265ba3a891f0232": {"prediction": {"id": "cb733e283162413ba265ba3a891f0232", "prediction_text": "G551D"}, "reference": {"id": "cb733e283162413ba265ba3a891f0232", "answers": {"answer_start": [1396], "text": ["deltaF508"]}}}, "06da672b697c40a995bbf93be5546ed5": {"prediction": {"id": "06da672b697c40a995bbf93be5546ed5", "prediction_text": "Increased levels of reported ill health among GWV"}, "reference": {"id": "06da672b697c40a995bbf93be5546ed5", "answers": {"answer_start": [1279], "text": ["memory loss"]}}}, "4212384718f8463b91df409305c477b3": {"prediction": {"id": "4212384718f8463b91df409305c477b3", "prediction_text": "ISIS-SMNRx"}, "reference": {"id": "4212384718f8463b91df409305c477b3", "answers": {"answer_start": [112], "text": ["Spinal Muscular Atrophy"]}}}, "bb2f2cc9942a4492aacb01c147d9f616": {"prediction": {"id": "bb2f2cc9942a4492aacb01c147d9f616", "prediction_text": "childhood spinal muscular atrophy"}, "reference": {"id": "bb2f2cc9942a4492aacb01c147d9f616", "answers": {"answer_start": [233, 1481], "text": ["Spinal Muscular Atrophy", "SMA"]}}}, "0303ab86b8bf4ef69cb0dccb9a6259e0": {"prediction": {"id": "0303ab86b8bf4ef69cb0dccb9a6259e0", "prediction_text": "infantile-onset spinal muscular atrophy"}, "reference": {"id": "0303ab86b8bf4ef69cb0dccb9a6259e0", "answers": {"answer_start": [702], "text": ["Spinal Muscular Atrophy"]}}}, "904024fdb322413baa0505293d841c09": {"prediction": {"id": "904024fdb322413baa0505293d841c09", "prediction_text": "Spt-Ada-Gcn5-acetyltransferase"}, "reference": {"id": "904024fdb322413baa0505293d841c09", "answers": {"answer_start": [429], "text": ["Spt-Ada-Gcn5-acetyltransferase"]}}}, "b7cb10ba5c6240478e2f4523eab3c5ce": {"prediction": {"id": "b7cb10ba5c6240478e2f4523eab3c5ce", "prediction_text": "TFIID (a complex of TBP and TBP-associated factors [TAFs])-dependent ribosomal protein genes involved in ribosome biogenesis. However, it is not clearly understood how NuA4 regulates the transcription of ribosomal protein genes. Here, we show that NuA4 is recruited to the promoters of ribosomal protein genes, such as RPS5, RPL2B, and RPS11B, for TFIID recruitment to initiate transcription, and the recruitment of NuA4 to these promoters is impaired in the absence of its Eaf1p component. Intriguingly, impaired NuA4 recruitment in a \u0394eaf1 strain depletes recruitment of TFIID (a TAF-dependent form of TBP) but not the TAF-independent form of TBP to the promoters of ribosomal protein genes. However, in the absence of NuA4, SAGA (Spt-Ada-Gcn5-acetyltransferase"}, "reference": {"id": "b7cb10ba5c6240478e2f4523eab3c5ce", "answers": {"answer_start": [814], "text": ["Spt-Ada-Gcn5-acetyltransferase"]}}}, "d9b5c6a232304e3095ddded9845567d1": {"prediction": {"id": "d9b5c6a232304e3095ddded9845567d1", "prediction_text": "yeast Spt-Ada-Gcn5-acetyltransferase"}, "reference": {"id": "d9b5c6a232304e3095ddded9845567d1", "answers": {"answer_start": [10], "text": ["Spt-Ada-Gcn5-acetyltransferase"]}}}, "592cffaedc494ef9a76eda21d55442be": {"prediction": {"id": "592cffaedc494ef9a76eda21d55442be", "prediction_text": "LHCII"}, "reference": {"id": "592cffaedc494ef9a76eda21d55442be", "answers": {"answer_start": [0], "text": ["LHCII"]}}}, "5beb6af10a2f42038536ca298d0790ad": {"prediction": {"id": "5beb6af10a2f42038536ca298d0790ad", "prediction_text": "chlorophyll a/b-protein complex of photosystem II"}, "reference": {"id": "5beb6af10a2f42038536ca298d0790ad", "answers": {"answer_start": [327], "text": ["LHCII"]}}}, "b8a3e1e8c7dd4636ae5e7905d38d0be0": {"prediction": {"id": "b8a3e1e8c7dd4636ae5e7905d38d0be0", "prediction_text": "LHCII"}, "reference": {"id": "b8a3e1e8c7dd4636ae5e7905d38d0be0", "answers": {"answer_start": [889], "text": ["LHCII"]}}}, "72d0e332ccb14f87b5b911784c450eb5": {"prediction": {"id": "72d0e332ccb14f87b5b911784c450eb5", "prediction_text": "LHCII"}, "reference": {"id": "72d0e332ccb14f87b5b911784c450eb5", "answers": {"answer_start": [0], "text": ["LHCII"]}}}, "37d03dae639645668144f8cead7c4205": {"prediction": {"id": "37d03dae639645668144f8cead7c4205", "prediction_text": "Photosystem II"}, "reference": {"id": "37d03dae639645668144f8cead7c4205", "answers": {"answer_start": [0, 1477], "text": ["Light-harvesting pigment-protein complex of Photosystem II", "LHCII"]}}}, "ed4125bbfe464a9d8dccf8b25f372e14": {"prediction": {"id": "ed4125bbfe464a9d8dccf8b25f372e14", "prediction_text": "early and late"}, "reference": {"id": "ed4125bbfe464a9d8dccf8b25f372e14", "answers": {"answer_start": [1071], "text": ["Early"]}}}, "298fa1e5b28a4c73ae95913752b875e8": {"prediction": {"id": "298fa1e5b28a4c73ae95913752b875e8", "prediction_text": "late"}, "reference": {"id": "298fa1e5b28a4c73ae95913752b875e8", "answers": {"answer_start": [81], "text": ["Early"]}}}, "be1d081a519e4bb09d2c86c210f908ea": {"prediction": {"id": "be1d081a519e4bb09d2c86c210f908ea", "prediction_text": "early"}, "reference": {"id": "be1d081a519e4bb09d2c86c210f908ea", "answers": {"answer_start": [1688], "text": ["Early"]}}}, "c0a46aa217b247a59828a38bdd0cafce": {"prediction": {"id": "c0a46aa217b247a59828a38bdd0cafce", "prediction_text": "psygenet2r"}, "reference": {"id": "c0a46aa217b247a59828a38bdd0cafce", "answers": {"answer_start": [745], "text": ["Psygenet2r"]}}}, "5111a0feed8543ed8ffa2c9ca53890cd": {"prediction": {"id": "5111a0feed8543ed8ffa2c9ca53890cd", "prediction_text": "lysyl oxidase-like 2 (LOXL2) enzyme"}, "reference": {"id": "5111a0feed8543ed8ffa2c9ca53890cd", "answers": {"answer_start": [414], "text": ["LOXL2"]}}}, "a55a59b9b6bf490d8ef1b6c0061b9365": {"prediction": {"id": "a55a59b9b6bf490d8ef1b6c0061b9365", "prediction_text": "lysyl oxidase (LOX) and lysyl oxidase"}, "reference": {"id": "a55a59b9b6bf490d8ef1b6c0061b9365", "answers": {"answer_start": [421], "text": ["LOXL2"]}}}, "485ce48b52e747e5b7e68ae928eeb993": {"prediction": {"id": "485ce48b52e747e5b7e68ae928eeb993", "prediction_text": "125 mg/mL simtuzumab or placebo"}, "reference": {"id": "485ce48b52e747e5b7e68ae928eeb993", "answers": {"answer_start": [562], "text": ["LOXL2"]}}}, "54cef6da78294c22ad4d2879de13b045": {"prediction": {"id": "54cef6da78294c22ad4d2879de13b045", "prediction_text": "Bacteroidetes and Firmicutes"}, "reference": {"id": "54cef6da78294c22ad4d2879de13b045", "answers": {"answer_start": [275], "text": ["Bacteroidetes and Firmicutes"]}}}, "45ba37a2502e43bfb1af41af422ca0ff": {"prediction": {"id": "45ba37a2502e43bfb1af41af422ca0ff", "prediction_text": "Mutations in rfx6"}, "reference": {"id": "45ba37a2502e43bfb1af41af422ca0ff", "answers": {"answer_start": [176], "text": ["RFX6"]}}}, "1e9a292de4614eecbed90d0d5b926330": {"prediction": {"id": "1e9a292de4614eecbed90d0d5b926330", "prediction_text": "RFX6"}, "reference": {"id": "1e9a292de4614eecbed90d0d5b926330", "answers": {"answer_start": [750], "text": ["RFX6"]}}}, "10727d74afc449168911bdbf63ccd904": {"prediction": {"id": "10727d74afc449168911bdbf63ccd904", "prediction_text": "Yap and Taz"}, "reference": {"id": "10727d74afc449168911bdbf63ccd904", "answers": {"answer_start": [335], "text": ["Tead (TEA domain) transcription factors."]}}}, "f440912b2e0d488ebabd5bd75dbf2a7c": {"prediction": {"id": "f440912b2e0d488ebabd5bd75dbf2a7c", "prediction_text": "streptococcal pharyngitis"}, "reference": {"id": "f440912b2e0d488ebabd5bd75dbf2a7c", "answers": {"answer_start": [738], "text": ["streptococcal pharyngitis"]}}}, "b6c53da0db064fafa02480035b9d3ae9": {"prediction": {"id": "b6c53da0db064fafa02480035b9d3ae9", "prediction_text": "non-GAS"}, "reference": {"id": "b6c53da0db064fafa02480035b9d3ae9", "answers": {"answer_start": [252], "text": ["streptococcal pharyngitis"]}}}, "f97ac0ef12544b06b03b2c0f56cc9c65": {"prediction": {"id": "f97ac0ef12544b06b03b2c0f56cc9c65", "prediction_text": "acute strep pharyngitis"}, "reference": {"id": "f97ac0ef12544b06b03b2c0f56cc9c65", "answers": {"answer_start": [1984], "text": ["streptococcal pharyngitis"]}}}, "3384340d21b94477b5a70bd07b189dfe": {"prediction": {"id": "3384340d21b94477b5a70bd07b189dfe", "prediction_text": "fever"}, "reference": {"id": "3384340d21b94477b5a70bd07b189dfe", "answers": {"answer_start": [1277], "text": ["streptococcal pharyngitis"]}}}, "0a8f2716a52c42518fad5fea92401953": {"prediction": {"id": "0a8f2716a52c42518fad5fea92401953", "prediction_text": "inhibits many Src-family tyrosine kinases"}, "reference": {"id": "0a8f2716a52c42518fad5fea92401953", "answers": {"answer_start": [300], "text": ["inhibits"]}}}, "28bbf663497a4ced87c180499baac556": {"prediction": {"id": "28bbf663497a4ced87c180499baac556", "prediction_text": "inhibits"}, "reference": {"id": "28bbf663497a4ced87c180499baac556", "answers": {"answer_start": [448], "text": ["inhibits"]}}}, "44df93ffe4504ed494ab6b81a76281b2": {"prediction": {"id": "44df93ffe4504ed494ab6b81a76281b2", "prediction_text": "X"}, "reference": {"id": "44df93ffe4504ed494ab6b81a76281b2", "answers": {"answer_start": [173], "text": ["X"]}}}, "436f246f9a5941f3b492eee9490030f2": {"prediction": {"id": "436f246f9a5941f3b492eee9490030f2", "prediction_text": "X"}, "reference": {"id": "436f246f9a5941f3b492eee9490030f2", "answers": {"answer_start": [735], "text": ["X"]}}}, "6478269f74d447219f7f7bd656149c22": {"prediction": {"id": "6478269f74d447219f7f7bd656149c22", "prediction_text": "14"}, "reference": {"id": "6478269f74d447219f7f7bd656149c22", "answers": {"answer_start": [490], "text": ["X"]}}}, "ae7fb5c71a1e492f931c945d7b05d68a": {"prediction": {"id": "ae7fb5c71a1e492f931c945d7b05d68a", "prediction_text": "X"}, "reference": {"id": "ae7fb5c71a1e492f931c945d7b05d68a", "answers": {"answer_start": [84], "text": ["X"]}}}, "41c95c9fb3b84a5da8925bac6fa364c0": {"prediction": {"id": "41c95c9fb3b84a5da8925bac6fa364c0", "prediction_text": "X"}, "reference": {"id": "41c95c9fb3b84a5da8925bac6fa364c0", "answers": {"answer_start": [293], "text": ["X"]}}}, "10ae35fd21434352afd76ef500b9ad17": {"prediction": {"id": "10ae35fd21434352afd76ef500b9ad17", "prediction_text": "sSMC"}, "reference": {"id": "10ae35fd21434352afd76ef500b9ad17", "answers": {"answer_start": [734], "text": ["X"]}}}, "a6548c7412034ea291ad392b61cb91ce": {"prediction": {"id": "a6548c7412034ea291ad392b61cb91ce", "prediction_text": "X"}, "reference": {"id": "a6548c7412034ea291ad392b61cb91ce", "answers": {"answer_start": [98], "text": ["X"]}}}, "1ef3241d8d734b56a22db1b768838efb": {"prediction": {"id": "1ef3241d8d734b56a22db1b768838efb", "prediction_text": "karyotype"}, "reference": {"id": "1ef3241d8d734b56a22db1b768838efb", "answers": {"answer_start": [225], "text": ["X"]}}}, "9911b9fd46614139918855e316b5f4d6": {"prediction": {"id": "9911b9fd46614139918855e316b5f4d6", "prediction_text": "X"}, "reference": {"id": "9911b9fd46614139918855e316b5f4d6", "answers": {"answer_start": [0], "text": ["X"]}}}, "e1efd22af6094643be5fc39fd8abd7d4": {"prediction": {"id": "e1efd22af6094643be5fc39fd8abd7d4", "prediction_text": "22q11.2 deletion syndrome"}, "reference": {"id": "e1efd22af6094643be5fc39fd8abd7d4", "answers": {"answer_start": [72], "text": ["X"]}}}, "cc1188ef9b9748c4b600f772ace5f941": {"prediction": {"id": "cc1188ef9b9748c4b600f772ace5f941", "prediction_text": "mouse X"}, "reference": {"id": "cc1188ef9b9748c4b600f772ace5f941", "answers": {"answer_start": [0], "text": ["X"]}}}, "41421a5d60c34f6ab6856a9e53689c54": {"prediction": {"id": "41421a5d60c34f6ab6856a9e53689c54", "prediction_text": "X"}, "reference": {"id": "41421a5d60c34f6ab6856a9e53689c54", "answers": {"answer_start": [595], "text": ["X"]}}}, "adc7efe66b8046168ef0b43c01697b0c": {"prediction": {"id": "adc7efe66b8046168ef0b43c01697b0c", "prediction_text": "X"}, "reference": {"id": "adc7efe66b8046168ef0b43c01697b0c", "answers": {"answer_start": [1191], "text": ["X"]}}}, "2ffc5b75c9d14b4aafdc07ef40108692": {"prediction": {"id": "2ffc5b75c9d14b4aafdc07ef40108692", "prediction_text": "X"}, "reference": {"id": "2ffc5b75c9d14b4aafdc07ef40108692", "answers": {"answer_start": [1288], "text": ["X"]}}}, "a939db4ce90643be91a7569616064004": {"prediction": {"id": "a939db4ce90643be91a7569616064004", "prediction_text": "46,X+m"}, "reference": {"id": "a939db4ce90643be91a7569616064004", "answers": {"answer_start": [705], "text": ["X"]}}}, "0267d12c2e674e24bc5e0717fe29bbfc": {"prediction": {"id": "0267d12c2e674e24bc5e0717fe29bbfc", "prediction_text": "an X"}, "reference": {"id": "0267d12c2e674e24bc5e0717fe29bbfc", "answers": {"answer_start": [86], "text": ["X"]}}}, "7b8846fecb244d57b8f3f8892d4f08cc": {"prediction": {"id": "7b8846fecb244d57b8f3f8892d4f08cc", "prediction_text": "one X"}, "reference": {"id": "7b8846fecb244d57b8f3f8892d4f08cc", "answers": {"answer_start": [70], "text": ["X"]}}}, "19bcdf731fd144aebe71f52f438b5ac2": {"prediction": {"id": "19bcdf731fd144aebe71f52f438b5ac2", "prediction_text": "X"}, "reference": {"id": "19bcdf731fd144aebe71f52f438b5ac2", "answers": {"answer_start": [17], "text": ["X"]}}}, "ebdf16504fb54c06b5a59edf4f75d7eb": {"prediction": {"id": "ebdf16504fb54c06b5a59edf4f75d7eb", "prediction_text": "monosomy"}, "reference": {"id": "ebdf16504fb54c06b5a59edf4f75d7eb", "answers": {"answer_start": [77], "text": ["X"]}}}, "f60d1b68400d4d6e9352bf0e77198ace": {"prediction": {"id": "f60d1b68400d4d6e9352bf0e77198ace", "prediction_text": "complex samples, and that the interaction increases after inhibition of MDM2-dependent p53 degradation using Nutlin-3A. Further, using proximity ligation assay, we show that the interaction takes place in the cell nucleus"}, "reference": {"id": "f60d1b68400d4d6e9352bf0e77198ace", "answers": {"answer_start": [660], "text": ["nucleus"]}}}, "2c0b01f2230b4e45a7308ce161b407bd": {"prediction": {"id": "2c0b01f2230b4e45a7308ce161b407bd", "prediction_text": "tumor shrinkage"}, "reference": {"id": "2c0b01f2230b4e45a7308ce161b407bd", "answers": {"answer_start": [37], "text": ["PI3K-\u03b4"]}}}, "5d33a71b1a814ba688fb210f81f97b02": {"prediction": {"id": "5d33a71b1a814ba688fb210f81f97b02", "prediction_text": "Cseq-Simulator"}, "reference": {"id": "5d33a71b1a814ba688fb210f81f97b02", "answers": {"answer_start": [648], "text": ["Cseq-Simulator"]}}}, "061196104227411b97e325e4bcb1aa27": {"prediction": {"id": "061196104227411b97e325e4bcb1aa27", "prediction_text": "malaria"}, "reference": {"id": "061196104227411b97e325e4bcb1aa27", "answers": {"answer_start": [878], "text": ["malaria"]}}}, "83b5b145dcf64e2d989163534869c87d": {"prediction": {"id": "83b5b145dcf64e2d989163534869c87d", "prediction_text": "malaria"}, "reference": {"id": "83b5b145dcf64e2d989163534869c87d", "answers": {"answer_start": [0], "text": ["malaria"]}}}, "2a1adc11c01c4f12b31d8f5c50fbce02": {"prediction": {"id": "2a1adc11c01c4f12b31d8f5c50fbce02", "prediction_text": "rabies"}, "reference": {"id": "2a1adc11c01c4f12b31d8f5c50fbce02", "answers": {"answer_start": [148], "text": ["malaria"]}}}, "5921347aa14a44e6b28db7215d5793eb": {"prediction": {"id": "5921347aa14a44e6b28db7215d5793eb", "prediction_text": "malaria"}, "reference": {"id": "5921347aa14a44e6b28db7215d5793eb", "answers": {"answer_start": [1155], "text": ["malaria"]}}}, "a9378e3b18634cba9996d6371cf182f8": {"prediction": {"id": "a9378e3b18634cba9996d6371cf182f8", "prediction_text": "Malaria"}, "reference": {"id": "a9378e3b18634cba9996d6371cf182f8", "answers": {"answer_start": [114], "text": ["malaria"]}}}, "c1575f92468249b4b752599f205a6228": {"prediction": {"id": "c1575f92468249b4b752599f205a6228", "prediction_text": "Malaria continues to be a worldwide leading cause of morbidity and mortality, and the development of an effective malaria vaccine remains a research imperative. Of the multiple approaches that have been pursued, the RTS,S/AS01 vaccine candidate represents the most developed and clinically validated malaria"}, "reference": {"id": "c1575f92468249b4b752599f205a6228", "answers": {"answer_start": [586], "text": ["malaria"]}}}, "3a28858f195d4788b492544f43fb922a": {"prediction": {"id": "3a28858f195d4788b492544f43fb922a", "prediction_text": "malaria"}, "reference": {"id": "3a28858f195d4788b492544f43fb922a", "answers": {"answer_start": [232], "text": ["malaria"]}}}, "0c8830354ee544b892d5367f7a883347": {"prediction": {"id": "0c8830354ee544b892d5367f7a883347", "prediction_text": "malaria"}, "reference": {"id": "0c8830354ee544b892d5367f7a883347", "answers": {"answer_start": [663], "text": ["malaria"]}}}, "7d5dc7c6ec9845e8ab9c759111c53a63": {"prediction": {"id": "7d5dc7c6ec9845e8ab9c759111c53a63", "prediction_text": "pre-erythrocytic"}, "reference": {"id": "7d5dc7c6ec9845e8ab9c759111c53a63", "answers": {"answer_start": [0], "text": ["malaria"]}}}, "afa0b674e9254cbeb7de8d2d0614d2e8": {"prediction": {"id": "afa0b674e9254cbeb7de8d2d0614d2e8", "prediction_text": "malaria"}, "reference": {"id": "afa0b674e9254cbeb7de8d2d0614d2e8", "answers": {"answer_start": [192], "text": ["malaria"]}}}, "5a8c3f8675074a32a8a0b3b3bed0e7c9": {"prediction": {"id": "5a8c3f8675074a32a8a0b3b3bed0e7c9", "prediction_text": "malaria"}, "reference": {"id": "5a8c3f8675074a32a8a0b3b3bed0e7c9", "answers": {"answer_start": [719], "text": ["malaria"]}}}, "2debbe231edf4a4da90f19ae387c8164": {"prediction": {"id": "2debbe231edf4a4da90f19ae387c8164", "prediction_text": "malaria"}, "reference": {"id": "2debbe231edf4a4da90f19ae387c8164", "answers": {"answer_start": [4], "text": ["malaria"]}}}, "b15048e9eb2a4e1ca68b07e3745a8aad": {"prediction": {"id": "b15048e9eb2a4e1ca68b07e3745a8aad", "prediction_text": "malaria"}, "reference": {"id": "b15048e9eb2a4e1ca68b07e3745a8aad", "answers": {"answer_start": [267], "text": ["malaria"]}}}, "fecac8b7f2354dad93d1afcfaa9c761f": {"prediction": {"id": "fecac8b7f2354dad93d1afcfaa9c761f", "prediction_text": "malaria"}, "reference": {"id": "fecac8b7f2354dad93d1afcfaa9c761f", "answers": {"answer_start": [44], "text": ["malaria"]}}}, "b459145edade40f798affd76e2a0426d": {"prediction": {"id": "b459145edade40f798affd76e2a0426d", "prediction_text": "malaria"}, "reference": {"id": "b459145edade40f798affd76e2a0426d", "answers": {"answer_start": [2311], "text": ["malaria"]}}}, "a44565bbebec4d6b86e2ce5629e36d30": {"prediction": {"id": "a44565bbebec4d6b86e2ce5629e36d30", "prediction_text": "Plasmodium falciparum"}, "reference": {"id": "a44565bbebec4d6b86e2ce5629e36d30", "answers": {"answer_start": [1017], "text": ["malaria"]}}}, "87f8dd4ade60430dbbea3ccb2cc761d3": {"prediction": {"id": "87f8dd4ade60430dbbea3ccb2cc761d3", "prediction_text": "malaria"}, "reference": {"id": "87f8dd4ade60430dbbea3ccb2cc761d3", "answers": {"answer_start": [1279], "text": ["malaria"]}}}, "13a634ea473a4ba49e133436e37d8487": {"prediction": {"id": "13a634ea473a4ba49e133436e37d8487", "prediction_text": "malaria"}, "reference": {"id": "13a634ea473a4ba49e133436e37d8487", "answers": {"answer_start": [18], "text": ["malaria"]}}}, "d54e35b8c6ca415dbe8f9a92558a23f1": {"prediction": {"id": "d54e35b8c6ca415dbe8f9a92558a23f1", "prediction_text": "malaria"}, "reference": {"id": "d54e35b8c6ca415dbe8f9a92558a23f1", "answers": {"answer_start": [1217], "text": ["malaria"]}}}, "c213540a3bef45f1a6927427b6ad9487": {"prediction": {"id": "c213540a3bef45f1a6927427b6ad9487", "prediction_text": "oligodeoxynucleotides"}, "reference": {"id": "c213540a3bef45f1a6927427b6ad9487", "answers": {"answer_start": [260], "text": ["circularized oligodeoxynucleotides"]}}}, "8e326bdecc864588b32c3f6d58d6127b": {"prediction": {"id": "8e326bdecc864588b32c3f6d58d6127b", "prediction_text": "viroids"}, "reference": {"id": "8e326bdecc864588b32c3f6d58d6127b", "answers": {"answer_start": [90], "text": ["Viroids"]}}}, "f4421d1f15d54f089e26146fdfc2d618": {"prediction": {"id": "f4421d1f15d54f089e26146fdfc2d618", "prediction_text": "viroids"}, "reference": {"id": "f4421d1f15d54f089e26146fdfc2d618", "answers": {"answer_start": [239], "text": ["Viroids"]}}}, "921ca05ea08042c08abb76b0018a9880": {"prediction": {"id": "921ca05ea08042c08abb76b0018a9880", "prediction_text": "Viroids"}, "reference": {"id": "921ca05ea08042c08abb76b0018a9880", "answers": {"answer_start": [323], "text": ["Viroids"]}}}, "105916527d7745c397d59c35b4279681": {"prediction": {"id": "105916527d7745c397d59c35b4279681", "prediction_text": "Viroids"}, "reference": {"id": "105916527d7745c397d59c35b4279681", "answers": {"answer_start": [0], "text": ["Viroids"]}}}, "72b7edf17f7f4f1b99f8060ccd0f7c96": {"prediction": {"id": "72b7edf17f7f4f1b99f8060ccd0f7c96", "prediction_text": "viruses"}, "reference": {"id": "72b7edf17f7f4f1b99f8060ccd0f7c96", "answers": {"answer_start": [465], "text": ["Viroids"]}}}, "2e898dd68fc6433683f837075d90282e": {"prediction": {"id": "2e898dd68fc6433683f837075d90282e", "prediction_text": "Viroids, satellite RNAs, satellites viruses and the human hepatitis delta virus"}, "reference": {"id": "2e898dd68fc6433683f837075d90282e", "answers": {"answer_start": [721], "text": ["Viroids"]}}}, "da0c844f695743668f977f98f97fea2e": {"prediction": {"id": "da0c844f695743668f977f98f97fea2e", "prediction_text": "viroids"}, "reference": {"id": "da0c844f695743668f977f98f97fea2e", "answers": {"answer_start": [1033], "text": ["Viroids"]}}}, "298952b81070479880a16faa65572c00": {"prediction": {"id": "298952b81070479880a16faa65572c00", "prediction_text": "viroids"}, "reference": {"id": "298952b81070479880a16faa65572c00", "answers": {"answer_start": [1520], "text": ["Viroids"]}}}, "d18b34e8cfe34131bc59b05cc97e4d83": {"prediction": {"id": "d18b34e8cfe34131bc59b05cc97e4d83", "prediction_text": "Viroids"}, "reference": {"id": "d18b34e8cfe34131bc59b05cc97e4d83", "answers": {"answer_start": [0], "text": ["Viroids"]}}}, "7dcb5571525246ac95a53d2485e118a1": {"prediction": {"id": "7dcb5571525246ac95a53d2485e118a1", "prediction_text": "Viroids"}, "reference": {"id": "7dcb5571525246ac95a53d2485e118a1", "answers": {"answer_start": [419], "text": ["Viroids"]}}}, "eee61bb98267455fa3f746c46bc45d3b": {"prediction": {"id": "eee61bb98267455fa3f746c46bc45d3b", "prediction_text": "calsequestrin gene"}, "reference": {"id": "eee61bb98267455fa3f746c46bc45d3b", "answers": {"answer_start": [504], "text": ["autosomal dominant"]}}}, "23074f14db7a4c8b956fd2d5b810a634": {"prediction": {"id": "23074f14db7a4c8b956fd2d5b810a634", "prediction_text": "chromosome 1q42-43"}, "reference": {"id": "23074f14db7a4c8b956fd2d5b810a634", "answers": {"answer_start": [12], "text": ["autosomal dominant"]}}}, "98a984074bf84e4ea8d3577bf147afa7": {"prediction": {"id": "98a984074bf84e4ea8d3577bf147afa7", "prediction_text": "arrhythmogenic right ventricular dysplasia type 2"}, "reference": {"id": "98a984074bf84e4ea8d3577bf147afa7", "answers": {"answer_start": [1063], "text": ["autosomal dominant"]}}}, "2357e4fa423e4d94a60ee4c3fab34134": {"prediction": {"id": "2357e4fa423e4d94a60ee4c3fab34134", "prediction_text": "alpha-proteobacterium"}, "reference": {"id": "2357e4fa423e4d94a60ee4c3fab34134", "answers": {"answer_start": [0], "text": ["Biologists agree that the ancestor of mitochondria was an alpha-proteobacterium."]}}}, "93bfdb9ccfbb49639987633eda182f3b": {"prediction": {"id": "93bfdb9ccfbb49639987633eda182f3b", "prediction_text": "luminal side of the endoplasmic reticulum"}, "reference": {"id": "93bfdb9ccfbb49639987633eda182f3b", "answers": {"answer_start": [286], "text": ["luminal side of the endoplasmic reticulum"]}}}, "980da538b0de421ebffc8eb03ba3d137": {"prediction": {"id": "980da538b0de421ebffc8eb03ba3d137", "prediction_text": "longer than the general population, as indicated by lower mortality and higher longevity. Lower cardiovascular disease mortality is likely the primary reason for their better survival rates. On the other hand, there are inconsistent results among studies of power (anaerobic) athletes. When elite athletes engaging in various sports are analysed together, their mortality is lower"}, "reference": {"id": "980da538b0de421ebffc8eb03ba3d137", "answers": {"answer_start": [754], "text": ["longer than the general population"]}}}, "7f77bcc0c2874e198bbf3e9adccc1ca9": {"prediction": {"id": "7f77bcc0c2874e198bbf3e9adccc1ca9", "prediction_text": "autosomal"}, "reference": {"id": "7f77bcc0c2874e198bbf3e9adccc1ca9", "answers": {"answer_start": [64], "text": ["autosomal dominant"]}}}, "586d8130d22d479c99f99484620ee3bc": {"prediction": {"id": "586d8130d22d479c99f99484620ee3bc", "prediction_text": "autosomal"}, "reference": {"id": "586d8130d22d479c99f99484620ee3bc", "answers": {"answer_start": [157], "text": ["autosomal dominant"]}}}, "24d5401c2e23414593908887d12ccc9f": {"prediction": {"id": "24d5401c2e23414593908887d12ccc9f", "prediction_text": "autosomal"}, "reference": {"id": "24d5401c2e23414593908887d12ccc9f", "answers": {"answer_start": [139], "text": ["autosomal dominant"]}}}, "1a49a72f162d4114a116d915af9a751f": {"prediction": {"id": "1a49a72f162d4114a116d915af9a751f", "prediction_text": "autosomal"}, "reference": {"id": "1a49a72f162d4114a116d915af9a751f", "answers": {"answer_start": [193], "text": ["autosomal dominant"]}}}, "734484009356456291de489edf92e4f5": {"prediction": {"id": "734484009356456291de489edf92e4f5", "prediction_text": "autosomal dominant pattern"}, "reference": {"id": "734484009356456291de489edf92e4f5", "answers": {"answer_start": [771], "text": ["autosomal dominant"]}}}, "40bc36d094364cbaabb3e0711f48c4a3": {"prediction": {"id": "40bc36d094364cbaabb3e0711f48c4a3", "prediction_text": "an autosomal dominant inherited disorder"}, "reference": {"id": "40bc36d094364cbaabb3e0711f48c4a3", "answers": {"answer_start": [37], "text": ["autosomal dominant"]}}}, "5c95de84ade14f05a3a98a2c5e26b1e1": {"prediction": {"id": "5c95de84ade14f05a3a98a2c5e26b1e1", "prediction_text": "autosomal dominant inherited trait"}, "reference": {"id": "5c95de84ade14f05a3a98a2c5e26b1e1", "answers": {"answer_start": [46], "text": ["autosomal dominant"]}}}, "4b5eb650ca524c11bf370f0dc556d612": {"prediction": {"id": "4b5eb650ca524c11bf370f0dc556d612", "prediction_text": "autosomal dominant pattern"}, "reference": {"id": "4b5eb650ca524c11bf370f0dc556d612", "answers": {"answer_start": [388], "text": ["autosomal dominant"]}}}, "6f6e2ac53ef14d89ae426210a3023a22": {"prediction": {"id": "6f6e2ac53ef14d89ae426210a3023a22", "prediction_text": "autosomal dominant"}, "reference": {"id": "6f6e2ac53ef14d89ae426210a3023a22", "answers": {"answer_start": [47], "text": ["autosomal dominant"]}}}, "3b2b1847bae74d7a8f13d2c788c4c810": {"prediction": {"id": "3b2b1847bae74d7a8f13d2c788c4c810", "prediction_text": "autosomal-dominant"}, "reference": {"id": "3b2b1847bae74d7a8f13d2c788c4c810", "answers": {"answer_start": [400], "text": ["autosomal dominant"]}}}, "6213dd9a89344714b8506f8550ca6371": {"prediction": {"id": "6213dd9a89344714b8506f8550ca6371", "prediction_text": "autosomal"}, "reference": {"id": "6213dd9a89344714b8506f8550ca6371", "answers": {"answer_start": [27], "text": ["autosomal dominant"]}}}, "f11e1119e7654cce8b219ae4e4b6b0d8": {"prediction": {"id": "f11e1119e7654cce8b219ae4e4b6b0d8", "prediction_text": "KCNQ1 splice variant"}, "reference": {"id": "f11e1119e7654cce8b219ae4e4b6b0d8", "answers": {"answer_start": [1640], "text": ["autosomal dominant"]}}}, "c5ae3e5b31a740c2a686bf2bfd087d96": {"prediction": {"id": "c5ae3e5b31a740c2a686bf2bfd087d96", "prediction_text": "RADAR"}, "reference": {"id": "c5ae3e5b31a740c2a686bf2bfd087d96", "answers": {"answer_start": [493], "text": ["RADAR"]}}}, "15e960b1ac8d42a08551b7dcca72ce0c": {"prediction": {"id": "15e960b1ac8d42a08551b7dcca72ce0c", "prediction_text": "post-traumatic stress disorder"}, "reference": {"id": "15e960b1ac8d42a08551b7dcca72ce0c", "answers": {"answer_start": [141, 173], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "da47edb923ea416b9ef113bfee83b0eb": {"prediction": {"id": "da47edb923ea416b9ef113bfee83b0eb", "prediction_text": "Validity"}, "reference": {"id": "da47edb923ea416b9ef113bfee83b0eb", "answers": {"answer_start": [130, 309], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "8d9900e1661a4b35873640e4ab4f7789": {"prediction": {"id": "8d9900e1661a4b35873640e4ab4f7789", "prediction_text": "depressive"}, "reference": {"id": "8d9900e1661a4b35873640e4ab4f7789", "answers": {"answer_start": [564], "text": ["PTSD"]}}}, "73a9c9064e4549b99a83adf37429d11d": {"prediction": {"id": "73a9c9064e4549b99a83adf37429d11d", "prediction_text": "PTSD"}, "reference": {"id": "73a9c9064e4549b99a83adf37429d11d", "answers": {"answer_start": [118, 267], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "6bec10875735425894c1f6e62032fc38": {"prediction": {"id": "6bec10875735425894c1f6e62032fc38", "prediction_text": "PTSD"}, "reference": {"id": "6bec10875735425894c1f6e62032fc38", "answers": {"answer_start": [191], "text": ["PTSD"]}}}, "f3820f8f687f45da9241be9604440cc6": {"prediction": {"id": "f3820f8f687f45da9241be9604440cc6", "prediction_text": "post-traumatic stress"}, "reference": {"id": "f3820f8f687f45da9241be9604440cc6", "answers": {"answer_start": [97, 129], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "f3f92bc81d054d95afc2a66b116ff874": {"prediction": {"id": "f3f92bc81d054d95afc2a66b116ff874", "prediction_text": "posttraumatic stress disorder"}, "reference": {"id": "f3f92bc81d054d95afc2a66b116ff874", "answers": {"answer_start": [1095], "text": ["PTSD"]}}}, "030f1a41b24d484aa13f5d2b361c4463": {"prediction": {"id": "030f1a41b24d484aa13f5d2b361c4463", "prediction_text": "post-traumatic stress"}, "reference": {"id": "030f1a41b24d484aa13f5d2b361c4463", "answers": {"answer_start": [104, 453], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "0e7764aa3683476185549bf5d953a3f2": {"prediction": {"id": "0e7764aa3683476185549bf5d953a3f2", "prediction_text": "chronic posttraumatic stress disorder"}, "reference": {"id": "0e7764aa3683476185549bf5d953a3f2", "answers": {"answer_start": [904], "text": ["PTSD"]}}}, "8fb807d2d7c644e09a47a582ee5d1cf1": {"prediction": {"id": "8fb807d2d7c644e09a47a582ee5d1cf1", "prediction_text": "posttraumatic stress disorder"}, "reference": {"id": "8fb807d2d7c644e09a47a582ee5d1cf1", "answers": {"answer_start": [102], "text": ["PTSD"]}}}, "b9c92cd3f448446e892500254b0d1691": {"prediction": {"id": "b9c92cd3f448446e892500254b0d1691", "prediction_text": "posttraumatic stress disorder (PTSD). Eighty patients were randomly assigned to treatment with either quetiapine or placebo. The primary outcome measure was the Clinician-Administered PTSD Scale (CAPS). Secondary efficacy measures included the CAPS subscales, the Davidson Trauma Scale, the Positive and Negative Syndrome Scale (PANSS), the Clinical Global Impressions (CGI) scales for severity of Illness and improvement, the Hamilton Depression Rating Scale (HAM-D), and the Hamilton Anxiety Rating Scale (HAM-A). Safety measurements included adverse events, vital signs, the Abnormal Involuntary Movement Scale, the Barnes Akathisia Scale, the Simpson-Angus Scale, and the Arizona Sexual Experiences Scale. After a 1-week placebo run-in, quetiapine was started at a daily dosage of 25 mg and increased to a maximum of 800 mg; the average was 258 mg (range, 50-800 mg). Reductions in CAPS total, re-experiencing, and hyperarousal scores were significantly greater for the quetiapine group than for the placebo group. Greater improvements were also observed for quetiapine"}, "reference": {"id": "b9c92cd3f448446e892500254b0d1691", "answers": {"answer_start": [1617], "text": ["PTSD"]}}}, "8134533e27884d8ebfe41376caae8a2d": {"prediction": {"id": "8134533e27884d8ebfe41376caae8a2d", "prediction_text": "posttraumatic stress disorder"}, "reference": {"id": "8134533e27884d8ebfe41376caae8a2d", "answers": {"answer_start": [768], "text": ["PTSD"]}}}, "9f35093fdcde4702b6a1afeb3b81188f": {"prediction": {"id": "9f35093fdcde4702b6a1afeb3b81188f", "prediction_text": "PTSD"}, "reference": {"id": "9f35093fdcde4702b6a1afeb3b81188f", "answers": {"answer_start": [165], "text": ["PTSD"]}}}, "c73978e2633b49e28abf16abde620d04": {"prediction": {"id": "c73978e2633b49e28abf16abde620d04", "prediction_text": "PTSD"}, "reference": {"id": "c73978e2633b49e28abf16abde620d04", "answers": {"answer_start": [1745], "text": ["PTSD"]}}}, "e6c30d52a20b47a8ac5a146a44d1e930": {"prediction": {"id": "e6c30d52a20b47a8ac5a146a44d1e930", "prediction_text": "PTSD"}, "reference": {"id": "e6c30d52a20b47a8ac5a146a44d1e930", "answers": {"answer_start": [839], "text": ["PTSD"]}}}, "ad8c364703ff414a867519829070948c": {"prediction": {"id": "ad8c364703ff414a867519829070948c", "prediction_text": "PTSD and depression"}, "reference": {"id": "ad8c364703ff414a867519829070948c", "answers": {"answer_start": [477], "text": ["PTSD"]}}}, "e424f09be0be44989d08fbbd13bbe307": {"prediction": {"id": "e424f09be0be44989d08fbbd13bbe307", "prediction_text": "post-traumatic stress disorder"}, "reference": {"id": "e424f09be0be44989d08fbbd13bbe307", "answers": {"answer_start": [178, 844], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "735f47a972d44c008eff5123aebc9476": {"prediction": {"id": "735f47a972d44c008eff5123aebc9476", "prediction_text": "bipolar disorder II"}, "reference": {"id": "735f47a972d44c008eff5123aebc9476", "answers": {"answer_start": [785], "text": ["PTSD"]}}}, "040e193fb33b4ae9b18e80998d121b6b": {"prediction": {"id": "040e193fb33b4ae9b18e80998d121b6b", "prediction_text": "PTSD"}, "reference": {"id": "040e193fb33b4ae9b18e80998d121b6b", "answers": {"answer_start": [627], "text": ["PTSD"]}}}, "c548222ce28b42ad81c8acd3f3151e53": {"prediction": {"id": "c548222ce28b42ad81c8acd3f3151e53", "prediction_text": "PTSD"}, "reference": {"id": "c548222ce28b42ad81c8acd3f3151e53", "answers": {"answer_start": [871], "text": ["PTSD"]}}}, "4052fe619d124f37b827c802e7e24151": {"prediction": {"id": "4052fe619d124f37b827c802e7e24151", "prediction_text": "Structured Interview for PTSD"}, "reference": {"id": "4052fe619d124f37b827c802e7e24151", "answers": {"answer_start": [83, 263], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "b65bfe34c51f48338d5c27569afb500c": {"prediction": {"id": "b65bfe34c51f48338d5c27569afb500c", "prediction_text": "posttraumatic stress disorder"}, "reference": {"id": "b65bfe34c51f48338d5c27569afb500c", "answers": {"answer_start": [691], "text": ["PTSD"]}}}, "7695abadb87a47e1a408be7ffef956ec": {"prediction": {"id": "7695abadb87a47e1a408be7ffef956ec", "prediction_text": "posttraumatic stress disorder"}, "reference": {"id": "7695abadb87a47e1a408be7ffef956ec", "answers": {"answer_start": [224], "text": ["PTSD"]}}}, "037fbad56bfe45d98092696f29e17e8e": {"prediction": {"id": "037fbad56bfe45d98092696f29e17e8e", "prediction_text": "PTSD"}, "reference": {"id": "037fbad56bfe45d98092696f29e17e8e", "answers": {"answer_start": [3, 1493], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "66917071e70145968f5950d1b5938671": {"prediction": {"id": "66917071e70145968f5950d1b5938671", "prediction_text": "PTSD"}, "reference": {"id": "66917071e70145968f5950d1b5938671", "answers": {"answer_start": [1349], "text": ["PTSD"]}}}, "7530b21171b34b42905ac698ed46bb47": {"prediction": {"id": "7530b21171b34b42905ac698ed46bb47", "prediction_text": "Hospital Anxiety and Depression Scale (HADS), Depression Anxiety Stress Scales"}, "reference": {"id": "7530b21171b34b42905ac698ed46bb47", "answers": {"answer_start": [689, 1895], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "14c4b56880594e9b98b13f8247356c03": {"prediction": {"id": "14c4b56880594e9b98b13f8247356c03", "prediction_text": "posttraumatic stress disorder"}, "reference": {"id": "14c4b56880594e9b98b13f8247356c03", "answers": {"answer_start": [371], "text": ["PTSD"]}}}, "18ca706fa1034f1797a2a21e921f3be1": {"prediction": {"id": "18ca706fa1034f1797a2a21e921f3be1", "prediction_text": "post-traumatic stress"}, "reference": {"id": "18ca706fa1034f1797a2a21e921f3be1", "answers": {"answer_start": [71, 103], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "7a98cbe90cad471eb17a7eef101054b4": {"prediction": {"id": "7a98cbe90cad471eb17a7eef101054b4", "prediction_text": "1"}, "reference": {"id": "7a98cbe90cad471eb17a7eef101054b4", "answers": {"answer_start": [1374], "text": ["PP1"]}}}, "da1a4465488744b1ad70dc1f746a7a3a": {"prediction": {"id": "da1a4465488744b1ad70dc1f746a7a3a", "prediction_text": "Epstein-Barr"}, "reference": {"id": "da1a4465488744b1ad70dc1f746a7a3a", "answers": {"answer_start": [15], "text": ["Epstein-Barr virus"]}}}, "70d5f82ec98f4cbd95f27d23ff7d8d53": {"prediction": {"id": "70d5f82ec98f4cbd95f27d23ff7d8d53", "prediction_text": "Cytomegalovirus"}, "reference": {"id": "70d5f82ec98f4cbd95f27d23ff7d8d53", "answers": {"answer_start": [373], "text": ["Epstein-Barr virus"]}}}, "317011c26d3d4613a8feb1a86bc1aa6c": {"prediction": {"id": "317011c26d3d4613a8feb1a86bc1aa6c", "prediction_text": "Epstein-Barr virus viral load"}, "reference": {"id": "317011c26d3d4613a8feb1a86bc1aa6c", "answers": {"answer_start": [675], "text": ["Epstein-Barr virus"]}}}, "4300e95c791143c696739bc79f2fc45e": {"prediction": {"id": "4300e95c791143c696739bc79f2fc45e", "prediction_text": "Epstein-Barr"}, "reference": {"id": "4300e95c791143c696739bc79f2fc45e", "answers": {"answer_start": [15], "text": ["Epstein-Barr virus"]}}}, "5f278b0ff1424a98b094dee01cb885a8": {"prediction": {"id": "5f278b0ff1424a98b094dee01cb885a8", "prediction_text": "Epstein-Barr"}, "reference": {"id": "5f278b0ff1424a98b094dee01cb885a8", "answers": {"answer_start": [0], "text": ["Epstein-Barr virus"]}}}, "e223205e0a094cf8b59f5f411d25615b": {"prediction": {"id": "e223205e0a094cf8b59f5f411d25615b", "prediction_text": "Epstein-Barr"}, "reference": {"id": "e223205e0a094cf8b59f5f411d25615b", "answers": {"answer_start": [336], "text": ["Epstein-Barr virus"]}}}, "c73f1cfe38e84213b58cbfc0597b003d": {"prediction": {"id": "c73f1cfe38e84213b58cbfc0597b003d", "prediction_text": "CMV"}, "reference": {"id": "c73f1cfe38e84213b58cbfc0597b003d", "answers": {"answer_start": [324], "text": ["Epstein-Barr virus"]}}}, "f723f57bee7949bd86f4fd512ee46661": {"prediction": {"id": "f723f57bee7949bd86f4fd512ee46661", "prediction_text": "Epstein-Barr"}, "reference": {"id": "f723f57bee7949bd86f4fd512ee46661", "answers": {"answer_start": [682], "text": ["Epstein-Barr virus"]}}}, "8e47a31354ff40c8abd0fc02297bd3d4": {"prediction": {"id": "8e47a31354ff40c8abd0fc02297bd3d4", "prediction_text": "Epstein-Barr Virus (EBV). It usually resolves over a period of weeks or months without sequelae but may occasionally be complicated by a wide variety of neurologic, hematologic, hepatic, respiratory, and psychological complications. In this report we describe a patient with acute hepatitis following EBV-IM in a previously healthy woman. A 26-year-old woman who presented with fever, generalized weakness, nausea, sore throat, yellowing of skin, and a generalized skin rash was admitted to our clinic. Tonsillar enlargement, pharyngeal erythema, palatal petechiae, lymphadenopathy, and jaundice were noted. Significant atypical lymphocytes ( > 10%) were seen on the peripheral blood smear. Liver function tests such as ALT: 303 U/L, AST: 172 U/L, ALP: 193 U/L and total bilirubin: 7.3 mg/dl were elevated. Serological tests for EBV infection were consistent with acute infection (EBV virus capsid antigen"}, "reference": {"id": "8e47a31354ff40c8abd0fc02297bd3d4", "answers": {"answer_start": [115], "text": ["Epstein-Barr virus"]}}}, "fcc775904da84f2580648e94698f7898": {"prediction": {"id": "fcc775904da84f2580648e94698f7898", "prediction_text": "Epstein-Barr virus"}, "reference": {"id": "fcc775904da84f2580648e94698f7898", "answers": {"answer_start": [239], "text": ["Epstein-Barr virus"]}}}, "ab9e22a52f364268b219ea69c0980d42": {"prediction": {"id": "ab9e22a52f364268b219ea69c0980d42", "prediction_text": "Epstein-Barr"}, "reference": {"id": "ab9e22a52f364268b219ea69c0980d42", "answers": {"answer_start": [945], "text": ["Epstein-Barr virus"]}}}, "fb07991e6cfb4d4c89a9fbecb9fc9857": {"prediction": {"id": "fb07991e6cfb4d4c89a9fbecb9fc9857", "prediction_text": "SLC48"}, "reference": {"id": "fb07991e6cfb4d4c89a9fbecb9fc9857", "answers": {"answer_start": [843], "text": ["SLC49"]}}}, "44f5a0d6eb484afe98b7fbc437a5b567": {"prediction": {"id": "44f5a0d6eb484afe98b7fbc437a5b567", "prediction_text": "a small regulatory peptide"}, "reference": {"id": "44f5a0d6eb484afe98b7fbc437a5b567", "answers": {"answer_start": [115], "text": ["Apelin, a small regulatory peptide, is the endogenous ligand for the apelin receptor (APJ) receptor."]}}}, "191917904dc74ac1ab88e23ae80dcf7b": {"prediction": {"id": "191917904dc74ac1ab88e23ae80dcf7b", "prediction_text": "multisubunit nucleosome-remodeling"}, "reference": {"id": "191917904dc74ac1ab88e23ae80dcf7b", "answers": {"answer_start": [500], "text": ["SWR1"]}}}, "6a08d7c95ced487aa4b97c440076256c": {"prediction": {"id": "6a08d7c95ced487aa4b97c440076256c", "prediction_text": "bromodomain"}, "reference": {"id": "6a08d7c95ced487aa4b97c440076256c", "answers": {"answer_start": [636], "text": ["SWR1"]}}}, "814d36ce52f147f498f68a04b51d1a37": {"prediction": {"id": "814d36ce52f147f498f68a04b51d1a37", "prediction_text": "H2A.Z and Mcd1"}, "reference": {"id": "814d36ce52f147f498f68a04b51d1a37", "answers": {"answer_start": [854], "text": ["SWR1"]}}}, "42d6f4b8648f40e5af97131e7565d7a5": {"prediction": {"id": "42d6f4b8648f40e5af97131e7565d7a5", "prediction_text": "Htz1"}, "reference": {"id": "42d6f4b8648f40e5af97131e7565d7a5", "answers": {"answer_start": [1007], "text": ["SWR1"]}}}, "7c3a7622d6b74ef2811a18f6ab438677": {"prediction": {"id": "7c3a7622d6b74ef2811a18f6ab438677", "prediction_text": "Swr1"}, "reference": {"id": "7c3a7622d6b74ef2811a18f6ab438677", "answers": {"answer_start": [526], "text": ["SWR1"]}}}, "6803654c607e49fa8431caf68fac8017": {"prediction": {"id": "6803654c607e49fa8431caf68fac8017", "prediction_text": "multiprotein SWR1 complex"}, "reference": {"id": "6803654c607e49fa8431caf68fac8017", "answers": {"answer_start": [824], "text": ["SWR1"]}}}, "060062296b6647b682eb7b06d24f5320": {"prediction": {"id": "060062296b6647b682eb7b06d24f5320", "prediction_text": "nucleosomal"}, "reference": {"id": "060062296b6647b682eb7b06d24f5320", "answers": {"answer_start": [239], "text": ["SWR1"]}}}, "ebf7ba84d3204265a1cf79f19876b377": {"prediction": {"id": "ebf7ba84d3204265a1cf79f19876b377", "prediction_text": "chromatin remodeler SWR1"}, "reference": {"id": "ebf7ba84d3204265a1cf79f19876b377", "answers": {"answer_start": [646], "text": ["SWR1"]}}}, "2211156e943844028a8085ad639b130f": {"prediction": {"id": "2211156e943844028a8085ad639b130f", "prediction_text": "Swr1"}, "reference": {"id": "2211156e943844028a8085ad639b130f", "answers": {"answer_start": [368], "text": ["SWR1"]}}}, "c543b103e3e4406f90a0e7e87c8f1b69": {"prediction": {"id": "c543b103e3e4406f90a0e7e87c8f1b69", "prediction_text": "Histone variant H2A.Z-containing nucleosomes are incorporated at most eukaryotic promoters. This incorporation is mediated by the conserved SWR1 complex, which replaces histone H2A in canonical nucleosomes with H2A.Z in an ATP-dependent manner. Here, we show that promoter-proximal nucleosomes"}, "reference": {"id": "c543b103e3e4406f90a0e7e87c8f1b69", "answers": {"answer_start": [140], "text": ["SWR1"]}}}, "e2a8d269e8e64877820ec7f825bef43a": {"prediction": {"id": "e2a8d269e8e64877820ec7f825bef43a", "prediction_text": "SWR1 complex"}, "reference": {"id": "e2a8d269e8e64877820ec7f825bef43a", "answers": {"answer_start": [159], "text": ["SWR1"]}}}, "720b371b0f89469d8d0ccd441e6fbd1e": {"prediction": {"id": "720b371b0f89469d8d0ccd441e6fbd1e", "prediction_text": "Swc4p protein"}, "reference": {"id": "720b371b0f89469d8d0ccd441e6fbd1e", "answers": {"answer_start": [178], "text": ["SWR1"]}}}, "795f19710e654e4eaba47e7470cf7061": {"prediction": {"id": "795f19710e654e4eaba47e7470cf7061", "prediction_text": "polypeptides"}, "reference": {"id": "795f19710e654e4eaba47e7470cf7061", "answers": {"answer_start": [611], "text": ["SWR1"]}}}, "4a05d6b2f85d481ea0730919614c7331": {"prediction": {"id": "4a05d6b2f85d481ea0730919614c7331", "prediction_text": "SWR1C"}, "reference": {"id": "4a05d6b2f85d481ea0730919614c7331", "answers": {"answer_start": [403], "text": ["SWR1"]}}}, "0509fa7f2de643c6b00915540cd6b11e": {"prediction": {"id": "0509fa7f2de643c6b00915540cd6b11e", "prediction_text": "pneumonia"}, "reference": {"id": "0509fa7f2de643c6b00915540cd6b11e", "answers": {"answer_start": [984], "text": ["pneumonia"]}}}, "c8ad90baa2d34672b58c4541c40a724b": {"prediction": {"id": "c8ad90baa2d34672b58c4541c40a724b", "prediction_text": "pneumonia"}, "reference": {"id": "c8ad90baa2d34672b58c4541c40a724b", "answers": {"answer_start": [72], "text": ["pneumonia"]}}}, "570dd82c781645ff9942680bd92c9030": {"prediction": {"id": "570dd82c781645ff9942680bd92c9030", "prediction_text": "pneumonia"}, "reference": {"id": "570dd82c781645ff9942680bd92c9030", "answers": {"answer_start": [1588], "text": ["pneumonia"]}}}, "cf39393e305048b7a00789ad1bef1963": {"prediction": {"id": "cf39393e305048b7a00789ad1bef1963", "prediction_text": "pneumonia"}, "reference": {"id": "cf39393e305048b7a00789ad1bef1963", "answers": {"answer_start": [105], "text": ["pneumonia"]}}}, "42e145ebb50b405fa37a1b2a4a6fef34": {"prediction": {"id": "42e145ebb50b405fa37a1b2a4a6fef34", "prediction_text": "pneumonia"}, "reference": {"id": "42e145ebb50b405fa37a1b2a4a6fef34", "answers": {"answer_start": [274], "text": ["pneumonia"]}}}, "28305051336f4b6781139515931ea0f4": {"prediction": {"id": "28305051336f4b6781139515931ea0f4", "prediction_text": "pneumonia"}, "reference": {"id": "28305051336f4b6781139515931ea0f4", "answers": {"answer_start": [19], "text": ["pneumonia"]}}}, "2964a02ebb724ea08135cc39855fe040": {"prediction": {"id": "2964a02ebb724ea08135cc39855fe040", "prediction_text": "pneumonia"}, "reference": {"id": "2964a02ebb724ea08135cc39855fe040", "answers": {"answer_start": [134], "text": ["pneumonia"]}}}, "29e0d9edccbe485aa620db6b90d8baf8": {"prediction": {"id": "29e0d9edccbe485aa620db6b90d8baf8", "prediction_text": "PSI"}, "reference": {"id": "29e0d9edccbe485aa620db6b90d8baf8", "answers": {"answer_start": [320], "text": ["pneumonia"]}}}, "f6438d1ccf144ef19ed976041aef38a8": {"prediction": {"id": "f6438d1ccf144ef19ed976041aef38a8", "prediction_text": "liver transplant"}, "reference": {"id": "f6438d1ccf144ef19ed976041aef38a8", "answers": {"answer_start": [387], "text": ["Amanita phalloides"]}}}, "22bbf5b4e1bc4594bd3946c40db3bba9": {"prediction": {"id": "22bbf5b4e1bc4594bd3946c40db3bba9", "prediction_text": "Eco R1 enzyme"}, "reference": {"id": "22bbf5b4e1bc4594bd3946c40db3bba9", "answers": {"answer_start": [267], "text": ["E coli"]}}}, "55412c0099e44e9ba85a0bcc27b3b0d1": {"prediction": {"id": "55412c0099e44e9ba85a0bcc27b3b0d1", "prediction_text": "flattened, protein-enriched corneocytes, and 'mortar', represented by intercellular lipid-enriched layers"}, "reference": {"id": "55412c0099e44e9ba85a0bcc27b3b0d1", "answers": {"answer_start": [582], "text": ["Intermediate filaments"]}}}, "bffa57b66319456683f449fc0514d6ea": {"prediction": {"id": "bffa57b66319456683f449fc0514d6ea", "prediction_text": "actin microfilaments, microtubules and intermediate filaments"}, "reference": {"id": "bffa57b66319456683f449fc0514d6ea", "answers": {"answer_start": [112], "text": ["Intermediate filaments"]}}}, "ba34ceb1eb3f4b67b09cb9050fd92d87": {"prediction": {"id": "ba34ceb1eb3f4b67b09cb9050fd92d87", "prediction_text": "scaffold structures within cells"}, "reference": {"id": "ba34ceb1eb3f4b67b09cb9050fd92d87", "answers": {"answer_start": [519], "text": ["Intermediate filaments"]}}}, "3a56ea44d42745a8af975fa882af64d3": {"prediction": {"id": "3a56ea44d42745a8af975fa882af64d3", "prediction_text": "cell-cell adhesion structures"}, "reference": {"id": "3a56ea44d42745a8af975fa882af64d3", "answers": {"answer_start": [106], "text": ["Intermediate filaments"]}}}, "67d51e2c5f8245a7b6a17d76ae50e7d5": {"prediction": {"id": "67d51e2c5f8245a7b6a17d76ae50e7d5", "prediction_text": "Bacillus anthracis plasmid pXO1"}, "reference": {"id": "67d51e2c5f8245a7b6a17d76ae50e7d5", "answers": {"answer_start": [495], "text": ["CO2"]}}}, "3f9343168d424272970f2b54362b54b9": {"prediction": {"id": "3f9343168d424272970f2b54362b54b9", "prediction_text": "atxA"}, "reference": {"id": "3f9343168d424272970f2b54362b54b9", "answers": {"answer_start": [797], "text": ["CO2"]}}}, "73f1239469e845ca9b3b60f4a478ca39": {"prediction": {"id": "73f1239469e845ca9b3b60f4a478ca39", "prediction_text": "Bacillus anthracis"}, "reference": {"id": "73f1239469e845ca9b3b60f4a478ca39", "answers": {"answer_start": [142, 130], "text": ["CO2", "bicarbonate"]}}}, "853cad4029c84cf58a96f284bc4257d3": {"prediction": {"id": "853cad4029c84cf58a96f284bc4257d3", "prediction_text": "Sap"}, "reference": {"id": "853cad4029c84cf58a96f284bc4257d3", "answers": {"answer_start": [872], "text": ["CO2"]}}}, "1b876026d3374c0b95e7939c2ae39e88": {"prediction": {"id": "1b876026d3374c0b95e7939c2ae39e88", "prediction_text": "atxA, activates transcription of the cap region genes located on pXO2. We identified two major apparent transcriptional start sites, designated P1 and P2, located at positions 731 bp and 625 bp, respectively, upstream of the translation-initiation codon of capB. Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate"}, "reference": {"id": "1b876026d3374c0b95e7939c2ae39e88", "answers": {"answer_start": [1568], "text": ["bicarbonate"]}}}, "38bcee542b99464dbd5fcf5fd6f316ba": {"prediction": {"id": "38bcee542b99464dbd5fcf5fd6f316ba", "prediction_text": "Bacillus anthracis"}, "reference": {"id": "38bcee542b99464dbd5fcf5fd6f316ba", "answers": {"answer_start": [1428], "text": ["bicarbonate"]}}}, "d56625d6a8c4449f98274902e9f7593c": {"prediction": {"id": "d56625d6a8c4449f98274902e9f7593c", "prediction_text": "Rotor syndrome"}, "reference": {"id": "d56625d6a8c4449f98274902e9f7593c", "answers": {"answer_start": [323], "text": ["Rotor syndrome"]}}}, "d85a62a0acae4ac5bf443a22e76e23c7": {"prediction": {"id": "d85a62a0acae4ac5bf443a22e76e23c7", "prediction_text": "Rotor syndrome"}, "reference": {"id": "d85a62a0acae4ac5bf443a22e76e23c7", "answers": {"answer_start": [323], "text": ["Rotor syndrome"]}}}, "19794fd414a147e4af93d1a407df7750": {"prediction": {"id": "19794fd414a147e4af93d1a407df7750", "prediction_text": "adriamycin"}, "reference": {"id": "19794fd414a147e4af93d1a407df7750", "answers": {"answer_start": [135], "text": ["lncRNA H19"]}}}, "05f4130c37ba436e921db209974f1244": {"prediction": {"id": "05f4130c37ba436e921db209974f1244", "prediction_text": "extracellular vesicles"}, "reference": {"id": "05f4130c37ba436e921db209974f1244", "answers": {"answer_start": [0], "text": ["Exosomes are a subset of extracellular vesicles (EVs) that have important roles in intercellular communication. They contain and carry bioactive molecules within their membranes which are delivered to target cells."]}}}, "cb7934d2a386476b8a2a5d7a2afb27fc": {"prediction": {"id": "cb7934d2a386476b8a2a5d7a2afb27fc", "prediction_text": "IL-17"}, "reference": {"id": "cb7934d2a386476b8a2a5d7a2afb27fc", "answers": {"answer_start": [48], "text": ["interleukin-17A"]}}}, "8e186c21ec1d4bc09e90bec30d7e7d0b": {"prediction": {"id": "8e186c21ec1d4bc09e90bec30d7e7d0b", "prediction_text": "MAb"}, "reference": {"id": "8e186c21ec1d4bc09e90bec30d7e7d0b", "answers": {"answer_start": [127], "text": ["interleukin-17A"]}}}, "9eb794e2f7cc4c02ab082d3a2344c75a": {"prediction": {"id": "9eb794e2f7cc4c02ab082d3a2344c75a", "prediction_text": "PFS"}, "reference": {"id": "9eb794e2f7cc4c02ab082d3a2344c75a", "answers": {"answer_start": [32], "text": ["interleukin-17A"]}}}, "d110ff7769954b7998b19f603551023f": {"prediction": {"id": "d110ff7769954b7998b19f603551023f", "prediction_text": "Secukinumab is a fully human anti-interleukin-17A"}, "reference": {"id": "d110ff7769954b7998b19f603551023f", "answers": {"answer_start": [34], "text": ["interleukin-17A"]}}}, "b2c63b74cc0f4deab23be554f71a24c7": {"prediction": {"id": "b2c63b74cc0f4deab23be554f71a24c7", "prediction_text": "secukinumab"}, "reference": {"id": "b2c63b74cc0f4deab23be554f71a24c7", "answers": {"answer_start": [119], "text": ["interleukin-17A"]}}}, "739b09610be148a79b4aa223d153bd05": {"prediction": {"id": "739b09610be148a79b4aa223d153bd05", "prediction_text": "secukinumab"}, "reference": {"id": "739b09610be148a79b4aa223d153bd05", "answers": {"answer_start": [0], "text": ["interleukin-17A"]}}}, "58e79346e00b475c9faba2c5d3baea08": {"prediction": {"id": "58e79346e00b475c9faba2c5d3baea08", "prediction_text": "poorly understood and under-investigated"}, "reference": {"id": "58e79346e00b475c9faba2c5d3baea08", "answers": {"answer_start": [734], "text": ["Cellular adhesion function"]}}}, "e1d01c5224d5401a8cc6865333a4d839": {"prediction": {"id": "e1d01c5224d5401a8cc6865333a4d839", "prediction_text": "CNTO 328"}, "reference": {"id": "e1d01c5224d5401a8cc6865333a4d839", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "8eb12b4a4daf413aaae090816f210726": {"prediction": {"id": "8eb12b4a4daf413aaae090816f210726", "prediction_text": "IL-6"}, "reference": {"id": "8eb12b4a4daf413aaae090816f210726", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "ca8844dbc49040baa14f6b1af3f7efae": {"prediction": {"id": "ca8844dbc49040baa14f6b1af3f7efae", "prediction_text": "CNTO 328"}, "reference": {"id": "ca8844dbc49040baa14f6b1af3f7efae", "answers": {"answer_start": [887], "text": ["interleukin-6"]}}}, "3b1cf1103e6c40e4b32a800c9770530f": {"prediction": {"id": "3b1cf1103e6c40e4b32a800c9770530f", "prediction_text": "CNTO 328"}, "reference": {"id": "3b1cf1103e6c40e4b32a800c9770530f", "answers": {"answer_start": [65], "text": ["interleukin-6"]}}}, "01e8939a982e440abb1bd2c0683a0f7c": {"prediction": {"id": "01e8939a982e440abb1bd2c0683a0f7c", "prediction_text": "IL-6"}, "reference": {"id": "01e8939a982e440abb1bd2c0683a0f7c", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "16a4fd0daf774748b854fd3bb1b206c2": {"prediction": {"id": "16a4fd0daf774748b854fd3bb1b206c2", "prediction_text": "S"}, "reference": {"id": "16a4fd0daf774748b854fd3bb1b206c2", "answers": {"answer_start": [63], "text": ["interleukin-6"]}}}, "cb03665b02954b28b3a4148fb0e15b78": {"prediction": {"id": "cb03665b02954b28b3a4148fb0e15b78", "prediction_text": "IL6"}, "reference": {"id": "cb03665b02954b28b3a4148fb0e15b78", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "58611efcd942481c820bf237b26f9387": {"prediction": {"id": "58611efcd942481c820bf237b26f9387", "prediction_text": "CNTO 328"}, "reference": {"id": "58611efcd942481c820bf237b26f9387", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "bbd3a3134dfd479b9a3ee4c644c0e899": {"prediction": {"id": "bbd3a3134dfd479b9a3ee4c644c0e899", "prediction_text": "CRPC) patients. We assessed the safety and tolerability of siltuximab in combination with docetaxel, the pharmacokinetics of docetaxel alone and with siltuximab, and the efficacy and pharmacodynamics of siltuximab plus docetaxel. In an open-label, dose-escalation, multicenter, phase 1 study, patients with metastatic, progressive CRPC received docetaxel 75 mg/m(2) q3w plus siltuximab 6 mg/kg q2w (n=12), 9 mg/kg q3w (n=12), or 12 mg/kg q3w (n=15). Dose-limiting toxicity (DLT), PSA, and radiologic response according to WHO criteria were evaluated. DLT was reported in 1 of 11 patients receiving 6 mg/kg, 1 of 12 receiving 9 mg/kg, and in 1 of 14 receiving 12 mg/kg. Common Grade \u2265 3 adverse events were neutropenia (73 %), leukopenia (60 %), lymphopenia (30 %), dyspnea (19 %), and fatigue (14 %). Toxicities were not dose dependent. Siltuximab did not affect docetaxel pharmacokinetics. The pharmacokinetic profile for siltuximab in combination was similar to single-agent siltuximab pharmacokinetics. Twenty-three (62 %; 95 % CI 45 %, 78 %) of 37 combination-treated patients achieved a confirmed \u2265 50 % PSA decline. Of 17 patients with measurable disease at baseline, 2 confirmed and 2 unconfirmed radiologic partial responses ranging 190 to 193 days were achieved with 9- and 12-mg/kg siltuximab. C-reactive"}, "reference": {"id": "bbd3a3134dfd479b9a3ee4c644c0e899", "answers": {"answer_start": [31], "text": ["interleukin-6"]}}}, "d854b0a43160426ea09ae6adef3666d3": {"prediction": {"id": "d854b0a43160426ea09ae6adef3666d3", "prediction_text": "IL-6"}, "reference": {"id": "d854b0a43160426ea09ae6adef3666d3", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "6eb3e425792842e4941211137e455d53": {"prediction": {"id": "6eb3e425792842e4941211137e455d53", "prediction_text": "DLTs"}, "reference": {"id": "6eb3e425792842e4941211137e455d53", "answers": {"answer_start": [82], "text": ["interleukin-6"]}}}, "a9e6997deb2a4d808f546027aab8c298": {"prediction": {"id": "a9e6997deb2a4d808f546027aab8c298", "prediction_text": "Stat3"}, "reference": {"id": "a9e6997deb2a4d808f546027aab8c298", "answers": {"answer_start": [42], "text": ["interleukin-6"]}}}, "d9a947c0ccc7439aae972734e8a0c3f6": {"prediction": {"id": "d9a947c0ccc7439aae972734e8a0c3f6", "prediction_text": "Imatinib mesylate (IM"}, "reference": {"id": "d9a947c0ccc7439aae972734e8a0c3f6", "answers": {"answer_start": [505], "text": ["BCR-ABL"]}}}, "11441b8bc0c14ae89c36a83f50538eb4": {"prediction": {"id": "11441b8bc0c14ae89c36a83f50538eb4", "prediction_text": "BCR-ABL"}, "reference": {"id": "11441b8bc0c14ae89c36a83f50538eb4", "answers": {"answer_start": [609], "text": ["BCR-ABL"]}}}, "c2846d96831344d59854c868542d197b": {"prediction": {"id": "c2846d96831344d59854c868542d197b", "prediction_text": "BCR-ABL fusion gene"}, "reference": {"id": "c2846d96831344d59854c868542d197b", "answers": {"answer_start": [559], "text": ["BCR-ABL"]}}}, "408a023773e74614a594bf6c253265d6": {"prediction": {"id": "408a023773e74614a594bf6c253265d6", "prediction_text": "BCR-ABL"}, "reference": {"id": "408a023773e74614a594bf6c253265d6", "answers": {"answer_start": [291], "text": ["BCR-ABL"]}}}, "12707c9f82d04e8ca4b10f4a82328469": {"prediction": {"id": "12707c9f82d04e8ca4b10f4a82328469", "prediction_text": "BCR-ABL"}, "reference": {"id": "12707c9f82d04e8ca4b10f4a82328469", "answers": {"answer_start": [1032], "text": ["BCR-ABL"]}}}, "72ba85976fa54dab9fbc26aa7c035e26": {"prediction": {"id": "72ba85976fa54dab9fbc26aa7c035e26", "prediction_text": "Bcr-Abl"}, "reference": {"id": "72ba85976fa54dab9fbc26aa7c035e26", "answers": {"answer_start": [44], "text": ["BCR-ABL"]}}}, "5577b350cf9142e691f55a9294498c45": {"prediction": {"id": "5577b350cf9142e691f55a9294498c45", "prediction_text": "BCR-ABL tyrosine kinase inhibitors, such as imatinib (Gleevec) are highly effective in treating human Philadelphia"}, "reference": {"id": "5577b350cf9142e691f55a9294498c45", "answers": {"answer_start": [995], "text": ["BCR-ABL"]}}}, "ff1875c719ce4fbd935edd48ee8325c1": {"prediction": {"id": "ff1875c719ce4fbd935edd48ee8325c1", "prediction_text": "Philadelphia"}, "reference": {"id": "ff1875c719ce4fbd935edd48ee8325c1", "answers": {"answer_start": [133], "text": ["BCR-ABL"]}}}, "e03182dcf4144f669a390b660ab7c5e5": {"prediction": {"id": "e03182dcf4144f669a390b660ab7c5e5", "prediction_text": "P210 BCR-ABL"}, "reference": {"id": "e03182dcf4144f669a390b660ab7c5e5", "answers": {"answer_start": [361], "text": ["BCR-ABL"]}}}, "d91bd6f5d3ac4271b7020c7eb1f69676": {"prediction": {"id": "d91bd6f5d3ac4271b7020c7eb1f69676", "prediction_text": "Philadelphia"}, "reference": {"id": "d91bd6f5d3ac4271b7020c7eb1f69676", "answers": {"answer_start": [133], "text": ["BCR-ABL"]}}}, "10ef2e6e82204b728c1c490972ff7f93": {"prediction": {"id": "10ef2e6e82204b728c1c490972ff7f93", "prediction_text": "bcr-abl tyrosine kinase, the product of the Philadelphia"}, "reference": {"id": "10ef2e6e82204b728c1c490972ff7f93", "answers": {"answer_start": [1284], "text": ["BCR-ABL"]}}}, "b48f054bb30340d2b61a158570eba2dd": {"prediction": {"id": "b48f054bb30340d2b61a158570eba2dd", "prediction_text": "breakpoint cluster region"}, "reference": {"id": "b48f054bb30340d2b61a158570eba2dd", "answers": {"answer_start": [1199], "text": ["BCR-ABL"]}}}, "90b6a7fdadd848168bc0b54cf8fa32f6": {"prediction": {"id": "90b6a7fdadd848168bc0b54cf8fa32f6", "prediction_text": "BCR-ABL"}, "reference": {"id": "90b6a7fdadd848168bc0b54cf8fa32f6", "answers": {"answer_start": [1409], "text": ["BCR-ABL"]}}}, "0404ea8ac7da4c9b88d543fd9552ceed": {"prediction": {"id": "0404ea8ac7da4c9b88d543fd9552ceed", "prediction_text": "Philadelphia"}, "reference": {"id": "0404ea8ac7da4c9b88d543fd9552ceed", "answers": {"answer_start": [281], "text": ["BCR-ABL"]}}}, "2c292569c7e34b328cb015dd1277254c": {"prediction": {"id": "2c292569c7e34b328cb015dd1277254c", "prediction_text": "BCR-ABL is critical to the pathogenesis of chronic myelogenous leukemia and a subset of acute leukemias. The chimeric Bcr-Abl protein has constitutively elevated tyrosine phosphokinase activity. This abnormal enzymatic activation is critical to the oncogenic potential of Bcr-Abl. Initially, protein kinases were thought to be poor therapeutic targets because of their ubiquitous nature and crucial role in many normal physiologic processes. However, the advent of imatinib mesylate"}, "reference": {"id": "2c292569c7e34b328cb015dd1277254c", "answers": {"answer_start": [169], "text": ["BCR-ABL"]}}}, "cb43b52f9f914d6f914b6448cecd1569": {"prediction": {"id": "cb43b52f9f914d6f914b6448cecd1569", "prediction_text": "Abl kinase"}, "reference": {"id": "cb43b52f9f914d6f914b6448cecd1569", "answers": {"answer_start": [1070], "text": ["BCR-ABL"]}}}, "3598291a1a8e4651863d614db5ee4dc4": {"prediction": {"id": "3598291a1a8e4651863d614db5ee4dc4", "prediction_text": "imatinib mesylate"}, "reference": {"id": "3598291a1a8e4651863d614db5ee4dc4", "answers": {"answer_start": [319], "text": ["BCR-ABL"]}}}, "eb20f1a6379e4e38a3935ce6d166398c": {"prediction": {"id": "eb20f1a6379e4e38a3935ce6d166398c", "prediction_text": "Abl tyrosine kinase"}, "reference": {"id": "eb20f1a6379e4e38a3935ce6d166398c", "answers": {"answer_start": [203], "text": ["BCR-ABL"]}}}, "92bc3515c77542a7ac2a146c8fd26a93": {"prediction": {"id": "92bc3515c77542a7ac2a146c8fd26a93", "prediction_text": "Philadelphia"}, "reference": {"id": "92bc3515c77542a7ac2a146c8fd26a93", "answers": {"answer_start": [720], "text": ["BCR-ABL"]}}}, "a47838ced53743b4b62201cfdbbc671d": {"prediction": {"id": "a47838ced53743b4b62201cfdbbc671d", "prediction_text": "Imatinib mesylate"}, "reference": {"id": "a47838ced53743b4b62201cfdbbc671d", "answers": {"answer_start": [30], "text": ["BCR-ABL"]}}}, "d462e64d08a84751a27716068469a456": {"prediction": {"id": "d462e64d08a84751a27716068469a456", "prediction_text": "Philadelphia"}, "reference": {"id": "d462e64d08a84751a27716068469a456", "answers": {"answer_start": [394], "text": ["BCR-ABL"]}}}, "6a2a2d24084b4bf0960fee0f8891cec4": {"prediction": {"id": "6a2a2d24084b4bf0960fee0f8891cec4", "prediction_text": "Bcr-Abl kinase"}, "reference": {"id": "6a2a2d24084b4bf0960fee0f8891cec4", "answers": {"answer_start": [243], "text": ["BCR-ABL"]}}}, "7b547798328d41dca0255be3c8f2b060": {"prediction": {"id": "7b547798328d41dca0255be3c8f2b060", "prediction_text": "Philadelphia"}, "reference": {"id": "7b547798328d41dca0255be3c8f2b060", "answers": {"answer_start": [866], "text": ["BCR-ABL"]}}}, "9cd1f7297e8546d7927b80fc2124903e": {"prediction": {"id": "9cd1f7297e8546d7927b80fc2124903e", "prediction_text": "BCR-ABL tyrosine kinase with additional inhibitory effects on platelet derived growth factor (PDGF) receptors alpha and beta, and KIT. It has revolutionized the treatment of adult and pediatric patients with Philadelphia"}, "reference": {"id": "9cd1f7297e8546d7927b80fc2124903e", "answers": {"answer_start": [172], "text": ["BCR-ABL"]}}}, "b1401f865ef34e4bac6e497fc63fd90d": {"prediction": {"id": "b1401f865ef34e4bac6e497fc63fd90d", "prediction_text": "CML"}, "reference": {"id": "b1401f865ef34e4bac6e497fc63fd90d", "answers": {"answer_start": [735], "text": ["BCR-ABL"]}}}, "534fae39a809479995e87e60762ba6c4": {"prediction": {"id": "534fae39a809479995e87e60762ba6c4", "prediction_text": "BCR-ABL tyrosine"}, "reference": {"id": "534fae39a809479995e87e60762ba6c4", "answers": {"answer_start": [465], "text": ["BCR-ABL"]}}}, "f462dd6d4eb74898848b6b9de4ef5178": {"prediction": {"id": "f462dd6d4eb74898848b6b9de4ef5178", "prediction_text": "BCR-ABL"}, "reference": {"id": "f462dd6d4eb74898848b6b9de4ef5178", "answers": {"answer_start": [317], "text": ["BCR-ABL"]}}}, "a79b2b2e9f0044d597ba7a7f11f27c70": {"prediction": {"id": "a79b2b2e9f0044d597ba7a7f11f27c70", "prediction_text": "Bcr-Abl"}, "reference": {"id": "a79b2b2e9f0044d597ba7a7f11f27c70", "answers": {"answer_start": [31], "text": ["BCR-ABL"]}}}, "87d82c2d54ac45d080afe44d9bdbca10": {"prediction": {"id": "87d82c2d54ac45d080afe44d9bdbca10", "prediction_text": "Philadelphia"}, "reference": {"id": "87d82c2d54ac45d080afe44d9bdbca10", "answers": {"answer_start": [324], "text": ["BCR-ABL"]}}}, "82de34e5fa8f484fa49cc54cf44de05e": {"prediction": {"id": "82de34e5fa8f484fa49cc54cf44de05e", "prediction_text": "Philadelphia"}, "reference": {"id": "82de34e5fa8f484fa49cc54cf44de05e", "answers": {"answer_start": [242], "text": ["BCR-ABL"]}}}, "5626b2edb240435784153fec3ba60e15": {"prediction": {"id": "5626b2edb240435784153fec3ba60e15", "prediction_text": "fusion oncoprotein"}, "reference": {"id": "5626b2edb240435784153fec3ba60e15", "answers": {"answer_start": [1195], "text": ["BCR-ABL"]}}}, "35450280d1ab47698c1a741972fc48d7": {"prediction": {"id": "35450280d1ab47698c1a741972fc48d7", "prediction_text": "Philadelphia"}, "reference": {"id": "35450280d1ab47698c1a741972fc48d7", "answers": {"answer_start": [797], "text": ["BCR-ABL"]}}}, "3d4136aa269241e8969979ecc086b773": {"prediction": {"id": "3d4136aa269241e8969979ecc086b773", "prediction_text": "tyrosine"}, "reference": {"id": "3d4136aa269241e8969979ecc086b773", "answers": {"answer_start": [655], "text": ["BCR-ABL"]}}}, "c690734947da40e1a7f6ecf77c697102": {"prediction": {"id": "c690734947da40e1a7f6ecf77c697102", "prediction_text": "22"}, "reference": {"id": "c690734947da40e1a7f6ecf77c697102", "answers": {"answer_start": [183], "text": ["BCR-ABL"]}}}, "16ed21761c1a479c801983a1c5734df4": {"prediction": {"id": "16ed21761c1a479c801983a1c5734df4", "prediction_text": "Bcr-Abl tyrosine kinase and suppressing the Ph chromosome positive clone, has revolutionized the treatment of chronic myeloid leukaemia (CML) patients. Given the high rates of clinical and cytogenetic remission achieved, the molecular monitoring of BCR-ABL transcript levels by RT-qPCR has become always more important to assess minimal residual disease. Recently, recommendations for harmonizing current methodologies for detecting and measuring BCR-ABL transcripts in CML patients have been suggested. Studies of imatinib-treated patients have determined that the BCR-ABL levels measured early in therapy may predict durable cytogenetic remission and in turn prolonged progression free-survival or acquisition of resistance. The major mechanism of imatinib resistance is clonal expansion of leukaemia cells with mutations in the Bcr-Abl fusion"}, "reference": {"id": "16ed21761c1a479c801983a1c5734df4", "answers": {"answer_start": [506], "text": ["BCR-ABL"]}}}, "4b069535c71b4377b429551f8dd9dde1": {"prediction": {"id": "4b069535c71b4377b429551f8dd9dde1", "prediction_text": "Philadelphia"}, "reference": {"id": "4b069535c71b4377b429551f8dd9dde1", "answers": {"answer_start": [779], "text": ["BCR-ABL"]}}}, "61ea58ff25714e53beed019078d8ca08": {"prediction": {"id": "61ea58ff25714e53beed019078d8ca08", "prediction_text": "BCR-ABL"}, "reference": {"id": "61ea58ff25714e53beed019078d8ca08", "answers": {"answer_start": [52], "text": ["BCR-ABL"]}}}, "3edb0d0b8ef24bbdb965f0fd2740691d": {"prediction": {"id": "3edb0d0b8ef24bbdb965f0fd2740691d", "prediction_text": "Philadelphia"}, "reference": {"id": "3edb0d0b8ef24bbdb965f0fd2740691d", "answers": {"answer_start": [476], "text": ["BCR-ABL"]}}}, "0332680443e14861acbd77b6301ad541": {"prediction": {"id": "0332680443e14861acbd77b6301ad541", "prediction_text": "Bcr-Abl"}, "reference": {"id": "0332680443e14861acbd77b6301ad541", "answers": {"answer_start": [376], "text": ["BCR-ABL"]}}}, "e3760c96983c43a5b540b55188e9529c": {"prediction": {"id": "e3760c96983c43a5b540b55188e9529c", "prediction_text": "tyrosine"}, "reference": {"id": "e3760c96983c43a5b540b55188e9529c", "answers": {"answer_start": [949], "text": ["BCR-ABL"]}}}, "89e310785eba4eeaa5355a01ba7e399f": {"prediction": {"id": "89e310785eba4eeaa5355a01ba7e399f", "prediction_text": "Ph(+"}, "reference": {"id": "89e310785eba4eeaa5355a01ba7e399f", "answers": {"answer_start": [238], "text": ["BCR-ABL"]}}}, "7a11674696c2431baf0053e76ee5a142": {"prediction": {"id": "7a11674696c2431baf0053e76ee5a142", "prediction_text": "Bcr-Abl fusion protein"}, "reference": {"id": "7a11674696c2431baf0053e76ee5a142", "answers": {"answer_start": [73], "text": ["BCR-ABL"]}}}, "d0e4f781bb694d1cad5651f0fcbe8a97": {"prediction": {"id": "d0e4f781bb694d1cad5651f0fcbe8a97", "prediction_text": "Novartis"}, "reference": {"id": "d0e4f781bb694d1cad5651f0fcbe8a97", "answers": {"answer_start": [445], "text": ["BCR-ABL"]}}}, "d92461660d424ba2bb4cf78a2b0ea945": {"prediction": {"id": "d92461660d424ba2bb4cf78a2b0ea945", "prediction_text": "BCR-ABL"}, "reference": {"id": "d92461660d424ba2bb4cf78a2b0ea945", "answers": {"answer_start": [283], "text": ["BCR-ABL"]}}}, "c1117a4ba0774a72b9c87dd4ba8ece87": {"prediction": {"id": "c1117a4ba0774a72b9c87dd4ba8ece87", "prediction_text": "Imatinib mesylate"}, "reference": {"id": "c1117a4ba0774a72b9c87dd4ba8ece87", "answers": {"answer_start": [805], "text": ["BCR-ABL"]}}}, "e438a86c4d4741c3b301f05aad1b929e": {"prediction": {"id": "e438a86c4d4741c3b301f05aad1b929e", "prediction_text": "Imatinib mesylate"}, "reference": {"id": "e438a86c4d4741c3b301f05aad1b929e", "answers": {"answer_start": [76], "text": ["BCR-ABL"]}}}, "8d1f099a1a5847b080a107c380bbf959": {"prediction": {"id": "8d1f099a1a5847b080a107c380bbf959", "prediction_text": "Philadelphia"}, "reference": {"id": "8d1f099a1a5847b080a107c380bbf959", "answers": {"answer_start": [23], "text": ["BCR-ABL"]}}}, "8df59877d1d5473f845e80a8665a3dbd": {"prediction": {"id": "8df59877d1d5473f845e80a8665a3dbd", "prediction_text": "Philadelphia"}, "reference": {"id": "8df59877d1d5473f845e80a8665a3dbd", "answers": {"answer_start": [522], "text": ["BCR-ABL"]}}}, "fac65ced489b43f79f462c443d3470d2": {"prediction": {"id": "fac65ced489b43f79f462c443d3470d2", "prediction_text": "BCR-ABL fusion protein, a constitutively active tyrosine kinase (TK"}, "reference": {"id": "fac65ced489b43f79f462c443d3470d2", "answers": {"answer_start": [1287], "text": ["BCR-ABL"]}}}, "175aa84fb19b45f3b5d1cbf1b7769d68": {"prediction": {"id": "175aa84fb19b45f3b5d1cbf1b7769d68", "prediction_text": "Imatinib mesylate"}, "reference": {"id": "175aa84fb19b45f3b5d1cbf1b7769d68", "answers": {"answer_start": [134], "text": ["BCR-ABL"]}}}, "c93f1c1026d640acab0388de91e85b24": {"prediction": {"id": "c93f1c1026d640acab0388de91e85b24", "prediction_text": "BCR-ABL"}, "reference": {"id": "c93f1c1026d640acab0388de91e85b24", "answers": {"answer_start": [794], "text": ["BCR-ABL"]}}}, "7213364e1f5c4de6a9f64d396fe66ca7": {"prediction": {"id": "7213364e1f5c4de6a9f64d396fe66ca7", "prediction_text": "Imatinib mesylate"}, "reference": {"id": "7213364e1f5c4de6a9f64d396fe66ca7", "answers": {"answer_start": [853], "text": ["BCR-ABL"]}}}, "5cc12a7daf6f48b7ad4ba4da9c2262e2": {"prediction": {"id": "5cc12a7daf6f48b7ad4ba4da9c2262e2", "prediction_text": "Bcr-Abl"}, "reference": {"id": "5cc12a7daf6f48b7ad4ba4da9c2262e2", "answers": {"answer_start": [268], "text": ["BCR-ABL"]}}}, "a84b5685ce514682bb8c7a1d0de8397c": {"prediction": {"id": "a84b5685ce514682bb8c7a1d0de8397c", "prediction_text": "Philadelphia"}, "reference": {"id": "a84b5685ce514682bb8c7a1d0de8397c", "answers": {"answer_start": [572], "text": ["BCR-ABL"]}}}, "1438c5f3fa8d4a42bb2c34ea37c478cd": {"prediction": {"id": "1438c5f3fa8d4a42bb2c34ea37c478cd", "prediction_text": "Philadelphia"}, "reference": {"id": "1438c5f3fa8d4a42bb2c34ea37c478cd", "answers": {"answer_start": [332], "text": ["BCR-ABL"]}}}, "bc134d287e264e5696a34d7741355618": {"prediction": {"id": "bc134d287e264e5696a34d7741355618", "prediction_text": "BCR-ABL fusion gene, which is the result of a reciprocal translocation between chromosomes 9 and 22, and is cytogenetically visible as a shortened chromosome 22 (Philadelphia). Research during the past two decades has established that BCR-ABL is probably the pathogenetic pathway leading to CML, and that constitutive tyrosine kinase activity is central to BCR-ABL capacity to transform hematopoietic cells in vitro and in vivo. The tyrosine kinase inhibitor imatinib mesylate"}, "reference": {"id": "bc134d287e264e5696a34d7741355618", "answers": {"answer_start": [69], "text": ["BCR-ABL"]}}}, "c78c8365d0704a9989d7f97878ba3113": {"prediction": {"id": "c78c8365d0704a9989d7f97878ba3113", "prediction_text": "Bcr-Abl, the receptors for platelet-derived growth factor receptor(PDGF) and stem cell factor, or c-kit. Chronic myeloid leukemia (CML) is distinguished by the presence of a reciprocal translocation between chromosomes 9 and 22"}, "reference": {"id": "c78c8365d0704a9989d7f97878ba3113", "answers": {"answer_start": [606], "text": ["BCR-ABL"]}}}, "f4d00241bffa4b9b963820189ae988ce": {"prediction": {"id": "f4d00241bffa4b9b963820189ae988ce", "prediction_text": "Philadelphia"}, "reference": {"id": "f4d00241bffa4b9b963820189ae988ce", "answers": {"answer_start": [1058], "text": ["BCR-ABL"]}}}, "a9fe45b808ce4353929ab665e1712140": {"prediction": {"id": "a9fe45b808ce4353929ab665e1712140", "prediction_text": "Philadelphia"}, "reference": {"id": "a9fe45b808ce4353929ab665e1712140", "answers": {"answer_start": [488], "text": ["BCR-ABL"]}}}, "f0d682cc24fb413e96ecea6b2d614fd9": {"prediction": {"id": "f0d682cc24fb413e96ecea6b2d614fd9", "prediction_text": "BCR-ABL kinase activity by its kinase inhibitor such as imatinib mesylate"}, "reference": {"id": "f0d682cc24fb413e96ecea6b2d614fd9", "answers": {"answer_start": [765], "text": ["BCR-ABL"]}}}, "d509548a12a84cc1a636d64188f7ddcd": {"prediction": {"id": "d509548a12a84cc1a636d64188f7ddcd", "prediction_text": "Philadelphia"}, "reference": {"id": "d509548a12a84cc1a636d64188f7ddcd", "answers": {"answer_start": [250], "text": ["BCR-ABL"]}}}, "ad2a557991df49c78c4b069fe9f00c3b": {"prediction": {"id": "ad2a557991df49c78c4b069fe9f00c3b", "prediction_text": "Imatinib mesylate"}, "reference": {"id": "ad2a557991df49c78c4b069fe9f00c3b", "answers": {"answer_start": [260], "text": ["BCR-ABL"]}}}, "2f5f55d15b3a43b0a32fb42f2063841a": {"prediction": {"id": "2f5f55d15b3a43b0a32fb42f2063841a", "prediction_text": "BCR-ABL"}, "reference": {"id": "2f5f55d15b3a43b0a32fb42f2063841a", "answers": {"answer_start": [144], "text": ["BCR-ABL"]}}}, "0c2cf4d68050437b9e2f225aeb71f459": {"prediction": {"id": "0c2cf4d68050437b9e2f225aeb71f459", "prediction_text": "BCR/ABL fusion tyrosine"}, "reference": {"id": "0c2cf4d68050437b9e2f225aeb71f459", "answers": {"answer_start": [1397], "text": ["BCR-ABL"]}}}, "bf68497bac924297aaa4fc6e6ca5fde8": {"prediction": {"id": "bf68497bac924297aaa4fc6e6ca5fde8", "prediction_text": "Aurora kinase"}, "reference": {"id": "bf68497bac924297aaa4fc6e6ca5fde8", "answers": {"answer_start": [147], "text": ["BCR-ABL"]}}}, "6d98d3f44c77408f83d78e811a3b88d3": {"prediction": {"id": "6d98d3f44c77408f83d78e811a3b88d3", "prediction_text": "Philadelphia"}, "reference": {"id": "6d98d3f44c77408f83d78e811a3b88d3", "answers": {"answer_start": [238], "text": ["BCR-ABL"]}}}, "b6f0d257c8424a368fe8d4ddbbb990f7": {"prediction": {"id": "b6f0d257c8424a368fe8d4ddbbb990f7", "prediction_text": "bcr-abl"}, "reference": {"id": "b6f0d257c8424a368fe8d4ddbbb990f7", "answers": {"answer_start": [432], "text": ["BCR-ABL"]}}}, "c02cbb175ffd4c60bbfc894af06d94c7": {"prediction": {"id": "c02cbb175ffd4c60bbfc894af06d94c7", "prediction_text": "9 and 22"}, "reference": {"id": "c02cbb175ffd4c60bbfc894af06d94c7", "answers": {"answer_start": [447], "text": ["BCR-ABL"]}}}, "b7e4f90a64ec467085e93c2dca6cf0f6": {"prediction": {"id": "b7e4f90a64ec467085e93c2dca6cf0f6", "prediction_text": "ABL-kinase inhibitors"}, "reference": {"id": "b7e4f90a64ec467085e93c2dca6cf0f6", "answers": {"answer_start": [944], "text": ["BCR-ABL"]}}}, "e1d4cbc9782f424fb490034131d2d7c3": {"prediction": {"id": "e1d4cbc9782f424fb490034131d2d7c3", "prediction_text": "BCR-ABL protein"}, "reference": {"id": "e1d4cbc9782f424fb490034131d2d7c3", "answers": {"answer_start": [398], "text": ["BCR-ABL"]}}}, "2f2a9c06e2794975ae6255f32972b16b": {"prediction": {"id": "2f2a9c06e2794975ae6255f32972b16b", "prediction_text": "Bcr-Abl tyrosine"}, "reference": {"id": "2f2a9c06e2794975ae6255f32972b16b", "answers": {"answer_start": [374], "text": ["BCR-ABL"]}}}, "9903af5dac8a4ba5b333687f2bc8cf20": {"prediction": {"id": "9903af5dac8a4ba5b333687f2bc8cf20", "prediction_text": "BCR-ABL fusion"}, "reference": {"id": "9903af5dac8a4ba5b333687f2bc8cf20", "answers": {"answer_start": [1381], "text": ["BCR-ABL"]}}}, "17ba7ac2986e4f4da5c01dc9c954887f": {"prediction": {"id": "17ba7ac2986e4f4da5c01dc9c954887f", "prediction_text": "Bcr-Abl tyrosine"}, "reference": {"id": "17ba7ac2986e4f4da5c01dc9c954887f", "answers": {"answer_start": [31], "text": ["BCR-ABL"]}}}, "07eb1eecffa94bd5acb3aaf4abd57c1d": {"prediction": {"id": "07eb1eecffa94bd5acb3aaf4abd57c1d", "prediction_text": "Bcr-Abl"}, "reference": {"id": "07eb1eecffa94bd5acb3aaf4abd57c1d", "answers": {"answer_start": [103], "text": ["BCR-ABL"]}}}, "0903e340217d4f48b7d0fbb250df8990": {"prediction": {"id": "0903e340217d4f48b7d0fbb250df8990", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "0903e340217d4f48b7d0fbb250df8990", "answers": {"answer_start": [86], "text": ["MRSA"]}}}, "7c4cd4399052405da9c00a46b7a4b281": {"prediction": {"id": "7c4cd4399052405da9c00a46b7a4b281", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "7c4cd4399052405da9c00a46b7a4b281", "answers": {"answer_start": [203], "text": ["MRSA"]}}}, "6913e747deb849d9bf767b5e818f4740": {"prediction": {"id": "6913e747deb849d9bf767b5e818f4740", "prediction_text": "Community-associated methicillin resistant"}, "reference": {"id": "6913e747deb849d9bf767b5e818f4740", "answers": {"answer_start": [307], "text": ["MRSA"]}}}, "8a9d91afbc9a4e1aba91e31f3a0650e0": {"prediction": {"id": "8a9d91afbc9a4e1aba91e31f3a0650e0", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "8a9d91afbc9a4e1aba91e31f3a0650e0", "answers": {"answer_start": [533], "text": ["MRSA"]}}}, "14c75906335543ed97b83f966f6f1632": {"prediction": {"id": "14c75906335543ed97b83f966f6f1632", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "14c75906335543ed97b83f966f6f1632", "answers": {"answer_start": [1448], "text": ["MRSA"]}}}, "8efad9a444db495396ef26468bd926d5": {"prediction": {"id": "8efad9a444db495396ef26468bd926d5", "prediction_text": "HA-MRSA"}, "reference": {"id": "8efad9a444db495396ef26468bd926d5", "answers": {"answer_start": [1802], "text": ["MRSA"]}}}, "2da6b01559de4423bd26d76c6d561d84": {"prediction": {"id": "2da6b01559de4423bd26d76c6d561d84", "prediction_text": "CA-MRSA"}, "reference": {"id": "2da6b01559de4423bd26d76c6d561d84", "answers": {"answer_start": [1482], "text": ["MRSA"]}}}, "8feb21a3b2014feaabef048a5d5b7425": {"prediction": {"id": "8feb21a3b2014feaabef048a5d5b7425", "prediction_text": "Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging threat to public health"}, "reference": {"id": "8feb21a3b2014feaabef048a5d5b7425", "answers": {"answer_start": [296], "text": ["MRSA"]}}}, "e6eefecd3b0a4c999d66a966f78058e9": {"prediction": {"id": "e6eefecd3b0a4c999d66a966f78058e9", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "e6eefecd3b0a4c999d66a966f78058e9", "answers": {"answer_start": [863], "text": ["MRSA"]}}}, "8c0c3c79488b487482ca3d6f5c712c3c": {"prediction": {"id": "8c0c3c79488b487482ca3d6f5c712c3c", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "8c0c3c79488b487482ca3d6f5c712c3c", "answers": {"answer_start": [568], "text": ["MRSA"]}}}, "5854d978ddee4954a31b3d37ff374e70": {"prediction": {"id": "5854d978ddee4954a31b3d37ff374e70", "prediction_text": "clinical methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "5854d978ddee4954a31b3d37ff374e70", "answers": {"answer_start": [641], "text": ["MRSA"]}}}, "6254282a4d8742fd8a1274f0e2cb0fe2": {"prediction": {"id": "6254282a4d8742fd8a1274f0e2cb0fe2", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "6254282a4d8742fd8a1274f0e2cb0fe2", "answers": {"answer_start": [457], "text": ["MRSA"]}}}, "5308a051fd764963bcd996c258bbc0fd": {"prediction": {"id": "5308a051fd764963bcd996c258bbc0fd", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "5308a051fd764963bcd996c258bbc0fd", "answers": {"answer_start": [191], "text": ["MRSA"]}}}, "04bf74946c3a4f6aa11128d7d49cd440": {"prediction": {"id": "04bf74946c3a4f6aa11128d7d49cd440", "prediction_text": "Methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "04bf74946c3a4f6aa11128d7d49cd440", "answers": {"answer_start": [2237], "text": ["MRSA"]}}}, "ed8858e742fd4e28a7f72625279c65c2": {"prediction": {"id": "ed8858e742fd4e28a7f72625279c65c2", "prediction_text": "clinical methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "ed8858e742fd4e28a7f72625279c65c2", "answers": {"answer_start": [215], "text": ["MRSA"]}}}, "65c4c1b905e44d008376111792781c8c": {"prediction": {"id": "65c4c1b905e44d008376111792781c8c", "prediction_text": "Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA"}, "reference": {"id": "65c4c1b905e44d008376111792781c8c", "answers": {"answer_start": [191], "text": ["MRSA"]}}}, "d68c150e39d64a67b8c73f639a2295b7": {"prediction": {"id": "d68c150e39d64a67b8c73f639a2295b7", "prediction_text": "meticillin-resistant Staphylococcus aureus"}, "reference": {"id": "d68c150e39d64a67b8c73f639a2295b7", "answers": {"answer_start": [392], "text": ["MRSA"]}}}, "51844a2bb29346e2b744be47c9ec2c4f": {"prediction": {"id": "51844a2bb29346e2b744be47c9ec2c4f", "prediction_text": "Methicillin Resistant Staphylococcus aureus"}, "reference": {"id": "51844a2bb29346e2b744be47c9ec2c4f", "answers": {"answer_start": [584], "text": ["MRSA"]}}}, "6d198f58bc2f4d3fa9f640b38d338766": {"prediction": {"id": "6d198f58bc2f4d3fa9f640b38d338766", "prediction_text": "Postoperative methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "6d198f58bc2f4d3fa9f640b38d338766", "answers": {"answer_start": [519], "text": ["MRSA"]}}}, "183dbd510f98453e97808a4977024b03": {"prediction": {"id": "183dbd510f98453e97808a4977024b03", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "183dbd510f98453e97808a4977024b03", "answers": {"answer_start": [106], "text": ["MRSA"]}}}, "dccba624884443ccb22e2778ac10177e": {"prediction": {"id": "dccba624884443ccb22e2778ac10177e", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "dccba624884443ccb22e2778ac10177e", "answers": {"answer_start": [839], "text": ["MRSA"]}}}, "24e087e6fc9340bca15cd4dec69b0e9e": {"prediction": {"id": "24e087e6fc9340bca15cd4dec69b0e9e", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "24e087e6fc9340bca15cd4dec69b0e9e", "answers": {"answer_start": [1036], "text": ["MRSA"]}}}, "2ed170324b01472b9eedb9cca856f055": {"prediction": {"id": "2ed170324b01472b9eedb9cca856f055", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "2ed170324b01472b9eedb9cca856f055", "answers": {"answer_start": [129, 100], "text": ["methicillin-resistant S. aureus", "MRSA"]}}}, "20fd221d6a6b4b8aa49a3c3dc341ab55": {"prediction": {"id": "20fd221d6a6b4b8aa49a3c3dc341ab55", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "20fd221d6a6b4b8aa49a3c3dc341ab55", "answers": {"answer_start": [2208], "text": ["MRSA"]}}}, "87fecfe0f12644bc8e4877421bdeda46": {"prediction": {"id": "87fecfe0f12644bc8e4877421bdeda46", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "87fecfe0f12644bc8e4877421bdeda46", "answers": {"answer_start": [1094], "text": ["MRSA"]}}}, "ab6192d45ef94070a5912c94e1b82b03": {"prediction": {"id": "ab6192d45ef94070a5912c94e1b82b03", "prediction_text": "empirical methicillin resistance"}, "reference": {"id": "ab6192d45ef94070a5912c94e1b82b03", "answers": {"answer_start": [144, 250], "text": ["methicillin-resistant S. aureus", "MRSA"]}}}, "ede406a2b420437f879b20361b4a968a": {"prediction": {"id": "ede406a2b420437f879b20361b4a968a", "prediction_text": "CO-MRSA"}, "reference": {"id": "ede406a2b420437f879b20361b4a968a", "answers": {"answer_start": [1148], "text": ["MRSA"]}}}, "13a4da4f751f4e6cb33c0bc5852a2a12": {"prediction": {"id": "13a4da4f751f4e6cb33c0bc5852a2a12", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "13a4da4f751f4e6cb33c0bc5852a2a12", "answers": {"answer_start": [390], "text": ["MRSA"]}}}, "9af41db9adc44a85ac45a4a997d7fc2d": {"prediction": {"id": "9af41db9adc44a85ac45a4a997d7fc2d", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "9af41db9adc44a85ac45a4a997d7fc2d", "answers": {"answer_start": [368], "text": ["MRSA"]}}}, "8a0fddf3b4c94120968232a950bee3dd": {"prediction": {"id": "8a0fddf3b4c94120968232a950bee3dd", "prediction_text": "a cross-sectional analytical study"}, "reference": {"id": "8a0fddf3b4c94120968232a950bee3dd", "answers": {"answer_start": [181], "text": ["MRSA"]}}}, "c9a4425811f847e0a961ffcee9fdf7a4": {"prediction": {"id": "c9a4425811f847e0a961ffcee9fdf7a4", "prediction_text": "methicillin-resistant S. aureus"}, "reference": {"id": "c9a4425811f847e0a961ffcee9fdf7a4", "answers": {"answer_start": [302, 479], "text": ["methicillin-resistant S. aureus", "MRSA"]}}}, "73b52bcb507e4f5b8d1f61dcf475f9fb": {"prediction": {"id": "73b52bcb507e4f5b8d1f61dcf475f9fb", "prediction_text": "Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of both hospital and community infections globally. It's important to illuminate the differences between community-acquired MRSA (CA-MRSA"}, "reference": {"id": "73b52bcb507e4f5b8d1f61dcf475f9fb", "answers": {"answer_start": [238], "text": ["MRSA"]}}}, "cad516487d664c2e93b29b19e9fe6e5f": {"prediction": {"id": "cad516487d664c2e93b29b19e9fe6e5f", "prediction_text": "methicillin resistant Staphylococcus aureus"}, "reference": {"id": "cad516487d664c2e93b29b19e9fe6e5f", "answers": {"answer_start": [1066], "text": ["MRSA"]}}}, "a2da7f8de20f4bcd816df35d362a6db8": {"prediction": {"id": "a2da7f8de20f4bcd816df35d362a6db8", "prediction_text": "methicillin-resistant Staphylococcus aureus) MRSA screening and subsequent decolonization to reduce MRSA surgical site infection (SSI). This is the first study to date correlating nasal MRSA colonization with postoperative spinal MRSA SSI. To assess the significance of nasal MRSA colonization in the setting of MRSA SSI. A retrospective electronic chart review of patients from year 2011 to June 2013 was conducted for patients with both nasal MRSA colonization within 30 days prior to spinal surgery. Patients who tested positive for MRSA were put on contact isolation protocol. None of these patients received topical antibiotics for decolonization of nasal MRSA. A total of 519 patients were identified; 384 negative (74%), 110 MSSA-positive (21.2%), and 25 (4.8%) MRSA-positive"}, "reference": {"id": "a2da7f8de20f4bcd816df35d362a6db8", "answers": {"answer_start": [358], "text": ["MRSA"]}}}, "5dcfd55d87bf4e239ec1936bc66f3cdb": {"prediction": {"id": "5dcfd55d87bf4e239ec1936bc66f3cdb", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "5dcfd55d87bf4e239ec1936bc66f3cdb", "answers": {"answer_start": [2726], "text": ["MRSA"]}}}, "53ecff5a7bcf4395b0cbe46257e527c7": {"prediction": {"id": "53ecff5a7bcf4395b0cbe46257e527c7", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "53ecff5a7bcf4395b0cbe46257e527c7", "answers": {"answer_start": [1110], "text": ["MRSA"]}}}, "d69d7de2fdd7417fb17261876479295b": {"prediction": {"id": "d69d7de2fdd7417fb17261876479295b", "prediction_text": "health care-associated MRSA (HCA-MRSA"}, "reference": {"id": "d69d7de2fdd7417fb17261876479295b", "answers": {"answer_start": [434], "text": ["MRSA"]}}}, "c58f58f2e45f44f18e792bb64f602d00": {"prediction": {"id": "c58f58f2e45f44f18e792bb64f602d00", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "c58f58f2e45f44f18e792bb64f602d00", "answers": {"answer_start": [849], "text": ["MRSA"]}}}, "87d668ab7a5442289ac6c4834d4119b7": {"prediction": {"id": "87d668ab7a5442289ac6c4834d4119b7", "prediction_text": "meticillin)-resistant Staphylococcus aureus colonization"}, "reference": {"id": "87d668ab7a5442289ac6c4834d4119b7", "answers": {"answer_start": [172], "text": ["MRSA"]}}}, "647b256d7270466194e54f29edefd240": {"prediction": {"id": "647b256d7270466194e54f29edefd240", "prediction_text": "Methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "647b256d7270466194e54f29edefd240", "answers": {"answer_start": [557], "text": ["MRSA"]}}}, "725b4f043554421d88faf7374f246700": {"prediction": {"id": "725b4f043554421d88faf7374f246700", "prediction_text": "Methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "725b4f043554421d88faf7374f246700", "answers": {"answer_start": [841], "text": ["MRSA"]}}}, "8634bc8bd62a49bb831c9333b47c6afb": {"prediction": {"id": "8634bc8bd62a49bb831c9333b47c6afb", "prediction_text": "a common multidrug-resistant (MDR) pathogen"}, "reference": {"id": "8634bc8bd62a49bb831c9333b47c6afb", "answers": {"answer_start": [315], "text": ["MRSA"]}}}, "703ad01cfa19496ebbd6e2d913b9a5f3": {"prediction": {"id": "703ad01cfa19496ebbd6e2d913b9a5f3", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "703ad01cfa19496ebbd6e2d913b9a5f3", "answers": {"answer_start": [1902], "text": ["MRSA"]}}}, "a467fefaabb24481905e4b97e04192c3": {"prediction": {"id": "a467fefaabb24481905e4b97e04192c3", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "a467fefaabb24481905e4b97e04192c3", "answers": {"answer_start": [274], "text": ["MRSA"]}}}, "e63196e08cf94e9eaa991dfbdbdee449": {"prediction": {"id": "e63196e08cf94e9eaa991dfbdbdee449", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "e63196e08cf94e9eaa991dfbdbdee449", "answers": {"answer_start": [89], "text": ["MRSA"]}}}, "fc8d45e959ac47ecafa39e9462454cb1": {"prediction": {"id": "fc8d45e959ac47ecafa39e9462454cb1", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "fc8d45e959ac47ecafa39e9462454cb1", "answers": {"answer_start": [119], "text": ["MRSA"]}}}, "c8e8ad8127334a639e03acb7280789d3": {"prediction": {"id": "c8e8ad8127334a639e03acb7280789d3", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "c8e8ad8127334a639e03acb7280789d3", "answers": {"answer_start": [1297], "text": ["MRSA"]}}}, "b28e4adf4e1c4ef596c31ebf07e5680f": {"prediction": {"id": "b28e4adf4e1c4ef596c31ebf07e5680f", "prediction_text": "meticillin)-resistant Staphylococcus aureus"}, "reference": {"id": "b28e4adf4e1c4ef596c31ebf07e5680f", "answers": {"answer_start": [409], "text": ["MRSA"]}}}, "3c0d413e0f664efab3e9dd675926ce2e": {"prediction": {"id": "3c0d413e0f664efab3e9dd675926ce2e", "prediction_text": "Flumazenil is indicated for reversal of sedation from benzodiazepines"}, "reference": {"id": "3c0d413e0f664efab3e9dd675926ce2e", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "98ebec3ad4d7438b84c8949aa7922cbc": {"prediction": {"id": "98ebec3ad4d7438b84c8949aa7922cbc", "prediction_text": "flumazenil"}, "reference": {"id": "98ebec3ad4d7438b84c8949aa7922cbc", "answers": {"answer_start": [767], "text": ["flumazenil"]}}}, "0b001892bf334e43b81cbd66d77460c5": {"prediction": {"id": "0b001892bf334e43b81cbd66d77460c5", "prediction_text": "Flumazenil"}, "reference": {"id": "0b001892bf334e43b81cbd66d77460c5", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "254ffc9733fa4dd58489c74b1c2a701a": {"prediction": {"id": "254ffc9733fa4dd58489c74b1c2a701a", "prediction_text": "benzodiazepines"}, "reference": {"id": "254ffc9733fa4dd58489c74b1c2a701a", "answers": {"answer_start": [696], "text": ["flumazenil"]}}}, "6ba6d2ca97e14c89b88760d434607a55": {"prediction": {"id": "6ba6d2ca97e14c89b88760d434607a55", "prediction_text": "Flumazenil"}, "reference": {"id": "6ba6d2ca97e14c89b88760d434607a55", "answers": {"answer_start": [640], "text": ["flumazenil"]}}}, "f86f366ab2e54c6e817a6d0b250c010b": {"prediction": {"id": "f86f366ab2e54c6e817a6d0b250c010b", "prediction_text": "Flumazenil"}, "reference": {"id": "f86f366ab2e54c6e817a6d0b250c010b", "answers": {"answer_start": [153], "text": ["flumazenil"]}}}, "ad3a3cf1225b478d815c3648ab05ab0b": {"prediction": {"id": "ad3a3cf1225b478d815c3648ab05ab0b", "prediction_text": "flumazenil"}, "reference": {"id": "ad3a3cf1225b478d815c3648ab05ab0b", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "827aba2b311d41c7b2e93c0506f6dd62": {"prediction": {"id": "827aba2b311d41c7b2e93c0506f6dd62", "prediction_text": "Flumazenil"}, "reference": {"id": "827aba2b311d41c7b2e93c0506f6dd62", "answers": {"answer_start": [976], "text": ["flumazenil"]}}}, "232f5799b634449f9205b355c1279c8c": {"prediction": {"id": "232f5799b634449f9205b355c1279c8c", "prediction_text": "benzodiazepines"}, "reference": {"id": "232f5799b634449f9205b355c1279c8c", "answers": {"answer_start": [1327], "text": ["flumazenil"]}}}, "7b7ba3a2d1da41f99792fdfd2a72911b": {"prediction": {"id": "7b7ba3a2d1da41f99792fdfd2a72911b", "prediction_text": "flumazenil"}, "reference": {"id": "7b7ba3a2d1da41f99792fdfd2a72911b", "answers": {"answer_start": [564], "text": ["flumazenil"]}}}, "45010deff22c45f8b2678b00e30dc5b2": {"prediction": {"id": "45010deff22c45f8b2678b00e30dc5b2", "prediction_text": "flumazenil"}, "reference": {"id": "45010deff22c45f8b2678b00e30dc5b2", "answers": {"answer_start": [469], "text": ["flumazenil"]}}}, "b749ff09d32340a89553fc657dc81ea1": {"prediction": {"id": "b749ff09d32340a89553fc657dc81ea1", "prediction_text": "nordiazepam"}, "reference": {"id": "b749ff09d32340a89553fc657dc81ea1", "answers": {"answer_start": [119], "text": ["flumazenil"]}}}, "fad182b6b17d4d80a04163473c7ba6ae": {"prediction": {"id": "fad182b6b17d4d80a04163473c7ba6ae", "prediction_text": "Flumazenil"}, "reference": {"id": "fad182b6b17d4d80a04163473c7ba6ae", "answers": {"answer_start": [1324], "text": ["flumazenil"]}}}, "1ee2cb97154840e683d8414b2a8b3e66": {"prediction": {"id": "1ee2cb97154840e683d8414b2a8b3e66", "prediction_text": "flumazenil"}, "reference": {"id": "1ee2cb97154840e683d8414b2a8b3e66", "answers": {"answer_start": [1112], "text": ["flumazenil"]}}}, "0a1750b46d4b445fbc464733732dea39": {"prediction": {"id": "0a1750b46d4b445fbc464733732dea39", "prediction_text": "Flumazenil"}, "reference": {"id": "0a1750b46d4b445fbc464733732dea39", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "34149037dc3d44749a507a4732b20485": {"prediction": {"id": "34149037dc3d44749a507a4732b20485", "prediction_text": "flumazenil"}, "reference": {"id": "34149037dc3d44749a507a4732b20485", "answers": {"answer_start": [1555], "text": ["flumazenil"]}}}, "38856a2829974762b7b2a067146174de": {"prediction": {"id": "38856a2829974762b7b2a067146174de", "prediction_text": "flumazenil"}, "reference": {"id": "38856a2829974762b7b2a067146174de", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "c52a1a47c4ad46cda0ed0d872f4e105c": {"prediction": {"id": "c52a1a47c4ad46cda0ed0d872f4e105c", "prediction_text": "Incremental intravenous bolus injections"}, "reference": {"id": "c52a1a47c4ad46cda0ed0d872f4e105c", "answers": {"answer_start": [435], "text": ["flumazenil"]}}}, "81ff89e2fa264e58b6a12759554208b5": {"prediction": {"id": "81ff89e2fa264e58b6a12759554208b5", "prediction_text": "BDZ"}, "reference": {"id": "81ff89e2fa264e58b6a12759554208b5", "answers": {"answer_start": [865], "text": ["flumazenil"]}}}, "b7caddf6332743ddbf9b28f9d86e694b": {"prediction": {"id": "b7caddf6332743ddbf9b28f9d86e694b", "prediction_text": "Flumazenil"}, "reference": {"id": "b7caddf6332743ddbf9b28f9d86e694b", "answers": {"answer_start": [176], "text": ["flumazenil"]}}}, "44d1b4f495c244f695f48da59377f0d6": {"prediction": {"id": "44d1b4f495c244f695f48da59377f0d6", "prediction_text": "antagonist"}, "reference": {"id": "44d1b4f495c244f695f48da59377f0d6", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "7e621bca03f04bd9add9140b03a18945": {"prediction": {"id": "7e621bca03f04bd9add9140b03a18945", "prediction_text": "Flumazenil"}, "reference": {"id": "7e621bca03f04bd9add9140b03a18945", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "ed32a6f5f5ad4e509ebc074fd8df734a": {"prediction": {"id": "ed32a6f5f5ad4e509ebc074fd8df734a", "prediction_text": "Flumazenil"}, "reference": {"id": "ed32a6f5f5ad4e509ebc074fd8df734a", "answers": {"answer_start": [161], "text": ["flumazenil"]}}}, "3c65685eb59347dcab4d823a4a032ddd": {"prediction": {"id": "3c65685eb59347dcab4d823a4a032ddd", "prediction_text": "flumazenil"}, "reference": {"id": "3c65685eb59347dcab4d823a4a032ddd", "answers": {"answer_start": [2297], "text": ["flumazenil"]}}}, "ed04caf1987344f6a4ef5f21d3d3562a": {"prediction": {"id": "ed04caf1987344f6a4ef5f21d3d3562a", "prediction_text": "proximal anterior tibia"}, "reference": {"id": "ed04caf1987344f6a4ef5f21d3d3562a", "answers": {"answer_start": [0], "text": ["Posterior cruciate ligament"]}}}, "5db3f7c2d17247bcb1ad58acde87f29f": {"prediction": {"id": "5db3f7c2d17247bcb1ad58acde87f29f", "prediction_text": "Hyperflexion"}, "reference": {"id": "5db3f7c2d17247bcb1ad58acde87f29f", "answers": {"answer_start": [271], "text": ["Posterior cruciate ligament"]}}}, "00f7165f0c7f49eaac371618d6cc5444": {"prediction": {"id": "00f7165f0c7f49eaac371618d6cc5444", "prediction_text": "Yersinia pestis"}, "reference": {"id": "00f7165f0c7f49eaac371618d6cc5444", "answers": {"answer_start": [211], "text": ["Yersinia pestis"]}}}, "dfff475d13464d15bfeb4d2ed83777e4": {"prediction": {"id": "dfff475d13464d15bfeb4d2ed83777e4", "prediction_text": "MDM two binding protein"}, "reference": {"id": "dfff475d13464d15bfeb4d2ed83777e4", "answers": {"answer_start": [303], "text": ["MDM two binding protein (MTBP)"]}}}, "8be95f26b55840b387a8f93f5f739c61": {"prediction": {"id": "8be95f26b55840b387a8f93f5f739c61", "prediction_text": "stroke"}, "reference": {"id": "8be95f26b55840b387a8f93f5f739c61", "answers": {"answer_start": [77], "text": ["stroke"]}}}, "fb000bc1ba6945729a37b77c4265d1d0": {"prediction": {"id": "fb000bc1ba6945729a37b77c4265d1d0", "prediction_text": "Recognition of Stroke in the Emergency Room"}, "reference": {"id": "fb000bc1ba6945729a37b77c4265d1d0", "answers": {"answer_start": [917], "text": ["stroke"]}}}, "29474673b0ca42eaa169d2c125f60892": {"prediction": {"id": "29474673b0ca42eaa169d2c125f60892", "prediction_text": "suspected stroke"}, "reference": {"id": "29474673b0ca42eaa169d2c125f60892", "answers": {"answer_start": [662], "text": ["stroke"]}}}, "9e9f6a2089a34024bc6cfe4ff677ebd0": {"prediction": {"id": "9e9f6a2089a34024bc6cfe4ff677ebd0", "prediction_text": "ischaemic attack"}, "reference": {"id": "9e9f6a2089a34024bc6cfe4ff677ebd0", "answers": {"answer_start": [95], "text": ["stroke"]}}}, "955efb9fc7ff4f70956923067712356d": {"prediction": {"id": "955efb9fc7ff4f70956923067712356d", "prediction_text": "Cincinnati Pre-Hospital Stroke Scale (CPSS), Los Angeles Pre-Hospital Stroke Screen"}, "reference": {"id": "955efb9fc7ff4f70956923067712356d", "answers": {"answer_start": [703], "text": ["stroke"]}}}, "77de9b19def046edb0d7a1630bbfe38e": {"prediction": {"id": "77de9b19def046edb0d7a1630bbfe38e", "prediction_text": "childhood arterial ischemic stroke"}, "reference": {"id": "77de9b19def046edb0d7a1630bbfe38e", "answers": {"answer_start": [0], "text": ["stroke"]}}}, "172e075b605b411d9ca87d8272c9c522": {"prediction": {"id": "172e075b605b411d9ca87d8272c9c522", "prediction_text": "acute stroke"}, "reference": {"id": "172e075b605b411d9ca87d8272c9c522", "answers": {"answer_start": [99], "text": ["stroke"]}}}, "89ba0494991e4c4e907c863580b5061b": {"prediction": {"id": "89ba0494991e4c4e907c863580b5061b", "prediction_text": "stroke"}, "reference": {"id": "89ba0494991e4c4e907c863580b5061b", "answers": {"answer_start": [1681], "text": ["stroke"]}}}, "2a40b304a7b64f2ca3b36aeee4100e06": {"prediction": {"id": "2a40b304a7b64f2ca3b36aeee4100e06", "prediction_text": "transient ischaemic attacks"}, "reference": {"id": "2a40b304a7b64f2ca3b36aeee4100e06", "answers": {"answer_start": [83], "text": ["stroke"]}}}, "e5a4aacb67674b708000c89a4d7f41b2": {"prediction": {"id": "e5a4aacb67674b708000c89a4d7f41b2", "prediction_text": "Trr"}, "reference": {"id": "e5a4aacb67674b708000c89a4d7f41b2", "answers": {"answer_start": [1147], "text": ["H3K4"]}}}, "5573078d27954fecaaa482466f0aa655": {"prediction": {"id": "5573078d27954fecaaa482466f0aa655", "prediction_text": "methyltransferase"}, "reference": {"id": "5573078d27954fecaaa482466f0aa655", "answers": {"answer_start": [1493], "text": ["H3K4"]}}}, "80cd134486c14bd288d2c004507ae373": {"prediction": {"id": "80cd134486c14bd288d2c004507ae373", "prediction_text": "leukemia 1"}, "reference": {"id": "80cd134486c14bd288d2c004507ae373", "answers": {"answer_start": [799], "text": ["H3K4"]}}}, "606b8c78ccd4468c9c6204bba3a5cba0": {"prediction": {"id": "606b8c78ccd4468c9c6204bba3a5cba0", "prediction_text": "H3K4"}, "reference": {"id": "606b8c78ccd4468c9c6204bba3a5cba0", "answers": {"answer_start": [950], "text": ["H3K4"]}}}, "e224a88184664da0b55d23e937e96216": {"prediction": {"id": "e224a88184664da0b55d23e937e96216", "prediction_text": "H3K4"}, "reference": {"id": "e224a88184664da0b55d23e937e96216", "answers": {"answer_start": [528], "text": ["H3K4"]}}}, "ed02b11ef4d04271934680e95af0273f": {"prediction": {"id": "ed02b11ef4d04271934680e95af0273f", "prediction_text": "hematopoiesis"}, "reference": {"id": "ed02b11ef4d04271934680e95af0273f", "answers": {"answer_start": [193], "text": ["H3K4"]}}}, "df5d7698121e4a9c8e26061200691a50": {"prediction": {"id": "df5d7698121e4a9c8e26061200691a50", "prediction_text": "Drosophila trithorax"}, "reference": {"id": "df5d7698121e4a9c8e26061200691a50", "answers": {"answer_start": [944], "text": ["H3K4"]}}}, "1964bcead0814156b38c15ad58a3cfe1": {"prediction": {"id": "1964bcead0814156b38c15ad58a3cfe1", "prediction_text": "H3K4) is associated with transcriptional activation. One of the chief effectors of H3K4 methylation is mixed-lineage leukemia 1"}, "reference": {"id": "1964bcead0814156b38c15ad58a3cfe1", "answers": {"answer_start": [118], "text": ["H3K4"]}}}, "dabc6ee559c745e08d690aae227cdd9a": {"prediction": {"id": "dabc6ee559c745e08d690aae227cdd9a", "prediction_text": "Set1 in yeast"}, "reference": {"id": "dabc6ee559c745e08d690aae227cdd9a", "answers": {"answer_start": [234], "text": ["H3K4"]}}}, "2c4aa6814fa34854983fedaaf3026008": {"prediction": {"id": "2c4aa6814fa34854983fedaaf3026008", "prediction_text": "Mixed Lineage Leukemia 1"}, "reference": {"id": "2c4aa6814fa34854983fedaaf3026008", "answers": {"answer_start": [1620], "text": ["H3K4"]}}}, "3d721ba716f64f09aa74ed5e7f4d1f7b": {"prediction": {"id": "3d721ba716f64f09aa74ed5e7f4d1f7b", "prediction_text": "leukemia 1"}, "reference": {"id": "3d721ba716f64f09aa74ed5e7f4d1f7b", "answers": {"answer_start": [823], "text": ["H3K4"]}}}, "a7a2f6bc023b4b169422b15b28bc2e36": {"prediction": {"id": "a7a2f6bc023b4b169422b15b28bc2e36", "prediction_text": "in skin and connective tissue"}, "reference": {"id": "a7a2f6bc023b4b169422b15b28bc2e36", "answers": {"answer_start": [590], "text": ["plasma membrane"]}}}, "b04ba7ebe5bf48f9bd489a099ef87d9a": {"prediction": {"id": "b04ba7ebe5bf48f9bd489a099ef87d9a", "prediction_text": "c.20A>T"}, "reference": {"id": "b04ba7ebe5bf48f9bd489a099ef87d9a", "answers": {"answer_start": [73], "text": ["HBB"]}}}, "9949cdf23c3a412fad0880fb1eab6139": {"prediction": {"id": "9949cdf23c3a412fad0880fb1eab6139", "prediction_text": "Cyclosporine mediates its immunosuppressive effect by preventing the synthesis of lymphokine mRNA during the process of T lymphocyte activation. Although the detailed molecular mechanism by which CsA achieves this effect is unknown, two proteins have been identified as putative intracellular CsA-receptor proteins. One of these, calmodulin, is an important Ca++-binding protein and enzyme cofactor and the other, cyclophilin, is a novel protein that is reported to have protein kinase activity. In this study the CsA-binding capacity of both these proteins has been assessed using CsA-coated ELISA plates and CsA-affinity gel matrices. CsA binding was shown by cyclophilin whereas no CsA-calmodulin binding could be detected under identical conditions. However, it was not possible to demonstrate any cyclophilin-associated protein kinase activity. Jurkat cells were probed for the presence of CsA-binding proteins using the CsA-affinity gel matrix; a 17 KD"}, "reference": {"id": "9949cdf23c3a412fad0880fb1eab6139", "answers": {"answer_start": [982], "text": ["cyclophilin"]}}}, "0f9d047f7b0a4c619302c2eae3ed6333": {"prediction": {"id": "0f9d047f7b0a4c619302c2eae3ed6333", "prediction_text": "macrolide FK506"}, "reference": {"id": "0f9d047f7b0a4c619302c2eae3ed6333", "answers": {"answer_start": [568], "text": ["cyclophilin"]}}}, "5dc0bf4afc464ad1998fa67f64df02df": {"prediction": {"id": "5dc0bf4afc464ad1998fa67f64df02df", "prediction_text": "delta-distance"}, "reference": {"id": "5dc0bf4afc464ad1998fa67f64df02df", "answers": {"answer_start": [666], "text": ["delta-distance"]}}}, "a3c4242369c24bd886f63d37268c6149": {"prediction": {"id": "a3c4242369c24bd886f63d37268c6149", "prediction_text": "traseR"}, "reference": {"id": "a3c4242369c24bd886f63d37268c6149", "answers": {"answer_start": [910], "text": ["traseR"]}}}, "d4a636b025984691833a4f252eddd803": {"prediction": {"id": "d4a636b025984691833a4f252eddd803", "prediction_text": "Cornelia de Lange syndrome"}, "reference": {"id": "d4a636b025984691833a4f252eddd803", "answers": {"answer_start": [0], "text": ["Cornelia de Lange syndrome."]}}}, "d3c5c609a1154327bb491508ca1af1a5": {"prediction": {"id": "d3c5c609a1154327bb491508ca1af1a5", "prediction_text": "Cornelia de Lange syndrome"}, "reference": {"id": "d3c5c609a1154327bb491508ca1af1a5", "answers": {"answer_start": [210], "text": ["Cornelia de Lange syndrome."]}}}, "8609bcbc6b114915b5d4456fc8db26f1": {"prediction": {"id": "8609bcbc6b114915b5d4456fc8db26f1", "prediction_text": "LIRCPs"}, "reference": {"id": "8609bcbc6b114915b5d4456fc8db26f1", "answers": {"answer_start": [1416], "text": ["The iLIR database"]}}}, "a1321482fa0a4af0a0b74dfbc7485c7c": {"prediction": {"id": "a1321482fa0a4af0a0b74dfbc7485c7c", "prediction_text": "FOXP2"}, "reference": {"id": "a1321482fa0a4af0a0b74dfbc7485c7c", "answers": {"answer_start": [232], "text": ["FOXP2"]}}}, "dc747992d5f3445a994480474c0242b7": {"prediction": {"id": "dc747992d5f3445a994480474c0242b7", "prediction_text": "FOXP2"}, "reference": {"id": "dc747992d5f3445a994480474c0242b7", "answers": {"answer_start": [609], "text": ["FOXP2"]}}}, "249457d932e6486b970e0424f4b95c0a": {"prediction": {"id": "249457d932e6486b970e0424f4b95c0a", "prediction_text": "FOXP2"}, "reference": {"id": "249457d932e6486b970e0424f4b95c0a", "answers": {"answer_start": [1268], "text": ["FOXP2"]}}}, "9a469897f15d48cd914814d2b321777a": {"prediction": {"id": "9a469897f15d48cd914814d2b321777a", "prediction_text": "FOXP2"}, "reference": {"id": "9a469897f15d48cd914814d2b321777a", "answers": {"answer_start": [736], "text": ["FOXP2"]}}}, "412a21367d4146058c0b1ad1a6c5b49f": {"prediction": {"id": "412a21367d4146058c0b1ad1a6c5b49f", "prediction_text": "Transcription factor forkhead box protein P2"}, "reference": {"id": "412a21367d4146058c0b1ad1a6c5b49f", "answers": {"answer_start": [261], "text": ["FOXP2"]}}}, "8b64e7ae6df343248acf4fbe00c213d6": {"prediction": {"id": "8b64e7ae6df343248acf4fbe00c213d6", "prediction_text": "chromosome 7q31"}, "reference": {"id": "8b64e7ae6df343248acf4fbe00c213d6", "answers": {"answer_start": [727], "text": ["FOXP2"]}}}, "e8c2f9976cfd4c9291c1d4d66bdbf712": {"prediction": {"id": "e8c2f9976cfd4c9291c1d4d66bdbf712", "prediction_text": "FOXP2"}, "reference": {"id": "e8c2f9976cfd4c9291c1d4d66bdbf712", "answers": {"answer_start": [193], "text": ["FOXP2"]}}}, "c9d0722f706540ebab1a4c4b627278f1": {"prediction": {"id": "c9d0722f706540ebab1a4c4b627278f1", "prediction_text": "Forkhead box protein P2"}, "reference": {"id": "c9d0722f706540ebab1a4c4b627278f1", "answers": {"answer_start": [25], "text": ["FOXP2"]}}}, "a458c75419484c369ae460fa823ed470": {"prediction": {"id": "a458c75419484c369ae460fa823ed470", "prediction_text": "intravenous drug abuse"}, "reference": {"id": "a458c75419484c369ae460fa823ed470", "answers": {"answer_start": [55], "text": ["intravenous drug abuse"]}}}, "763a53ba903646f0bd3a494e2d26af14": {"prediction": {"id": "763a53ba903646f0bd3a494e2d26af14", "prediction_text": "intravenous drug abuse"}, "reference": {"id": "763a53ba903646f0bd3a494e2d26af14", "answers": {"answer_start": [41], "text": ["intravenous drug abuse"]}}}, "6d831150ae3b486da7f331afb71fba3e": {"prediction": {"id": "6d831150ae3b486da7f331afb71fba3e", "prediction_text": "IVDA complications in the upper extremity affecting blood vessels and lymphatics include hematoma, arterial aneurysm and pseudoaneurysm, thrombosis, thrombophlebitis"}, "reference": {"id": "6d831150ae3b486da7f331afb71fba3e", "answers": {"answer_start": [30], "text": ["intravenous drug abuse"]}}}, "f716858d938c40d9b5f852acb95d976d": {"prediction": {"id": "f716858d938c40d9b5f852acb95d976d", "prediction_text": "Plasmodium spp"}, "reference": {"id": "f716858d938c40d9b5f852acb95d976d", "answers": {"answer_start": [145], "text": ["Plasmodium spp."]}}}, "2ef127cd20cf483ebb2e3430f85604e1": {"prediction": {"id": "2ef127cd20cf483ebb2e3430f85604e1", "prediction_text": "Plasmodia species"}, "reference": {"id": "2ef127cd20cf483ebb2e3430f85604e1", "answers": {"answer_start": [971], "text": ["Plasmodium species"]}}}, "67153063ef894bcab0f64dbc09c23564": {"prediction": {"id": "67153063ef894bcab0f64dbc09c23564", "prediction_text": "Plasmodium spp"}, "reference": {"id": "67153063ef894bcab0f64dbc09c23564", "answers": {"answer_start": [362], "text": ["Plasmodium spp."]}}}, "68c5e7c8a64946bdbbe2211081be92a2": {"prediction": {"id": "68c5e7c8a64946bdbbe2211081be92a2", "prediction_text": "P. vivax"}, "reference": {"id": "68c5e7c8a64946bdbbe2211081be92a2", "answers": {"answer_start": [453], "text": ["Plasmodium spp."]}}}, "7e242f30cc7d450a9a3b89cc74414ccd": {"prediction": {"id": "7e242f30cc7d450a9a3b89cc74414ccd", "prediction_text": "Plasmodium falciparum"}, "reference": {"id": "7e242f30cc7d450a9a3b89cc74414ccd", "answers": {"answer_start": [615], "text": ["Plasmodium species"]}}}, "6665f377f62442dca3dcb5dc338ac6fd": {"prediction": {"id": "6665f377f62442dca3dcb5dc338ac6fd", "prediction_text": "Plasmodium"}, "reference": {"id": "6665f377f62442dca3dcb5dc338ac6fd", "answers": {"answer_start": [429], "text": ["Plasmodium species"]}}}, "c90a169c5ae34b999203b13a5b8a1bee": {"prediction": {"id": "c90a169c5ae34b999203b13a5b8a1bee", "prediction_text": "Plasmodium"}, "reference": {"id": "c90a169c5ae34b999203b13a5b8a1bee", "answers": {"answer_start": [491], "text": ["Plasmodium species"]}}}, "f72a51e10c7e45489927f65edc70212a": {"prediction": {"id": "f72a51e10c7e45489927f65edc70212a", "prediction_text": "Plasmodium species"}, "reference": {"id": "f72a51e10c7e45489927f65edc70212a", "answers": {"answer_start": [364], "text": ["Plasmodium species"]}}}, "e66e6c41986e475eba1ba19d6a3fd72c": {"prediction": {"id": "e66e6c41986e475eba1ba19d6a3fd72c", "prediction_text": "P. vivax"}, "reference": {"id": "e66e6c41986e475eba1ba19d6a3fd72c", "answers": {"answer_start": [401], "text": ["Plasmodium species"]}}}, "144223df625842518458f2b6d70f46dc": {"prediction": {"id": "144223df625842518458f2b6d70f46dc", "prediction_text": "PEO-PCL"}, "reference": {"id": "144223df625842518458f2b6d70f46dc", "answers": {"answer_start": [149], "text": ["HIV"]}}}, "90f26ac59909406ea6d1545629f9212b": {"prediction": {"id": "90f26ac59909406ea6d1545629f9212b", "prediction_text": "TMC 120"}, "reference": {"id": "90f26ac59909406ea6d1545629f9212b", "answers": {"answer_start": [70], "text": ["HIV"]}}}, "b96c8a33a9bf4774aca2f9e507dfbe5f": {"prediction": {"id": "b96c8a33a9bf4774aca2f9e507dfbe5f", "prediction_text": "immunodeficiency virus (HIV)"}, "reference": {"id": "b96c8a33a9bf4774aca2f9e507dfbe5f", "answers": {"answer_start": [479], "text": ["HIV"]}}}, "a5e3f516c0b64d9ba0eb2e5a7a2908d6": {"prediction": {"id": "a5e3f516c0b64d9ba0eb2e5a7a2908d6", "prediction_text": "CVF on Days 1 and 10 and in cervicovaginal tissues on Day 10. Safety was evaluated through laboratory tests (hematology, clinical chemistry, and urinalysis), physical examinations, and assessment of adverse events. Plasma concentrations of dapivirine increased over time with gel dose and were greater on Day 10 (C(max) 31 to 471\u2009pg/ml) than Day 1 (C(max) 23 to 80\u2009pg/ml). T(max) was 10-12\u2009h on Day 1, and 9\u2009h on Day 10. Concentrations in CVF generally increased with dose but were highly variable among participants. Mean peak values ranged from 4.6-8.3\u2009\u00d7\u200910(6) pg/ml on Day 1 and from 2.3-20.7\u2009\u00d7\u200910(6) pg/ml on Day 10 across dose groups. Dapivirine was detectable in all tissue biopsies on Day 10 at concentrations of 1.0-356\u2009\u00d7\u200910(3) pg/mg"}, "reference": {"id": "a5e3f516c0b64d9ba0eb2e5a7a2908d6", "answers": {"answer_start": [218], "text": ["HIV"]}}}, "6a9cd66ef3294820ac4c9826365f161f": {"prediction": {"id": "6a9cd66ef3294820ac4c9826365f161f", "prediction_text": "reverse transcriptase inhibitor"}, "reference": {"id": "6a9cd66ef3294820ac4c9826365f161f", "answers": {"answer_start": [76], "text": ["HIV"]}}}, "97c5eaf9f9314152a734b3e954a84e4d": {"prediction": {"id": "97c5eaf9f9314152a734b3e954a84e4d", "prediction_text": "HIV"}, "reference": {"id": "97c5eaf9f9314152a734b3e954a84e4d", "answers": {"answer_start": [132], "text": ["HIV"]}}}, "efdf0c9ce567463286e463942d6db467": {"prediction": {"id": "efdf0c9ce567463286e463942d6db467", "prediction_text": "Immunodeficiency Virus"}, "reference": {"id": "efdf0c9ce567463286e463942d6db467", "answers": {"answer_start": [1255], "text": ["HIV"]}}}, "edc300489d154b4d8f4954f3cf545a33": {"prediction": {"id": "edc300489d154b4d8f4954f3cf545a33", "prediction_text": "HIV"}, "reference": {"id": "edc300489d154b4d8f4954f3cf545a33", "answers": {"answer_start": [509], "text": ["HIV"]}}}, "ffe39742aff54beeb9bb26de2f9cd609": {"prediction": {"id": "ffe39742aff54beeb9bb26de2f9cd609", "prediction_text": "explant"}, "reference": {"id": "ffe39742aff54beeb9bb26de2f9cd609", "answers": {"answer_start": [16], "text": ["HIV"]}}}, "1fcff1e413484c70838b8f6826cc92fc": {"prediction": {"id": "1fcff1e413484c70838b8f6826cc92fc", "prediction_text": "migratory cells"}, "reference": {"id": "1fcff1e413484c70838b8f6826cc92fc", "answers": {"answer_start": [732], "text": ["HIV"]}}}, "0f84d7ad9f1c43c99358b2f1e6700072": {"prediction": {"id": "0f84d7ad9f1c43c99358b2f1e6700072", "prediction_text": "HIV-1"}, "reference": {"id": "0f84d7ad9f1c43c99358b2f1e6700072", "answers": {"answer_start": [1622], "text": ["HIV"]}}}, "688c99c1d69147e0b5b4d4986c2ad30c": {"prediction": {"id": "688c99c1d69147e0b5b4d4986c2ad30c", "prediction_text": "HIV infection through pre-exposure prophylaxis"}, "reference": {"id": "688c99c1d69147e0b5b4d4986c2ad30c", "answers": {"answer_start": [936], "text": ["HIV"]}}}, "c9d1365a55f246a5979576df1a460eb1": {"prediction": {"id": "c9d1365a55f246a5979576df1a460eb1", "prediction_text": "vaginal ring"}, "reference": {"id": "c9d1365a55f246a5979576df1a460eb1", "answers": {"answer_start": [136], "text": ["HIV"]}}}, "04fd133ee3d8468693fd0d80da3fb514": {"prediction": {"id": "04fd133ee3d8468693fd0d80da3fb514", "prediction_text": "HIV"}, "reference": {"id": "04fd133ee3d8468693fd0d80da3fb514", "answers": {"answer_start": [820], "text": ["HIV"]}}}, "c4dbe33fa97d4962a29310e7dd0bb65b": {"prediction": {"id": "c4dbe33fa97d4962a29310e7dd0bb65b", "prediction_text": "reverse transcriptase inhibitor"}, "reference": {"id": "c4dbe33fa97d4962a29310e7dd0bb65b", "answers": {"answer_start": [404], "text": ["HIV"]}}}, "a5cfec52a8fb473199fa9224ef8c12b1": {"prediction": {"id": "a5cfec52a8fb473199fa9224ef8c12b1", "prediction_text": "anti-HIV drug"}, "reference": {"id": "a5cfec52a8fb473199fa9224ef8c12b1", "answers": {"answer_start": [505], "text": ["HIV"]}}}, "554d0a78cff944e890b787a56eb24667": {"prediction": {"id": "554d0a78cff944e890b787a56eb24667", "prediction_text": "Diaphragm devices comprising various dapivirine-loaded polymer spring cores"}, "reference": {"id": "554d0a78cff944e890b787a56eb24667", "answers": {"answer_start": [1078], "text": ["HIV"]}}}, "afab112ad0c14fae9f920c65bc78e86b": {"prediction": {"id": "afab112ad0c14fae9f920c65bc78e86b", "prediction_text": "HIV-1"}, "reference": {"id": "afab112ad0c14fae9f920c65bc78e86b", "answers": {"answer_start": [309], "text": ["HIV"]}}}, "4b7de28128c340d3ba29895c48cde309": {"prediction": {"id": "4b7de28128c340d3ba29895c48cde309", "prediction_text": "placebo ring"}, "reference": {"id": "4b7de28128c340d3ba29895c48cde309", "answers": {"answer_start": [1959], "text": ["HIV"]}}}, "246e6904f90143bd98c91888ce60537b": {"prediction": {"id": "246e6904f90143bd98c91888ce60537b", "prediction_text": "HIV-1"}, "reference": {"id": "246e6904f90143bd98c91888ce60537b", "answers": {"answer_start": [417], "text": ["HIV"]}}}, "481db03efbc24de39b24c3c907d1154b": {"prediction": {"id": "481db03efbc24de39b24c3c907d1154b", "prediction_text": "vaginal ring"}, "reference": {"id": "481db03efbc24de39b24c3c907d1154b", "answers": {"answer_start": [171], "text": ["HIV"]}}}, "3e6f6f2a68ca4b1db6da8d4428085984": {"prediction": {"id": "3e6f6f2a68ca4b1db6da8d4428085984", "prediction_text": "vaginal ring"}, "reference": {"id": "3e6f6f2a68ca4b1db6da8d4428085984", "answers": {"answer_start": [65], "text": ["HIV"]}}}, "93c893467287463c8998714625fcf479": {"prediction": {"id": "93c893467287463c8998714625fcf479", "prediction_text": "chaperone-like"}, "reference": {"id": "93c893467287463c8998714625fcf479", "answers": {"answer_start": [83], "text": ["mitochondrial inner membrane"]}}}, "830ccb7e123e410f841d56b1c8f77c37": {"prediction": {"id": "830ccb7e123e410f841d56b1c8f77c37", "prediction_text": "decreasing food intake"}, "reference": {"id": "830ccb7e123e410f841d56b1c8f77c37", "answers": {"answer_start": [375], "text": ["Reduces body weight"]}}}, "0de3cc511c634ffa908abcd67c4dddbb": {"prediction": {"id": "0de3cc511c634ffa908abcd67c4dddbb", "prediction_text": "CRISPR loci"}, "reference": {"id": "0de3cc511c634ffa908abcd67c4dddbb", "answers": {"answer_start": [39], "text": ["CRISPR-Cas"]}}}, "187161d700e94874bca22e669ded1617": {"prediction": {"id": "187161d700e94874bca22e669ded1617", "prediction_text": "short RNAs"}, "reference": {"id": "187161d700e94874bca22e669ded1617", "answers": {"answer_start": [4], "text": ["CRISPR-Cas"]}}}, "eca92ddcd3b44b79ba784a6a4fa01eb8": {"prediction": {"id": "eca92ddcd3b44b79ba784a6a4fa01eb8", "prediction_text": "CRISPR-Cas"}, "reference": {"id": "eca92ddcd3b44b79ba784a6a4fa01eb8", "answers": {"answer_start": [4], "text": ["CRISPR-Cas"]}}}, "d14dded6aaf44447bd328d24d697509a": {"prediction": {"id": "d14dded6aaf44447bd328d24d697509a", "prediction_text": "CRISPR-Cas system"}, "reference": {"id": "d14dded6aaf44447bd328d24d697509a", "answers": {"answer_start": [736], "text": ["CRISPR-Cas"]}}}, "f51be8711ae9468b833376a6e3cfd37f": {"prediction": {"id": "f51be8711ae9468b833376a6e3cfd37f", "prediction_text": "SGLT2"}, "reference": {"id": "f51be8711ae9468b833376a6e3cfd37f", "answers": {"answer_start": [35], "text": ["SGLT2"]}}}, "05c1af6aa617490bb75158c238e4c101": {"prediction": {"id": "05c1af6aa617490bb75158c238e4c101", "prediction_text": "sodium glucose"}, "reference": {"id": "05c1af6aa617490bb75158c238e4c101", "answers": {"answer_start": [63], "text": ["SGLT2"]}}}, "1ee45c5a8ecf459da01490f929370956": {"prediction": {"id": "1ee45c5a8ecf459da01490f929370956", "prediction_text": "2 (SGLT2) inhibitors, which have unique characteristics. SGLT2 inhibitors focus on the kidney"}, "reference": {"id": "1ee45c5a8ecf459da01490f929370956", "answers": {"answer_start": [569], "text": ["SGLT2"]}}}, "3344a5a43fc54f33a502790bc55a17fd": {"prediction": {"id": "3344a5a43fc54f33a502790bc55a17fd", "prediction_text": "glucose"}, "reference": {"id": "3344a5a43fc54f33a502790bc55a17fd", "answers": {"answer_start": [549], "text": ["SGLT2"]}}}, "ab8e88965935487e80f9bb0d28635e29": {"prediction": {"id": "ab8e88965935487e80f9bb0d28635e29", "prediction_text": "SGLT2 inhibitor with a mechanism of action that is independent of \u03b2-cell function and the insulin pathway. Data from a comprehensive phase III clinical trial program have demonstrated its efficacy as monotherapy, as add-on to other glucose-lowering agents, and in different patient populations. In these studies, empagliflozin resulted in improvements in blood glucose levels as well as reductions in body weight and blood pressure. Empagliflozin was well tolerated and was not associated with an increased risk of hypoglycemia versus placebo. The oral antidiabetes agent, empagliflozin, can be used as monotherapy or alongside other glucose-lowering treatments, including insulin"}, "reference": {"id": "ab8e88965935487e80f9bb0d28635e29", "answers": {"answer_start": [621], "text": ["SGLT2"]}}}, "781e94984edd4d5aa2406d7b38057721": {"prediction": {"id": "781e94984edd4d5aa2406d7b38057721", "prediction_text": "insulin"}, "reference": {"id": "781e94984edd4d5aa2406d7b38057721", "answers": {"answer_start": [927], "text": ["SGLT2"]}}}, "7001a0f1fd0c49c99cd3d260fc2338a9": {"prediction": {"id": "7001a0f1fd0c49c99cd3d260fc2338a9", "prediction_text": "macrophage chemoattractant protein-1 (MCP-1), transforming growth factor \u03b21 and fibronectin mRNA observed in the diabetic animals, while telmisartan decreased transcription of MCP-1 and fibronectin. Empagliflozin increased GLUT1 mRNA expression and telmisartan increased SGLT2 mRNA"}, "reference": {"id": "7001a0f1fd0c49c99cd3d260fc2338a9", "answers": {"answer_start": [914], "text": ["SGLT2"]}}}, "4c0b74866a5b49d9b7d0fe3ceee789f6": {"prediction": {"id": "4c0b74866a5b49d9b7d0fe3ceee789f6", "prediction_text": "sodium glucose cotransporter 2"}, "reference": {"id": "4c0b74866a5b49d9b7d0fe3ceee789f6", "answers": {"answer_start": [115], "text": ["SGLT2"]}}}, "d160bafcbac14f038823c3a58a092b8a": {"prediction": {"id": "d160bafcbac14f038823c3a58a092b8a", "prediction_text": "hypoglycemia"}, "reference": {"id": "d160bafcbac14f038823c3a58a092b8a", "answers": {"answer_start": [673], "text": ["SGLT2"]}}}, "2225aaf3723042438713bccbe8df2990": {"prediction": {"id": "2225aaf3723042438713bccbe8df2990", "prediction_text": "sodium-glucose"}, "reference": {"id": "2225aaf3723042438713bccbe8df2990", "answers": {"answer_start": [1723], "text": ["SGLT2"]}}}, "1ce9cb6b128a430ca27c5e7076a2d531": {"prediction": {"id": "1ce9cb6b128a430ca27c5e7076a2d531", "prediction_text": "glucosuria"}, "reference": {"id": "1ce9cb6b128a430ca27c5e7076a2d531", "answers": {"answer_start": [156], "text": ["SGLT2"]}}}, "dd7caa76e6d94b4f93e8f94c5028d65c": {"prediction": {"id": "dd7caa76e6d94b4f93e8f94c5028d65c", "prediction_text": "insulin"}, "reference": {"id": "dd7caa76e6d94b4f93e8f94c5028d65c", "answers": {"answer_start": [270], "text": ["SGLT2"]}}}, "a17042d7d69b49b4978fba59de6055e7": {"prediction": {"id": "a17042d7d69b49b4978fba59de6055e7", "prediction_text": "gluconeogenesis"}, "reference": {"id": "a17042d7d69b49b4978fba59de6055e7", "answers": {"answer_start": [83], "text": ["SGLT2"]}}}, "ae43c91f5a36430494757e6928c52520": {"prediction": {"id": "ae43c91f5a36430494757e6928c52520", "prediction_text": "1"}, "reference": {"id": "ae43c91f5a36430494757e6928c52520", "answers": {"answer_start": [1017], "text": ["SGLT2"]}}}, "c9bee4f3a7ee466c8bc1153da1368356": {"prediction": {"id": "c9bee4f3a7ee466c8bc1153da1368356", "prediction_text": "sodium glucose"}, "reference": {"id": "c9bee4f3a7ee466c8bc1153da1368356", "answers": {"answer_start": [61], "text": ["SGLT2"]}}}, "67e60913fd7740cf8fc3d8c2222adfd6": {"prediction": {"id": "67e60913fd7740cf8fc3d8c2222adfd6", "prediction_text": "sodium glucose"}, "reference": {"id": "67e60913fd7740cf8fc3d8c2222adfd6", "answers": {"answer_start": [278], "text": ["SGLT2"]}}}, "3868d55291d94ee3863ee57134ea2276": {"prediction": {"id": "3868d55291d94ee3863ee57134ea2276", "prediction_text": "25 mg"}, "reference": {"id": "3868d55291d94ee3863ee57134ea2276", "answers": {"answer_start": [32], "text": ["SGLT2"]}}}, "261eb6ab7d294e25a28b22c72b4192ac": {"prediction": {"id": "261eb6ab7d294e25a28b22c72b4192ac", "prediction_text": "spinal AMs"}, "reference": {"id": "261eb6ab7d294e25a28b22c72b4192ac", "answers": {"answer_start": [437], "text": ["meningioma"]}}}, "a45e5fd5e29b4dcd8914a484c8cd963a": {"prediction": {"id": "a45e5fd5e29b4dcd8914a484c8cd963a", "prediction_text": "WHO Grade I meningioma"}, "reference": {"id": "a45e5fd5e29b4dcd8914a484c8cd963a", "answers": {"answer_start": [1761], "text": ["meningioma"]}}}, "1fabf84348d04f9b97331e6e32e42325": {"prediction": {"id": "1fabf84348d04f9b97331e6e32e42325", "prediction_text": "WHO Grade I meningiomas"}, "reference": {"id": "1fabf84348d04f9b97331e6e32e42325", "answers": {"answer_start": [364], "text": ["meningioma"]}}}, "f77692a4d14245d28ae241422cfdb3d7": {"prediction": {"id": "f77692a4d14245d28ae241422cfdb3d7", "prediction_text": "surgical"}, "reference": {"id": "f77692a4d14245d28ae241422cfdb3d7", "answers": {"answer_start": [63], "text": ["meningioma"]}}}, "befa88a3a9e3493e9346dc4dc005798d": {"prediction": {"id": "befa88a3a9e3493e9346dc4dc005798d", "prediction_text": "Simpson Grade 1"}, "reference": {"id": "befa88a3a9e3493e9346dc4dc005798d", "answers": {"answer_start": [184], "text": ["meningioma"]}}}, "159f3f4cda8a40b48246de5f988ac456": {"prediction": {"id": "159f3f4cda8a40b48246de5f988ac456", "prediction_text": "Subtotal resections"}, "reference": {"id": "159f3f4cda8a40b48246de5f988ac456", "answers": {"answer_start": [62], "text": ["meningioma"]}}}, "34dacebb5d424ea6b41c0fb9c8f92b31": {"prediction": {"id": "34dacebb5d424ea6b41c0fb9c8f92b31", "prediction_text": "dura mater"}, "reference": {"id": "34dacebb5d424ea6b41c0fb9c8f92b31", "answers": {"answer_start": [20], "text": ["meningioma"]}}}, "69360ee6a7bc4d359edac7158d16d908": {"prediction": {"id": "69360ee6a7bc4d359edac7158d16d908", "prediction_text": "1p and 3q"}, "reference": {"id": "69360ee6a7bc4d359edac7158d16d908", "answers": {"answer_start": [980], "text": ["seven"]}}}, "abd59b97498c4479ae4f52053b777ba9": {"prediction": {"id": "abd59b97498c4479ae4f52053b777ba9", "prediction_text": "seven"}, "reference": {"id": "abd59b97498c4479ae4f52053b777ba9", "answers": {"answer_start": [313], "text": ["seven"]}}}, "4bb7ff1190824c9ca8ae04495b241343": {"prediction": {"id": "4bb7ff1190824c9ca8ae04495b241343", "prediction_text": "crowding"}, "reference": {"id": "4bb7ff1190824c9ca8ae04495b241343", "answers": {"answer_start": [17], "text": ["membrane-free microcompartments"]}}}, "6da24aec6a2c448b98364b01f8231907": {"prediction": {"id": "6da24aec6a2c448b98364b01f8231907", "prediction_text": "41 out of 48 genes being identical. Transcriptional profiling of 14"}, "reference": {"id": "6da24aec6a2c448b98364b01f8231907", "answers": {"answer_start": [695], "text": ["48 genes"]}}}, "6c994d45703948aa94a6ea6edafe8075": {"prediction": {"id": "6c994d45703948aa94a6ea6edafe8075", "prediction_text": "48"}, "reference": {"id": "6c994d45703948aa94a6ea6edafe8075", "answers": {"answer_start": [217], "text": ["48 genes"]}}}, "b18e1c76940948b7beaa9babed3d129a": {"prediction": {"id": "b18e1c76940948b7beaa9babed3d129a", "prediction_text": "48"}, "reference": {"id": "b18e1c76940948b7beaa9babed3d129a", "answers": {"answer_start": [213], "text": ["48 genes"]}}}, "2913bb15767141c09c8e7dc81e270448": {"prediction": {"id": "2913bb15767141c09c8e7dc81e270448", "prediction_text": "Nivolumab was developed as a monoclonal antibody against programmed death receptor-1"}, "reference": {"id": "2913bb15767141c09c8e7dc81e270448", "answers": {"answer_start": [57], "text": ["programmed death receptor-1"]}}}, "658def61685240009a4e2488a2b1a370": {"prediction": {"id": "658def61685240009a4e2488a2b1a370", "prediction_text": "PD-1) inhibitors pembrolizumab"}, "reference": {"id": "658def61685240009a4e2488a2b1a370", "answers": {"answer_start": [47], "text": ["programmed death receptor-1"]}}}, "49560e1c26ec4bda96d48e16457232a2": {"prediction": {"id": "49560e1c26ec4bda96d48e16457232a2", "prediction_text": "DNA-dependent RNA polymerase II"}, "reference": {"id": "49560e1c26ec4bda96d48e16457232a2", "answers": {"answer_start": [515], "text": ["RNA polymerase II"]}}}, "4a1cbe7c5c8644938d511256a3e0ef8f": {"prediction": {"id": "4a1cbe7c5c8644938d511256a3e0ef8f", "prediction_text": "RNA polymerase II"}, "reference": {"id": "4a1cbe7c5c8644938d511256a3e0ef8f", "answers": {"answer_start": [113], "text": ["RNA polymerase II"]}}}, "18522cd8f09c4d96994c234669223aa9": {"prediction": {"id": "18522cd8f09c4d96994c234669223aa9", "prediction_text": "Polymerase II"}, "reference": {"id": "18522cd8f09c4d96994c234669223aa9", "answers": {"answer_start": [717, 736], "text": ["RNA polymerase II", "RNAPII"]}}}, "a9b8bf5ad54c4c61bd51e939def1d648": {"prediction": {"id": "a9b8bf5ad54c4c61bd51e939def1d648", "prediction_text": "RNA polymerase II"}, "reference": {"id": "a9b8bf5ad54c4c61bd51e939def1d648", "answers": {"answer_start": [198], "text": ["RNA polymerase II"]}}}, "7b1dd1ea1e004f339824ee96218a99b3": {"prediction": {"id": "7b1dd1ea1e004f339824ee96218a99b3", "prediction_text": "RNA polymerase II"}, "reference": {"id": "7b1dd1ea1e004f339824ee96218a99b3", "answers": {"answer_start": [69], "text": ["RNA polymerase II"]}}}, "05aede09e0ea425ab1fa695711421293": {"prediction": {"id": "05aede09e0ea425ab1fa695711421293", "prediction_text": "159, 166, 168 and 172"}, "reference": {"id": "05aede09e0ea425ab1fa695711421293", "answers": {"answer_start": [372], "text": ["RNA polymerase II"]}}}, "b0e8b040df8c497fb02a74b05d3831b0": {"prediction": {"id": "b0e8b040df8c497fb02a74b05d3831b0", "prediction_text": "RNA polymerase II"}, "reference": {"id": "b0e8b040df8c497fb02a74b05d3831b0", "answers": {"answer_start": [75], "text": ["RNA polymerase II"]}}}, "1cf17e3c2c8e4cd689bfb7d3bf13fec9": {"prediction": {"id": "1cf17e3c2c8e4cd689bfb7d3bf13fec9", "prediction_text": "lnc-pri-miRNAs"}, "reference": {"id": "1cf17e3c2c8e4cd689bfb7d3bf13fec9", "answers": {"answer_start": [165], "text": ["RNA polymerase II"]}}}, "7f8244cb684744069d92bfb04de923f8": {"prediction": {"id": "7f8244cb684744069d92bfb04de923f8", "prediction_text": "polymerase II"}, "reference": {"id": "7f8244cb684744069d92bfb04de923f8", "answers": {"answer_start": [405], "text": ["RNA polymerase II"]}}}, "6a44e839b1604b95b194791efc055894": {"prediction": {"id": "6a44e839b1604b95b194791efc055894", "prediction_text": "alpha-amanitin"}, "reference": {"id": "6a44e839b1604b95b194791efc055894", "answers": {"answer_start": [576], "text": ["RNA polymerase II"]}}}, "9d9463b5e4ae400e98326baf326c048d": {"prediction": {"id": "9d9463b5e4ae400e98326baf326c048d", "prediction_text": "RNA polymerase II"}, "reference": {"id": "9d9463b5e4ae400e98326baf326c048d", "answers": {"answer_start": [930], "text": ["RNA polymerase II"]}}}, "c3a36fca071f4f29aec24521303dce99": {"prediction": {"id": "c3a36fca071f4f29aec24521303dce99", "prediction_text": "RNA polymerase II"}, "reference": {"id": "c3a36fca071f4f29aec24521303dce99", "answers": {"answer_start": [192], "text": ["RNA polymerase II"]}}}, "6414ab48eea0435bb8d27259fcfd7aba": {"prediction": {"id": "6414ab48eea0435bb8d27259fcfd7aba", "prediction_text": "MicroRNAs (miRNAs) are non-coding, short (21-23nt) regulators of protein-coding genes that are generally transcribed first into primary miRNA (pri-miR), followed by the generation of precursor miRNA (pre-miR). This finally leads to the production of the mature miRNA. A large amount of information is available on the pre- and mature miRNAs. However, very little is known about the pri-miRs, due to a lack of knowledge about their transcription start sites (TSSs). Based on the genomic loci, miRNAs can be categorized into two types --intragenic (intra-miR) and intergenic (inter-miR). While it is already an established fact that intra-miRs are commonly transcribed in conjunction with their host genes, the transcription machinery of inter-miRs is poorly understood. Although it is assumed that miRNA promoters are similar in structure to gene promoters, since both are transcribed by RNA polymerase II"}, "reference": {"id": "6414ab48eea0435bb8d27259fcfd7aba", "answers": {"answer_start": [887], "text": ["RNA polymerase II"]}}}, "155341feada54b2d801142172fb48e72": {"prediction": {"id": "155341feada54b2d801142172fb48e72", "prediction_text": "miRNA"}, "reference": {"id": "155341feada54b2d801142172fb48e72", "answers": {"answer_start": [354], "text": ["RNA polymerase II"]}}}, "06b3886ae6824595b00b32838733c82e": {"prediction": {"id": "06b3886ae6824595b00b32838733c82e", "prediction_text": "disruption of the yeast gene (YHC3), which is a homologue"}, "reference": {"id": "06b3886ae6824595b00b32838733c82e", "answers": {"answer_start": [95], "text": ["Batten disease"]}}}, "78b9d91e3881464e99ae5f767cfd3954": {"prediction": {"id": "78b9d91e3881464e99ae5f767cfd3954", "prediction_text": "neurodegenerative disorder"}, "reference": {"id": "78b9d91e3881464e99ae5f767cfd3954", "answers": {"answer_start": [41], "text": ["Batten disease"]}}}, "098457ddbcb249fd866827693e18feec": {"prediction": {"id": "098457ddbcb249fd866827693e18feec", "prediction_text": "chromosome 16p11.2-12.1"}, "reference": {"id": "098457ddbcb249fd866827693e18feec", "answers": {"answer_start": [0, 16, 63], "text": ["Batten disease", "juvenile-onset neuronal ceroid lipofuscinosis", "JNCL"]}}}, "989c169ec1724842b41b9efec19c3ecc": {"prediction": {"id": "989c169ec1724842b41b9efec19c3ecc", "prediction_text": "depletion of arginine in cells derived from individuals with juvenile Batten disease. We have, therefore, characterized lysosomal arginine transport in normal lysosomes and show that it is ATP-, v-ATPase- and cationic-dependent. This and previous studies have shown that both arginine and lysine are transported by the same transport system, designated system c. However, we report that lysosomes isolated from juvenile Batten disease lymphoblasts are only defective for arginine transport. These results suggest that the CLN3 defect in juvenile Batten disease may affect how intracellular levels of arginine are regulated or distributed throughout the cell"}, "reference": {"id": "989c169ec1724842b41b9efec19c3ecc", "answers": {"answer_start": [132, 1423], "text": ["Batten disease", "JNCL"]}}}, "85465f4adbcb4fa6b6b82280a2a7a08a": {"prediction": {"id": "85465f4adbcb4fa6b6b82280a2a7a08a", "prediction_text": "increases survival"}, "reference": {"id": "85465f4adbcb4fa6b6b82280a2a7a08a", "answers": {"answer_start": [138], "text": ["Batten disease"]}}}, "7df48fa30f284320a989e4b3a601d341": {"prediction": {"id": "7df48fa30f284320a989e4b3a601d341", "prediction_text": "anti-neuronal death function"}, "reference": {"id": "7df48fa30f284320a989e4b3a601d341", "answers": {"answer_start": [277, 197], "text": ["Batten disease", "JNCL"]}}}, "faab3f728cd64bbeb306a267990d971e": {"prediction": {"id": "faab3f728cd64bbeb306a267990d971e", "prediction_text": "unknown function"}, "reference": {"id": "faab3f728cd64bbeb306a267990d971e", "answers": {"answer_start": [0, 16, 660], "text": ["Batten disease", "juvenile-onset neuronal ceroid lipofuscinosis", "JNCL"]}}}, "06cd301a53954dfaad7308db9e17e509": {"prediction": {"id": "06cd301a53954dfaad7308db9e17e509", "prediction_text": "localizes to the vacuole"}, "reference": {"id": "06cd301a53954dfaad7308db9e17e509", "answers": {"answer_start": [338], "text": ["Batten disease"]}}}, "00a667c50472420a9875e0b5287db920": {"prediction": {"id": "00a667c50472420a9875e0b5287db920", "prediction_text": "increased expression of BTN2"}, "reference": {"id": "00a667c50472420a9875e0b5287db920", "answers": {"answer_start": [69, 953], "text": ["Batten disease", "JNCL"]}}}, "8b9d24833fa448e0a9f1f4feb7d3a132": {"prediction": {"id": "8b9d24833fa448e0a9f1f4feb7d3a132", "prediction_text": "in\u00a0vitro"}, "reference": {"id": "8b9d24833fa448e0a9f1f4feb7d3a132", "answers": {"answer_start": [325], "text": ["UCP1+ adipocytes"]}}}, "fc5cb84617f146ffb40a40347bab70ce": {"prediction": {"id": "fc5cb84617f146ffb40a40347bab70ce", "prediction_text": "in UCP1+ adipocytes"}, "reference": {"id": "fc5cb84617f146ffb40a40347bab70ce", "answers": {"answer_start": [608], "text": ["UCP1+ adipocytes"]}}}, "2305f68f2ad34bbabcffe70ce6fe7745": {"prediction": {"id": "2305f68f2ad34bbabcffe70ce6fe7745", "prediction_text": "CaM-kinase"}, "reference": {"id": "2305f68f2ad34bbabcffe70ce6fe7745", "answers": {"answer_start": [367], "text": ["The calcium/calmodulin-dependent protein kinase-II"]}}}, "a5f4c2ee11b843cd8359d19f21120898": {"prediction": {"id": "a5f4c2ee11b843cd8359d19f21120898", "prediction_text": "CaM kinase II activation was inhibited by KN-93 pretreatment (IC(50) approximately 1 microM). KN-93 inhibited histamine-induced tonic force maintenance, whereas early force development and MLC(20) phosphorylation responses during the entire time course were unaffected. Both force development and maintenance in response to KCl were inhibited by KN-93. Rapid increases in KCl-induced MLC(20) phosphorylation"}, "reference": {"id": "a5f4c2ee11b843cd8359d19f21120898", "answers": {"answer_start": [334], "text": ["CaM kinase II"]}}}, "66ae568791f349cbb4c89dfddeb02ec9": {"prediction": {"id": "66ae568791f349cbb4c89dfddeb02ec9", "prediction_text": "histamine and forskolin"}, "reference": {"id": "66ae568791f349cbb4c89dfddeb02ec9", "answers": {"answer_start": [1141], "text": ["CaM kinase II"]}}}, "875f169a8f7e426dbe09a15814467ce3": {"prediction": {"id": "875f169a8f7e426dbe09a15814467ce3", "prediction_text": "tyrosine hydroxylase"}, "reference": {"id": "875f169a8f7e426dbe09a15814467ce3", "answers": {"answer_start": [1361], "text": ["CaM kinase II"]}}}, "72e8d57621444e4cbf7e999713637818": {"prediction": {"id": "72e8d57621444e4cbf7e999713637818", "prediction_text": "CaM"}, "reference": {"id": "72e8d57621444e4cbf7e999713637818", "answers": {"answer_start": [322, 1139], "text": ["The calcium/calmodulin-dependent protein kinase-II", "CaM kinase II"]}}}, "9408a2b40b6c46a69531fe16145a72db": {"prediction": {"id": "9408a2b40b6c46a69531fe16145a72db", "prediction_text": "CaM kinase II"}, "reference": {"id": "9408a2b40b6c46a69531fe16145a72db", "answers": {"answer_start": [1369], "text": ["CaM kinase II"]}}}, "74a950ed59914f99bd87f190c1ca1431": {"prediction": {"id": "74a950ed59914f99bd87f190c1ca1431", "prediction_text": "Mycobacterium tuberculosis"}, "reference": {"id": "74a950ed59914f99bd87f190c1ca1431", "answers": {"answer_start": [658], "text": ["tuberculosis"]}}}, "81703de55cb44fa8959989daec863ea4": {"prediction": {"id": "81703de55cb44fa8959989daec863ea4", "prediction_text": "XDR-TB"}, "reference": {"id": "81703de55cb44fa8959989daec863ea4", "answers": {"answer_start": [47], "text": ["tuberculosis"]}}}, "c32288bc35164098bdfe3f06472daa97": {"prediction": {"id": "c32288bc35164098bdfe3f06472daa97", "prediction_text": "MDR-TB"}, "reference": {"id": "c32288bc35164098bdfe3f06472daa97", "answers": {"answer_start": [405], "text": ["tuberculosis"]}}}, "4311b512e7384054afbb8937f2c41c68": {"prediction": {"id": "4311b512e7384054afbb8937f2c41c68", "prediction_text": "Tuberculosis"}, "reference": {"id": "4311b512e7384054afbb8937f2c41c68", "answers": {"answer_start": [0], "text": ["tuberculosis"]}}}, "f28283d9c8a6458aa000a0dfc5700be1": {"prediction": {"id": "f28283d9c8a6458aa000a0dfc5700be1", "prediction_text": "multidrug-resistant tuberculosis"}, "reference": {"id": "f28283d9c8a6458aa000a0dfc5700be1", "answers": {"answer_start": [933], "text": ["tuberculosis"]}}}, "a669f1fd81f546ebb3cd70163e75c59a": {"prediction": {"id": "a669f1fd81f546ebb3cd70163e75c59a", "prediction_text": "pneumonic anthrax"}, "reference": {"id": "a669f1fd81f546ebb3cd70163e75c59a", "answers": {"answer_start": [386], "text": ["Bacillus Anthracis"]}}}, "0b006e05777843849621453ee841d5a4": {"prediction": {"id": "0b006e05777843849621453ee841d5a4", "prediction_text": "antigen"}, "reference": {"id": "0b006e05777843849621453ee841d5a4", "answers": {"answer_start": [724], "text": ["a 17 nucleotide deletion"]}}}, "65a5ee887d9344d4bad7d017000ad1e2": {"prediction": {"id": "65a5ee887d9344d4bad7d017000ad1e2", "prediction_text": "XK"}, "reference": {"id": "65a5ee887d9344d4bad7d017000ad1e2", "answers": {"answer_start": [433], "text": ["XK"]}}}, "f9b60a01bc1a40a7a99ea2bda393632a": {"prediction": {"id": "f9b60a01bc1a40a7a99ea2bda393632a", "prediction_text": "XK"}, "reference": {"id": "f9b60a01bc1a40a7a99ea2bda393632a", "answers": {"answer_start": [334], "text": ["XK"]}}}, "ea608bb77c194556b7a5b3052a10e05e": {"prediction": {"id": "ea608bb77c194556b7a5b3052a10e05e", "prediction_text": "XK"}, "reference": {"id": "ea608bb77c194556b7a5b3052a10e05e", "answers": {"answer_start": [282], "text": ["XK"]}}}, "e1e3d1dad7e649fc9e20afc802ea1c4d": {"prediction": {"id": "e1e3d1dad7e649fc9e20afc802ea1c4d", "prediction_text": "XK"}, "reference": {"id": "e1e3d1dad7e649fc9e20afc802ea1c4d", "answers": {"answer_start": [1150], "text": ["XK"]}}}, "792f8126c9754d9185004891d9b604db": {"prediction": {"id": "792f8126c9754d9185004891d9b604db", "prediction_text": "XK"}, "reference": {"id": "792f8126c9754d9185004891d9b604db", "answers": {"answer_start": [570], "text": ["XK"]}}}, "0ff734ecf0ea42d990bbfc581b1722e6": {"prediction": {"id": "0ff734ecf0ea42d990bbfc581b1722e6", "prediction_text": "XK"}, "reference": {"id": "0ff734ecf0ea42d990bbfc581b1722e6", "answers": {"answer_start": [291], "text": ["XK"]}}}, "477e096a10f447c8a571f5ade198a6aa": {"prediction": {"id": "477e096a10f447c8a571f5ade198a6aa", "prediction_text": "chorea"}, "reference": {"id": "477e096a10f447c8a571f5ade198a6aa", "answers": {"answer_start": [424], "text": ["XK"]}}}, "015df79c29fb428aa48109ed5e9b3692": {"prediction": {"id": "015df79c29fb428aa48109ed5e9b3692", "prediction_text": "XK"}, "reference": {"id": "015df79c29fb428aa48109ed5e9b3692", "answers": {"answer_start": [490], "text": ["XK"]}}}, "7c06dd0a873d4fe981eb21c49085b377": {"prediction": {"id": "7c06dd0a873d4fe981eb21c49085b377", "prediction_text": "MLS"}, "reference": {"id": "7c06dd0a873d4fe981eb21c49085b377", "answers": {"answer_start": [715], "text": ["XK"]}}}, "cec729fde7fc4e30b1204620ae6db377": {"prediction": {"id": "cec729fde7fc4e30b1204620ae6db377", "prediction_text": "XK"}, "reference": {"id": "cec729fde7fc4e30b1204620ae6db377", "answers": {"answer_start": [372], "text": ["XK"]}}}, "9e2a2f8ad4534fc6b91a0315849943bb": {"prediction": {"id": "9e2a2f8ad4534fc6b91a0315849943bb", "prediction_text": "XK"}, "reference": {"id": "9e2a2f8ad4534fc6b91a0315849943bb", "answers": {"answer_start": [330], "text": ["XK"]}}}, "d474c57cdf5f41cc9062afc8454f8488": {"prediction": {"id": "d474c57cdf5f41cc9062afc8454f8488", "prediction_text": "XK"}, "reference": {"id": "d474c57cdf5f41cc9062afc8454f8488", "answers": {"answer_start": [372], "text": ["XK"]}}}, "2900fbdf85d74b85aa74f7aa29dbf348": {"prediction": {"id": "2900fbdf85d74b85aa74f7aa29dbf348", "prediction_text": "MLS"}, "reference": {"id": "2900fbdf85d74b85aa74f7aa29dbf348", "answers": {"answer_start": [1112], "text": ["XK"]}}}, "451938e514774e33b258a369061515db": {"prediction": {"id": "451938e514774e33b258a369061515db", "prediction_text": "XK"}, "reference": {"id": "451938e514774e33b258a369061515db", "answers": {"answer_start": [443], "text": ["XK"]}}}, "0032700161c946ac912d6f83523194ac": {"prediction": {"id": "0032700161c946ac912d6f83523194ac", "prediction_text": "XK"}, "reference": {"id": "0032700161c946ac912d6f83523194ac", "answers": {"answer_start": [355], "text": ["XK"]}}}, "3aa33c9d13b94988b6cc6808c9087cce": {"prediction": {"id": "3aa33c9d13b94988b6cc6808c9087cce", "prediction_text": "McLeod blood group"}, "reference": {"id": "3aa33c9d13b94988b6cc6808c9087cce", "answers": {"answer_start": [359], "text": ["XK"]}}}, "856bcb1063bc4b4f94b69d9b4cf2e49c": {"prediction": {"id": "856bcb1063bc4b4f94b69d9b4cf2e49c", "prediction_text": "Kell antigen"}, "reference": {"id": "856bcb1063bc4b4f94b69d9b4cf2e49c", "answers": {"answer_start": [276], "text": ["XK"]}}}, "44f71134d7a749bfa28cd73fcc94a372": {"prediction": {"id": "44f71134d7a749bfa28cd73fcc94a372", "prediction_text": "XK"}, "reference": {"id": "44f71134d7a749bfa28cd73fcc94a372", "answers": {"answer_start": [169], "text": ["XK"]}}}, "4cef075e05524870a4acdd8f8fe151f9": {"prediction": {"id": "4cef075e05524870a4acdd8f8fe151f9", "prediction_text": "NADPH oxidase"}, "reference": {"id": "4cef075e05524870a4acdd8f8fe151f9", "answers": {"answer_start": [1155], "text": ["XK"]}}}, "12cfecaa86884f999aca5af6c4b21339": {"prediction": {"id": "12cfecaa86884f999aca5af6c4b21339", "prediction_text": "XK"}, "reference": {"id": "12cfecaa86884f999aca5af6c4b21339", "answers": {"answer_start": [92], "text": ["XK"]}}}, "d29e3073b3064ccdad873d1e3c692b1d": {"prediction": {"id": "d29e3073b3064ccdad873d1e3c692b1d", "prediction_text": "XK"}, "reference": {"id": "d29e3073b3064ccdad873d1e3c692b1d", "answers": {"answer_start": [574], "text": ["XK"]}}}, "9932bc0f45034598a6cccc72b17082d1": {"prediction": {"id": "9932bc0f45034598a6cccc72b17082d1", "prediction_text": "E327K missense"}, "reference": {"id": "9932bc0f45034598a6cccc72b17082d1", "answers": {"answer_start": [1160], "text": ["XK"]}}}, "ef16411a5b5f4cf1b72712055ac84892": {"prediction": {"id": "ef16411a5b5f4cf1b72712055ac84892", "prediction_text": "XK"}, "reference": {"id": "ef16411a5b5f4cf1b72712055ac84892", "answers": {"answer_start": [366], "text": ["XK"]}}}, "6d5d3626c5c44a6e891b200a3b21add6": {"prediction": {"id": "6d5d3626c5c44a6e891b200a3b21add6", "prediction_text": "XK"}, "reference": {"id": "6d5d3626c5c44a6e891b200a3b21add6", "answers": {"answer_start": [34], "text": ["XK"]}}}, "f2a50e4de7844a4bbcfbc235ce4b3df3": {"prediction": {"id": "f2a50e4de7844a4bbcfbc235ce4b3df3", "prediction_text": "XK"}, "reference": {"id": "f2a50e4de7844a4bbcfbc235ce4b3df3", "answers": {"answer_start": [372], "text": ["XK"]}}}, "e46314961ed647ee9228805a6fe0f6dc": {"prediction": {"id": "e46314961ed647ee9228805a6fe0f6dc", "prediction_text": "CGD"}, "reference": {"id": "e46314961ed647ee9228805a6fe0f6dc", "answers": {"answer_start": [1154], "text": ["XK"]}}}, "43c54e7427744faba7d2301ca40ec52a": {"prediction": {"id": "43c54e7427744faba7d2301ca40ec52a", "prediction_text": "XK"}, "reference": {"id": "43c54e7427744faba7d2301ca40ec52a", "answers": {"answer_start": [1068], "text": ["XK"]}}}, "0e4492b541054d24b341213bbb04d3ab": {"prediction": {"id": "0e4492b541054d24b341213bbb04d3ab", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "0e4492b541054d24b341213bbb04d3ab", "answers": {"answer_start": [94, 551], "text": ["Alzheimer's Disease", "AD"]}}}, "a8f9e8ce26fa4fc78b3b9e1c5e2ee37e": {"prediction": {"id": "a8f9e8ce26fa4fc78b3b9e1c5e2ee37e", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "a8f9e8ce26fa4fc78b3b9e1c5e2ee37e", "answers": {"answer_start": [140], "text": ["Alzheimer's Disease"]}}}, "3cd5557547d547fa840ba1af111f8e6b": {"prediction": {"id": "3cd5557547d547fa840ba1af111f8e6b", "prediction_text": "Alzheimer's"}, "reference": {"id": "3cd5557547d547fa840ba1af111f8e6b", "answers": {"answer_start": [0, 21], "text": ["Alzheimer's Disease", "AD"]}}}, "24106fdd6cf8415eb1ff5314a74bd070": {"prediction": {"id": "24106fdd6cf8415eb1ff5314a74bd070", "prediction_text": "Alzheimer's"}, "reference": {"id": "24106fdd6cf8415eb1ff5314a74bd070", "answers": {"answer_start": [786, 428], "text": ["Alzheimer's Disease", "AD"]}}}, "de0238a3228d40dd8300f127c48efdbc": {"prediction": {"id": "de0238a3228d40dd8300f127c48efdbc", "prediction_text": "transgenic APP/V717I"}, "reference": {"id": "de0238a3228d40dd8300f127c48efdbc", "answers": {"answer_start": [1582], "text": ["Alzheimer's Disease"]}}}, "f29150b2b3164a29a04d56439a87e3a3": {"prediction": {"id": "f29150b2b3164a29a04d56439a87e3a3", "prediction_text": "Alzheimer's"}, "reference": {"id": "f29150b2b3164a29a04d56439a87e3a3", "answers": {"answer_start": [0, 1472], "text": ["Alzheimer's Disease", "AD"]}}}, "baf03c277f5f488eb68946a4065c0960": {"prediction": {"id": "baf03c277f5f488eb68946a4065c0960", "prediction_text": "double Swedish"}, "reference": {"id": "baf03c277f5f488eb68946a4065c0960", "answers": {"answer_start": [115, 1066], "text": ["Alzheimer's Disease", "AD"]}}}, "80238a0b357c480ba66cc1424fae8434": {"prediction": {"id": "80238a0b357c480ba66cc1424fae8434", "prediction_text": "amyloid precursor protein"}, "reference": {"id": "80238a0b357c480ba66cc1424fae8434", "answers": {"answer_start": [1060], "text": ["Alzheimer's Disease"]}}}, "222de23b3592419d9cc1d686dbfa08fa": {"prediction": {"id": "222de23b3592419d9cc1d686dbfa08fa", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "222de23b3592419d9cc1d686dbfa08fa", "answers": {"answer_start": [40], "text": ["Alzheimer's Disease"]}}}, "24333bfaae3148d8a82df7f62d89f2bc": {"prediction": {"id": "24333bfaae3148d8a82df7f62d89f2bc", "prediction_text": "Alzheimer's"}, "reference": {"id": "24333bfaae3148d8a82df7f62d89f2bc", "answers": {"answer_start": [454], "text": ["Alzheimer's Disease"]}}}, "f8aa09e7138a41398052a1f94246280e": {"prediction": {"id": "f8aa09e7138a41398052a1f94246280e", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "f8aa09e7138a41398052a1f94246280e", "answers": {"answer_start": [186, 875], "text": ["Alzheimer's Disease", "AD"]}}}, "f55f3242699f44189d7ff38c5ed34f0c": {"prediction": {"id": "f55f3242699f44189d7ff38c5ed34f0c", "prediction_text": "Alzheimer's disease (AD) exhibits robust brain and spinal cord axonal degeneration and hippocampal CA1 neuron loss starting at 6 months of age. It expresses human mutant APP751"}, "reference": {"id": "f55f3242699f44189d7ff38c5ed34f0c", "answers": {"answer_start": [30, 51], "text": ["Alzheimer's Disease", "AD"]}}}, "ebe69f0ae28c4231a4664664d4e4bca6": {"prediction": {"id": "ebe69f0ae28c4231a4664664d4e4bca6", "prediction_text": "APP/Lo mice"}, "reference": {"id": "ebe69f0ae28c4231a4664664d4e4bca6", "answers": {"answer_start": [22, 43], "text": ["Alzheimer's Disease", "AD"]}}}, "2c6c5d45d57d4814b00841145a44298c": {"prediction": {"id": "2c6c5d45d57d4814b00841145a44298c", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "2c6c5d45d57d4814b00841145a44298c", "answers": {"answer_start": [110, 672], "text": ["Alzheimer's Disease", "AD"]}}}, "4b6ed8483a10416ba5903ecf1f7e35e8": {"prediction": {"id": "4b6ed8483a10416ba5903ecf1f7e35e8", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "4b6ed8483a10416ba5903ecf1f7e35e8", "answers": {"answer_start": [138, 1914], "text": ["Alzheimer's Disease", "AD"]}}}, "58c85fbf32554614ae709181b08b708a": {"prediction": {"id": "58c85fbf32554614ae709181b08b708a", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "58c85fbf32554614ae709181b08b708a", "answers": {"answer_start": [43], "text": ["Alzheimer's Disease"]}}}, "ad8f428117f34471990bc95766c4478d": {"prediction": {"id": "ad8f428117f34471990bc95766c4478d", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "ad8f428117f34471990bc95766c4478d", "answers": {"answer_start": [1763], "text": ["Alzheimer's Disease"]}}}, "67245c5b365b4f0b8840c841a2a4bc55": {"prediction": {"id": "67245c5b365b4f0b8840c841a2a4bc55", "prediction_text": "APPSwe/Lon"}, "reference": {"id": "67245c5b365b4f0b8840c841a2a4bc55", "answers": {"answer_start": [68], "text": ["Alzheimer's Disease"]}}}, "cb15fff6c85d4e788b6a90381904d903": {"prediction": {"id": "cb15fff6c85d4e788b6a90381904d903", "prediction_text": "JAMM"}, "reference": {"id": "cb15fff6c85d4e788b6a90381904d903", "answers": {"answer_start": [829], "text": ["JAMM"]}}}, "ce1c4b10ac554c79a6110085e099bc94": {"prediction": {"id": "ce1c4b10ac554c79a6110085e099bc94", "prediction_text": "stationary-phase"}, "reference": {"id": "ce1c4b10ac554c79a6110085e099bc94", "answers": {"answer_start": [746], "text": ["stationary phase"]}}}, "aec879a561154f029968f10e6de2d4b2": {"prediction": {"id": "aec879a561154f029968f10e6de2d4b2", "prediction_text": "stationary phase"}, "reference": {"id": "aec879a561154f029968f10e6de2d4b2", "answers": {"answer_start": [10], "text": ["stationary phase"]}}}, "00888af57c3d465eb80b2dc1d1cf2915": {"prediction": {"id": "00888af57c3d465eb80b2dc1d1cf2915", "prediction_text": "stationary-phase"}, "reference": {"id": "00888af57c3d465eb80b2dc1d1cf2915", "answers": {"answer_start": [1044], "text": ["stationary phase"]}}}, "1e0533779b87452293892edff4be7972": {"prediction": {"id": "1e0533779b87452293892edff4be7972", "prediction_text": "stationary-phase"}, "reference": {"id": "1e0533779b87452293892edff4be7972", "answers": {"answer_start": [200], "text": ["stationary phase"]}}}, "4e91781f3b554f97bcfd129e3c9a617e": {"prediction": {"id": "4e91781f3b554f97bcfd129e3c9a617e", "prediction_text": "nestin"}, "reference": {"id": "4e91781f3b554f97bcfd129e3c9a617e", "answers": {"answer_start": [394], "text": ["Nestin"]}}}, "1018c091739e45c49591c2e2d0eb878b": {"prediction": {"id": "1018c091739e45c49591c2e2d0eb878b", "prediction_text": "Bcl-2"}, "reference": {"id": "1018c091739e45c49591c2e2d0eb878b", "answers": {"answer_start": [456], "text": ["Nestin"]}}}, "6849a740eb924e0fb4eb4213f7373e40": {"prediction": {"id": "6849a740eb924e0fb4eb4213f7373e40", "prediction_text": "SVZ"}, "reference": {"id": "6849a740eb924e0fb4eb4213f7373e40", "answers": {"answer_start": [618], "text": ["Nestin"]}}}, "864c73da7d82477ba0ca1560ba9d5a61": {"prediction": {"id": "864c73da7d82477ba0ca1560ba9d5a61", "prediction_text": "SVZ"}, "reference": {"id": "864c73da7d82477ba0ca1560ba9d5a61", "answers": {"answer_start": [992], "text": ["Nestin"]}}}, "726edef975994ffa8543d3173ac543b3": {"prediction": {"id": "726edef975994ffa8543d3173ac543b3", "prediction_text": "Nestin"}, "reference": {"id": "726edef975994ffa8543d3173ac543b3", "answers": {"answer_start": [0], "text": ["Nestin"]}}}, "ea358d1ff100462e88d78f7428585ac1": {"prediction": {"id": "ea358d1ff100462e88d78f7428585ac1", "prediction_text": "VZ/SVZ"}, "reference": {"id": "ea358d1ff100462e88d78f7428585ac1", "answers": {"answer_start": [596], "text": ["Nestin"]}}}, "c82e194759a6480da5682c046acc1ad0": {"prediction": {"id": "c82e194759a6480da5682c046acc1ad0", "prediction_text": "Nestin"}, "reference": {"id": "c82e194759a6480da5682c046acc1ad0", "answers": {"answer_start": [0], "text": ["Nestin"]}}}, "5d14a7a4c1ba4851b572f216604c213c": {"prediction": {"id": "5d14a7a4c1ba4851b572f216604c213c", "prediction_text": "nestin"}, "reference": {"id": "5d14a7a4c1ba4851b572f216604c213c", "answers": {"answer_start": [261], "text": ["Nestin"]}}}, "30b9e57304dd4bef8c1e50051d7af158": {"prediction": {"id": "30b9e57304dd4bef8c1e50051d7af158", "prediction_text": "SVZ"}, "reference": {"id": "30b9e57304dd4bef8c1e50051d7af158", "answers": {"answer_start": [640], "text": ["Nestin"]}}}, "1c7d97118c98434cb82da704eb8e8a70": {"prediction": {"id": "1c7d97118c98434cb82da704eb8e8a70", "prediction_text": "neocortex"}, "reference": {"id": "1c7d97118c98434cb82da704eb8e8a70", "answers": {"answer_start": [647], "text": ["Nestin"]}}}, "9f6fe5a94f044b3c81eb6bdd4116f365": {"prediction": {"id": "9f6fe5a94f044b3c81eb6bdd4116f365", "prediction_text": "glial fibrillary acidic protein, neuron-specific Class III beta-tubulin"}, "reference": {"id": "9f6fe5a94f044b3c81eb6bdd4116f365", "answers": {"answer_start": [994], "text": ["Nestin"]}}}, "3f9b1f06a026400bb35faf566e68b78c": {"prediction": {"id": "3f9b1f06a026400bb35faf566e68b78c", "prediction_text": "SGZ"}, "reference": {"id": "3f9b1f06a026400bb35faf566e68b78c", "answers": {"answer_start": [669], "text": ["Nestin"]}}}, "cf05cf9ace364432b1733cd6dd85b347": {"prediction": {"id": "cf05cf9ace364432b1733cd6dd85b347", "prediction_text": "nestin"}, "reference": {"id": "cf05cf9ace364432b1733cd6dd85b347", "answers": {"answer_start": [1078], "text": ["Nestin"]}}}, "6dea8481b9c740b9be2a59aa707a7bc3": {"prediction": {"id": "6dea8481b9c740b9be2a59aa707a7bc3", "prediction_text": "nestin"}, "reference": {"id": "6dea8481b9c740b9be2a59aa707a7bc3", "answers": {"answer_start": [624], "text": ["Nestin"]}}}, "27b37cc85e08422c9dd07f42fa2773da": {"prediction": {"id": "27b37cc85e08422c9dd07f42fa2773da", "prediction_text": "Cu/Zn superoxide dismutase"}, "reference": {"id": "27b37cc85e08422c9dd07f42fa2773da", "answers": {"answer_start": [818], "text": ["Nestin"]}}}, "1798433241954b459138691c01bfadd0": {"prediction": {"id": "1798433241954b459138691c01bfadd0", "prediction_text": "equimolar dose"}, "reference": {"id": "1798433241954b459138691c01bfadd0", "answers": {"answer_start": [746], "text": ["dabigatran"]}}}, "d7ba317125bc423abf35f046088005d1": {"prediction": {"id": "d7ba317125bc423abf35f046088005d1", "prediction_text": "anticoagulants"}, "reference": {"id": "d7ba317125bc423abf35f046088005d1", "answers": {"answer_start": [30], "text": ["dabigatran"]}}}, "8ae55c73595c4d18b01cb2de9d5d5a27": {"prediction": {"id": "8ae55c73595c4d18b01cb2de9d5d5a27", "prediction_text": "antibody fragment"}, "reference": {"id": "8ae55c73595c4d18b01cb2de9d5d5a27", "answers": {"answer_start": [1870], "text": ["dabigatran"]}}}, "a40bbf385ca44ca99a4137c763b65817": {"prediction": {"id": "a40bbf385ca44ca99a4137c763b65817", "prediction_text": "dabigatran"}, "reference": {"id": "a40bbf385ca44ca99a4137c763b65817", "answers": {"answer_start": [1357], "text": ["dabigatran"]}}}, "37d51d0e253c44c0ab63d14d9192fedd": {"prediction": {"id": "37d51d0e253c44c0ab63d14d9192fedd", "prediction_text": "Pse-in-One"}, "reference": {"id": "37d51d0e253c44c0ab63d14d9192fedd", "answers": {"answer_start": [847], "text": ["Pse-in-One"]}}}, "594744bba27640a39cce0f9ab8795084": {"prediction": {"id": "594744bba27640a39cce0f9ab8795084", "prediction_text": "osteoblast biology. Sclerostin is a soluble antagonist of Wnt/\u03b2-catenin signaling secreted primarily by osteocytes. Current evidence indicates that sclerostin likely functions as a local/paracrine regulator of bone metabolism"}, "reference": {"id": "594744bba27640a39cce0f9ab8795084", "answers": {"answer_start": [273], "text": ["bone metabolism"]}}}, "615c51c1e67848e09e8ba316106ba67a": {"prediction": {"id": "615c51c1e67848e09e8ba316106ba67a", "prediction_text": "vascular calcification"}, "reference": {"id": "615c51c1e67848e09e8ba316106ba67a", "answers": {"answer_start": [64], "text": ["bone metabolism"]}}}, "deeb2d58cbff4eff873fc8e2376ef576": {"prediction": {"id": "deeb2d58cbff4eff873fc8e2376ef576", "prediction_text": "Wnt signaling pathway"}, "reference": {"id": "deeb2d58cbff4eff873fc8e2376ef576", "answers": {"answer_start": [17], "text": ["bone metabolism"]}}}, "58a2db89013148da8643ffb135842244": {"prediction": {"id": "58a2db89013148da8643ffb135842244", "prediction_text": "bone formation. To gain insights into the mechanism of action of sclerostin, we examined the interactions of sclerostin with bone proteins using a sclerostin affinity capture technique. Proteins from decalcified rat bone were captured on a sclerostin-maltose binding protein (MBP) amylose column, or on a MBP amylose column. The columns were extensively washed with low ionic strength buffer, and bound proteins were eluted with buffer containing 1M sodium chloride. Eluted proteins were separated by denaturing sodium-dodecyl sulfate gel electrophoresis and were identified by mass spectrometry. Several previously unidentified full-length sclerostin-interacting proteins such as alkaline phosphatase, carbonic anhydrase, gremlin-1, fetuin A, midkine, annexin A1 and A2, and collagen \u03b11, which have established roles in bone formation or resorption processes, were bound to the sclerostin-MBP amylose resin but not to the MBP amylose resin. Other full-length sclerostin-interacting proteins such as casein kinase II and secreted frizzled related protein 4 that modulate Wnt signaling were identified. Several peptides derived from proteins such as Phex, asporin and follistatin that regulate bone metabolism also bound sclerostin. Sclerostin interacts with multiple proteins that alter bone formation and resorption"}, "reference": {"id": "58a2db89013148da8643ffb135842244", "answers": {"answer_start": [1238], "text": ["bone metabolism"]}}}, "40a2566f045841ff894c9b31feb211c3": {"prediction": {"id": "40a2566f045841ff894c9b31feb211c3", "prediction_text": "miR-138"}, "reference": {"id": "40a2566f045841ff894c9b31feb211c3", "answers": {"answer_start": [1329], "text": ["mir-138"]}}}, "0dfc9b49f9494e4785db273cb6da9b3e": {"prediction": {"id": "0dfc9b49f9494e4785db273cb6da9b3e", "prediction_text": "MicroRNAs"}, "reference": {"id": "0dfc9b49f9494e4785db273cb6da9b3e", "answers": {"answer_start": [1199], "text": ["mir-138"]}}}, "21618e75744645feb0ffd89dbe895351": {"prediction": {"id": "21618e75744645feb0ffd89dbe895351", "prediction_text": "CDR1as"}, "reference": {"id": "21618e75744645feb0ffd89dbe895351", "answers": {"answer_start": [284], "text": ["mir-138"]}}}, "d48553ac3bdb4ca3a7f28c1f1865bd0b": {"prediction": {"id": "d48553ac3bdb4ca3a7f28c1f1865bd0b", "prediction_text": "Naloxone hydrochloride"}, "reference": {"id": "d48553ac3bdb4ca3a7f28c1f1865bd0b", "answers": {"answer_start": [480], "text": ["naloxone"]}}}, "53c77969fbb14dbfbab9a6d3158ec8f6": {"prediction": {"id": "53c77969fbb14dbfbab9a6d3158ec8f6", "prediction_text": "out-of-hospital"}, "reference": {"id": "53c77969fbb14dbfbab9a6d3158ec8f6", "answers": {"answer_start": [1204], "text": ["naloxone"]}}}, "7f24dfee02564182ad1102825cf79b36": {"prediction": {"id": "7f24dfee02564182ad1102825cf79b36", "prediction_text": "naloxone"}, "reference": {"id": "7f24dfee02564182ad1102825cf79b36", "answers": {"answer_start": [125], "text": ["naloxone"]}}}, "fb4a86046b9840f5aabb71a81cdcf87c": {"prediction": {"id": "fb4a86046b9840f5aabb71a81cdcf87c", "prediction_text": "naloxone"}, "reference": {"id": "fb4a86046b9840f5aabb71a81cdcf87c", "answers": {"answer_start": [332], "text": ["naloxone"]}}}, "6239b073c8dc4af4a0abf1ef8ca491b5": {"prediction": {"id": "6239b073c8dc4af4a0abf1ef8ca491b5", "prediction_text": "dextromethorphan"}, "reference": {"id": "6239b073c8dc4af4a0abf1ef8ca491b5", "answers": {"answer_start": [2918], "text": ["naloxone"]}}}, "7e22c8bdf1424ab5a0f0958724d1e454": {"prediction": {"id": "7e22c8bdf1424ab5a0f0958724d1e454", "prediction_text": "naloxone"}, "reference": {"id": "7e22c8bdf1424ab5a0f0958724d1e454", "answers": {"answer_start": [103], "text": ["naloxone"]}}}, "d055af1e5ded46fdbc72e0ca373a54fd": {"prediction": {"id": "d055af1e5ded46fdbc72e0ca373a54fd", "prediction_text": "UTR RNA"}, "reference": {"id": "d055af1e5ded46fdbc72e0ca373a54fd", "answers": {"answer_start": [241], "text": ["SECIS"]}}}, "a59436a6fc054e988ece1fe2df53d2d5": {"prediction": {"id": "a59436a6fc054e988ece1fe2df53d2d5", "prediction_text": "Sec insertion sequence"}, "reference": {"id": "a59436a6fc054e988ece1fe2df53d2d5", "answers": {"answer_start": [771], "text": ["SECIS"]}}}, "63e02df9d6fb44c19e2dc6739b101d33": {"prediction": {"id": "63e02df9d6fb44c19e2dc6739b101d33", "prediction_text": "UTR"}, "reference": {"id": "63e02df9d6fb44c19e2dc6739b101d33", "answers": {"answer_start": [0], "text": ["SECIS"]}}}, "b414bedd880844499d713dfc0230777e": {"prediction": {"id": "b414bedd880844499d713dfc0230777e", "prediction_text": "Sec insertion sequence"}, "reference": {"id": "b414bedd880844499d713dfc0230777e", "answers": {"answer_start": [1154], "text": ["SECIS"]}}}, "f69b48430be44c0abad80afb59df6485": {"prediction": {"id": "f69b48430be44c0abad80afb59df6485", "prediction_text": "selenocysteine insertion sequence"}, "reference": {"id": "f69b48430be44c0abad80afb59df6485", "answers": {"answer_start": [960], "text": ["SECIS"]}}}, "b9ef60f08bf9434bac3c367379b25519": {"prediction": {"id": "b9ef60f08bf9434bac3c367379b25519", "prediction_text": "selenoprotein P mRNA"}, "reference": {"id": "b9ef60f08bf9434bac3c367379b25519", "answers": {"answer_start": [464], "text": ["SECIS"]}}}, "96f18a2179c144d39f9d77e9f070010b": {"prediction": {"id": "96f18a2179c144d39f9d77e9f070010b", "prediction_text": "selenocysteine insertion sequence"}, "reference": {"id": "96f18a2179c144d39f9d77e9f070010b", "answers": {"answer_start": [950], "text": ["SECIS"]}}}, "b9b4ad263429466c9dc9e7f76ec6648f": {"prediction": {"id": "b9b4ad263429466c9dc9e7f76ec6648f", "prediction_text": "Sec insertion sequence"}, "reference": {"id": "b9b4ad263429466c9dc9e7f76ec6648f", "answers": {"answer_start": [439], "text": ["SECIS"]}}}, "eb8aaa2e04ae4af6af74239e4ff4e200": {"prediction": {"id": "eb8aaa2e04ae4af6af74239e4ff4e200", "prediction_text": "Sec insertion sequence element"}, "reference": {"id": "eb8aaa2e04ae4af6af74239e4ff4e200", "answers": {"answer_start": [957], "text": ["SECIS"]}}}, "aaac58cf383048abb5236d60dd131fe6": {"prediction": {"id": "aaac58cf383048abb5236d60dd131fe6", "prediction_text": "UGA codon"}, "reference": {"id": "aaac58cf383048abb5236d60dd131fe6", "answers": {"answer_start": [763], "text": ["SECIS"]}}}, "7b87902d97a443eb9a8f9f857c7051fe": {"prediction": {"id": "7b87902d97a443eb9a8f9f857c7051fe", "prediction_text": "conserved nucleotides"}, "reference": {"id": "7b87902d97a443eb9a8f9f857c7051fe", "answers": {"answer_start": [702], "text": ["SECIS"]}}}, "f656287eaff0486590dc88c706dce838": {"prediction": {"id": "f656287eaff0486590dc88c706dce838", "prediction_text": "selenocysteine"}, "reference": {"id": "f656287eaff0486590dc88c706dce838", "answers": {"answer_start": [1184], "text": ["SECIS"]}}}, "0baa923adcc8403189239fe0b75203d2": {"prediction": {"id": "0baa923adcc8403189239fe0b75203d2", "prediction_text": "SElenoCysteine Insertion Sequence"}, "reference": {"id": "0baa923adcc8403189239fe0b75203d2", "answers": {"answer_start": [997], "text": ["SECIS"]}}}, "0f911806427246be8d32468068528fed": {"prediction": {"id": "0f911806427246be8d32468068528fed", "prediction_text": "selenocysteine insertion sequence"}, "reference": {"id": "0f911806427246be8d32468068528fed", "answers": {"answer_start": [754], "text": ["SECIS"]}}}, "e07b6d3be1ea40cdb009ae58d71954d0": {"prediction": {"id": "e07b6d3be1ea40cdb009ae58d71954d0", "prediction_text": "SECIS"}, "reference": {"id": "e07b6d3be1ea40cdb009ae58d71954d0", "answers": {"answer_start": [749], "text": ["SECIS"]}}}, "ffd2d59bf65d4dfc97e87fce21a2cb0d": {"prediction": {"id": "ffd2d59bf65d4dfc97e87fce21a2cb0d", "prediction_text": "selenocysteine insertion sequence (SECIS"}, "reference": {"id": "ffd2d59bf65d4dfc97e87fce21a2cb0d", "answers": {"answer_start": [430], "text": ["SECIS"]}}}, "42a257629dc6430595fcf2fee648cab3": {"prediction": {"id": "42a257629dc6430595fcf2fee648cab3", "prediction_text": "SEC incorporation sequence (SECIS)"}, "reference": {"id": "42a257629dc6430595fcf2fee648cab3", "answers": {"answer_start": [862], "text": ["SECIS"]}}}, "9c2a24cdf20f43ad9fdf90093784722b": {"prediction": {"id": "9c2a24cdf20f43ad9fdf90093784722b", "prediction_text": "SECIS"}, "reference": {"id": "9c2a24cdf20f43ad9fdf90093784722b", "answers": {"answer_start": [353], "text": ["SECIS"]}}}, "1cce65fcd71d4c85bf42727e0fc382ca": {"prediction": {"id": "1cce65fcd71d4c85bf42727e0fc382ca", "prediction_text": "UTRs) of eukaryotic selenoprotein mRNAs that are required for directing cotranslational selenocysteine incorporation at UGA codons. In prokaryotes, stem-loops mediating selenocysteine incorporation are located immediately downstream of the UGA selenocysteine codon, in the coding region. Previous characterization studies of the mammalian SECIS elements of type 1 deiodinase, glutathione peroxidase, and selenoprotein P showed that conserved nucleotides in the loops and unpaired bulges, and base pairing in the stems are required for SECIS function. These initial studies utilized approximately 175-230-nt segments of the 3'UTRs of the selenoprotein mRNAs. Here we define the minimal functional rat type 1 deiodinase SECIS element"}, "reference": {"id": "1cce65fcd71d4c85bf42727e0fc382ca", "answers": {"answer_start": [0], "text": ["SECIS"]}}}, "cc5edcc79984422593b1f0efadf2ff45": {"prediction": {"id": "cc5edcc79984422593b1f0efadf2ff45", "prediction_text": "proximal"}, "reference": {"id": "cc5edcc79984422593b1f0efadf2ff45", "answers": {"answer_start": [741], "text": ["SECIS"]}}}, "88e36d3cfb65425cab91332111831806": {"prediction": {"id": "88e36d3cfb65425cab91332111831806", "prediction_text": "Sec"}, "reference": {"id": "88e36d3cfb65425cab91332111831806", "answers": {"answer_start": [762], "text": ["SECIS"]}}}, "cae2f3be255d46d9820ef866eef5456b": {"prediction": {"id": "cae2f3be255d46d9820ef866eef5456b", "prediction_text": "SECISearch"}, "reference": {"id": "cae2f3be255d46d9820ef866eef5456b", "answers": {"answer_start": [311], "text": ["SECIS"]}}}, "6b1fc0c50e5f444ea8c1c4c217c19624": {"prediction": {"id": "6b1fc0c50e5f444ea8c1c4c217c19624", "prediction_text": "SECIS), an element lying in the 3'-untranslated region of selenoprotein mRNAs. We report a detailed experimental study of the secondary structures of the SECIS elements of three selenoprotein mRNAs, the rat and human type I iodothyronine deiodinase (5'DI) and rat glutathione peroxidase (GPx). Based on RNase and chemical probing, a new secondary structure model is established. It is characterized by a stem-loop structure, comprising two helices (I and II) separated by an internal loop, with an apical loop surmounting helix II"}, "reference": {"id": "6b1fc0c50e5f444ea8c1c4c217c19624", "answers": {"answer_start": [712], "text": ["SECIS"]}}}, "6dd1aaf3b6ce4dcdb2c214c8889934cb": {"prediction": {"id": "6dd1aaf3b6ce4dcdb2c214c8889934cb", "prediction_text": "BCR-ABL gene fusion in chronic myeloid leukemia"}, "reference": {"id": "6dd1aaf3b6ce4dcdb2c214c8889934cb", "answers": {"answer_start": [93], "text": ["The BCR/ABL gene fusion"]}}}, "9073b2eed9cd497789ce42246c57a68f": {"prediction": {"id": "9073b2eed9cd497789ce42246c57a68f", "prediction_text": "BCR/ABL gene fusion"}, "reference": {"id": "9073b2eed9cd497789ce42246c57a68f", "answers": {"answer_start": [4], "text": ["The BCR/ABL gene fusion"]}}}, "fe6bd1b59403466ea842351775fba783": {"prediction": {"id": "fe6bd1b59403466ea842351775fba783", "prediction_text": "ABL gene on chromosome 9 and the BCL"}, "reference": {"id": "fe6bd1b59403466ea842351775fba783", "answers": {"answer_start": [1444], "text": ["The BCR/ABL gene fusion"]}}}, "12ccbc08897a4a488450e073b533777c": {"prediction": {"id": "12ccbc08897a4a488450e073b533777c", "prediction_text": "BCR-ABL"}, "reference": {"id": "12ccbc08897a4a488450e073b533777c", "answers": {"answer_start": [1388], "text": ["ABL/BCR fusion"]}}}, "5030ce1ddf424ba9821f6d2992ddd636": {"prediction": {"id": "5030ce1ddf424ba9821f6d2992ddd636", "prediction_text": "BCR-ABL"}, "reference": {"id": "5030ce1ddf424ba9821f6d2992ddd636", "answers": {"answer_start": [1426], "text": ["The BCR/ABL gene fusion"]}}}, "19c7d2568b334c00b4f9012fd0adf8ac": {"prediction": {"id": "19c7d2568b334c00b4f9012fd0adf8ac", "prediction_text": "BCR-ABL"}, "reference": {"id": "19c7d2568b334c00b4f9012fd0adf8ac", "answers": {"answer_start": [92], "text": ["The BCR/ABL gene fusion"]}}}, "1e4df47ee9d24ca99dc5837ad85eed58": {"prediction": {"id": "1e4df47ee9d24ca99dc5837ad85eed58", "prediction_text": "AML1-EVI1"}, "reference": {"id": "1e4df47ee9d24ca99dc5837ad85eed58", "answers": {"answer_start": [1469], "text": ["ABL/BCR fusion"]}}}, "01aaaeaee1d340d6bfdc7a82cea0cc23": {"prediction": {"id": "01aaaeaee1d340d6bfdc7a82cea0cc23", "prediction_text": "Chronic myeloid leukemia"}, "reference": {"id": "01aaaeaee1d340d6bfdc7a82cea0cc23", "answers": {"answer_start": [141], "text": ["The BCR/ABL gene fusion"]}}}, "3859f0e29ef6484b99ecf4ed9a182ab5": {"prediction": {"id": "3859f0e29ef6484b99ecf4ed9a182ab5", "prediction_text": "Shprintzen-Goldberg syndrome"}, "reference": {"id": "3859f0e29ef6484b99ecf4ed9a182ab5", "answers": {"answer_start": [144], "text": ["Craniosynostosis"]}}}, "35512421476e4fa0a524c69bab5f4afb": {"prediction": {"id": "35512421476e4fa0a524c69bab5f4afb", "prediction_text": "choanal atresia and stenosis"}, "reference": {"id": "35512421476e4fa0a524c69bab5f4afb", "answers": {"answer_start": [25], "text": ["Craniosynostosis"]}}}, "c62e06fe484241c1a01ff83bd9e2037d": {"prediction": {"id": "c62e06fe484241c1a01ff83bd9e2037d", "prediction_text": "Shprintzen-Goldberg syndrome"}, "reference": {"id": "c62e06fe484241c1a01ff83bd9e2037d", "answers": {"answer_start": [389], "text": ["Craniosynostosis"]}}}, "55ff499a2dfe4e60959ab07a99f3107a": {"prediction": {"id": "55ff499a2dfe4e60959ab07a99f3107a", "prediction_text": "Shprintzen-Goldberg syndrome"}, "reference": {"id": "55ff499a2dfe4e60959ab07a99f3107a", "answers": {"answer_start": [117], "text": ["Craniosynostosis"]}}}, "f96507ca78d647c4b54bff0ce487859b": {"prediction": {"id": "f96507ca78d647c4b54bff0ce487859b", "prediction_text": "Shprintzen-Goldberg syndrome"}, "reference": {"id": "f96507ca78d647c4b54bff0ce487859b", "answers": {"answer_start": [1356], "text": ["Craniosynostosis"]}}}, "d4d961760ec746e8b985d2ef14468a7c": {"prediction": {"id": "d4d961760ec746e8b985d2ef14468a7c", "prediction_text": "Marfan syndrome"}, "reference": {"id": "d4d961760ec746e8b985d2ef14468a7c", "answers": {"answer_start": [778], "text": ["Craniosynostosis"]}}}, "e64cce5cfde248bf8b2a70960d1cef4a": {"prediction": {"id": "e64cce5cfde248bf8b2a70960d1cef4a", "prediction_text": "Shprintzen-Goldberg syndrome"}, "reference": {"id": "e64cce5cfde248bf8b2a70960d1cef4a", "answers": {"answer_start": [55], "text": ["Craniosynostosis"]}}}, "72f377f25c024bd38451db64e638fff6": {"prediction": {"id": "72f377f25c024bd38451db64e638fff6", "prediction_text": "craniosynostosis"}, "reference": {"id": "72f377f25c024bd38451db64e638fff6", "answers": {"answer_start": [81], "text": ["Craniosynostosis"]}}}, "67fc4e4edab548a2be275ef2336fc6fe": {"prediction": {"id": "67fc4e4edab548a2be275ef2336fc6fe", "prediction_text": "RNA"}, "reference": {"id": "67fc4e4edab548a2be275ef2336fc6fe", "answers": {"answer_start": [291], "text": ["The glutamine-rich prion-related domain (PRD)"]}}}, "8819e22e66bc4eefb86e1a373f5b6c53": {"prediction": {"id": "8819e22e66bc4eefb86e1a373f5b6c53", "prediction_text": "four"}, "reference": {"id": "8819e22e66bc4eefb86e1a373f5b6c53", "answers": {"answer_start": [435], "text": ["Hepcidin contains eight cysteine residues that form four disulfide bridges"]}}}, "310ff9b7ea004065bd29097aeaff0259": {"prediction": {"id": "310ff9b7ea004065bd29097aeaff0259", "prediction_text": "alpha-synuclein"}, "reference": {"id": "310ff9b7ea004065bd29097aeaff0259", "answers": {"answer_start": [118], "text": ["alpha-Synuclein"]}}}, "303debd207a3423caeff02760395d99b": {"prediction": {"id": "303debd207a3423caeff02760395d99b", "prediction_text": "LBs"}, "reference": {"id": "303debd207a3423caeff02760395d99b", "answers": {"answer_start": [9], "text": ["alpha-Synuclein"]}}}, "78099a4d6a474b87bce88a42a9da53d5": {"prediction": {"id": "78099a4d6a474b87bce88a42a9da53d5", "prediction_text": "LB"}, "reference": {"id": "78099a4d6a474b87bce88a42a9da53d5", "answers": {"answer_start": [619], "text": ["alpha-Synuclein"]}}}, "c0e6d5b0272f4a8f89af6b9e86c2a839": {"prediction": {"id": "c0e6d5b0272f4a8f89af6b9e86c2a839", "prediction_text": "alpha-synuclein immunoreactivity"}, "reference": {"id": "c0e6d5b0272f4a8f89af6b9e86c2a839", "answers": {"answer_start": [742], "text": ["alpha-Synuclein"]}}}, "e4a38944aec44da6866adf73fcb10a0e": {"prediction": {"id": "e4a38944aec44da6866adf73fcb10a0e", "prediction_text": "LBs"}, "reference": {"id": "e4a38944aec44da6866adf73fcb10a0e", "answers": {"answer_start": [1376], "text": ["alpha-Synuclein"]}}}, "70c09425746b4c8caf271a645d0a9848": {"prediction": {"id": "70c09425746b4c8caf271a645d0a9848", "prediction_text": "LB"}, "reference": {"id": "70c09425746b4c8caf271a645d0a9848", "answers": {"answer_start": [177], "text": ["alpha-Synuclein"]}}}, "1c8b6911c6154b939f6273bfed531ce1": {"prediction": {"id": "1c8b6911c6154b939f6273bfed531ce1", "prediction_text": "alpha-Synuclein"}, "reference": {"id": "1c8b6911c6154b939f6273bfed531ce1", "answers": {"answer_start": [195], "text": ["alpha-Synuclein"]}}}, "726f3372b89b405495406510e4c44057": {"prediction": {"id": "726f3372b89b405495406510e4c44057", "prediction_text": "CLBs"}, "reference": {"id": "726f3372b89b405495406510e4c44057", "answers": {"answer_start": [785], "text": ["alpha-Synuclein"]}}}, "bd8743002acd462f90c4d7f5d2d86fa8": {"prediction": {"id": "bd8743002acd462f90c4d7f5d2d86fa8", "prediction_text": "alpha-synuclein"}, "reference": {"id": "bd8743002acd462f90c4d7f5d2d86fa8", "answers": {"answer_start": [508], "text": ["alpha-Synuclein"]}}}, "7fa31779340c4d03bd37ade339032919": {"prediction": {"id": "7fa31779340c4d03bd37ade339032919", "prediction_text": "alphaSYN protein fibrils"}, "reference": {"id": "7fa31779340c4d03bd37ade339032919", "answers": {"answer_start": [124], "text": ["alpha-Synuclein"]}}}, "3f1caf50e27d4b5bb968d78cc0acaf1d": {"prediction": {"id": "3f1caf50e27d4b5bb968d78cc0acaf1d", "prediction_text": "LBs"}, "reference": {"id": "3f1caf50e27d4b5bb968d78cc0acaf1d", "answers": {"answer_start": [1302], "text": ["alpha-Synuclein"]}}}, "70bd1547807b4a07bd6748a50bbd2692": {"prediction": {"id": "70bd1547807b4a07bd6748a50bbd2692", "prediction_text": "tau"}, "reference": {"id": "70bd1547807b4a07bd6748a50bbd2692", "answers": {"answer_start": [1661], "text": ["alpha-Synuclein"]}}}, "55ffdb5c258445db8fa39fe040fa1960": {"prediction": {"id": "55ffdb5c258445db8fa39fe040fa1960", "prediction_text": "alpha-synuclein"}, "reference": {"id": "55ffdb5c258445db8fa39fe040fa1960", "answers": {"answer_start": [1220], "text": ["alpha-Synuclein"]}}}, "66f67f2bac674be5bdda99036abdc7e7": {"prediction": {"id": "66f67f2bac674be5bdda99036abdc7e7", "prediction_text": "urethral mobility"}, "reference": {"id": "66f67f2bac674be5bdda99036abdc7e7", "answers": {"answer_start": [252], "text": ["stress urinary incontinence"]}}}, "25c86e0bd73d44b5aa2254907947e79e": {"prediction": {"id": "25c86e0bd73d44b5aa2254907947e79e", "prediction_text": "urodynamic stress urinary incontinence (SUI) were randomized into biological material TOT (PELVILACE\u00ae TO) or synthetic material TOT (ALIGN\u00aeTO Urethral Support System) groups. Preoperative"}, "reference": {"id": "25c86e0bd73d44b5aa2254907947e79e", "answers": {"answer_start": [246], "text": ["stress urinary incontinence"]}}}, "5002d9dc125e4416822d68cd91298db0": {"prediction": {"id": "5002d9dc125e4416822d68cd91298db0", "prediction_text": "clinical stress"}, "reference": {"id": "5002d9dc125e4416822d68cd91298db0", "answers": {"answer_start": [325], "text": ["stress urinary incontinence"]}}}, "2532d5cd041448afb069d4244b996baa": {"prediction": {"id": "2532d5cd041448afb069d4244b996baa", "prediction_text": "negative"}, "reference": {"id": "2532d5cd041448afb069d4244b996baa", "answers": {"answer_start": [58], "text": ["stress urinary incontinence"]}}}, "5f89e936c9a949ab9e91162aeaa87ba0": {"prediction": {"id": "5f89e936c9a949ab9e91162aeaa87ba0", "prediction_text": "stress"}, "reference": {"id": "5f89e936c9a949ab9e91162aeaa87ba0", "answers": {"answer_start": [216], "text": ["stress urinary incontinence"]}}}, "2d8b0a6036a04e2590c6e4e240b0195c": {"prediction": {"id": "2d8b0a6036a04e2590c6e4e240b0195c", "prediction_text": "SUI"}, "reference": {"id": "2d8b0a6036a04e2590c6e4e240b0195c", "answers": {"answer_start": [61], "text": ["stress urinary incontinence"]}}}, "3dfb02bf4de2444e80e0f6a2f142b3a9": {"prediction": {"id": "3dfb02bf4de2444e80e0f6a2f142b3a9", "prediction_text": "female stress"}, "reference": {"id": "3dfb02bf4de2444e80e0f6a2f142b3a9", "answers": {"answer_start": [90], "text": ["stress urinary incontinence"]}}}, "372bc925800749ce956d00fafed26c1c": {"prediction": {"id": "372bc925800749ce956d00fafed26c1c", "prediction_text": "stress"}, "reference": {"id": "372bc925800749ce956d00fafed26c1c", "answers": {"answer_start": [1490], "text": ["stress urinary incontinence"]}}}, "b5371322499548278136b4005c19c83e": {"prediction": {"id": "b5371322499548278136b4005c19c83e", "prediction_text": "MoRFs"}, "reference": {"id": "b5371322499548278136b4005c19c83e", "answers": {"answer_start": [941], "text": ["mpMoRFsDB"]}}}, "b9b5d4d380614e7bb4acd1ab3623bee0": {"prediction": {"id": "b9b5d4d380614e7bb4acd1ab3623bee0", "prediction_text": "complexity"}, "reference": {"id": "b9b5d4d380614e7bb4acd1ab3623bee0", "answers": {"answer_start": [4], "text": ["The excision of introns from nascent eukaryotic transcripts is catalyzed by the spliceosome."]}}}, "4fce1c8051874e6fbdc0f93596750c8a": {"prediction": {"id": "4fce1c8051874e6fbdc0f93596750c8a", "prediction_text": "anti-nerve growth factor"}, "reference": {"id": "4fce1c8051874e6fbdc0f93596750c8a", "answers": {"answer_start": [10], "text": ["nerve growth factor"]}}}, "d24de15b1a5f44ba91d6bb0222b5a366": {"prediction": {"id": "d24de15b1a5f44ba91d6bb0222b5a366", "prediction_text": "nerve growth factor"}, "reference": {"id": "d24de15b1a5f44ba91d6bb0222b5a366", "answers": {"answer_start": [26], "text": ["nerve growth factor"]}}}, "1fdffa36b93c47e980398dcad4ebf1ce": {"prediction": {"id": "1fdffa36b93c47e980398dcad4ebf1ce", "prediction_text": "nerve growth factor"}, "reference": {"id": "1fdffa36b93c47e980398dcad4ebf1ce", "answers": {"answer_start": [72], "text": ["nerve growth factor"]}}}, "7eeb5f9395a14e9aa19dc8d66359abd7": {"prediction": {"id": "7eeb5f9395a14e9aa19dc8d66359abd7", "prediction_text": "chronic pain"}, "reference": {"id": "7eeb5f9395a14e9aa19dc8d66359abd7", "answers": {"answer_start": [150, 171], "text": ["nerve growth factor", "NGF"]}}}, "8481b2fa61c14730833d7fdb5c5c51ff": {"prediction": {"id": "8481b2fa61c14730833d7fdb5c5c51ff", "prediction_text": "pain relief"}, "reference": {"id": "8481b2fa61c14730833d7fdb5c5c51ff", "answers": {"answer_start": [325, 346], "text": ["nerve growth factor", "NGF"]}}}, "f994b9a6e4e24fa8a2fd49c798d2987f": {"prediction": {"id": "f994b9a6e4e24fa8a2fd49c798d2987f", "prediction_text": "Nerve growth factor (NGF) is indispensable during normal embryonic development and critical for the amplification of pain signals in adults. Intervention in NGF signaling holds promise for the alleviation of pain resulting from human diseases such as osteoarthritis, cancer and chronic lower back disorders. We developed a fast, high-fidelity method to convert a hybridoma-derived NGF-targeted mouse antibody into a clinical candidate. This method, termed Library Scanning Mutagenesis (LSM), resulted in the ultra-high affinity antibody tanezumab, a first-in-class anti-hyperalgesic specific for an NGF epitope"}, "reference": {"id": "f994b9a6e4e24fa8a2fd49c798d2987f", "answers": {"answer_start": [0, 381], "text": ["nerve growth factor", "NGF"]}}}, "8062405b868c4294b5dc7dfd95c0fe91": {"prediction": {"id": "8062405b868c4294b5dc7dfd95c0fe91", "prediction_text": "Nerve growth factor"}, "reference": {"id": "8062405b868c4294b5dc7dfd95c0fe91", "answers": {"answer_start": [0, 21], "text": ["nerve growth factor", "NGF"]}}}, "6b4286f1be374c67af476f5c7b4aa2a0": {"prediction": {"id": "6b4286f1be374c67af476f5c7b4aa2a0", "prediction_text": "Trk family members"}, "reference": {"id": "6b4286f1be374c67af476f5c7b4aa2a0", "answers": {"answer_start": [145], "text": ["nerve growth factor"]}}}, "201b1786612e44429e909902204b1a96": {"prediction": {"id": "201b1786612e44429e909902204b1a96", "prediction_text": "osteoarthritis"}, "reference": {"id": "201b1786612e44429e909902204b1a96", "answers": {"answer_start": [0, 934], "text": ["nerve growth factor", "NGF"]}}}, "05f334d8361343dea97de535d3882a8a": {"prediction": {"id": "05f334d8361343dea97de535d3882a8a", "prediction_text": "well tolerated"}, "reference": {"id": "05f334d8361343dea97de535d3882a8a", "answers": {"answer_start": [83], "text": ["nerve growth factor"]}}}, "16f02839564e4b3988f660e499886ab3": {"prediction": {"id": "16f02839564e4b3988f660e499886ab3", "prediction_text": "interstitial cystitis pain"}, "reference": {"id": "16f02839564e4b3988f660e499886ab3", "answers": {"answer_start": [153], "text": ["nerve growth factor"]}}}, "628742de996641fb8611ffcf82210075": {"prediction": {"id": "628742de996641fb8611ffcf82210075", "prediction_text": "gait deficiency"}, "reference": {"id": "628742de996641fb8611ffcf82210075", "answers": {"answer_start": [38, 1214], "text": ["nerve growth factor", "NGF"]}}}, "90aa79f52dfd4841b256deef874d25a7": {"prediction": {"id": "90aa79f52dfd4841b256deef874d25a7", "prediction_text": "more effectiveness and less incidence of adverse effects"}, "reference": {"id": "90aa79f52dfd4841b256deef874d25a7", "answers": {"answer_start": [727], "text": ["nerve growth factor"]}}}, "18f7067d2f5847c5bf3d19c45c6c1bfa": {"prediction": {"id": "18f7067d2f5847c5bf3d19c45c6c1bfa", "prediction_text": "NSAIDs and opioids"}, "reference": {"id": "18f7067d2f5847c5bf3d19c45c6c1bfa", "answers": {"answer_start": [44], "text": ["NGF"]}}}, "8876172bf006459e874e580ba6ec8d46": {"prediction": {"id": "8876172bf006459e874e580ba6ec8d46", "prediction_text": "NGF pathway"}, "reference": {"id": "8876172bf006459e874e580ba6ec8d46", "answers": {"answer_start": [273, 590], "text": ["nerve growth factor", "NGF"]}}}, "dab52c1cf337472ca3643ca214c0d59a": {"prediction": {"id": "dab52c1cf337472ca3643ca214c0d59a", "prediction_text": "NGF"}, "reference": {"id": "dab52c1cf337472ca3643ca214c0d59a", "answers": {"answer_start": [390, 925], "text": ["nerve growth factor", "NGF"]}}}, "49cb019debea4c919ab5d8abece8b86d": {"prediction": {"id": "49cb019debea4c919ab5d8abece8b86d", "prediction_text": "pain"}, "reference": {"id": "49cb019debea4c919ab5d8abece8b86d", "answers": {"answer_start": [271, 422], "text": ["nerve growth factor", "NGF"]}}}, "6a24072f081746e9ac546ba65601fcdc": {"prediction": {"id": "6a24072f081746e9ac546ba65601fcdc", "prediction_text": "nerve growth factor"}, "reference": {"id": "6a24072f081746e9ac546ba65601fcdc", "answers": {"answer_start": [130], "text": ["nerve growth factor"]}}}, "9926017ca2794feb86b1421b1cfac7f1": {"prediction": {"id": "9926017ca2794feb86b1421b1cfac7f1", "prediction_text": "nerve growth factor"}, "reference": {"id": "9926017ca2794feb86b1421b1cfac7f1", "answers": {"answer_start": [43], "text": ["nerve growth factor"]}}}, "9374e49d5bf742189724ab3b1779fc77": {"prediction": {"id": "9374e49d5bf742189724ab3b1779fc77", "prediction_text": "low back pain treatment"}, "reference": {"id": "9374e49d5bf742189724ab3b1779fc77", "answers": {"answer_start": [817, 845], "text": ["nerve growth factor", "NGF"]}}}, "b8406a4d3fa54dacabd8f126088bdf7f": {"prediction": {"id": "b8406a4d3fa54dacabd8f126088bdf7f", "prediction_text": "nerve growth factor"}, "reference": {"id": "b8406a4d3fa54dacabd8f126088bdf7f", "answers": {"answer_start": [269], "text": ["nerve growth factor"]}}}, "d65405b7412247c9a2f5d24135610456": {"prediction": {"id": "d65405b7412247c9a2f5d24135610456", "prediction_text": "painful bladder"}, "reference": {"id": "d65405b7412247c9a2f5d24135610456", "answers": {"answer_start": [786, 807], "text": ["nerve growth factor", "NGF"]}}}, "93ac15d2d5574b178c86c17c58b6a07f": {"prediction": {"id": "93ac15d2d5574b178c86c17c58b6a07f", "prediction_text": "nerve growth factor"}, "reference": {"id": "93ac15d2d5574b178c86c17c58b6a07f", "answers": {"answer_start": [83], "text": ["nerve growth factor"]}}}}